{"id": "88_177_1_116", "text": "A novel domain in the protein kinase SOS2 mediates interaction with the protein phosphatase 2C ABI2.", "text_with_entity_marker": "A novel domain in the protein kinase [E1]SOS2[/E1] mediates interaction with the protein phosphatase [E2]2C ABI2[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "SOS2", "entity_1_idx": [[37, 41]], "entity_1_idx_in_text_with_entity_marker": [41, 45], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "2C ABI2", "entity_2_idx": [[92, 99]], "entity_2_idx_in_text_with_entity_marker": [105, 112], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "88_178_2_117", "text": "In this study, we identified the protein phosphatase 2C ABI2 (abscisic acid-insensitive 2) as a SOS2-interacting protein", "text_with_entity_marker": "In this study, we identified the protein phosphatase [E1]2C ABI2 (abscisic acid-insensitive 2)[/E1] as a [E2]SOS2[/E2]-interacting protein", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "2C ABI2 (abscisic acid-insensitive 2)", "entity_1_idx": [[53, 90]], "entity_1_idx_in_text_with_entity_marker": [57, 94], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "SOS2", "entity_2_idx": [[96, 100]], "entity_2_idx_in_text_with_entity_marker": [109, 113], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "18_38_8_36", "text": "Live-cell imaging analyses revealed that ORP3a is localized at the ER, and that binding to this organelle depends on a direct interaction with PVA12, a member of the largely uncharacterized VAP33 family of plant proteins", "text_with_entity_marker": "Live-cell imaging analyses revealed that ORP3a is localized at the ER, and that binding to this organelle depends on a direct interaction with [E1]PVA12[/E1][E2]ORP3a[/E2] is localized at the ER, and that binding to this organelle depends on a direct interaction with PVA12, a member of the largely uncharacterized VAP33 family of plant proteins", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "PVA12", "entity_1_idx": [[143, 148]], "entity_1_idx_in_text_with_entity_marker": [147, 152], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "ORP3a", "entity_2_idx": [[41, 46]], "entity_2_idx_in_text_with_entity_marker": [161, 166], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "327_655_1_442", "text": "Genetic analysis of CAND1-CUL1 interactions in Arabidopsis supports a role for CAND1-mediated cycling of the SCFTIR1 complex.", "text_with_entity_marker": "Genetic analysis of [E1]CAND1[/E1]-[E2]CUL1[/E2] interactions in Arabidopsis supports a role for CAND1-mediated cycling of the SCFTIR1 complex.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "CAND1", "entity_1_idx": [[20, 25]], "entity_1_idx_in_text_with_entity_marker": [24, 29], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "CUL1", "entity_2_idx": [[26, 30]], "entity_2_idx_in_text_with_entity_marker": [39, 43], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "327_656_2_443", "text": "Cullin-Associated and Neddylation-Dissociated (CAND1) modulates SCF function through its interactions with the CUL1 subunit", "text_with_entity_marker": "[E1]Cullin-Associated and Neddylation-Dissociated (CAND1)[/E1] modulates SCF function through its interactions with the [E2]CUL1[/E2] subunit", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Cullin-Associated and Neddylation-Dissociated (CAND1)", "entity_1_idx": [[0, 53]], "entity_1_idx_in_text_with_entity_marker": [4, 57], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "CUL1", "entity_2_idx": [[111, 115]], "entity_2_idx_in_text_with_entity_marker": [124, 128], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "253_507_1_336", "text": "Rab39a interacts with phosphatidylinositol 3-kinase and negatively regulates autophagy induced by lipopolysaccharide stimulation in macrophages.", "text_with_entity_marker": "[E1]Rab39a[/E1] interacts with [E2]phosphatidylinositol 3-kinase[/E2] and negatively regulates autophagy induced by lipopolysaccharide stimulation in macrophages.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Rab39a", "entity_1_idx": [[0, 6]], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "phosphatidylinositol 3-kinase", "entity_2_idx": [[22, 51]], "entity_2_idx_in_text_with_entity_marker": [35, 64], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "253_508_6_337", "text": "Immunoprecipitation analysis revealed that Rab39a interacts with PI3K and that the amino acid residues from 34(th) to 41(st) in Rab39a were indispensable for this interaction", "text_with_entity_marker": "Immunoprecipitation analysis revealed that [E1]Rab39a[/E1] interacts with [E2]PI3K[/E2] and that the amino acid residues from 34(th) to 41(st) in Rab39a were indispensable for this interaction", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Rab39a", "entity_1_idx": [[43, 49]], "entity_1_idx_in_text_with_entity_marker": [47, 53], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "PI3K", "entity_2_idx": [[65, 69]], "entity_2_idx_in_text_with_entity_marker": [78, 82], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "23_47_1_44", "text": "The sporulation protein SirA inhibits the binding of DnaA to the origin of replication by contacting a patch of clustered amino acids.", "text_with_entity_marker": "The sporulation protein [E1]SirA[/E1] inhibits the binding of [E2]DnaA[/E2] to the origin of replication by contacting a patch of clustered amino acids.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "SirA", "entity_1_idx": [[24, 28]], "entity_1_idx_in_text_with_entity_marker": [28, 32], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "DnaA", "entity_2_idx": [[53, 57]], "entity_2_idx_in_text_with_entity_marker": [66, 70], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "23_48_2_45", "text": "SirA is a recently discovered regulator of DnaA in Bacillus subtilis whose synthesis is turned on at the start of sporulation", "text_with_entity_marker": "[E1]SirA[/E1] is a recently discovered regulator of [E2]DnaA[/E2] in Bacillus subtilis whose synthesis is turned on at the start of sporulation", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "SirA", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "DnaA", "entity_2_idx": [[43, 47]], "entity_2_idx_in_text_with_entity_marker": [56, 60], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "94_189_1_121", "text": "A possible interaction of thioredoxin with VDUP1 in HeLa cells detected in a yeast two-hybrid system.", "text_with_entity_marker": "A possible interaction of [E1]thioredoxin[/E1] with [E2]VDUP1[/E2] in HeLa cells detected in a yeast two-hybrid system.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "thioredoxin", "entity_1_idx": [[26, 37]], "entity_1_idx_in_text_with_entity_marker": [30, 41], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "VDUP1", "entity_2_idx": [[43, 48]], "entity_2_idx_in_text_with_entity_marker": [56, 61], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "11_24_1_22", "text": "Axin interactor, dorsalization-associated (Aida) was identified as a regulatory factor that utilizes its C-terminal region to interact with axis formation inhibitor (Axin)", "text_with_entity_marker": "Axin interactor, dorsalization-associated ([E1]Aida[/E1][E2]Axin[/E2] interactor, dorsalization-associated (Aida) was identified as a regulatory factor that utilizes its C-terminal region to interact with axis formation inhibitor (Axin)", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Aida", "entity_1_idx": [[43, 47]], "entity_1_idx_in_text_with_entity_marker": [47, 51], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "Axin", "entity_2_idx": [[0, 4]], "entity_2_idx_in_text_with_entity_marker": [60, 64], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "245_492_3_321", "text": "Recently, PHD finger proteins, like Yng1 in the NuA3 HAT complex, were shown to interact with H3K4me3, indicating a biochemical link between K4 methylation and hyperacetylation", "text_with_entity_marker": "Recently, PHD finger proteins, like [E1]Yng1[/E1] in the NuA3 HAT complex, were shown to interact with [E2]H3K4me3[/E2], indicating a biochemical link between K4 methylation and hyperacetylation", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Yng1", "entity_1_idx": [[36, 40]], "entity_1_idx_in_text_with_entity_marker": [40, 44], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "H3K4me3", "entity_2_idx": [[94, 101]], "entity_2_idx_in_text_with_entity_marker": [107, 114], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "225_452_10_294", "text": "The interaction of syndecan-4 with PKC alpha appears unique since PKC delta and epsilon did not interact with 4V in yeast two-hybrid assays or coimmunoprecipitate with syndecan-4", "text_with_entity_marker": "The interaction of [E1]syndecan-4[/E1] with [E2]PKC alpha[/E2] appears unique since PKC delta and epsilon did not interact with 4V in yeast two-hybrid assays or coimmunoprecipitate with syndecan-4", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "syndecan-4", "entity_1_idx": [[19, 29]], "entity_1_idx_in_text_with_entity_marker": [23, 33], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "PKC alpha", "entity_2_idx": [[35, 44]], "entity_2_idx_in_text_with_entity_marker": [48, 57], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "195_391_1_257", "text": "RPA facilitates telomerase activity at chromosome ends in budding and fission yeasts.", "text_with_entity_marker": "[E1]RPA[/E1] facilitates [E2]telomerase[/E2] activity at chromosome ends in budding and fission yeasts.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "RPA", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "telomerase", "entity_2_idx": [[16, 26]], "entity_2_idx_in_text_with_entity_marker": [29, 39], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "195_392_4_258", "text": "The interaction of RPA with telomerase appears to be mediated by both yKu and the telomerase subunit Est1", "text_with_entity_marker": "The interaction of [E1]RPA[/E1] with [E2]telomerase[/E2] appears to be mediated by both yKu and the telomerase subunit Est1", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "RPA", "entity_1_idx": [[19, 22]], "entity_1_idx_in_text_with_entity_marker": [23, 26], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "telomerase", "entity_2_idx": [[28, 38]], "entity_2_idx_in_text_with_entity_marker": [41, 51], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "67_135_1_90", "text": "Functional interaction of glutathione S-transferase pi and peroxiredoxin 6 in intact cells.", "text_with_entity_marker": "Functional interaction of [E1]glutathione S-transferase pi[/E1] and [E2]peroxiredoxin 6[/E2] in intact cells.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "glutathione S-transferase pi", "entity_1_idx": [[26, 54]], "entity_1_idx_in_text_with_entity_marker": [30, 58], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "peroxiredoxin 6", "entity_2_idx": [[59, 74]], "entity_2_idx_in_text_with_entity_marker": [72, 87], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "32_65_1_57", "text": "Identification of an anchor residue for CheA-CheY interactions in the chemotaxis system of Escherichia coli.", "text_with_entity_marker": "Identification of an anchor residue for [E1]CheA[/E1]-[E2]CheY[/E2] interactions in the chemotaxis system of Escherichia coli.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "CheA", "entity_1_idx": [[40, 44]], "entity_1_idx_in_text_with_entity_marker": [44, 48], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "CheY", "entity_2_idx": [[45, 49]], "entity_2_idx_in_text_with_entity_marker": [58, 62], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "32_66_2_58", "text": "This reaction involves CheY (i) binding to the P2 domain of P-CheA and then (ii) acquiring the phosphoryl group from the P1 domain", "text_with_entity_marker": "This reaction involves [E1]CheY[/E1] (i) binding to the P2 domain of P-[E2]CheA[/E2] and then (ii) acquiring the phosphoryl group from the P1 domain", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "CheY", "entity_1_idx": [[23, 27]], "entity_1_idx_in_text_with_entity_marker": [27, 31], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "CheA", "entity_2_idx": [[62, 66]], "entity_2_idx_in_text_with_entity_marker": [75, 79], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "136_274_1_189", "text": "Crystal structures have been determined of recombinant human tumor necrosis factor-alpha (TNF-alpha) and its R31D mutant that preferentially binds to TNF receptor R1 with more than seven times the relative affinity of binding to receptor R2", "text_with_entity_marker": "Crystal structures have been determined of recombinant [E1]human tumor necrosis factor-alpha (TNF-alpha)[/E1] and its R31D mutant that preferentially binds to [E2]TNF receptor R1[/E2] with more than seven times the relative affinity of binding to receptor R2", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "human tumor necrosis factor-alpha (TNF-alpha)", "entity_1_idx": [[55, 100]], "entity_1_idx_in_text_with_entity_marker": [59, 104], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "TNF receptor R1", "entity_2_idx": [[150, 165]], "entity_2_idx_in_text_with_entity_marker": [163, 178], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "207_415_1_271", "text": "Binding of ras to phosphoinositide 3-kinase p110alpha is required for ras-driven tumorigenesis in mice.", "text_with_entity_marker": "Binding of [E1]ras[/E1] to [E2]phosphoinositide 3-kinase p110alpha[/E2] is required for ras-driven tumorigenesis in mice.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "ras", "entity_1_idx": [[11, 14]], "entity_1_idx_in_text_with_entity_marker": [15, 18], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "phosphoinositide 3-kinase p110alpha", "entity_2_idx": [[18, 53]], "entity_2_idx_in_text_with_entity_marker": [31, 66], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "207_416_7_272", "text": "The interaction of Ras with p110alpha is thus required in vivo for certain normal growth factor signaling and for Ras-driven tumor formation.", "text_with_entity_marker": "The interaction of [E1]Ras[/E1] with [E2]p110alpha[/E2] is thus required in vivo for certain normal growth factor signaling and for Ras-driven tumor formation.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Ras", "entity_1_idx": [[19, 22]], "entity_1_idx_in_text_with_entity_marker": [23, 26], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "p110alpha", "entity_2_idx": [[28, 37]], "entity_2_idx_in_text_with_entity_marker": [41, 50], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "259_519_1_346", "text": "Phosphorylation of receptor protein-tyrosine phosphatase alpha on Tyr789, a binding site for the SH3-SH2-SH3 adaptor protein GRB-2 in vivo.", "text_with_entity_marker": "Phosphorylation of [E1]receptor protein-tyrosine phosphatase alpha[/E1] on Tyr789, a binding site for the SH3-SH2-SH3 adaptor protein [E2]GRB-2[/E2] in vivo.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "receptor protein-tyrosine phosphatase alpha", "entity_1_idx": [[19, 62]], "entity_1_idx_in_text_with_entity_marker": [23, 66], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "GRB-2", "entity_2_idx": [[125, 130]], "entity_2_idx_in_text_with_entity_marker": [138, 143], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "259_520_12_347", "text": "Our results suggest a role for RPTP alpha in attenuation of GRB2-mediated signaling.", "text_with_entity_marker": "Our results suggest a role for [E1]RPTP alpha[/E1] in attenuation of [E2]GRB2[/E2]-mediated signaling.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "RPTP alpha", "entity_1_idx": [[31, 41]], "entity_1_idx_in_text_with_entity_marker": [35, 45], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "GRB2", "entity_2_idx": [[60, 64]], "entity_2_idx_in_text_with_entity_marker": [73, 77], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "186_374_3_243", "text": "For example, the gene encoding the CDK inhibitor p18 is located on a segment of chromosome 1 that is often abnormal in human breast tumors", "text_with_entity_marker": "For example, the gene encoding the CDK inhibitor [E1]p18[/E1][E2]CDK[/E2] inhibitor p18 is located on a segment of chromosome 1 that is often abnormal in human breast tumors", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "p18", "entity_1_idx": [[49, 52]], "entity_1_idx_in_text_with_entity_marker": [53, 56], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "CDK", "entity_2_idx": [[35, 38]], "entity_2_idx_in_text_with_entity_marker": [65, 68], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "230_462_3_302", "text": "FOXC1 and PITX2A physically interact, and this interaction requires crucial functional domains on both proteins: the C-terminal activation domain of FOXC1 and the homeodomain of PITX2", "text_with_entity_marker": "[E1]FOXC1[/E1] and [E2]PITX2A[/E2] physically interact, and this interaction requires crucial functional domains on both proteins: the C-terminal activation domain of FOXC1 and the homeodomain of PITX2", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "FOXC1", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "PITX2A", "entity_2_idx": [[10, 16]], "entity_2_idx_in_text_with_entity_marker": [23, 29], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "69_139_1_91", "text": "Nephronectin binds to heparan sulfate proteoglycans via its MAM domain.", "text_with_entity_marker": "[E1]Nephronectin[/E1] binds to [E2]heparan sulfate proteoglycans[/E2] via its MAM domain.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Nephronectin", "entity_1_idx": [[0, 12]], "entity_1_idx_in_text_with_entity_marker": [4, 16], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "heparan sulfate proteoglycans", "entity_2_idx": [[22, 51]], "entity_2_idx_in_text_with_entity_marker": [35, 64], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "69_140_6_92", "text": "Consistent with these results, nephronectin bound to agrin and perlecan, which are heparan sulfate proteoglycans (HSPGs) in basement membranes, in HS-dependent manners", "text_with_entity_marker": "Consistent with these results, [E1]nephronectin[/E1] bound to [E2]agrin[/E2] and perlecan, which are heparan sulfate proteoglycans (HSPGs) in basement membranes, in HS-dependent manners", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "nephronectin", "entity_1_idx": [[31, 43]], "entity_1_idx_in_text_with_entity_marker": [35, 47], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "agrin", "entity_2_idx": [[53, 58]], "entity_2_idx_in_text_with_entity_marker": [66, 71], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "69_140_6_93", "text": "Consistent with these results, nephronectin bound to agrin and perlecan, which are heparan sulfate proteoglycans (HSPGs) in basement membranes, in HS-dependent manners", "text_with_entity_marker": "Consistent with these results, [E1]nephronectin[/E1] bound to agrin and [E2]perlecan[/E2], which are heparan sulfate proteoglycans (HSPGs) in basement membranes, in HS-dependent manners", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "nephronectin", "entity_1_idx": [[31, 43]], "entity_1_idx_in_text_with_entity_marker": [35, 47], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "perlecan", "entity_2_idx": [[63, 71]], "entity_2_idx_in_text_with_entity_marker": [76, 84], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "141_283_1_198", "text": "The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation.", "text_with_entity_marker": "The TNF receptor 1-associated protein [E1]TRADD[/E1] signals cell death and [E2]NF-kappa B[/E2] activation.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "TRADD", "entity_1_idx": [[38, 43]], "entity_1_idx_in_text_with_entity_marker": [42, 47], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "NF-kappa B", "entity_2_idx": [[67, 77]], "entity_2_idx_in_text_with_entity_marker": [80, 90], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "97_195_1_122", "text": "PH domain of ELMO functions in trans to regulate Rac activation via Dock180.", "text_with_entity_marker": "PH domain of [E1]ELMO[/E1] functions in trans to regulate Rac activation via [E2]Dock180[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "ELMO", "entity_1_idx": [[13, 17]], "entity_1_idx_in_text_with_entity_marker": [17, 21], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "Dock180", "entity_2_idx": [[68, 75]], "entity_2_idx_in_text_with_entity_marker": [81, 88], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "97_195_1_123", "text": "PH domain of ELMO functions in trans to regulate Rac activation via Dock180.", "text_with_entity_marker": "PH domain of ELMO functions in trans to regulate Rac activation via [E1]Dock180[/E1][E2]Rac[/E2] activation via Dock180.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Dock180", "entity_1_idx": [[68, 75]], "entity_1_idx_in_text_with_entity_marker": [72, 79], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "Rac", "entity_2_idx": [[49, 52]], "entity_2_idx_in_text_with_entity_marker": [88, 91], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "228_458_8_299", "text": "A two-hybrid screen implicated another Ste20p family member, the p21-activated protein kinase PAK1, as an OSR1 target", "text_with_entity_marker": "A two-hybrid screen implicated another Ste20p family member, the p21-activated protein kinase PAK1, as an [E1]OSR1[/E1][E2]PAK1[/E2], as an OSR1 target", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "OSR1", "entity_1_idx": [[106, 110]], "entity_1_idx_in_text_with_entity_marker": [110, 114], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "PAK1", "entity_2_idx": [[94, 98]], "entity_2_idx_in_text_with_entity_marker": [123, 127], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "320_642_2_435", "text": "Here, we show that 3BP2 directly interacts with the endocytic scaffold protein CIN85 and the actin-binding protein HIP-55", "text_with_entity_marker": "Here, we show that [E1]3BP2[/E1] directly interacts with the endocytic scaffold protein [E2]CIN85[/E2] and the actin-binding protein HIP-55", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "3BP2", "entity_1_idx": [[19, 23]], "entity_1_idx_in_text_with_entity_marker": [23, 27], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "CIN85", "entity_2_idx": [[79, 84]], "entity_2_idx_in_text_with_entity_marker": [92, 97], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "320_642_2_436", "text": "Here, we show that 3BP2 directly interacts with the endocytic scaffold protein CIN85 and the actin-binding protein HIP-55", "text_with_entity_marker": "Here, we show that [E1]3BP2[/E1] directly interacts with the endocytic scaffold protein CIN85 and the actin-binding protein [E2]HIP-55[/E2]", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "3BP2", "entity_1_idx": [[19, 23]], "entity_1_idx_in_text_with_entity_marker": [23, 27], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "HIP-55", "entity_2_idx": [[115, 121]], "entity_2_idx_in_text_with_entity_marker": [128, 134], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "140_282_4_197", "text": "The double loops (amino acids [aa] 137 to 150 and 175 to 209) in domain I of ClpY are necessary for initial recognition/tethering of natural substrates such as SulA, a cell division inhibitor protein", "text_with_entity_marker": "The double loops (amino acids [aa] 137 to 150 and 175 to 209) in domain I of [E1]ClpY[/E1] are necessary for initial recognition/tethering of natural substrates such as [E2]SulA[/E2], a cell division inhibitor protein", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "ClpY", "entity_1_idx": [[77, 81]], "entity_1_idx_in_text_with_entity_marker": [81, 85], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "SulA", "entity_2_idx": [[160, 164]], "entity_2_idx_in_text_with_entity_marker": [173, 177], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "35_71_1_61", "text": "The ErbB3 binding protein Ebp1 interacts with Sin3A to repress E2F1 and AR-mediated transcription.", "text_with_entity_marker": "The ErbB3 binding protein [E1]Ebp1[/E1] interacts with [E2]Sin3A[/E2] to repress E2F1 and AR-mediated transcription.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Ebp1", "entity_1_idx": [[26, 30]], "entity_1_idx_in_text_with_entity_marker": [30, 34], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "Sin3A", "entity_2_idx": [[46, 51]], "entity_2_idx_in_text_with_entity_marker": [59, 64], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "35_72_4_62", "text": "Ebp1 interacted with Sin3A both in vitro and in vivo as demonstrated by glutathione S-transferase (GST) pull-down and coimmunoprecipitation analysis", "text_with_entity_marker": "[E1]Ebp1[/E1] interacted with [E2]Sin3A[/E2] both in vitro and in vivo as demonstrated by glutathione S-transferase (GST) pull-down and coimmunoprecipitation analysis", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Ebp1", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "Sin3A", "entity_2_idx": [[21, 26]], "entity_2_idx_in_text_with_entity_marker": [34, 39], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d124.s1055_AIMed.d124.s1055.p0", "text": "The protein Raf-1, a key mediator of mitogenesis and differentiation, associates with p21ras (refs 1-3).", "text_with_entity_marker": "The protein [E1]Raf-1[/E1], a key mediator of mitogenesis and differentiation, associates with [E2]p21ras[/E2] (refs 1-3).", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Raf-1", "entity_1_idx": [[12, 17]], "entity_1_idx_in_text_with_entity_marker": [16, 21], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p21ras", "entity_2_idx": [[86, 92]], "entity_2_idx_in_text_with_entity_marker": [99, 105], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d96.s808_AIMed.d96.s808.p0", "text": "It binds homophilically, i.e., PTPmu on the surface of one cell binds to PTPmu on an apposing cell, and the binding site lies within the immunoglobulin domain.", "text_with_entity_marker": "It binds homophilically, i.e., [E1]PTPmu[/E1] on the surface of one cell binds to [E2]PTPmu[/E2] on an apposing cell, and the binding site lies within the immunoglobulin domain.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "PTPmu", "entity_1_idx": [[31, 36]], "entity_1_idx_in_text_with_entity_marker": [35, 40], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "PTPmu", "entity_2_idx": [[73, 78]], "entity_2_idx_in_text_with_entity_marker": [86, 91], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d96.s813_AIMed.d96.s813.p0", "text": "In vitro binding studies demonstrated that the intracellular segment of PTPmu binds directly to the intracellular domain of E-cadherin, but not to alpha- or beta-catenin.", "text_with_entity_marker": "In vitro binding studies demonstrated that the intracellular segment of [E1]PTPmu[/E1] binds directly to the intracellular domain of [E2]E-cadherin[/E2], but not to alpha- or beta-catenin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "PTPmu", "entity_1_idx": [[72, 77]], "entity_1_idx_in_text_with_entity_marker": [76, 81], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "E-cadherin", "entity_2_idx": [[124, 134]], "entity_2_idx_in_text_with_entity_marker": [137, 147], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d192.s1635_AIMed.d192.s1635.p4", "text": "Activation of interferon-gamma inducing factor mediated by interleukin-1beta converting enzyme.", "text_with_entity_marker": "Activation of [E1]interferon-gamma inducing factor[/E1] mediated by [E2]interleukin-1beta converting enzyme[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "interferon-gamma inducing factor", "entity_1_idx": [[14, 46]], "entity_1_idx_in_text_with_entity_marker": [18, 50], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "interleukin-1beta converting enzyme", "entity_2_idx": [[59, 94]], "entity_2_idx_in_text_with_entity_marker": [72, 107], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d192.s1636_AIMed.d192.s1636.p2", "text": "The interleukin-1beta (IL-1beta) converting enzyme (ICE) processes the inactive IL-1beta precursor to the proinflammatory cytokine.", "text_with_entity_marker": "The [E1]interleukin-1beta[/E1] (IL-1beta) converting enzyme ([E2]ICE[/E2]) processes the inactive IL-1beta precursor to the proinflammatory cytokine.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "interleukin-1beta", "entity_1_idx": [[4, 21]], "entity_1_idx_in_text_with_entity_marker": [8, 25], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "ICE", "entity_2_idx": [[52, 55]], "entity_2_idx_in_text_with_entity_marker": [65, 68], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d192.s1636_AIMed.d192.s1636.p5", "text": "The interleukin-1beta (IL-1beta) converting enzyme (ICE) processes the inactive IL-1beta precursor to the proinflammatory cytokine.", "text_with_entity_marker": "The interleukin-1beta ([E1]IL-1beta[/E1]) converting enzyme ([E2]ICE[/E2]) processes the inactive IL-1beta precursor to the proinflammatory cytokine.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "IL-1beta", "entity_1_idx": [[23, 31]], "entity_1_idx_in_text_with_entity_marker": [27, 35], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "ICE", "entity_2_idx": [[52, 55]], "entity_2_idx_in_text_with_entity_marker": [65, 68], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d192.s1637_AIMed.d192.s1637.p1", "text": "ICE was also shown to cleave the precursor of interferon-gamma inducing factor (IGIF) at the authentic processing site with high efficiency, thereby activating IGIF and facilitating its export.", "text_with_entity_marker": "[E1]ICE[/E1] was also shown to cleave the precursor of [E2]interferon-gamma inducing factor[/E2] (IGIF) at the authentic processing site with high efficiency, thereby activating IGIF and facilitating its export.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "ICE", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "interferon-gamma inducing factor", "entity_2_idx": [[46, 78]], "entity_2_idx_in_text_with_entity_marker": [59, 91], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d192.s1637_AIMed.d192.s1637.p2", "text": "ICE was also shown to cleave the precursor of interferon-gamma inducing factor (IGIF) at the authentic processing site with high efficiency, thereby activating IGIF and facilitating its export.", "text_with_entity_marker": "[E1]ICE[/E1] was also shown to cleave the precursor of interferon-gamma inducing factor ([E2]IGIF[/E2]) at the authentic processing site with high efficiency, thereby activating IGIF and facilitating its export.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "ICE", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IGIF", "entity_2_idx": [[80, 84]], "entity_2_idx_in_text_with_entity_marker": [93, 97], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d192.s1637_AIMed.d192.s1637.p3", "text": "ICE was also shown to cleave the precursor of interferon-gamma inducing factor (IGIF) at the authentic processing site with high efficiency, thereby activating IGIF and facilitating its export.", "text_with_entity_marker": "[E1]ICE[/E1] was also shown to cleave the precursor of interferon-gamma inducing factor (IGIF) at the authentic processing site with high efficiency, thereby activating [E2]IGIF[/E2] and facilitating its export.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "ICE", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IGIF", "entity_2_idx": [[160, 164]], "entity_2_idx_in_text_with_entity_marker": [173, 177], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d153.s1298_AIMed.d153.s1298.p0", "text": "Characterization of adenosine deaminase binding to human CD26 on T cells and its biologic role in immune response.", "text_with_entity_marker": "Characterization of [E1]adenosine deaminase[/E1] binding to human [E2]CD26[/E2] on T cells and its biologic role in immune response.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "adenosine deaminase", "entity_1_idx": [[20, 39]], "entity_1_idx_in_text_with_entity_marker": [24, 43], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CD26", "entity_2_idx": [[57, 61]], "entity_2_idx_in_text_with_entity_marker": [70, 74], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d153.s1299_AIMed.d153.s1299.p1", "text": "CD26, a T cell activation Ag, also known as dipeptidyl peptidase IV,is directly associated with adenosine deaminase (ADA) on the surface of T cells and T cell lines.", "text_with_entity_marker": "[E1]CD26[/E1], a T cell activation Ag, also known as dipeptidyl peptidase IV,is directly associated with [E2]adenosine deaminase[/E2] (ADA) on the surface of T cells and T cell lines.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "CD26", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "adenosine deaminase", "entity_2_idx": [[96, 115]], "entity_2_idx_in_text_with_entity_marker": [109, 128], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d153.s1299_AIMed.d153.s1299.p2", "text": "CD26, a T cell activation Ag, also known as dipeptidyl peptidase IV,is directly associated with adenosine deaminase (ADA) on the surface of T cells and T cell lines.", "text_with_entity_marker": "[E1]CD26[/E1], a T cell activation Ag, also known as dipeptidyl peptidase IV,is directly associated with adenosine deaminase ([E2]ADA[/E2]) on the surface of T cells and T cell lines.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "CD26", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "ADA", "entity_2_idx": [[117, 120]], "entity_2_idx_in_text_with_entity_marker": [130, 133], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d153.s1299_AIMed.d153.s1299.p3", "text": "CD26, a T cell activation Ag, also known as dipeptidyl peptidase IV,is directly associated with adenosine deaminase (ADA) on the surface of T cells and T cell lines.", "text_with_entity_marker": "CD26, a T cell activation Ag, also known as [E1]dipeptidyl peptidase IV[/E1],is directly associated with [E2]adenosine deaminase[/E2] (ADA) on the surface of T cells and T cell lines.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "dipeptidyl peptidase IV", "entity_1_idx": [[44, 67]], "entity_1_idx_in_text_with_entity_marker": [48, 71], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "adenosine deaminase", "entity_2_idx": [[96, 115]], "entity_2_idx_in_text_with_entity_marker": [109, 128], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d153.s1299_AIMed.d153.s1299.p4", "text": "CD26, a T cell activation Ag, also known as dipeptidyl peptidase IV,is directly associated with adenosine deaminase (ADA) on the surface of T cells and T cell lines.", "text_with_entity_marker": "CD26, a T cell activation Ag, also known as [E1]dipeptidyl peptidase IV[/E1],is directly associated with adenosine deaminase ([E2]ADA[/E2]) on the surface of T cells and T cell lines.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "dipeptidyl peptidase IV", "entity_1_idx": [[44, 67]], "entity_1_idx_in_text_with_entity_marker": [48, 71], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "ADA", "entity_2_idx": [[117, 120]], "entity_2_idx_in_text_with_entity_marker": [130, 133], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d153.s1301_AIMed.d153.s1301.p14", "text": "We found that ADA was associated with CD26 on T cell lines lacking either ADA or dipeptidyl peptidase IV enzymatic activity, indicating that the association between dipeptidyl peptidase IV and ADA did not require enzymatic activity.", "text_with_entity_marker": "We found that ADA was associated with CD26 on T cell lines lacking either ADA or dipeptidyl peptidase IV enzymatic activity, indicating that the association between [E1]dipeptidyl peptidase IV[/E1] and [E2]ADA[/E2] did not require enzymatic activity.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "dipeptidyl peptidase IV", "entity_1_idx": [[165, 188]], "entity_1_idx_in_text_with_entity_marker": [169, 192], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "ADA", "entity_2_idx": [[193, 196]], "entity_2_idx_in_text_with_entity_marker": [206, 209], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d153.s1306_AIMed.d153.s1306.p2", "text": "These data suggest that ADA on the cell surface is involved in an important immunoregulatory mechanism by which released ADA binds to cell surface CD26, and this complex is capable of reducing the local concentration of adenosine.", "text_with_entity_marker": "These data suggest that ADA on the cell surface is involved in an important immunoregulatory mechanism by which released [E1]ADA[/E1] binds to cell surface [E2]CD26[/E2], and this complex is capable of reducing the local concentration of adenosine.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "ADA", "entity_1_idx": [[121, 124]], "entity_1_idx_in_text_with_entity_marker": [125, 128], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CD26", "entity_2_idx": [[147, 151]], "entity_2_idx_in_text_with_entity_marker": [160, 164], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d117.s989_AIMed.d117.s989.p0", "text": "Here we show that beta:beta activin binds to the activin type II receptor kinase (ActRII) which induces activin binding to the type I receptor kinase SKR2 to form ActRII.beta:beta.", "text_with_entity_marker": "Here we show that beta:[E1]beta activin[/E1] binds to the [E2]activin type II receptor kinase[/E2] (ActRII) which induces activin binding to the type I receptor kinase SKR2 to form ActRII.beta:beta.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "beta activin", "entity_1_idx": [[23, 35]], "entity_1_idx_in_text_with_entity_marker": [27, 39], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "activin type II receptor kinase", "entity_2_idx": [[49, 80]], "entity_2_idx_in_text_with_entity_marker": [62, 93], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d117.s989_AIMed.d117.s989.p1", "text": "Here we show that beta:beta activin binds to the activin type II receptor kinase (ActRII) which induces activin binding to the type I receptor kinase SKR2 to form ActRII.beta:beta.", "text_with_entity_marker": "Here we show that beta:[E1]beta activin[/E1] binds to the activin type II receptor kinase ([E2]ActRII[/E2]) which induces activin binding to the type I receptor kinase SKR2 to form ActRII.beta:beta.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "beta activin", "entity_1_idx": [[23, 35]], "entity_1_idx_in_text_with_entity_marker": [27, 39], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "ActRII", "entity_2_idx": [[82, 88]], "entity_2_idx_in_text_with_entity_marker": [95, 101], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d117.s991_AIMed.d117.s991.p0", "text": "Inhibin also binds to ActRII through its beta subunit, competes with the binding of activin to ActRII, but fails to form the ActRII.", "text_with_entity_marker": "[E1]Inhibin[/E1] also binds to [E2]ActRII[/E2] through its beta subunit, competes with the binding of activin to ActRII, but fails to form the ActRII.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Inhibin", "entity_1_idx": [[0, 7]], "entity_1_idx_in_text_with_entity_marker": [4, 11], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "ActRII", "entity_2_idx": [[22, 28]], "entity_2_idx_in_text_with_entity_marker": [35, 41], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d59.s520_AIMed.d59.s520.p1", "text": "Myogenin is a muscle-specific HLH protein that binds DNA in vitro as a heterodimer with several widely expressed HLH proteins, such as the E2A gene products E12 and E47.", "text_with_entity_marker": "[E1]Myogenin[/E1] is a muscle-specific HLH protein that binds DNA in vitro as a heterodimer with several widely expressed HLH proteins, such as the E2A gene products [E2]E12[/E2] and E47.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Myogenin", "entity_1_idx": [[0, 8]], "entity_1_idx_in_text_with_entity_marker": [4, 12], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "E12", "entity_2_idx": [[157, 160]], "entity_2_idx_in_text_with_entity_marker": [170, 173], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d59.s520_AIMed.d59.s520.p2", "text": "Myogenin is a muscle-specific HLH protein that binds DNA in vitro as a heterodimer with several widely expressed HLH proteins, such as the E2A gene products E12 and E47.", "text_with_entity_marker": "[E1]Myogenin[/E1] is a muscle-specific HLH protein that binds DNA in vitro as a heterodimer with several widely expressed HLH proteins, such as the E2A gene products E12 and [E2]E47[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Myogenin", "entity_1_idx": [[0, 8]], "entity_1_idx_in_text_with_entity_marker": [4, 12], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "E47", "entity_2_idx": [[165, 168]], "entity_2_idx_in_text_with_entity_marker": [178, 181], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d59.s523_AIMed.d59.s523.p0", "text": "The results show that myogenin heterodimerizes with E12 and E47 in vivo, but it does not homodimerize to a measurable extent.", "text_with_entity_marker": "The results show that [E1]myogenin[/E1] heterodimerizes with [E2]E12[/E2] and E47 in vivo, but it does not homodimerize to a measurable extent.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "myogenin", "entity_1_idx": [[22, 30]], "entity_1_idx_in_text_with_entity_marker": [26, 34], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "E12", "entity_2_idx": [[52, 55]], "entity_2_idx_in_text_with_entity_marker": [65, 68], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d59.s523_AIMed.d59.s523.p1", "text": "The results show that myogenin heterodimerizes with E12 and E47 in vivo, but it does not homodimerize to a measurable extent.", "text_with_entity_marker": "The results show that [E1]myogenin[/E1] heterodimerizes with E12 and [E2]E47[/E2] in vivo, but it does not homodimerize to a measurable extent.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "myogenin", "entity_1_idx": [[22, 30]], "entity_1_idx_in_text_with_entity_marker": [26, 34], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "E47", "entity_2_idx": [[60, 63]], "entity_2_idx_in_text_with_entity_marker": [73, 76], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d149.s1262_AIMed.d149.s1262.p0", "text": "The SH2/SH3 domain-containing protein GRB2 interacts with tyrosine-phosphorylated IRS1 and Shc: implications for insulin control of ras signalling.", "text_with_entity_marker": "The SH2/SH3 domain-containing protein [E1]GRB2[/E1] interacts with tyrosine-phosphorylated [E2]IRS1[/E2] and Shc: implications for insulin control of ras signalling.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "GRB2", "entity_1_idx": [[38, 42]], "entity_1_idx_in_text_with_entity_marker": [42, 46], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IRS1", "entity_2_idx": [[82, 86]], "entity_2_idx_in_text_with_entity_marker": [95, 99], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d149.s1262_AIMed.d149.s1262.p1", "text": "The SH2/SH3 domain-containing protein GRB2 interacts with tyrosine-phosphorylated IRS1 and Shc: implications for insulin control of ras signalling.", "text_with_entity_marker": "The SH2/SH3 domain-containing protein [E1]GRB2[/E1] interacts with tyrosine-phosphorylated IRS1 and [E2]Shc[/E2]: implications for insulin control of ras signalling.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "GRB2", "entity_1_idx": [[38, 42]], "entity_1_idx_in_text_with_entity_marker": [42, 46], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Shc", "entity_2_idx": [[91, 94]], "entity_2_idx_in_text_with_entity_marker": [104, 107], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d149.s1267_AIMed.d149.s1267.p7", "text": "The interactions between GRB2 and these two proteins require ligand activation of the insulin receptor and are mediated by the binding of the SH2 domain of GRB2 to phosphotyrosines on both IRS-1 and Shc.", "text_with_entity_marker": "The interactions between GRB2 and these two proteins require ligand activation of the insulin receptor and are mediated by the binding of the SH2 domain of [E1]GRB2[/E1] to phosphotyrosines on both [E2]IRS-1[/E2] and Shc.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "GRB2", "entity_1_idx": [[156, 160]], "entity_1_idx_in_text_with_entity_marker": [160, 164], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IRS-1", "entity_2_idx": [[189, 194]], "entity_2_idx_in_text_with_entity_marker": [202, 207], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d149.s1267_AIMed.d149.s1267.p8", "text": "The interactions between GRB2 and these two proteins require ligand activation of the insulin receptor and are mediated by the binding of the SH2 domain of GRB2 to phosphotyrosines on both IRS-1 and Shc.", "text_with_entity_marker": "The interactions between GRB2 and these two proteins require ligand activation of the insulin receptor and are mediated by the binding of the SH2 domain of [E1]GRB2[/E1] to phosphotyrosines on both IRS-1 and [E2]Shc[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "GRB2", "entity_1_idx": [[156, 160]], "entity_1_idx_in_text_with_entity_marker": [160, 164], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Shc", "entity_2_idx": [[199, 202]], "entity_2_idx_in_text_with_entity_marker": [212, 215], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d149.s1268_AIMed.d149.s1268.p0", "text": "Although GRB2 associates with IRS-1 and Shc, it is not tyrosine-phosphorylated after insulin stimulation, implying that GRB2 is not a substrate for the insulin receptor.", "text_with_entity_marker": "Although [E1]GRB2[/E1] associates with [E2]IRS-1[/E2] and Shc, it is not tyrosine-phosphorylated after insulin stimulation, implying that GRB2 is not a substrate for the insulin receptor.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "GRB2", "entity_1_idx": [[9, 13]], "entity_1_idx_in_text_with_entity_marker": [13, 17], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IRS-1", "entity_2_idx": [[30, 35]], "entity_2_idx_in_text_with_entity_marker": [43, 48], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d149.s1268_AIMed.d149.s1268.p1", "text": "Although GRB2 associates with IRS-1 and Shc, it is not tyrosine-phosphorylated after insulin stimulation, implying that GRB2 is not a substrate for the insulin receptor.", "text_with_entity_marker": "Although [E1]GRB2[/E1] associates with IRS-1 and [E2]Shc[/E2], it is not tyrosine-phosphorylated after insulin stimulation, implying that GRB2 is not a substrate for the insulin receptor.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "GRB2", "entity_1_idx": [[9, 13]], "entity_1_idx_in_text_with_entity_marker": [13, 17], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Shc", "entity_2_idx": [[40, 43]], "entity_2_idx_in_text_with_entity_marker": [53, 56], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d149.s1270_AIMed.d149.s1270.p1", "text": "Interestingly, both GRB2 and phosphatidylinositol-3 (PI-3) kinase can simultaneously bind distinct tyrosine phosphorylated regions on the same IRS-1 molecule, suggesting a mechanism whereby IRS-1 could provide the core for a large signalling complex.", "text_with_entity_marker": "Interestingly, both [E1]GRB2[/E1] and phosphatidylinositol-3 (PI-3) kinase can simultaneously bind distinct tyrosine phosphorylated regions on the same [E2]IRS-1[/E2] molecule, suggesting a mechanism whereby IRS-1 could provide the core for a large signalling complex.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "GRB2", "entity_1_idx": [[20, 24]], "entity_1_idx_in_text_with_entity_marker": [24, 28], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IRS-1", "entity_2_idx": [[143, 148]], "entity_2_idx_in_text_with_entity_marker": [156, 161], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d149.s1270_AIMed.d149.s1270.p3", "text": "Interestingly, both GRB2 and phosphatidylinositol-3 (PI-3) kinase can simultaneously bind distinct tyrosine phosphorylated regions on the same IRS-1 molecule, suggesting a mechanism whereby IRS-1 could provide the core for a large signalling complex.", "text_with_entity_marker": "Interestingly, both GRB2 and [E1]phosphatidylinositol-3 (PI-3) kinase[/E1] can simultaneously bind distinct tyrosine phosphorylated regions on the same [E2]IRS-1[/E2] molecule, suggesting a mechanism whereby IRS-1 could provide the core for a large signalling complex.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "phosphatidylinositol-3 (PI-3) kinase", "entity_1_idx": [[29, 65]], "entity_1_idx_in_text_with_entity_marker": [33, 69], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IRS-1", "entity_2_idx": [[143, 148]], "entity_2_idx_in_text_with_entity_marker": [156, 161], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d53.s469_AIMed.d53.s469.p1", "text": "Kaposi's sarcoma-associated herpesvirus encodes a functional homolog of human interleukin-6 (IL-6) that activates human gp130.", "text_with_entity_marker": "Kaposi's sarcoma-associated herpesvirus encodes a functional homolog of human [E1]interleukin-6[/E1] (IL-6) that activates human [E2]gp130[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "interleukin-6", "entity_1_idx": [[78, 91]], "entity_1_idx_in_text_with_entity_marker": [82, 95], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "gp130", "entity_2_idx": [[120, 125]], "entity_2_idx_in_text_with_entity_marker": [133, 138], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d53.s469_AIMed.d53.s469.p2", "text": "Kaposi's sarcoma-associated herpesvirus encodes a functional homolog of human interleukin-6 (IL-6) that activates human gp130.", "text_with_entity_marker": "Kaposi's sarcoma-associated herpesvirus encodes a functional homolog of human interleukin-6 ([E1]IL-6[/E1]) that activates human [E2]gp130[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "IL-6", "entity_1_idx": [[93, 97]], "entity_1_idx_in_text_with_entity_marker": [97, 101], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "gp130", "entity_2_idx": [[120, 125]], "entity_2_idx_in_text_with_entity_marker": [133, 138], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d53.s470_AIMed.d53.s470.p0", "text": "In the 2.4 angstrom crystal structure of the extracellular signaling assembly between viral IL-6 and human gp130, two complexes are cross-linked into a tetramer through direct interactions between the immunoglobulin domain of gp130 and site III of viral IL-6, which is necessary for receptor activation.", "text_with_entity_marker": "In the 2.4 angstrom crystal structure of the extracellular signaling assembly between viral [E1]IL-6[/E1] and human [E2]gp130[/E2], two complexes are cross-linked into a tetramer through direct interactions between the immunoglobulin domain of gp130 and site III of viral IL-6, which is necessary for receptor activation.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "IL-6", "entity_1_idx": [[92, 96]], "entity_1_idx_in_text_with_entity_marker": [96, 100], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "gp130", "entity_2_idx": [[107, 112]], "entity_2_idx_in_text_with_entity_marker": [120, 125], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d53.s470_AIMed.d53.s470.p5", "text": "In the 2.4 angstrom crystal structure of the extracellular signaling assembly between viral IL-6 and human gp130, two complexes are cross-linked into a tetramer through direct interactions between the immunoglobulin domain of gp130 and site III of viral IL-6, which is necessary for receptor activation.", "text_with_entity_marker": "In the 2.4 angstrom crystal structure of the extracellular signaling assembly between viral IL-6 and human gp130, two complexes are cross-linked into a tetramer through direct interactions between the immunoglobulin domain of [E1]gp130[/E1] and site III of viral [E2]IL-6[/E2], which is necessary for receptor activation.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "gp130", "entity_1_idx": [[226, 231]], "entity_1_idx_in_text_with_entity_marker": [230, 235], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-6", "entity_2_idx": [[254, 258]], "entity_2_idx_in_text_with_entity_marker": [267, 271], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d53.s471_AIMed.d53.s471.p0", "text": "Unlike human IL-6 (which uses many hydrophilic residues), the viral cytokine largely uses hydrophobic amino acids to contact gp130, which enhances the complementarity of the viral IL-6-gp130 binding interfaces.", "text_with_entity_marker": "Unlike human [E1]IL-6[/E1] (which uses many hydrophilic residues), the viral cytokine largely uses hydrophobic amino acids to contact [E2]gp130[/E2], which enhances the complementarity of the viral IL-6-gp130 binding interfaces.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "IL-6", "entity_1_idx": [[13, 17]], "entity_1_idx_in_text_with_entity_marker": [17, 21], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "gp130", "entity_2_idx": [[125, 130]], "entity_2_idx_in_text_with_entity_marker": [138, 143], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d53.s471_AIMed.d53.s471.p5", "text": "Unlike human IL-6 (which uses many hydrophilic residues), the viral cytokine largely uses hydrophobic amino acids to contact gp130, which enhances the complementarity of the viral IL-6-gp130 binding interfaces.", "text_with_entity_marker": "Unlike human IL-6 (which uses many hydrophilic residues), the viral cytokine largely uses hydrophobic amino acids to contact gp130, which enhances the complementarity of the viral [E1]IL-6[/E1]-[E2]gp130[/E2] binding interfaces.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "IL-6", "entity_1_idx": [[180, 184]], "entity_1_idx_in_text_with_entity_marker": [184, 188], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "gp130", "entity_2_idx": [[185, 190]], "entity_2_idx_in_text_with_entity_marker": [198, 203], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d119.s1005_AIMed.d119.s1005.p0", "text": "Nuclear protein CBP is a coactivator for the transcription factor CREB.", "text_with_entity_marker": "Nuclear protein [E1]CBP[/E1] is a coactivator for the transcription factor [E2]CREB[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "CBP", "entity_1_idx": [[16, 19]], "entity_1_idx_in_text_with_entity_marker": [20, 23], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CREB", "entity_2_idx": [[66, 70]], "entity_2_idx_in_text_with_entity_marker": [79, 83], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d119.s1007_AIMed.d119.s1007.p0", "text": "CREB is activated through phosphorylation by protein kinase A (PKA), but precisely how phosphorylation stimulates CREB function is unknown.", "text_with_entity_marker": "[E1]CREB[/E1] is activated through phosphorylation by [E2]protein kinase A[/E2] (PKA), but precisely how phosphorylation stimulates CREB function is unknown.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "CREB", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "protein kinase A", "entity_2_idx": [[45, 61]], "entity_2_idx_in_text_with_entity_marker": [58, 74], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d119.s1007_AIMed.d119.s1007.p1", "text": "CREB is activated through phosphorylation by protein kinase A (PKA), but precisely how phosphorylation stimulates CREB function is unknown.", "text_with_entity_marker": "[E1]CREB[/E1] is activated through phosphorylation by protein kinase A ([E2]PKA[/E2]), but precisely how phosphorylation stimulates CREB function is unknown.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "CREB", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "PKA", "entity_2_idx": [[63, 66]], "entity_2_idx_in_text_with_entity_marker": [76, 79], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d119.s1009_AIMed.d119.s1009.p1", "text": "We have previously identified a nuclear protein of M(r)265K, CBP, that binds specifically to the PKA-phosphorylated form of CREB.", "text_with_entity_marker": "We have previously identified a nuclear protein of M(r)265K, [E1]CBP[/E1], that binds specifically to the PKA-phosphorylated form of [E2]CREB[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "CBP", "entity_1_idx": [[61, 64]], "entity_1_idx_in_text_with_entity_marker": [65, 68], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CREB", "entity_2_idx": [[124, 128]], "entity_2_idx_in_text_with_entity_marker": [137, 141], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d119.s1009_AIMed.d119.s1009.p2", "text": "We have previously identified a nuclear protein of M(r)265K, CBP, that binds specifically to the PKA-phosphorylated form of CREB.", "text_with_entity_marker": "We have previously identified a nuclear protein of M(r)265K, CBP, that binds specifically to the [E1]PKA[/E1]-phosphorylated form of [E2]CREB[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "PKA", "entity_1_idx": [[97, 100]], "entity_1_idx_in_text_with_entity_marker": [101, 104], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CREB", "entity_2_idx": [[124, 128]], "entity_2_idx_in_text_with_entity_marker": [137, 141], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d119.s1010_AIMed.d119.s1010.p0", "text": "We have used fluorescence anisotropy measurements to define the equilibrium binding parameters of the phosphoCREB:CBP interaction and report here that CBP can activate transcription through a region in its carboxy terminus.", "text_with_entity_marker": "We have used fluorescence anisotropy measurements to define the equilibrium binding parameters of the [E1]phosphoCREB[/E1]:[E2]CBP[/E2] interaction and report here that CBP can activate transcription through a region in its carboxy terminus.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "phosphoCREB", "entity_1_idx": [[102, 113]], "entity_1_idx_in_text_with_entity_marker": [106, 117], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CBP", "entity_2_idx": [[114, 117]], "entity_2_idx_in_text_with_entity_marker": [127, 130], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d119.s1011_AIMed.d119.s1011.p1", "text": "The activation domain of CBP interacts with the basal transcription factor TFIIB through a domain that is conserved in the yeast coactivator ADA-1 (ref. 8).", "text_with_entity_marker": "The activation domain of [E1]CBP[/E1] interacts with the basal transcription factor TFIIB through a domain that is conserved in the yeast coactivator [E2]ADA-1[/E2] (ref. 8).", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "CBP", "entity_1_idx": [[25, 28]], "entity_1_idx_in_text_with_entity_marker": [29, 32], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "ADA-1", "entity_2_idx": [[141, 146]], "entity_2_idx_in_text_with_entity_marker": [154, 159], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d119.s1012_AIMed.d119.s1012.p0", "text": "Consistent with its role as a coactivator, CBP augments the activity of phosphorylated CREB to activate transcription of cAMP-responsive genes.", "text_with_entity_marker": "Consistent with its role as a coactivator, [E1]CBP[/E1] augments the activity of phosphorylated [E2]CREB[/E2] to activate transcription of cAMP-responsive genes.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "CBP", "entity_1_idx": [[43, 46]], "entity_1_idx_in_text_with_entity_marker": [47, 50], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CREB", "entity_2_idx": [[87, 91]], "entity_2_idx_in_text_with_entity_marker": [100, 104], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d111.s932_AIMed.d111.s932.p0", "text": "The prototypic neuronal anchor protein AKAP75 has a COOH-terminal 22-residue RII beta binding (tethering) site.", "text_with_entity_marker": "The prototypic neuronal anchor protein [E1]AKAP75[/E1] has a COOH-terminal 22-residue [E2]RII beta[/E2] binding (tethering) site.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "AKAP75", "entity_1_idx": [[39, 45]], "entity_1_idx_in_text_with_entity_marker": [43, 49], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "RII beta", "entity_2_idx": [[77, 85]], "entity_2_idx_in_text_with_entity_marker": [90, 98], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d111.s934_AIMed.d111.s934.p0", "text": "Mutagenesis, recombinant protein expression, and physicochemical characterization were used to investigate the structural basis for the homodimerization and AKAP75 binding activities of RII beta.", "text_with_entity_marker": "Mutagenesis, recombinant protein expression, and physicochemical characterization were used to investigate the structural basis for the homodimerization and [E1]AKAP75[/E1] binding activities of [E2]RII beta[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "AKAP75", "entity_1_idx": [[157, 163]], "entity_1_idx_in_text_with_entity_marker": [161, 167], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "RII beta", "entity_2_idx": [[186, 194]], "entity_2_idx_in_text_with_entity_marker": [199, 207], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d111.s941_AIMed.d111.s941.p0", "text": "Other NH2-terminal residues directly modulate the affinity of RII beta dimers for the AKAP75 tethering site.", "text_with_entity_marker": "Other NH2-terminal residues directly modulate the affinity of [E1]RII beta[/E1] dimers for the [E2]AKAP75[/E2] tethering site.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "RII beta", "entity_1_idx": [[62, 70]], "entity_1_idx_in_text_with_entity_marker": [66, 74], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "AKAP75", "entity_2_idx": [[86, 92]], "entity_2_idx_in_text_with_entity_marker": [99, 105], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d111.s942_AIMed.d111.s942.p0", "text": "Replacement of Val20-Leu21 with Ala-Ala produced a dimeric RII beta protein that binds AKAP75 approximately 4% as avidly as wild-type RII beta.", "text_with_entity_marker": "Replacement of Val20-Leu21 with Ala-Ala produced a dimeric [E1]RII beta[/E1] protein that binds [E2]AKAP75[/E2] approximately 4% as avidly as wild-type RII beta.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "RII beta", "entity_1_idx": [[59, 67]], "entity_1_idx_in_text_with_entity_marker": [63, 71], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "AKAP75", "entity_2_idx": [[87, 93]], "entity_2_idx_in_text_with_entity_marker": [100, 106], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d212.s1838_AIMed.d212.s1838.p2", "text": "Because cells lacking the protein tyrosine kinase c-Abl are also defective in radiation-induced G1 arrest, we investigated the possibility that ATM might interact with c-Abl in response to radiation damage.", "text_with_entity_marker": "Because cells lacking the protein tyrosine kinase c-Abl are also defective in radiation-induced G1 arrest, we investigated the possibility that [E1]ATM[/E1] might interact with [E2]c-Abl[/E2] in response to radiation damage.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "ATM", "entity_1_idx": [[144, 147]], "entity_1_idx_in_text_with_entity_marker": [148, 151], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "c-Abl", "entity_2_idx": [[168, 173]], "entity_2_idx_in_text_with_entity_marker": [181, 186], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d212.s1842_AIMed.d212.s1842.p0", "text": "These findings indicate that ATM is involved in the activation of c-Abl by DNA damage and this interaction may in part mediate radiation-induced G1 arrest.", "text_with_entity_marker": "These findings indicate that [E1]ATM[/E1] is involved in the activation of [E2]c-Abl[/E2] by DNA damage and this interaction may in part mediate radiation-induced G1 arrest.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "ATM", "entity_1_idx": [[29, 32]], "entity_1_idx_in_text_with_entity_marker": [33, 36], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "c-Abl", "entity_2_idx": [[66, 71]], "entity_2_idx_in_text_with_entity_marker": [79, 84], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d63.s544_AIMed.d63.s544.p2", "text": "Coassociation of CD26 (dipeptidyl peptidase IV) with CD45 on the surface of human T lymphocytes.", "text_with_entity_marker": "Coassociation of CD26 ([E1]dipeptidyl peptidase IV[/E1]) with [E2]CD45[/E2] on the surface of human T lymphocytes.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "dipeptidyl peptidase IV", "entity_1_idx": [[23, 46]], "entity_1_idx_in_text_with_entity_marker": [27, 50], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CD45", "entity_2_idx": [[53, 57]], "entity_2_idx_in_text_with_entity_marker": [66, 70], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d63.s547_AIMed.d63.s547.p5", "text": "These findings strongly suggest that CD26 may be closely associated with the CD45 protein tyrosine phosphatase on T cell surface and further support the notion that the interaction of CD26 with CD45 results in enhanced tyrosine kinase activity, zeta chain phosphorylation, and T cell activation.", "text_with_entity_marker": "These findings strongly suggest that CD26 may be closely associated with the CD45 protein tyrosine phosphatase on T cell surface and further support the notion that the interaction of [E1]CD26[/E1] with [E2]CD45[/E2] results in enhanced tyrosine kinase activity, zeta chain phosphorylation, and T cell activation.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "CD26", "entity_1_idx": [[184, 188]], "entity_1_idx_in_text_with_entity_marker": [188, 192], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CD45", "entity_2_idx": [[194, 198]], "entity_2_idx_in_text_with_entity_marker": [207, 211], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d118.s996_AIMed.d118.s996.p0", "text": "The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA.", "text_with_entity_marker": "The [E1]p21[/E1] inhibitor of cyclin-dependent kinases controls DNA replication by interaction with [E2]PCNA[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "p21", "entity_1_idx": [[4, 7]], "entity_1_idx_in_text_with_entity_marker": [8, 11], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "PCNA", "entity_2_idx": [[91, 95]], "entity_2_idx_in_text_with_entity_marker": [104, 108], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d118.s999_AIMed.d118.s999.p0", "text": "In normal human cells, but not in many tumour cells, p21 exists in a quaternary complex with a cyclin, a CDK, and the proliferating-cell nuclear antigen (PCNA).", "text_with_entity_marker": "In normal human cells, but not in many tumour cells, [E1]p21[/E1] exists in a quaternary complex with a cyclin, a CDK, and the [E2]proliferating-cell nuclear antigen[/E2] (PCNA).", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "p21", "entity_1_idx": [[53, 56]], "entity_1_idx_in_text_with_entity_marker": [57, 60], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "proliferating-cell nuclear antigen", "entity_2_idx": [[118, 152]], "entity_2_idx_in_text_with_entity_marker": [131, 165], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d118.s999_AIMed.d118.s999.p1", "text": "In normal human cells, but not in many tumour cells, p21 exists in a quaternary complex with a cyclin, a CDK, and the proliferating-cell nuclear antigen (PCNA).", "text_with_entity_marker": "In normal human cells, but not in many tumour cells, [E1]p21[/E1] exists in a quaternary complex with a cyclin, a CDK, and the proliferating-cell nuclear antigen ([E2]PCNA[/E2]).", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "p21", "entity_1_idx": [[53, 56]], "entity_1_idx_in_text_with_entity_marker": [57, 60], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "PCNA", "entity_2_idx": [[154, 158]], "entity_2_idx_in_text_with_entity_marker": [167, 171], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d118.s1001_AIMed.d118.s1001.p0", "text": "Here we use simian virus 40 DNA replication in vitro to show than p21 directly inhibits PCNA-dependent DNA replication in the absence of a cyclin/CDK.", "text_with_entity_marker": "Here we use simian virus 40 DNA replication in vitro to show than [E1]p21[/E1] directly inhibits [E2]PCNA[/E2]-dependent DNA replication in the absence of a cyclin/CDK.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "p21", "entity_1_idx": [[66, 69]], "entity_1_idx_in_text_with_entity_marker": [70, 73], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "PCNA", "entity_2_idx": [[88, 92]], "entity_2_idx_in_text_with_entity_marker": [101, 105], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d118.s1002_AIMed.d118.s1002.p0", "text": "Furthermore, p21 blocks the ability of PCNA to activate DNA polymerase delta, the principal replicative DNA polymerase.", "text_with_entity_marker": "Furthermore, [E1]p21[/E1] blocks the ability of [E2]PCNA[/E2] to activate DNA polymerase delta, the principal replicative DNA polymerase.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "p21", "entity_1_idx": [[13, 16]], "entity_1_idx_in_text_with_entity_marker": [17, 20], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "PCNA", "entity_2_idx": [[39, 43]], "entity_2_idx_in_text_with_entity_marker": [52, 56], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d118.s1002_AIMed.d118.s1002.p2", "text": "Furthermore, p21 blocks the ability of PCNA to activate DNA polymerase delta, the principal replicative DNA polymerase.", "text_with_entity_marker": "Furthermore, p21 blocks the ability of [E1]PCNA[/E1] to activate [E2]DNA polymerase delta[/E2], the principal replicative DNA polymerase.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "PCNA", "entity_1_idx": [[39, 43]], "entity_1_idx_in_text_with_entity_marker": [43, 47], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "DNA polymerase delta", "entity_2_idx": [[56, 76]], "entity_2_idx_in_text_with_entity_marker": [69, 89], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d118.s1003_AIMed.d118.s1003.p0", "text": "This regulation results from a direct interaction between p21 and PCNA.", "text_with_entity_marker": "This regulation results from a direct interaction between [E1]p21[/E1] and [E2]PCNA[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "p21", "entity_1_idx": [[58, 61]], "entity_1_idx_in_text_with_entity_marker": [62, 65], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "PCNA", "entity_2_idx": [[66, 70]], "entity_2_idx_in_text_with_entity_marker": [79, 83], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d187.s1585_AIMed.d187.s1585.p0", "text": "Interaction of transthyretin with amyloid beta-protein: binding and inhibition of amyloid formation.", "text_with_entity_marker": "Interaction of [E1]transthyretin[/E1] with [E2]amyloid beta-protein[/E2]: binding and inhibition of amyloid formation.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "transthyretin", "entity_1_idx": [[15, 28]], "entity_1_idx_in_text_with_entity_marker": [19, 32], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "amyloid beta-protein", "entity_2_idx": [[34, 54]], "entity_2_idx_in_text_with_entity_marker": [47, 67], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d187.s1589_AIMed.d187.s1589.p1", "text": "Transthyretin (TTR), a second major CSF protein, formed SDS-stable complexes with A beta and significantly decreased the rate of A beta fibril formation.", "text_with_entity_marker": "[E1]Transthyretin[/E1] (TTR), a second major CSF protein, formed SDS-stable complexes with [E2]A beta[/E2] and significantly decreased the rate of A beta fibril formation.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Transthyretin", "entity_1_idx": [[0, 13]], "entity_1_idx_in_text_with_entity_marker": [4, 17], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "A beta", "entity_2_idx": [[82, 88]], "entity_2_idx_in_text_with_entity_marker": [95, 101], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d187.s1589_AIMed.d187.s1589.p3", "text": "Transthyretin (TTR), a second major CSF protein, formed SDS-stable complexes with A beta and significantly decreased the rate of A beta fibril formation.", "text_with_entity_marker": "Transthyretin ([E1]TTR[/E1]), a second major CSF protein, formed SDS-stable complexes with [E2]A beta[/E2] and significantly decreased the rate of A beta fibril formation.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "TTR", "entity_1_idx": [[15, 18]], "entity_1_idx_in_text_with_entity_marker": [19, 22], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "A beta", "entity_2_idx": [[82, 88]], "entity_2_idx_in_text_with_entity_marker": [95, 101], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d187.s1592_AIMed.d187.s1592.p0", "text": "Using site-directed mutagenesis and computer-assisted modelling, we identified amino acid residues on the surface of the TTR monomer that interact with A beta.", "text_with_entity_marker": "Using site-directed mutagenesis and computer-assisted modelling, we identified amino acid residues on the surface of the [E1]TTR[/E1] monomer that interact with [E2]A beta[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "TTR", "entity_1_idx": [[121, 124]], "entity_1_idx_in_text_with_entity_marker": [125, 128], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "A beta", "entity_2_idx": [[152, 158]], "entity_2_idx_in_text_with_entity_marker": [165, 171], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d216.s1872_AIMed.d216.s1872.p0", "text": "The Ras-RasGAP complex: structural basis for GTPase activation and its loss in oncogenic Ras mutants.", "text_with_entity_marker": "The [E1]Ras[/E1]-[E2]RasGAP[/E2] complex: structural basis for GTPase activation and its loss in oncogenic Ras mutants.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Ras", "entity_1_idx": [[4, 7]], "entity_1_idx_in_text_with_entity_marker": [8, 11], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "RasGAP", "entity_2_idx": [[8, 14]], "entity_2_idx_in_text_with_entity_marker": [21, 27], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d216.s1873_AIMed.d216.s1873.p1", "text": "The three-dimensional structure of the complex between human H-Ras bound to guanosine diphosphate and the guanosine triphosphatase (GTPase)-activating domain of the human GTPase-activating protein p120GAP (GAP-334) in the presence of aluminum fluoride was solved at a resolution of 2.5 angstroms.", "text_with_entity_marker": "The three-dimensional structure of the complex between human [E1]H-Ras[/E1] bound to guanosine diphosphate and the guanosine triphosphatase (GTPase)-activating domain of the human GTPase-activating protein [E2]p120GAP[/E2] (GAP-334) in the presence of aluminum fluoride was solved at a resolution of 2.5 angstroms.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "H-Ras", "entity_1_idx": [[61, 66]], "entity_1_idx_in_text_with_entity_marker": [65, 70], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p120GAP", "entity_2_idx": [[197, 204]], "entity_2_idx_in_text_with_entity_marker": [210, 217], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d216.s1873_AIMed.d216.s1873.p2", "text": "The three-dimensional structure of the complex between human H-Ras bound to guanosine diphosphate and the guanosine triphosphatase (GTPase)-activating domain of the human GTPase-activating protein p120GAP (GAP-334) in the presence of aluminum fluoride was solved at a resolution of 2.5 angstroms.", "text_with_entity_marker": "The three-dimensional structure of the complex between human [E1]H-Ras[/E1] bound to guanosine diphosphate and the guanosine triphosphatase (GTPase)-activating domain of the human GTPase-activating protein p120GAP ([E2]GAP-334[/E2]) in the presence of aluminum fluoride was solved at a resolution of 2.5 angstroms.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "H-Ras", "entity_1_idx": [[61, 66]], "entity_1_idx_in_text_with_entity_marker": [65, 70], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "GAP-334", "entity_2_idx": [[206, 213]], "entity_2_idx_in_text_with_entity_marker": [219, 226], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d216.s1876_AIMed.d216.s1876.p0", "text": "The switch II region of Ras is stabilized by GAP-334, thus allowing glutamine-61 of Ras, mutation of which activates the oncogenic potential, to participate in catalysis.", "text_with_entity_marker": "The switch II region of [E1]Ras[/E1] is stabilized by [E2]GAP-334[/E2], thus allowing glutamine-61 of Ras, mutation of which activates the oncogenic potential, to participate in catalysis.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Ras", "entity_1_idx": [[24, 27]], "entity_1_idx_in_text_with_entity_marker": [28, 31], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "GAP-334", "entity_2_idx": [[45, 52]], "entity_2_idx_in_text_with_entity_marker": [58, 65], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d203.s1746_AIMed.d203.s1746.p0", "text": "A new cytokine-receptor binding mode revealed by the crystal structure of the IL-1 receptor with an antagonist.", "text_with_entity_marker": "A new cytokine-receptor binding mode revealed by the crystal structure of the [E1-E2]IL-1[/E1] receptor[/E2] with an antagonist.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-1", "entity_1_idx": [[78, 82]], "entity_1_idx_in_text_with_entity_marker": [85, 89], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-1[/E1] receptor", "entity_2_idx": [[78, 91]], "entity_2_idx_in_text_with_entity_marker": [85, 103], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d203.s1747_AIMed.d203.s1747.p0", "text": "Inflammation, regardless of whether it is provoked by infection or by tissue damage, starts with the activation of macrophages which initiate a cascade of inflammatory responses by producing the cytokines interleukin-1 (IL-1) and tumour necrosis factor-alpha (ref. 1).", "text_with_entity_marker": "Inflammation, regardless of whether it is provoked by infection or by tissue damage, starts with the activation of macrophages which initiate a cascade of inflammatory responses by producing the cytokines [E1]interleukin-1[/E1] ([E2]IL-1[/E2]) and tumour necrosis factor-alpha (ref. 1).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "interleukin-1", "entity_1_idx": [[205, 218]], "entity_1_idx_in_text_with_entity_marker": [209, 222], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-1", "entity_2_idx": [[220, 224]], "entity_2_idx_in_text_with_entity_marker": [233, 237], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d203.s1747_AIMed.d203.s1747.p1", "text": "Inflammation, regardless of whether it is provoked by infection or by tissue damage, starts with the activation of macrophages which initiate a cascade of inflammatory responses by producing the cytokines interleukin-1 (IL-1) and tumour necrosis factor-alpha (ref. 1).", "text_with_entity_marker": "Inflammation, regardless of whether it is provoked by infection or by tissue damage, starts with the activation of macrophages which initiate a cascade of inflammatory responses by producing the cytokines [E1]interleukin-1[/E1] (IL-1) and [E2]tumour necrosis factor-alpha[/E2] (ref. 1).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "interleukin-1", "entity_1_idx": [[205, 218]], "entity_1_idx_in_text_with_entity_marker": [209, 222], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "tumour necrosis factor-alpha", "entity_2_idx": [[230, 258]], "entity_2_idx_in_text_with_entity_marker": [243, 271], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d203.s1747_AIMed.d203.s1747.p2", "text": "Inflammation, regardless of whether it is provoked by infection or by tissue damage, starts with the activation of macrophages which initiate a cascade of inflammatory responses by producing the cytokines interleukin-1 (IL-1) and tumour necrosis factor-alpha (ref. 1).", "text_with_entity_marker": "Inflammation, regardless of whether it is provoked by infection or by tissue damage, starts with the activation of macrophages which initiate a cascade of inflammatory responses by producing the cytokines interleukin-1 ([E1]IL-1[/E1]) and [E2]tumour necrosis factor-alpha[/E2] (ref. 1).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-1", "entity_1_idx": [[220, 224]], "entity_1_idx_in_text_with_entity_marker": [224, 228], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "tumour necrosis factor-alpha", "entity_2_idx": [[230, 258]], "entity_2_idx_in_text_with_entity_marker": [243, 271], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d203.s1754_AIMed.d203.s1754.p0", "text": "A region that is important for biological function in IL-1beta, the 'receptor trigger site' is not in direct contact with the receptor in the IL1RA complex.", "text_with_entity_marker": "A region that is important for biological function in [E1]IL-1beta[/E1], the 'receptor trigger site' is not in direct contact with the receptor in the [E2]IL1RA[/E2] complex.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-1beta", "entity_1_idx": [[54, 62]], "entity_1_idx_in_text_with_entity_marker": [58, 66], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL1RA", "entity_2_idx": [[142, 147]], "entity_2_idx_in_text_with_entity_marker": [155, 160], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d90.s767_AIMed.d90.s767.p0", "text": "Using radiolabeled PU.1 protein as a probe, we screened a B cell cDNA expression library and isolated a number of clones encoding PU.1 interacting proteins.", "text_with_entity_marker": "Using radiolabeled [E1]PU.1[/E1] protein as a probe, we screened a B cell cDNA expression library and isolated a number of clones encoding [E2]PU.1[/E2] interacting proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "PU.1", "entity_1_idx": [[19, 23]], "entity_1_idx_in_text_with_entity_marker": [23, 27], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "PU.1", "entity_2_idx": [[130, 134]], "entity_2_idx_in_text_with_entity_marker": [143, 147], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d90.s768_AIMed.d90.s768.p0", "text": "Three of these clones encode DNA binding proteins (NF-IL6 beta, HMG I/Y, and SSRP), one clone encodes a chaperone protein, and another clone encodes a multifunctional phosphatase.", "text_with_entity_marker": "Three of these clones encode DNA binding proteins ([E1]NF-IL6 beta[/E1], [E2]HMG I/Y[/E2], and SSRP), one clone encodes a chaperone protein, and another clone encodes a multifunctional phosphatase.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "NF-IL6 beta", "entity_1_idx": [[51, 62]], "entity_1_idx_in_text_with_entity_marker": [55, 66], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "HMG I/Y", "entity_2_idx": [[64, 71]], "entity_2_idx_in_text_with_entity_marker": [77, 84], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d90.s768_AIMed.d90.s768.p1", "text": "Three of these clones encode DNA binding proteins (NF-IL6 beta, HMG I/Y, and SSRP), one clone encodes a chaperone protein, and another clone encodes a multifunctional phosphatase.", "text_with_entity_marker": "Three of these clones encode DNA binding proteins ([E1]NF-IL6 beta[/E1], HMG I/Y, and [E2]SSRP[/E2]), one clone encodes a chaperone protein, and another clone encodes a multifunctional phosphatase.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "NF-IL6 beta", "entity_1_idx": [[51, 62]], "entity_1_idx_in_text_with_entity_marker": [55, 66], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "SSRP", "entity_2_idx": [[77, 81]], "entity_2_idx_in_text_with_entity_marker": [90, 94], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d90.s768_AIMed.d90.s768.p2", "text": "Three of these clones encode DNA binding proteins (NF-IL6 beta, HMG I/Y, and SSRP), one clone encodes a chaperone protein, and another clone encodes a multifunctional phosphatase.", "text_with_entity_marker": "Three of these clones encode DNA binding proteins (NF-IL6 beta, [E1]HMG I/Y[/E1], and [E2]SSRP[/E2]), one clone encodes a chaperone protein, and another clone encodes a multifunctional phosphatase.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "HMG I/Y", "entity_1_idx": [[64, 71]], "entity_1_idx_in_text_with_entity_marker": [68, 75], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "SSRP", "entity_2_idx": [[77, 81]], "entity_2_idx_in_text_with_entity_marker": [90, 94], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d133.s1133_AIMed.d133.s1133.p0", "text": "The ultraviolet (UV) response of mammalian cells is characterized by a rapid and selective increase in gene expression mediated by AP-1 and NF-kappa B.", "text_with_entity_marker": "The ultraviolet (UV) response of mammalian cells is characterized by a rapid and selective increase in gene expression mediated by [E1]AP-1[/E1] and [E2]NF-kappa B[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "AP-1", "entity_1_idx": [[131, 135]], "entity_1_idx_in_text_with_entity_marker": [135, 139], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "NF-kappa B", "entity_2_idx": [[140, 150]], "entity_2_idx_in_text_with_entity_marker": [153, 163], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d133.s1134_AIMed.d133.s1134.p0", "text": "The effect on AP-1 transcriptional activity results, in part, from enhanced phosphorylation of the c-Jun NH2-terminal activation domain.", "text_with_entity_marker": "The effect on [E1]AP-1[/E1] transcriptional activity results, in part, from enhanced phosphorylation of the [E2]c-Jun[/E2] NH2-terminal activation domain.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "AP-1", "entity_1_idx": [[14, 18]], "entity_1_idx_in_text_with_entity_marker": [18, 22], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "c-Jun", "entity_2_idx": [[99, 104]], "entity_2_idx_in_text_with_entity_marker": [112, 117], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1529_AIMed.d179.s1529.p0", "text": "Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin/CCKB G protein-coupled receptor and the insulin receptor.", "text_with_entity_marker": "Taken together, our results suggest that [E1]IRS-1[/E1] may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the [E2]gastrin[/E2]/CCKB G protein-coupled receptor and the insulin receptor.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IRS-1", "entity_1_idx": [[41, 46]], "entity_1_idx_in_text_with_entity_marker": [45, 50], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "gastrin", "entity_2_idx": [[177, 184]], "entity_2_idx_in_text_with_entity_marker": [190, 197], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1529_AIMed.d179.s1529.p1", "text": "Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin/CCKB G protein-coupled receptor and the insulin receptor.", "text_with_entity_marker": "Taken together, our results suggest that [E1]IRS-1[/E1] may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin/[E2]CCKB[/E2] G protein-coupled receptor and the insulin receptor.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IRS-1", "entity_1_idx": [[41, 46]], "entity_1_idx_in_text_with_entity_marker": [45, 50], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CCKB", "entity_2_idx": [[185, 189]], "entity_2_idx_in_text_with_entity_marker": [198, 202], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1529_AIMed.d179.s1529.p2", "text": "Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin/CCKB G protein-coupled receptor and the insulin receptor.", "text_with_entity_marker": "Taken together, our results suggest that [E1]IRS-1[/E1] may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin/[E2]CCKB G protein-coupled receptor[/E2] and the insulin receptor.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IRS-1", "entity_1_idx": [[41, 46]], "entity_1_idx_in_text_with_entity_marker": [45, 50], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CCKB G protein-coupled receptor", "entity_2_idx": [[185, 216]], "entity_2_idx_in_text_with_entity_marker": [198, 229], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1529_AIMed.d179.s1529.p3", "text": "Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin/CCKB G protein-coupled receptor and the insulin receptor.", "text_with_entity_marker": "Taken together, our results suggest that [E1]IRS-1[/E1] may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin/CCKB G protein-coupled receptor and the [E2]insulin[/E2] receptor.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IRS-1", "entity_1_idx": [[41, 46]], "entity_1_idx_in_text_with_entity_marker": [45, 50], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[225, 232]], "entity_2_idx_in_text_with_entity_marker": [238, 245], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1529_AIMed.d179.s1529.p4", "text": "Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin/CCKB G protein-coupled receptor and the insulin receptor.", "text_with_entity_marker": "Taken together, our results suggest that [E1]IRS-1[/E1] may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin/CCKB G protein-coupled receptor and the [E2]insulin receptor[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IRS-1", "entity_1_idx": [[41, 46]], "entity_1_idx_in_text_with_entity_marker": [45, 50], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "insulin receptor", "entity_2_idx": [[225, 241]], "entity_2_idx_in_text_with_entity_marker": [238, 254], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1529_AIMed.d179.s1529.p5", "text": "Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin/CCKB G protein-coupled receptor and the insulin receptor.", "text_with_entity_marker": "Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the [E1]gastrin[/E1]/[E2]CCKB[/E2] G protein-coupled receptor and the insulin receptor.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "gastrin", "entity_1_idx": [[177, 184]], "entity_1_idx_in_text_with_entity_marker": [181, 188], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CCKB", "entity_2_idx": [[185, 189]], "entity_2_idx_in_text_with_entity_marker": [198, 202], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1529_AIMed.d179.s1529.p6", "text": "Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin/CCKB G protein-coupled receptor and the insulin receptor.", "text_with_entity_marker": "Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the [E1]gastrin[/E1]/[E2]CCKB G protein-coupled receptor[/E2] and the insulin receptor.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "gastrin", "entity_1_idx": [[177, 184]], "entity_1_idx_in_text_with_entity_marker": [181, 188], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CCKB G protein-coupled receptor", "entity_2_idx": [[185, 216]], "entity_2_idx_in_text_with_entity_marker": [198, 229], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1529_AIMed.d179.s1529.p7", "text": "Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin/CCKB G protein-coupled receptor and the insulin receptor.", "text_with_entity_marker": "Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the [E1]gastrin[/E1]/CCKB G protein-coupled receptor and the [E2]insulin[/E2] receptor.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "gastrin", "entity_1_idx": [[177, 184]], "entity_1_idx_in_text_with_entity_marker": [181, 188], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[225, 232]], "entity_2_idx_in_text_with_entity_marker": [238, 245], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1529_AIMed.d179.s1529.p8", "text": "Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin/CCKB G protein-coupled receptor and the insulin receptor.", "text_with_entity_marker": "Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the [E1]gastrin[/E1]/CCKB G protein-coupled receptor and the [E2]insulin receptor[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "gastrin", "entity_1_idx": [[177, 184]], "entity_1_idx_in_text_with_entity_marker": [181, 188], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "insulin receptor", "entity_2_idx": [[225, 241]], "entity_2_idx_in_text_with_entity_marker": [238, 254], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1529_AIMed.d179.s1529.p9", "text": "Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin/CCKB G protein-coupled receptor and the insulin receptor.", "text_with_entity_marker": "Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin/[E1-E2]CCKB[/E1] G protein-coupled receptor[/E2] and the insulin receptor.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "CCKB", "entity_1_idx": [[185, 189]], "entity_1_idx_in_text_with_entity_marker": [192, 196], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CCKB[/E1] G protein-coupled receptor", "entity_2_idx": [[185, 216]], "entity_2_idx_in_text_with_entity_marker": [192, 228], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1529_AIMed.d179.s1529.p10", "text": "Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin/CCKB G protein-coupled receptor and the insulin receptor.", "text_with_entity_marker": "Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin/[E1]CCKB[/E1] G protein-coupled receptor and the [E2]insulin[/E2] receptor.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "CCKB", "entity_1_idx": [[185, 189]], "entity_1_idx_in_text_with_entity_marker": [189, 193], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[225, 232]], "entity_2_idx_in_text_with_entity_marker": [238, 245], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1529_AIMed.d179.s1529.p11", "text": "Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin/CCKB G protein-coupled receptor and the insulin receptor.", "text_with_entity_marker": "Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin/[E1]CCKB[/E1] G protein-coupled receptor and the [E2]insulin receptor[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "CCKB", "entity_1_idx": [[185, 189]], "entity_1_idx_in_text_with_entity_marker": [189, 193], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "insulin receptor", "entity_2_idx": [[225, 241]], "entity_2_idx_in_text_with_entity_marker": [238, 254], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1529_AIMed.d179.s1529.p12", "text": "Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin/CCKB G protein-coupled receptor and the insulin receptor.", "text_with_entity_marker": "Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin/[E1]CCKB G protein-coupled receptor[/E1] and the [E2]insulin[/E2] receptor.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "CCKB G protein-coupled receptor", "entity_1_idx": [[185, 216]], "entity_1_idx_in_text_with_entity_marker": [189, 220], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[225, 232]], "entity_2_idx_in_text_with_entity_marker": [238, 245], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1529_AIMed.d179.s1529.p13", "text": "Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin/CCKB G protein-coupled receptor and the insulin receptor.", "text_with_entity_marker": "Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin/[E1]CCKB G protein-coupled receptor[/E1] and the [E2]insulin receptor[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "CCKB G protein-coupled receptor", "entity_1_idx": [[185, 216]], "entity_1_idx_in_text_with_entity_marker": [189, 220], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "insulin receptor", "entity_2_idx": [[225, 241]], "entity_2_idx_in_text_with_entity_marker": [238, 254], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1529_AIMed.d179.s1529.p14", "text": "Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin/CCKB G protein-coupled receptor and the insulin receptor.", "text_with_entity_marker": "Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin/CCKB G protein-coupled receptor and the [E1-E2]insulin[/E1] receptor[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "insulin", "entity_1_idx": [[225, 232]], "entity_1_idx_in_text_with_entity_marker": [232, 239], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "insulin[/E1] receptor", "entity_2_idx": [[225, 241]], "entity_2_idx_in_text_with_entity_marker": [232, 253], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d169.s1424_AIMed.d169.s1424.p0", "text": "Cloning and characterization of a specific interleukin (IL)-13 binding protein structurally related to the IL-5 receptor alpha chain.", "text_with_entity_marker": "Cloning and characterization of a specific [E1]interleukin (IL)-13[/E1] binding protein structurally related to the [E2]IL-5[/E2] receptor alpha chain.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "interleukin (IL)-13", "entity_1_idx": [[43, 62]], "entity_1_idx_in_text_with_entity_marker": [47, 66], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-5", "entity_2_idx": [[107, 111]], "entity_2_idx_in_text_with_entity_marker": [120, 124], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d169.s1424_AIMed.d169.s1424.p1", "text": "Cloning and characterization of a specific interleukin (IL)-13 binding protein structurally related to the IL-5 receptor alpha chain.", "text_with_entity_marker": "Cloning and characterization of a specific [E1]interleukin (IL)-13[/E1] binding protein structurally related to the [E2]IL-5 receptor[/E2] alpha chain.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "interleukin (IL)-13", "entity_1_idx": [[43, 62]], "entity_1_idx_in_text_with_entity_marker": [47, 66], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-5 receptor", "entity_2_idx": [[107, 120]], "entity_2_idx_in_text_with_entity_marker": [120, 133], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d169.s1424_AIMed.d169.s1424.p2", "text": "Cloning and characterization of a specific interleukin (IL)-13 binding protein structurally related to the IL-5 receptor alpha chain.", "text_with_entity_marker": "Cloning and characterization of a specific interleukin (IL)-13 binding protein structurally related to the [E1-E2]IL-5[/E1] receptor[/E2] alpha chain.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-5", "entity_1_idx": [[107, 111]], "entity_1_idx_in_text_with_entity_marker": [114, 118], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-5[/E1] receptor", "entity_2_idx": [[107, 120]], "entity_2_idx_in_text_with_entity_marker": [114, 132], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d169.s1425_AIMed.d169.s1425.p0", "text": "Interleukin-13 (IL-13) is a cytokine secreted by activated T lymphocytes that shares many, but not all, biological activities with IL-4.", "text_with_entity_marker": "[E1]Interleukin-13[/E1] ([E2]IL-13[/E2]) is a cytokine secreted by activated T lymphocytes that shares many, but not all, biological activities with IL-4.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Interleukin-13", "entity_1_idx": [[0, 14]], "entity_1_idx_in_text_with_entity_marker": [4, 18], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-13", "entity_2_idx": [[16, 21]], "entity_2_idx_in_text_with_entity_marker": [29, 34], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d169.s1425_AIMed.d169.s1425.p1", "text": "Interleukin-13 (IL-13) is a cytokine secreted by activated T lymphocytes that shares many, but not all, biological activities with IL-4.", "text_with_entity_marker": "[E1]Interleukin-13[/E1] (IL-13) is a cytokine secreted by activated T lymphocytes that shares many, but not all, biological activities with [E2]IL-4[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Interleukin-13", "entity_1_idx": [[0, 14]], "entity_1_idx_in_text_with_entity_marker": [4, 18], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-4", "entity_2_idx": [[131, 135]], "entity_2_idx_in_text_with_entity_marker": [144, 148], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d169.s1425_AIMed.d169.s1425.p2", "text": "Interleukin-13 (IL-13) is a cytokine secreted by activated T lymphocytes that shares many, but not all, biological activities with IL-4.", "text_with_entity_marker": "Interleukin-13 ([E1]IL-13[/E1]) is a cytokine secreted by activated T lymphocytes that shares many, but not all, biological activities with [E2]IL-4[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-13", "entity_1_idx": [[16, 21]], "entity_1_idx_in_text_with_entity_marker": [20, 25], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-4", "entity_2_idx": [[131, 135]], "entity_2_idx_in_text_with_entity_marker": [144, 148], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d169.s1430_AIMed.d169.s1430.p0", "text": "The IL-13R shows homology with the IL-5 receptor, and to a lesser extent, with the prolactin receptor.", "text_with_entity_marker": "The [E1]IL-13R[/E1] shows homology with the [E2]IL-5[/E2] receptor, and to a lesser extent, with the prolactin receptor.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-13R", "entity_1_idx": [[4, 10]], "entity_1_idx_in_text_with_entity_marker": [8, 14], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-5", "entity_2_idx": [[35, 39]], "entity_2_idx_in_text_with_entity_marker": [48, 52], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d169.s1432_AIMed.d169.s1432.p0", "text": "COS-7 cells co-transfected with the cloned IL-13R cDNA and IL-4R cDNA resulted in the reconstitution of a small number of receptors that recognized both IL-4 and IL-13.", "text_with_entity_marker": "COS-7 cells co-transfected with the cloned [E1]IL-13R[/E1] cDNA and [E2]IL-4R[/E2] cDNA resulted in the reconstitution of a small number of receptors that recognized both IL-4 and IL-13.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-13R", "entity_1_idx": [[43, 49]], "entity_1_idx_in_text_with_entity_marker": [47, 53], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-4R", "entity_2_idx": [[59, 64]], "entity_2_idx_in_text_with_entity_marker": [72, 77], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d169.s1432_AIMed.d169.s1432.p1", "text": "COS-7 cells co-transfected with the cloned IL-13R cDNA and IL-4R cDNA resulted in the reconstitution of a small number of receptors that recognized both IL-4 and IL-13.", "text_with_entity_marker": "COS-7 cells co-transfected with the cloned [E1]IL-13R[/E1] cDNA and IL-4R cDNA resulted in the reconstitution of a small number of receptors that recognized both [E2]IL-4[/E2] and IL-13.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-13R", "entity_1_idx": [[43, 49]], "entity_1_idx_in_text_with_entity_marker": [47, 53], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-4", "entity_2_idx": [[153, 157]], "entity_2_idx_in_text_with_entity_marker": [166, 170], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d169.s1432_AIMed.d169.s1432.p2", "text": "COS-7 cells co-transfected with the cloned IL-13R cDNA and IL-4R cDNA resulted in the reconstitution of a small number of receptors that recognized both IL-4 and IL-13.", "text_with_entity_marker": "COS-7 cells co-transfected with the cloned [E1]IL-13R[/E1] cDNA and IL-4R cDNA resulted in the reconstitution of a small number of receptors that recognized both IL-4 and [E2]IL-13[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-13R", "entity_1_idx": [[43, 49]], "entity_1_idx_in_text_with_entity_marker": [47, 53], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-13", "entity_2_idx": [[162, 167]], "entity_2_idx_in_text_with_entity_marker": [175, 180], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d169.s1432_AIMed.d169.s1432.p3", "text": "COS-7 cells co-transfected with the cloned IL-13R cDNA and IL-4R cDNA resulted in the reconstitution of a small number of receptors that recognized both IL-4 and IL-13.", "text_with_entity_marker": "COS-7 cells co-transfected with the cloned IL-13R cDNA and [E1]IL-4R[/E1] cDNA resulted in the reconstitution of a small number of receptors that recognized both [E2]IL-4[/E2] and IL-13.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-4R", "entity_1_idx": [[59, 64]], "entity_1_idx_in_text_with_entity_marker": [63, 68], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-4", "entity_2_idx": [[153, 157]], "entity_2_idx_in_text_with_entity_marker": [166, 170], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d169.s1432_AIMed.d169.s1432.p4", "text": "COS-7 cells co-transfected with the cloned IL-13R cDNA and IL-4R cDNA resulted in the reconstitution of a small number of receptors that recognized both IL-4 and IL-13.", "text_with_entity_marker": "COS-7 cells co-transfected with the cloned IL-13R cDNA and [E1]IL-4R[/E1] cDNA resulted in the reconstitution of a small number of receptors that recognized both IL-4 and [E2]IL-13[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-4R", "entity_1_idx": [[59, 64]], "entity_1_idx_in_text_with_entity_marker": [63, 68], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-13", "entity_2_idx": [[162, 167]], "entity_2_idx_in_text_with_entity_marker": [175, 180], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d169.s1432_AIMed.d169.s1432.p5", "text": "COS-7 cells co-transfected with the cloned IL-13R cDNA and IL-4R cDNA resulted in the reconstitution of a small number of receptors that recognized both IL-4 and IL-13.", "text_with_entity_marker": "COS-7 cells co-transfected with the cloned IL-13R cDNA and IL-4R cDNA resulted in the reconstitution of a small number of receptors that recognized both [E1]IL-4[/E1] and [E2]IL-13[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-4", "entity_1_idx": [[153, 157]], "entity_1_idx_in_text_with_entity_marker": [157, 161], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-13", "entity_2_idx": [[162, 167]], "entity_2_idx_in_text_with_entity_marker": [175, 180], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d138.s1170_AIMed.d138.s1170.p0", "text": "Furthermore, the 60-kilodalton subunit of SF3a is related to the yeast splicing protein PRP9.", "text_with_entity_marker": "Furthermore, the 60-kilodalton subunit of [E1]SF3a[/E1] is related to the yeast splicing protein [E2]PRP9[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "SF3a", "entity_1_idx": [[42, 46]], "entity_1_idx_in_text_with_entity_marker": [46, 50], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "PRP9", "entity_2_idx": [[88, 92]], "entity_2_idx_in_text_with_entity_marker": [101, 105], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d79.s676_AIMed.d79.s676.p0", "text": "It contains an Rb-binding motif that shares an antigenic epitope with the C terminus of E1A.", "text_with_entity_marker": "It contains an [E1]Rb[/E1]-binding motif that shares an antigenic epitope with the C terminus of [E2]E1A[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Rb", "entity_1_idx": [[15, 17]], "entity_1_idx_in_text_with_entity_marker": [19, 21], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "E1A", "entity_2_idx": [[88, 91]], "entity_2_idx_in_text_with_entity_marker": [101, 104], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d79.s677_AIMed.d79.s677.p0", "text": "A domain is conserved between RIZ and the PRDI-BF1/Blimp-1 differentiation factor.", "text_with_entity_marker": "A domain is conserved between [E1]RIZ[/E1] and the [E2]PRDI-BF1[/E2]/Blimp-1 differentiation factor.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RIZ", "entity_1_idx": [[30, 33]], "entity_1_idx_in_text_with_entity_marker": [34, 37], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "PRDI-BF1", "entity_2_idx": [[42, 50]], "entity_2_idx_in_text_with_entity_marker": [55, 63], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d79.s677_AIMed.d79.s677.p1", "text": "A domain is conserved between RIZ and the PRDI-BF1/Blimp-1 differentiation factor.", "text_with_entity_marker": "A domain is conserved between [E1]RIZ[/E1] and the PRDI-BF1/[E2]Blimp-1[/E2] differentiation factor.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RIZ", "entity_1_idx": [[30, 33]], "entity_1_idx_in_text_with_entity_marker": [34, 37], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Blimp-1", "entity_2_idx": [[51, 58]], "entity_2_idx_in_text_with_entity_marker": [64, 71], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d79.s677_AIMed.d79.s677.p2", "text": "A domain is conserved between RIZ and the PRDI-BF1/Blimp-1 differentiation factor.", "text_with_entity_marker": "A domain is conserved between RIZ and the [E1]PRDI-BF1[/E1]/[E2]Blimp-1[/E2] differentiation factor.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "PRDI-BF1", "entity_1_idx": [[42, 50]], "entity_1_idx_in_text_with_entity_marker": [46, 54], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Blimp-1", "entity_2_idx": [[51, 58]], "entity_2_idx_in_text_with_entity_marker": [64, 71], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d79.s681_AIMed.d79.s681.p0", "text": "While the function of RIZ is not yet clear, its structure and pattern of expression suggest a role for RIZ in transcriptional regulation during neuronal differentiation and pathogenesis of retinoblastoma.", "text_with_entity_marker": "While the function of [E1]RIZ[/E1] is not yet clear, its structure and pattern of expression suggest a role for [E2]RIZ[/E2] in transcriptional regulation during neuronal differentiation and pathogenesis of retinoblastoma.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RIZ", "entity_1_idx": [[22, 25]], "entity_1_idx_in_text_with_entity_marker": [26, 29], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "RIZ", "entity_2_idx": [[103, 106]], "entity_2_idx_in_text_with_entity_marker": [116, 119], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d157.s1330_AIMed.d157.s1330.p0", "text": "The subcellular distributions of PKC and AKAP79 were similar in neurons.", "text_with_entity_marker": "The subcellular distributions of [E1]PKC[/E1] and [E2]AKAP79[/E2] were similar in neurons.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "PKC", "entity_1_idx": [[33, 36]], "entity_1_idx_in_text_with_entity_marker": [37, 40], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "AKAP79", "entity_2_idx": [[41, 47]], "entity_2_idx_in_text_with_entity_marker": [54, 60], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d10.s81_AIMed.d10.s81.p0", "text": "BMP-4 and BMP-6 involvement in the osteogenic properties of the HeLa cell line.", "text_with_entity_marker": "[E1]BMP-4[/E1] and [E2]BMP-6[/E2] involvement in the osteogenic properties of the HeLa cell line.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "BMP-4", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "BMP-6", "entity_2_idx": [[10, 15]], "entity_2_idx_in_text_with_entity_marker": [23, 28], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d10.s84_AIMed.d10.s84.p0", "text": "We postulate that the mechanism of bone induction is based on the secretion of bone morphogenetic proteins BMP-4 and BMP-6 by the grafted HeLa cells.", "text_with_entity_marker": "We postulate that the mechanism of bone induction is based on the secretion of bone morphogenetic proteins [E1]BMP-4[/E1] and [E2]BMP-6[/E2] by the grafted HeLa cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "BMP-4", "entity_1_idx": [[107, 112]], "entity_1_idx_in_text_with_entity_marker": [111, 116], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "BMP-6", "entity_2_idx": [[117, 122]], "entity_2_idx_in_text_with_entity_marker": [130, 135], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d116.s978_AIMed.d116.s978.p0", "text": "The protein encoded by the retinoblastoma susceptibility gene (Rb) functions as a tumour suppressor and negative growth regulator.", "text_with_entity_marker": "The protein encoded by the [E1]retinoblastoma susceptibility gene[/E1] ([E2]Rb[/E2]) functions as a tumour suppressor and negative growth regulator.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "retinoblastoma susceptibility gene", "entity_1_idx": [[27, 61]], "entity_1_idx_in_text_with_entity_marker": [31, 65], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Rb", "entity_2_idx": [[63, 65]], "entity_2_idx_in_text_with_entity_marker": [76, 78], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d116.s982_AIMed.d116.s982.p0", "text": "These results indicate that there is an additional mechanism by which Rb suppresses cell growth, namely that Rb directly represses transcription of the rRNA genes.", "text_with_entity_marker": "These results indicate that there is an additional mechanism by which [E1]Rb[/E1] suppresses cell growth, namely that [E2]Rb[/E2] directly represses transcription of the rRNA genes.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Rb", "entity_1_idx": [[70, 72]], "entity_1_idx_in_text_with_entity_marker": [74, 76], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Rb", "entity_2_idx": [[109, 111]], "entity_2_idx_in_text_with_entity_marker": [122, 124], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d114.s964_AIMed.d114.s964.p0", "text": "We expressed the cDNA of human beta 1-syntrophin and the COOH terminus of human dystrophin in reticulocyte lysates using an in vitro transcription/translation system.", "text_with_entity_marker": "We expressed the cDNA of human [E1]beta 1-syntrophin[/E1] and the COOH terminus of human [E2]dystrophin[/E2] in reticulocyte lysates using an in vitro transcription/translation system.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "beta 1-syntrophin", "entity_1_idx": [[31, 48]], "entity_1_idx_in_text_with_entity_marker": [35, 52], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "dystrophin", "entity_2_idx": [[80, 90]], "entity_2_idx_in_text_with_entity_marker": [93, 103], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d156.s1323_AIMed.d156.s1323.p0", "text": "A protein kinase designated IRAK (IL-1 receptor-associated kinase) was purified, and its complementary DNA was molecularly cloned.", "text_with_entity_marker": "A protein kinase designated [E1]IRAK[/E1] ([E2]IL-1[/E2] receptor-associated kinase) was purified, and its complementary DNA was molecularly cloned.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IRAK", "entity_1_idx": [[28, 32]], "entity_1_idx_in_text_with_entity_marker": [32, 36], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-1", "entity_2_idx": [[34, 38]], "entity_2_idx_in_text_with_entity_marker": [47, 51], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d156.s1323_AIMed.d156.s1323.p1", "text": "A protein kinase designated IRAK (IL-1 receptor-associated kinase) was purified, and its complementary DNA was molecularly cloned.", "text_with_entity_marker": "A protein kinase designated [E1]IRAK[/E1] ([E2]IL-1 receptor-associated kinase[/E2]) was purified, and its complementary DNA was molecularly cloned.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IRAK", "entity_1_idx": [[28, 32]], "entity_1_idx_in_text_with_entity_marker": [32, 36], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-1 receptor-associated kinase", "entity_2_idx": [[34, 65]], "entity_2_idx_in_text_with_entity_marker": [47, 78], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d156.s1323_AIMed.d156.s1323.p2", "text": "A protein kinase designated IRAK (IL-1 receptor-associated kinase) was purified, and its complementary DNA was molecularly cloned.", "text_with_entity_marker": "A protein kinase designated IRAK ([E1-E2]IL-1[/E1] receptor-associated kinase[/E2]) was purified, and its complementary DNA was molecularly cloned.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-1", "entity_1_idx": [[34, 38]], "entity_1_idx_in_text_with_entity_marker": [41, 45], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-1[/E1] receptor-associated kinase", "entity_2_idx": [[34, 65]], "entity_2_idx_in_text_with_entity_marker": [41, 77], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d156.s1325_AIMed.d156.s1325.p0", "text": "The primary amino acid sequence of IRAK shares similarity with that of pelle,a protein kinase that is essential for the activation of a NF-kappa B homolog in Drosophila.", "text_with_entity_marker": "The primary amino acid sequence of [E1]IRAK[/E1] shares similarity with that of pelle,a protein kinase that is essential for the activation of a [E2]NF-kappa B[/E2] homolog in Drosophila.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IRAK", "entity_1_idx": [[35, 39]], "entity_1_idx_in_text_with_entity_marker": [39, 43], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "NF-kappa B", "entity_2_idx": [[136, 146]], "entity_2_idx_in_text_with_entity_marker": [149, 159], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d12.s96_AIMed.d12.s96.p0", "text": "Soluble interleukin 2 receptor and interleukin 1alpha in toxic epidermal necrolysis: a comparative analysis of serum and blister fluid samples.", "text_with_entity_marker": "Soluble [E1-E2]interleukin 2[/E1] receptor[/E2] and interleukin 1alpha in toxic epidermal necrolysis: a comparative analysis of serum and blister fluid samples.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "interleukin 2", "entity_1_idx": [[8, 21]], "entity_1_idx_in_text_with_entity_marker": [15, 28], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "interleukin 2[/E1] receptor", "entity_2_idx": [[8, 30]], "entity_2_idx_in_text_with_entity_marker": [15, 42], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d12.s96_AIMed.d12.s96.p1", "text": "Soluble interleukin 2 receptor and interleukin 1alpha in toxic epidermal necrolysis: a comparative analysis of serum and blister fluid samples.", "text_with_entity_marker": "Soluble [E1]interleukin 2[/E1] receptor and [E2]interleukin 1alpha[/E2] in toxic epidermal necrolysis: a comparative analysis of serum and blister fluid samples.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "interleukin 2", "entity_1_idx": [[8, 21]], "entity_1_idx_in_text_with_entity_marker": [12, 25], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "interleukin 1alpha", "entity_2_idx": [[35, 53]], "entity_2_idx_in_text_with_entity_marker": [48, 66], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d12.s96_AIMed.d12.s96.p2", "text": "Soluble interleukin 2 receptor and interleukin 1alpha in toxic epidermal necrolysis: a comparative analysis of serum and blister fluid samples.", "text_with_entity_marker": "Soluble [E1]interleukin 2 receptor[/E1] and [E2]interleukin 1alpha[/E2] in toxic epidermal necrolysis: a comparative analysis of serum and blister fluid samples.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "interleukin 2 receptor", "entity_1_idx": [[8, 30]], "entity_1_idx_in_text_with_entity_marker": [12, 34], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "interleukin 1alpha", "entity_2_idx": [[35, 53]], "entity_2_idx_in_text_with_entity_marker": [48, 66], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d12.s102_AIMed.d12.s102.p0", "text": "MAIN OUTCOME MEASURES: Measurement of soluble interleukin (IL) 2 receptor (sIL-2R) and IL-1alpha in serum samples and fluid of recent blisters.", "text_with_entity_marker": "MAIN OUTCOME MEASURES: Measurement of soluble [E1]interleukin (IL) 2 receptor[/E1] ([E2]sIL-2R[/E2]) and IL-1alpha in serum samples and fluid of recent blisters.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "interleukin (IL) 2 receptor", "entity_1_idx": [[46, 73]], "entity_1_idx_in_text_with_entity_marker": [50, 77], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "sIL-2R", "entity_2_idx": [[75, 81]], "entity_2_idx_in_text_with_entity_marker": [88, 94], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d12.s102_AIMed.d12.s102.p1", "text": "MAIN OUTCOME MEASURES: Measurement of soluble interleukin (IL) 2 receptor (sIL-2R) and IL-1alpha in serum samples and fluid of recent blisters.", "text_with_entity_marker": "MAIN OUTCOME MEASURES: Measurement of soluble [E1]interleukin (IL) 2 receptor[/E1] (sIL-2R) and [E2]IL-1alpha[/E2] in serum samples and fluid of recent blisters.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "interleukin (IL) 2 receptor", "entity_1_idx": [[46, 73]], "entity_1_idx_in_text_with_entity_marker": [50, 77], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-1alpha", "entity_2_idx": [[87, 96]], "entity_2_idx_in_text_with_entity_marker": [100, 109], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d12.s102_AIMed.d12.s102.p2", "text": "MAIN OUTCOME MEASURES: Measurement of soluble interleukin (IL) 2 receptor (sIL-2R) and IL-1alpha in serum samples and fluid of recent blisters.", "text_with_entity_marker": "MAIN OUTCOME MEASURES: Measurement of soluble interleukin (IL) 2 receptor ([E1]sIL-2R[/E1]) and [E2]IL-1alpha[/E2] in serum samples and fluid of recent blisters.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "sIL-2R", "entity_1_idx": [[75, 81]], "entity_1_idx_in_text_with_entity_marker": [79, 85], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-1alpha", "entity_2_idx": [[87, 96]], "entity_2_idx_in_text_with_entity_marker": [100, 109], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d12.s103_AIMed.d12.s103.p0", "text": "RESULTS: In the blister fluid of patients with TEN, we found significantly higher levels of sIL-2R than in patients with burns, whereas IL-1alpha levels were higher in the blister fluid of burned patients.", "text_with_entity_marker": "RESULTS: In the blister fluid of patients with TEN, we found significantly higher levels of [E1]sIL-2R[/E1] than in patients with burns, whereas [E2]IL-1alpha[/E2] levels were higher in the blister fluid of burned patients.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "sIL-2R", "entity_1_idx": [[92, 98]], "entity_1_idx_in_text_with_entity_marker": [96, 102], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-1alpha", "entity_2_idx": [[136, 145]], "entity_2_idx_in_text_with_entity_marker": [149, 158], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d12.s104_AIMed.d12.s104.p0", "text": "No significant differences were found in serum samples of patients with TEN and burns, in either sIL-2R or IL-1alpha.", "text_with_entity_marker": "No significant differences were found in serum samples of patients with TEN and burns, in either [E1]sIL-2R[/E1] or [E2]IL-1alpha[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "sIL-2R", "entity_1_idx": [[97, 103]], "entity_1_idx_in_text_with_entity_marker": [101, 107], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-1alpha", "entity_2_idx": [[107, 116]], "entity_2_idx_in_text_with_entity_marker": [120, 129], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d12.s105_AIMed.d12.s105.p0", "text": "In TEN we also found significantly higher levels of sIL-2R in the blister fluid compared with serum samples, pointing to a predominantly local production contrasting with the low concentration of sIL-2R in the blister fluid of burned patients.", "text_with_entity_marker": "In TEN we also found significantly higher levels of [E1]sIL-2R[/E1] in the blister fluid compared with serum samples, pointing to a predominantly local production contrasting with the low concentration of [E2]sIL-2R[/E2] in the blister fluid of burned patients.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "sIL-2R", "entity_1_idx": [[52, 58]], "entity_1_idx_in_text_with_entity_marker": [56, 62], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "sIL-2R", "entity_2_idx": [[196, 202]], "entity_2_idx_in_text_with_entity_marker": [209, 215], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d131.s1119_AIMed.d131.s1119.p0", "text": "Expression cloning and characterization of a human IL-10 receptor.", "text_with_entity_marker": "Expression cloning and characterization of a human [E1-E2]IL-10[/E1] receptor[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-10", "entity_1_idx": [[51, 56]], "entity_1_idx_in_text_with_entity_marker": [58, 63], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-10[/E1] receptor", "entity_2_idx": [[51, 65]], "entity_2_idx_in_text_with_entity_marker": [58, 77], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d131.s1122_AIMed.d131.s1122.p0", "text": "Mouse IL-10 does not bind to hIL-10R, and hIL-10R-expressing Ba/F3 cells do not respond to the mouse cytokine, observations consistent with the known species specificity of IL-10.", "text_with_entity_marker": "Mouse [E1]IL-10[/E1] does not bind to [E2]hIL-10R[/E2], and hIL-10R-expressing Ba/F3 cells do not respond to the mouse cytokine, observations consistent with the known species specificity of IL-10.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-10", "entity_1_idx": [[6, 11]], "entity_1_idx_in_text_with_entity_marker": [10, 15], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hIL-10R", "entity_2_idx": [[29, 36]], "entity_2_idx_in_text_with_entity_marker": [42, 49], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d131.s1122_AIMed.d131.s1122.p1", "text": "Mouse IL-10 does not bind to hIL-10R, and hIL-10R-expressing Ba/F3 cells do not respond to the mouse cytokine, observations consistent with the known species specificity of IL-10.", "text_with_entity_marker": "Mouse [E1]IL-10[/E1] does not bind to hIL-10R, and [E2]hIL-10R[/E2]-expressing Ba/F3 cells do not respond to the mouse cytokine, observations consistent with the known species specificity of IL-10.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-10", "entity_1_idx": [[6, 11]], "entity_1_idx_in_text_with_entity_marker": [10, 15], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hIL-10R", "entity_2_idx": [[42, 49]], "entity_2_idx_in_text_with_entity_marker": [55, 62], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d131.s1122_AIMed.d131.s1122.p2", "text": "Mouse IL-10 does not bind to hIL-10R, and hIL-10R-expressing Ba/F3 cells do not respond to the mouse cytokine, observations consistent with the known species specificity of IL-10.", "text_with_entity_marker": "Mouse [E1]IL-10[/E1] does not bind to hIL-10R, and hIL-10R-expressing Ba/F3 cells do not respond to the mouse cytokine, observations consistent with the known species specificity of [E2]IL-10[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-10", "entity_1_idx": [[6, 11]], "entity_1_idx_in_text_with_entity_marker": [10, 15], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-10", "entity_2_idx": [[173, 178]], "entity_2_idx_in_text_with_entity_marker": [186, 191], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d131.s1122_AIMed.d131.s1122.p3", "text": "Mouse IL-10 does not bind to hIL-10R, and hIL-10R-expressing Ba/F3 cells do not respond to the mouse cytokine, observations consistent with the known species specificity of IL-10.", "text_with_entity_marker": "Mouse IL-10 does not bind to [E1]hIL-10R[/E1], and [E2]hIL-10R[/E2]-expressing Ba/F3 cells do not respond to the mouse cytokine, observations consistent with the known species specificity of IL-10.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "hIL-10R", "entity_1_idx": [[29, 36]], "entity_1_idx_in_text_with_entity_marker": [33, 40], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hIL-10R", "entity_2_idx": [[42, 49]], "entity_2_idx_in_text_with_entity_marker": [55, 62], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d131.s1122_AIMed.d131.s1122.p4", "text": "Mouse IL-10 does not bind to hIL-10R, and hIL-10R-expressing Ba/F3 cells do not respond to the mouse cytokine, observations consistent with the known species specificity of IL-10.", "text_with_entity_marker": "Mouse IL-10 does not bind to [E1]hIL-10R[/E1], and hIL-10R-expressing Ba/F3 cells do not respond to the mouse cytokine, observations consistent with the known species specificity of [E2]IL-10[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "hIL-10R", "entity_1_idx": [[29, 36]], "entity_1_idx_in_text_with_entity_marker": [33, 40], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-10", "entity_2_idx": [[173, 178]], "entity_2_idx_in_text_with_entity_marker": [186, 191], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d131.s1122_AIMed.d131.s1122.p5", "text": "Mouse IL-10 does not bind to hIL-10R, and hIL-10R-expressing Ba/F3 cells do not respond to the mouse cytokine, observations consistent with the known species specificity of IL-10.", "text_with_entity_marker": "Mouse IL-10 does not bind to hIL-10R, and [E1]hIL-10R[/E1]-expressing Ba/F3 cells do not respond to the mouse cytokine, observations consistent with the known species specificity of [E2]IL-10[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "hIL-10R", "entity_1_idx": [[42, 49]], "entity_1_idx_in_text_with_entity_marker": [46, 53], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-10", "entity_2_idx": [[173, 178]], "entity_2_idx_in_text_with_entity_marker": [186, 191], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d131.s1124_AIMed.d131.s1124.p0", "text": "In a number of human T cell clones, expression of hIL-10R mRNA is down-regulated after activation of the cells with anti-CD3 Ab and phorbol ester.", "text_with_entity_marker": "In a number of human T cell clones, expression of [E1]hIL-10R[/E1] mRNA is down-regulated after activation of the cells with anti-[E2]CD3[/E2] Ab and phorbol ester.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "hIL-10R", "entity_1_idx": [[50, 57]], "entity_1_idx_in_text_with_entity_marker": [54, 61], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CD3", "entity_2_idx": [[121, 124]], "entity_2_idx_in_text_with_entity_marker": [134, 137], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d131.s1126_AIMed.d131.s1126.p0", "text": "Like mIL-10R, hIL-10R is structurally related to IFNR.", "text_with_entity_marker": "Like [E1]mIL-10R[/E1], [E2]hIL-10R[/E2] is structurally related to IFNR.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "mIL-10R", "entity_1_idx": [[5, 12]], "entity_1_idx_in_text_with_entity_marker": [9, 16], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hIL-10R", "entity_2_idx": [[14, 21]], "entity_2_idx_in_text_with_entity_marker": [27, 34], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d131.s1126_AIMed.d131.s1126.p1", "text": "Like mIL-10R, hIL-10R is structurally related to IFNR.", "text_with_entity_marker": "Like [E1]mIL-10R[/E1], hIL-10R is structurally related to [E2]IFNR[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "mIL-10R", "entity_1_idx": [[5, 12]], "entity_1_idx_in_text_with_entity_marker": [9, 16], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IFNR", "entity_2_idx": [[49, 53]], "entity_2_idx_in_text_with_entity_marker": [62, 66], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d131.s1126_AIMed.d131.s1126.p2", "text": "Like mIL-10R, hIL-10R is structurally related to IFNR.", "text_with_entity_marker": "Like mIL-10R, [E1]hIL-10R[/E1] is structurally related to [E2]IFNR[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "hIL-10R", "entity_1_idx": [[14, 21]], "entity_1_idx_in_text_with_entity_marker": [18, 25], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IFNR", "entity_2_idx": [[49, 53]], "entity_2_idx_in_text_with_entity_marker": [62, 66], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d131.s1127_AIMed.d131.s1127.p0", "text": "Because IL-10 inhibits macrophage activation by IFN-gamma, this relationship suggests possible shared receptor or signal transduction pathway components.", "text_with_entity_marker": "Because [E1]IL-10[/E1] inhibits macrophage activation by [E2]IFN-gamma[/E2], this relationship suggests possible shared receptor or signal transduction pathway components.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-10", "entity_1_idx": [[8, 13]], "entity_1_idx_in_text_with_entity_marker": [12, 17], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IFN-gamma", "entity_2_idx": [[48, 57]], "entity_2_idx_in_text_with_entity_marker": [61, 70], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d218.s1889_AIMed.d218.s1889.p0", "text": "Thrombopoietin (TPO) is a hematopoietin important for megakaryocyte proliferation and production of blood platelets.", "text_with_entity_marker": "[E1]Thrombopoietin[/E1] ([E2]TPO[/E2]) is a hematopoietin important for megakaryocyte proliferation and production of blood platelets.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Thrombopoietin", "entity_1_idx": [[0, 14]], "entity_1_idx_in_text_with_entity_marker": [4, 18], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TPO", "entity_2_idx": [[16, 19]], "entity_2_idx_in_text_with_entity_marker": [29, 32], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d218.s1891_AIMed.d218.s1891.p0", "text": "The erythropoietin-like domain of TPO (TPO1-153) has been fused to the gIII coat protein of M13 bacteriophage.", "text_with_entity_marker": "The [E1]erythropoietin[/E1]-like domain of [E2]TPO[/E2] (TPO1-153) has been fused to the gIII coat protein of M13 bacteriophage.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "erythropoietin", "entity_1_idx": [[4, 18]], "entity_1_idx_in_text_with_entity_marker": [8, 22], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TPO", "entity_2_idx": [[34, 37]], "entity_2_idx_in_text_with_entity_marker": [47, 50], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d218.s1891_AIMed.d218.s1891.p1", "text": "The erythropoietin-like domain of TPO (TPO1-153) has been fused to the gIII coat protein of M13 bacteriophage.", "text_with_entity_marker": "The [E1]erythropoietin[/E1]-like domain of TPO (TPO1-153) has been fused to the [E2]gIII[/E2] coat protein of M13 bacteriophage.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "erythropoietin", "entity_1_idx": [[4, 18]], "entity_1_idx_in_text_with_entity_marker": [8, 22], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "gIII", "entity_2_idx": [[71, 75]], "entity_2_idx_in_text_with_entity_marker": [84, 88], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d218.s1891_AIMed.d218.s1891.p2", "text": "The erythropoietin-like domain of TPO (TPO1-153) has been fused to the gIII coat protein of M13 bacteriophage.", "text_with_entity_marker": "The erythropoietin-like domain of [E1]TPO[/E1] (TPO1-153) has been fused to the [E2]gIII[/E2] coat protein of M13 bacteriophage.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TPO", "entity_1_idx": [[34, 37]], "entity_1_idx_in_text_with_entity_marker": [38, 41], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "gIII", "entity_2_idx": [[71, 75]], "entity_2_idx_in_text_with_entity_marker": [84, 88], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d218.s1893_AIMed.d218.s1893.p0", "text": "Phage enzyme-linked immunosorbent assay was used to determine affinities for binding to both the TPO receptor and five anti-TPO1-153 monoclonal antibodies.", "text_with_entity_marker": "Phage enzyme-linked immunosorbent assay was used to determine affinities for binding to both the [E1]TPO[/E1] receptor and five anti-[E2]TPO1[/E2]-153 monoclonal antibodies.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TPO", "entity_1_idx": [[97, 100]], "entity_1_idx_in_text_with_entity_marker": [101, 104], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TPO1", "entity_2_idx": [[124, 128]], "entity_2_idx_in_text_with_entity_marker": [137, 141], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d218.s1897_AIMed.d218.s1897.p0", "text": "In contrast, the other three monoclonal antibodies, which were effective at blocking TPO activity but did not block initial binding of TPO to its receptor, had epitopes predominantly on helix or 3.", "text_with_entity_marker": "In contrast, the other three monoclonal antibodies, which were effective at blocking [E1]TPO[/E1] activity but did not block initial binding of [E2]TPO[/E2] to its receptor, had epitopes predominantly on helix or 3.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TPO", "entity_1_idx": [[85, 88]], "entity_1_idx_in_text_with_entity_marker": [89, 92], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TPO", "entity_2_idx": [[135, 138]], "entity_2_idx_in_text_with_entity_marker": [148, 151], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d82.s695_AIMed.d82.s695.p0", "text": "Identification of an 11-kDa FKBP12-rapamycin-binding domain within the 289-kDa FKBP12-rapamycin-associated protein and characterization of a critical serine residue.", "text_with_entity_marker": "Identification of an 11-kDa [E1]FKBP12[/E1]-rapamycin-binding domain within the 289-kDa [E2]FKBP12-rapamycin-associated protein[/E2] and characterization of a critical serine residue.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "FKBP12", "entity_1_idx": [[28, 34]], "entity_1_idx_in_text_with_entity_marker": [32, 38], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "FKBP12-rapamycin-associated protein", "entity_2_idx": [[79, 114]], "entity_2_idx_in_text_with_entity_marker": [92, 127], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d46.s402_AIMed.d46.s402.p0", "text": "BMP-2 antagonists emerge from alterations in the low-affinity binding epitope for receptor BMPR-II.", "text_with_entity_marker": "[E1]BMP-2[/E1] antagonists emerge from alterations in the low-affinity binding epitope for receptor [E2]BMPR-II[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "BMP-2", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "BMPR-II", "entity_2_idx": [[91, 98]], "entity_2_idx_in_text_with_entity_marker": [104, 111], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d46.s403_AIMed.d46.s403.p0", "text": "Bone morphogenetic protein-2 (BMP-2) induces bone formation and regeneration in adult vertebrates and regulates important developmental processes in all animals.", "text_with_entity_marker": "[E1]Bone morphogenetic protein-2[/E1] ([E2]BMP-2[/E2]) induces bone formation and regeneration in adult vertebrates and regulates important developmental processes in all animals.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Bone morphogenetic protein-2", "entity_1_idx": [[0, 28]], "entity_1_idx_in_text_with_entity_marker": [4, 32], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "BMP-2", "entity_2_idx": [[30, 35]], "entity_2_idx_in_text_with_entity_marker": [43, 48], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d8.s60_AIMed.d8.s60.p0", "text": "Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of K-ras, p53, p16 and DPC4/Smad4.", "text_with_entity_marker": "Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of [E1]K-ras[/E1], [E2]p53[/E2], p16 and DPC4/Smad4.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "K-ras", "entity_1_idx": [[67, 72]], "entity_1_idx_in_text_with_entity_marker": [71, 76], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p53", "entity_2_idx": [[74, 77]], "entity_2_idx_in_text_with_entity_marker": [87, 90], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d8.s60_AIMed.d8.s60.p1", "text": "Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of K-ras, p53, p16 and DPC4/Smad4.", "text_with_entity_marker": "Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of [E1]K-ras[/E1], p53, [E2]p16[/E2] and DPC4/Smad4.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "K-ras", "entity_1_idx": [[67, 72]], "entity_1_idx_in_text_with_entity_marker": [71, 76], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p16", "entity_2_idx": [[79, 82]], "entity_2_idx_in_text_with_entity_marker": [92, 95], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d8.s60_AIMed.d8.s60.p2", "text": "Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of K-ras, p53, p16 and DPC4/Smad4.", "text_with_entity_marker": "Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of [E1]K-ras[/E1], p53, p16 and [E2]DPC4[/E2]/Smad4.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "K-ras", "entity_1_idx": [[67, 72]], "entity_1_idx_in_text_with_entity_marker": [71, 76], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "DPC4", "entity_2_idx": [[87, 91]], "entity_2_idx_in_text_with_entity_marker": [100, 104], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d8.s60_AIMed.d8.s60.p3", "text": "Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of K-ras, p53, p16 and DPC4/Smad4.", "text_with_entity_marker": "Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of [E1]K-ras[/E1], p53, p16 and DPC4/[E2]Smad4[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "K-ras", "entity_1_idx": [[67, 72]], "entity_1_idx_in_text_with_entity_marker": [71, 76], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Smad4", "entity_2_idx": [[92, 97]], "entity_2_idx_in_text_with_entity_marker": [105, 110], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d8.s60_AIMed.d8.s60.p4", "text": "Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of K-ras, p53, p16 and DPC4/Smad4.", "text_with_entity_marker": "Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of K-ras, [E1]p53[/E1], [E2]p16[/E2] and DPC4/Smad4.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p53", "entity_1_idx": [[74, 77]], "entity_1_idx_in_text_with_entity_marker": [78, 81], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p16", "entity_2_idx": [[79, 82]], "entity_2_idx_in_text_with_entity_marker": [92, 95], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d8.s60_AIMed.d8.s60.p5", "text": "Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of K-ras, p53, p16 and DPC4/Smad4.", "text_with_entity_marker": "Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of K-ras, [E1]p53[/E1], p16 and [E2]DPC4[/E2]/Smad4.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p53", "entity_1_idx": [[74, 77]], "entity_1_idx_in_text_with_entity_marker": [78, 81], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "DPC4", "entity_2_idx": [[87, 91]], "entity_2_idx_in_text_with_entity_marker": [100, 104], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d8.s60_AIMed.d8.s60.p6", "text": "Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of K-ras, p53, p16 and DPC4/Smad4.", "text_with_entity_marker": "Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of K-ras, [E1]p53[/E1], p16 and DPC4/[E2]Smad4[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p53", "entity_1_idx": [[74, 77]], "entity_1_idx_in_text_with_entity_marker": [78, 81], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Smad4", "entity_2_idx": [[92, 97]], "entity_2_idx_in_text_with_entity_marker": [105, 110], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d8.s60_AIMed.d8.s60.p7", "text": "Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of K-ras, p53, p16 and DPC4/Smad4.", "text_with_entity_marker": "Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of K-ras, p53, [E1]p16[/E1] and [E2]DPC4[/E2]/Smad4.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p16", "entity_1_idx": [[79, 82]], "entity_1_idx_in_text_with_entity_marker": [83, 86], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "DPC4", "entity_2_idx": [[87, 91]], "entity_2_idx_in_text_with_entity_marker": [100, 104], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d8.s60_AIMed.d8.s60.p8", "text": "Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of K-ras, p53, p16 and DPC4/Smad4.", "text_with_entity_marker": "Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of K-ras, p53, [E1]p16[/E1] and DPC4/[E2]Smad4[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p16", "entity_1_idx": [[79, 82]], "entity_1_idx_in_text_with_entity_marker": [83, 86], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Smad4", "entity_2_idx": [[92, 97]], "entity_2_idx_in_text_with_entity_marker": [105, 110], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d8.s60_AIMed.d8.s60.p9", "text": "Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of K-ras, p53, p16 and DPC4/Smad4.", "text_with_entity_marker": "Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of K-ras, p53, p16 and [E1]DPC4[/E1]/[E2]Smad4[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "DPC4", "entity_1_idx": [[87, 91]], "entity_1_idx_in_text_with_entity_marker": [91, 95], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Smad4", "entity_2_idx": [[92, 97]], "entity_2_idx_in_text_with_entity_marker": [105, 110], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d8.s61_AIMed.d8.s61.p0", "text": "The K-ras, p53, p16 and DPC4 genes are among those most frequently altered in pancreatic ductal carcinoma.", "text_with_entity_marker": "The [E1]K-ras[/E1], [E2]p53[/E2], p16 and DPC4 genes are among those most frequently altered in pancreatic ductal carcinoma.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "K-ras", "entity_1_idx": [[4, 9]], "entity_1_idx_in_text_with_entity_marker": [8, 13], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p53", "entity_2_idx": [[11, 14]], "entity_2_idx_in_text_with_entity_marker": [24, 27], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d8.s61_AIMed.d8.s61.p1", "text": "The K-ras, p53, p16 and DPC4 genes are among those most frequently altered in pancreatic ductal carcinoma.", "text_with_entity_marker": "The [E1]K-ras[/E1], p53, [E2]p16[/E2] and DPC4 genes are among those most frequently altered in pancreatic ductal carcinoma.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "K-ras", "entity_1_idx": [[4, 9]], "entity_1_idx_in_text_with_entity_marker": [8, 13], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p16", "entity_2_idx": [[16, 19]], "entity_2_idx_in_text_with_entity_marker": [29, 32], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d8.s61_AIMed.d8.s61.p2", "text": "The K-ras, p53, p16 and DPC4 genes are among those most frequently altered in pancreatic ductal carcinoma.", "text_with_entity_marker": "The [E1]K-ras[/E1], p53, p16 and [E2]DPC4[/E2] genes are among those most frequently altered in pancreatic ductal carcinoma.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "K-ras", "entity_1_idx": [[4, 9]], "entity_1_idx_in_text_with_entity_marker": [8, 13], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "DPC4", "entity_2_idx": [[24, 28]], "entity_2_idx_in_text_with_entity_marker": [37, 41], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d8.s61_AIMed.d8.s61.p3", "text": "The K-ras, p53, p16 and DPC4 genes are among those most frequently altered in pancreatic ductal carcinoma.", "text_with_entity_marker": "The K-ras, [E1]p53[/E1], [E2]p16[/E2] and DPC4 genes are among those most frequently altered in pancreatic ductal carcinoma.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p53", "entity_1_idx": [[11, 14]], "entity_1_idx_in_text_with_entity_marker": [15, 18], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p16", "entity_2_idx": [[16, 19]], "entity_2_idx_in_text_with_entity_marker": [29, 32], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d8.s61_AIMed.d8.s61.p4", "text": "The K-ras, p53, p16 and DPC4 genes are among those most frequently altered in pancreatic ductal carcinoma.", "text_with_entity_marker": "The K-ras, [E1]p53[/E1], p16 and [E2]DPC4[/E2] genes are among those most frequently altered in pancreatic ductal carcinoma.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p53", "entity_1_idx": [[11, 14]], "entity_1_idx_in_text_with_entity_marker": [15, 18], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "DPC4", "entity_2_idx": [[24, 28]], "entity_2_idx_in_text_with_entity_marker": [37, 41], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d8.s61_AIMed.d8.s61.p5", "text": "The K-ras, p53, p16 and DPC4 genes are among those most frequently altered in pancreatic ductal carcinoma.", "text_with_entity_marker": "The K-ras, p53, [E1]p16[/E1] and [E2]DPC4[/E2] genes are among those most frequently altered in pancreatic ductal carcinoma.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p16", "entity_1_idx": [[16, 19]], "entity_1_idx_in_text_with_entity_marker": [20, 23], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "DPC4", "entity_2_idx": [[24, 28]], "entity_2_idx_in_text_with_entity_marker": [37, 41], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d8.s63_AIMed.d8.s63.p0", "text": "These cell lines showed mutations in K-ras and p53 at frequencies of 91% and 95%, respectively.", "text_with_entity_marker": "These cell lines showed mutations in [E1]K-ras[/E1] and [E2]p53[/E2] at frequencies of 91% and 95%, respectively.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "K-ras", "entity_1_idx": [[37, 42]], "entity_1_idx_in_text_with_entity_marker": [41, 46], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p53", "entity_2_idx": [[47, 50]], "entity_2_idx_in_text_with_entity_marker": [60, 63], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d8.s66_AIMed.d8.s66.p0", "text": "The most typical mutational profile involved K-ras, p53, and p16INK4a, concurrently aberrated in 20 cases (91%).", "text_with_entity_marker": "The most typical mutational profile involved [E1]K-ras[/E1], [E2]p53[/E2], and p16INK4a, concurrently aberrated in 20 cases (91%).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "K-ras", "entity_1_idx": [[45, 50]], "entity_1_idx_in_text_with_entity_marker": [49, 54], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p53", "entity_2_idx": [[52, 55]], "entity_2_idx_in_text_with_entity_marker": [65, 68], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d8.s66_AIMed.d8.s66.p1", "text": "The most typical mutational profile involved K-ras, p53, and p16INK4a, concurrently aberrated in 20 cases (91%).", "text_with_entity_marker": "The most typical mutational profile involved [E1]K-ras[/E1], p53, and [E2]p16INK4a[/E2], concurrently aberrated in 20 cases (91%).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "K-ras", "entity_1_idx": [[45, 50]], "entity_1_idx_in_text_with_entity_marker": [49, 54], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p16INK4a", "entity_2_idx": [[61, 69]], "entity_2_idx_in_text_with_entity_marker": [74, 82], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d8.s66_AIMed.d8.s66.p2", "text": "The most typical mutational profile involved K-ras, p53, and p16INK4a, concurrently aberrated in 20 cases (91%).", "text_with_entity_marker": "The most typical mutational profile involved K-ras, [E1]p53[/E1], and [E2]p16INK4a[/E2], concurrently aberrated in 20 cases (91%).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p53", "entity_1_idx": [[52, 55]], "entity_1_idx_in_text_with_entity_marker": [56, 59], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p16INK4a", "entity_2_idx": [[61, 69]], "entity_2_idx_in_text_with_entity_marker": [74, 82], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d173.s0_BioInfer.d173.s0.p1", "text": "Digestion of isolated myofibrils with alkaline proteinase resulted in the degradation of myosin heavy chain and actin.", "text_with_entity_marker": "Digestion of isolated myofibrils with [E1]alkaline proteinase[/E1] resulted in the degradation of [E2]myosin heavy chain[/E2] and actin.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "alkaline proteinase", "entity_1_idx": [[38, 57]], "entity_1_idx_in_text_with_entity_marker": [42, 61], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "myosin heavy chain", "entity_2_idx": [[89, 107]], "entity_2_idx_in_text_with_entity_marker": [102, 120], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d173.s0_BioInfer.d173.s0.p2", "text": "Digestion of isolated myofibrils with alkaline proteinase resulted in the degradation of myosin heavy chain and actin.", "text_with_entity_marker": "Digestion of isolated myofibrils with [E1]alkaline proteinase[/E1] resulted in the degradation of myosin heavy chain and [E2]actin[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "alkaline proteinase", "entity_1_idx": [[38, 57]], "entity_1_idx_in_text_with_entity_marker": [42, 61], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[112, 117]], "entity_2_idx_in_text_with_entity_marker": [125, 130], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d436.s0_BioInfer.d436.s0.p6", "text": "Moreover, ectopic expression of cyclin D1 and Cdk4 can stimulate the Brca1 promoter in an E2F-dependent manner, and this is inhibited by coexpression of the p16(INK4a) cyclin-dependent kinase inhibitor.", "text_with_entity_marker": "Moreover, ectopic expression of cyclin D1 and Cdk4 can stimulate the Brca1 promoter in an E2F-dependent manner, and this is inhibited by coexpression of the [E1]p16[/E1](INK4a) [E2]cyclin-dependent kinase inhibitor[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "p16", "entity_1_idx": [[157, 160]], "entity_1_idx_in_text_with_entity_marker": [161, 164], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin-dependent kinase inhibitor", "entity_2_idx": [[168, 201]], "entity_2_idx_in_text_with_entity_marker": [181, 214], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d436.s0_BioInfer.d436.s0.p9", "text": "Moreover, ectopic expression of cyclin D1 and Cdk4 can stimulate the Brca1 promoter in an E2F-dependent manner, and this is inhibited by coexpression of the p16(INK4a) cyclin-dependent kinase inhibitor.", "text_with_entity_marker": "Moreover, ectopic expression of cyclin D1 and Cdk4 can stimulate the Brca1 promoter in an E2F-dependent manner, and this is inhibited by coexpression of the p16([E1]INK4a[/E1]) [E2]cyclin-dependent kinase inhibitor[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "INK4a", "entity_1_idx": [[161, 166]], "entity_1_idx_in_text_with_entity_marker": [165, 170], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin-dependent kinase inhibitor", "entity_2_idx": [[168, 201]], "entity_2_idx_in_text_with_entity_marker": [181, 214], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d734.s0_BioInfer.d734.s0.p3", "text": "They had altered adhesive properties as measured by their ability to bind to a fibronectin-coated glass surface, suggesting that the expression of a rac-1 GAP alters the assembly of integrin receptors, actin and cytoskeletal proteins such as vinculin and talin.", "text_with_entity_marker": "They had altered adhesive properties as measured by their ability to bind to a fibronectin-coated glass surface, suggesting that the expression of a [E1]rac-1 GAP[/E1] alters the assembly of [E2]integrin[/E2] receptors, actin and cytoskeletal proteins such as vinculin and talin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "rac-1 GAP", "entity_1_idx": [[149, 158]], "entity_1_idx_in_text_with_entity_marker": [153, 162], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "integrin", "entity_2_idx": [[182, 190]], "entity_2_idx_in_text_with_entity_marker": [195, 203], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d734.s0_BioInfer.d734.s0.p7", "text": "They had altered adhesive properties as measured by their ability to bind to a fibronectin-coated glass surface, suggesting that the expression of a rac-1 GAP alters the assembly of integrin receptors, actin and cytoskeletal proteins such as vinculin and talin.", "text_with_entity_marker": "They had altered adhesive properties as measured by their ability to bind to a fibronectin-coated glass surface, suggesting that the expression of a [E1]rac-1 GAP[/E1] alters the assembly of integrin receptors, actin and cytoskeletal proteins such as vinculin and [E2]talin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "rac-1 GAP", "entity_1_idx": [[149, 158]], "entity_1_idx_in_text_with_entity_marker": [153, 162], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[255, 260]], "entity_2_idx_in_text_with_entity_marker": [268, 273], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d734.s0_BioInfer.d734.s0.p10", "text": "They had altered adhesive properties as measured by their ability to bind to a fibronectin-coated glass surface, suggesting that the expression of a rac-1 GAP alters the assembly of integrin receptors, actin and cytoskeletal proteins such as vinculin and talin.", "text_with_entity_marker": "They had altered adhesive properties as measured by their ability to bind to a fibronectin-coated glass surface, suggesting that the expression of a [E1]rac-1 GAP[/E1] alters the assembly of integrin receptors, actin and cytoskeletal proteins such as [E2]vinculin[/E2] and talin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "rac-1 GAP", "entity_1_idx": [[149, 158]], "entity_1_idx_in_text_with_entity_marker": [153, 162], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vinculin", "entity_2_idx": [[242, 250]], "entity_2_idx_in_text_with_entity_marker": [255, 263], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d734.s0_BioInfer.d734.s0.p14", "text": "They had altered adhesive properties as measured by their ability to bind to a fibronectin-coated glass surface, suggesting that the expression of a rac-1 GAP alters the assembly of integrin receptors, actin and cytoskeletal proteins such as vinculin and talin.", "text_with_entity_marker": "They had altered adhesive properties as measured by their ability to bind to a fibronectin-coated glass surface, suggesting that the expression of a [E1]rac-1 GAP[/E1] alters the assembly of integrin receptors, [E2]actin[/E2] and cytoskeletal proteins such as vinculin and talin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "rac-1 GAP", "entity_1_idx": [[149, 158]], "entity_1_idx_in_text_with_entity_marker": [153, 162], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[202, 207]], "entity_2_idx_in_text_with_entity_marker": [215, 220], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d717.s0_BioInfer.d717.s0.p6", "text": "These separately encoded a complete HPIV3 genome (negative-sense), the HPIV3 nucleocapsid protein N, the phosphoprotein P, and the polymerase protein L.", "text_with_entity_marker": "These separately encoded a complete HPIV3 genome (negative-sense), the HPIV3 nucleocapsid protein N, the phosphoprotein P, and the [E1]polymerase protein[/E1] [E2]L[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "polymerase protein", "entity_1_idx": [[131, 149]], "entity_1_idx_in_text_with_entity_marker": [135, 153], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "L", "entity_2_idx": [[150, 151]], "entity_2_idx_in_text_with_entity_marker": [163, 164], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d639.s0_BioInfer.d639.s0.p1", "text": "The main inhibitory action of p27, a cyclin-dependent kinase inhibitor (CDKI), arises from its binding with the cyclin E/cyclin-dependent kinase 2 (Cdk2) complex that results in G(1)-S arrest.", "text_with_entity_marker": "The main inhibitory action of [E1]p27[/E1], a cyclin-dependent kinase inhibitor ([E2]CDKI[/E2]), arises from its binding with the cyclin E/cyclin-dependent kinase 2 (Cdk2) complex that results in G(1)-S arrest.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "p27", "entity_1_idx": [[30, 33]], "entity_1_idx_in_text_with_entity_marker": [34, 37], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CDKI", "entity_2_idx": [[72, 76]], "entity_2_idx_in_text_with_entity_marker": [85, 89], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d639.s0_BioInfer.d639.s0.p5", "text": "The main inhibitory action of p27, a cyclin-dependent kinase inhibitor (CDKI), arises from its binding with the cyclin E/cyclin-dependent kinase 2 (Cdk2) complex that results in G(1)-S arrest.", "text_with_entity_marker": "The main inhibitory action of [E1]p27[/E1], a cyclin-dependent kinase inhibitor (CDKI), arises from its binding with the cyclin E/[E2]cyclin-dependent kinase 2[/E2] (Cdk2) complex that results in G(1)-S arrest.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "p27", "entity_1_idx": [[30, 33]], "entity_1_idx_in_text_with_entity_marker": [34, 37], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin-dependent kinase 2", "entity_2_idx": [[121, 146]], "entity_2_idx_in_text_with_entity_marker": [134, 159], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d639.s0_BioInfer.d639.s0.p6", "text": "The main inhibitory action of p27, a cyclin-dependent kinase inhibitor (CDKI), arises from its binding with the cyclin E/cyclin-dependent kinase 2 (Cdk2) complex that results in G(1)-S arrest.", "text_with_entity_marker": "The main inhibitory action of p27, a cyclin-dependent kinase inhibitor (CDKI), arises from its binding with the cyclin E/[E1]cyclin-dependent kinase 2[/E1] ([E2]Cdk2[/E2]) complex that results in G(1)-S arrest.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "cyclin-dependent kinase 2", "entity_1_idx": [[121, 146]], "entity_1_idx_in_text_with_entity_marker": [125, 150], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Cdk2", "entity_2_idx": [[148, 152]], "entity_2_idx_in_text_with_entity_marker": [161, 165], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d639.s0_BioInfer.d639.s0.p8", "text": "The main inhibitory action of p27, a cyclin-dependent kinase inhibitor (CDKI), arises from its binding with the cyclin E/cyclin-dependent kinase 2 (Cdk2) complex that results in G(1)-S arrest.", "text_with_entity_marker": "The main inhibitory action of p27, a cyclin-dependent kinase inhibitor (CDKI), arises from its binding with the [E1]cyclin E[/E1]/[E2]cyclin-dependent kinase 2[/E2] (Cdk2) complex that results in G(1)-S arrest.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "cyclin E", "entity_1_idx": [[112, 120]], "entity_1_idx_in_text_with_entity_marker": [116, 124], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin-dependent kinase 2", "entity_2_idx": [[121, 146]], "entity_2_idx_in_text_with_entity_marker": [134, 159], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d639.s0_BioInfer.d639.s0.p9", "text": "The main inhibitory action of p27, a cyclin-dependent kinase inhibitor (CDKI), arises from its binding with the cyclin E/cyclin-dependent kinase 2 (Cdk2) complex that results in G(1)-S arrest.", "text_with_entity_marker": "The main inhibitory action of [E1]p27[/E1], a cyclin-dependent kinase inhibitor (CDKI), arises from its binding with the cyclin E/cyclin-dependent kinase 2 ([E2]Cdk2[/E2]) complex that results in G(1)-S arrest.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "p27", "entity_1_idx": [[30, 33]], "entity_1_idx_in_text_with_entity_marker": [34, 37], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Cdk2", "entity_2_idx": [[148, 152]], "entity_2_idx_in_text_with_entity_marker": [161, 165], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d639.s0_BioInfer.d639.s0.p10", "text": "The main inhibitory action of p27, a cyclin-dependent kinase inhibitor (CDKI), arises from its binding with the cyclin E/cyclin-dependent kinase 2 (Cdk2) complex that results in G(1)-S arrest.", "text_with_entity_marker": "The main inhibitory action of [E1]p27[/E1], a [E2]cyclin-dependent kinase inhibitor[/E2] (CDKI), arises from its binding with the cyclin E/cyclin-dependent kinase 2 (Cdk2) complex that results in G(1)-S arrest.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "p27", "entity_1_idx": [[30, 33]], "entity_1_idx_in_text_with_entity_marker": [34, 37], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin-dependent kinase inhibitor", "entity_2_idx": [[37, 70]], "entity_2_idx_in_text_with_entity_marker": [50, 83], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d639.s0_BioInfer.d639.s0.p11", "text": "The main inhibitory action of p27, a cyclin-dependent kinase inhibitor (CDKI), arises from its binding with the cyclin E/cyclin-dependent kinase 2 (Cdk2) complex that results in G(1)-S arrest.", "text_with_entity_marker": "The main inhibitory action of [E1]p27[/E1], a cyclin-dependent kinase inhibitor (CDKI), arises from its binding with the [E2]cyclin E[/E2]/cyclin-dependent kinase 2 (Cdk2) complex that results in G(1)-S arrest.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "p27", "entity_1_idx": [[30, 33]], "entity_1_idx_in_text_with_entity_marker": [34, 37], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin E", "entity_2_idx": [[112, 120]], "entity_2_idx_in_text_with_entity_marker": [125, 133], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d639.s0_BioInfer.d639.s0.p13", "text": "The main inhibitory action of p27, a cyclin-dependent kinase inhibitor (CDKI), arises from its binding with the cyclin E/cyclin-dependent kinase 2 (Cdk2) complex that results in G(1)-S arrest.", "text_with_entity_marker": "The main inhibitory action of p27, a cyclin-dependent kinase inhibitor (CDKI), arises from its binding with the [E1]cyclin E[/E1]/cyclin-dependent kinase 2 ([E2]Cdk2[/E2]) complex that results in G(1)-S arrest.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "cyclin E", "entity_1_idx": [[112, 120]], "entity_1_idx_in_text_with_entity_marker": [116, 124], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Cdk2", "entity_2_idx": [[148, 152]], "entity_2_idx_in_text_with_entity_marker": [161, 165], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d202.s0_BioInfer.d202.s0.p0", "text": "Expression of alpha-catenin was generally weak and did not correlate with the expression of either beta-catenin or E-cadherin.", "text_with_entity_marker": "Expression of [E1]alpha-catenin[/E1] was generally weak and did not correlate with the expression of either beta-catenin or [E2]E-cadherin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[14, 27]], "entity_1_idx_in_text_with_entity_marker": [18, 31], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E-cadherin", "entity_2_idx": [[115, 125]], "entity_2_idx_in_text_with_entity_marker": [128, 138], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d202.s0_BioInfer.d202.s0.p2", "text": "Expression of alpha-catenin was generally weak and did not correlate with the expression of either beta-catenin or E-cadherin.", "text_with_entity_marker": "Expression of [E1]alpha-catenin[/E1] was generally weak and did not correlate with the expression of either [E2]beta-catenin[/E2] or E-cadherin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[14, 27]], "entity_1_idx_in_text_with_entity_marker": [18, 31], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[99, 111]], "entity_2_idx_in_text_with_entity_marker": [112, 124], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d156.s0_BioInfer.d156.s0.p0", "text": "Coprecipitations revealed that transfected cadherin molecules are complexed with alpha-catenin and beta-catenin at plasma membranes.", "text_with_entity_marker": "Coprecipitations revealed that transfected cadherin molecules are complexed with [E1]alpha-catenin[/E1] and [E2]beta-catenin[/E2] at plasma membranes.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[81, 94]], "entity_1_idx_in_text_with_entity_marker": [85, 98], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[99, 111]], "entity_2_idx_in_text_with_entity_marker": [112, 124], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d156.s0_BioInfer.d156.s0.p1", "text": "Coprecipitations revealed that transfected cadherin molecules are complexed with alpha-catenin and beta-catenin at plasma membranes.", "text_with_entity_marker": "Coprecipitations revealed that transfected [E1]cadherin[/E1] molecules are complexed with alpha-catenin and [E2]beta-catenin[/E2] at plasma membranes.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "cadherin", "entity_1_idx": [[43, 51]], "entity_1_idx_in_text_with_entity_marker": [47, 55], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[99, 111]], "entity_2_idx_in_text_with_entity_marker": [112, 124], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d156.s0_BioInfer.d156.s0.p2", "text": "Coprecipitations revealed that transfected cadherin molecules are complexed with alpha-catenin and beta-catenin at plasma membranes.", "text_with_entity_marker": "Coprecipitations revealed that transfected [E1]cadherin[/E1] molecules are complexed with [E2]alpha-catenin[/E2] and beta-catenin at plasma membranes.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "cadherin", "entity_1_idx": [[43, 51]], "entity_1_idx_in_text_with_entity_marker": [47, 55], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[81, 94]], "entity_2_idx_in_text_with_entity_marker": [94, 107], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d308.s0_BioInfer.d308.s0.p0", "text": "In Acanthamoeba, the two isoforms of profilin may have specialized functions on the basis of their identical (approximately 10 microM) affinities for actin monomers and different affinities for PIP2.", "text_with_entity_marker": "In Acanthamoeba, the two isoforms of [E1]profilin[/E1] may have specialized functions on the basis of their identical (approximately 10 microM) affinities for [E2]actin[/E2] monomers and different affinities for PIP2.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[37, 45]], "entity_1_idx_in_text_with_entity_marker": [41, 49], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[150, 155]], "entity_2_idx_in_text_with_entity_marker": [163, 168], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d97.s0_BioInfer.d97.s0.p0", "text": "Binding of talin to actin occurs at a maximal molar ratio of 1:3 as determined by fluorescencetitration under G-buffer conditions.", "text_with_entity_marker": "Binding of [E1]talin[/E1] to [E2]actin[/E2] occurs at a maximal molar ratio of 1:3 as determined by fluorescencetitration under G-buffer conditions.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "talin", "entity_1_idx": [[11, 16]], "entity_1_idx_in_text_with_entity_marker": [15, 20], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[20, 25]], "entity_2_idx_in_text_with_entity_marker": [33, 38], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d97.s1_BioInfer.d97.s1.p0", "text": "Platelet talin binds to actin in vitro and hence is an actin binding protein.", "text_with_entity_marker": "[E1]Platelet talin[/E1] binds to [E2]actin[/E2] in vitro and hence is an actin binding protein.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Platelet talin", "entity_1_idx": [[0, 14]], "entity_1_idx_in_text_with_entity_marker": [4, 18], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[24, 29]], "entity_2_idx_in_text_with_entity_marker": [37, 42], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d97.s1_BioInfer.d97.s1.p1", "text": "Platelet talin binds to actin in vitro and hence is an actin binding protein.", "text_with_entity_marker": "[E1]Platelet talin[/E1] binds to actin in vitro and hence is an [E2]actin binding protein[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Platelet talin", "entity_1_idx": [[0, 14]], "entity_1_idx_in_text_with_entity_marker": [4, 18], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin binding protein", "entity_2_idx": [[55, 76]], "entity_2_idx_in_text_with_entity_marker": [68, 89], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d285.s0_BioInfer.d285.s0.p0", "text": "Immediately after synthesis, E-cadherin, beta-catenin, and plakoglobin cosedimented as complexes.", "text_with_entity_marker": "Immediately after synthesis, E-cadherin, [E1]beta-catenin[/E1], and [E2]plakoglobin[/E2] cosedimented as complexes.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[41, 53]], "entity_1_idx_in_text_with_entity_marker": [45, 57], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[59, 70]], "entity_2_idx_in_text_with_entity_marker": [72, 83], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d285.s0_BioInfer.d285.s0.p1", "text": "Immediately after synthesis, E-cadherin, beta-catenin, and plakoglobin cosedimented as complexes.", "text_with_entity_marker": "Immediately after synthesis, [E1]E-cadherin[/E1], [E2]beta-catenin[/E2], and plakoglobin cosedimented as complexes.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[29, 39]], "entity_1_idx_in_text_with_entity_marker": [33, 43], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[41, 53]], "entity_2_idx_in_text_with_entity_marker": [54, 66], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d285.s0_BioInfer.d285.s0.p2", "text": "Immediately after synthesis, E-cadherin, beta-catenin, and plakoglobin cosedimented as complexes.", "text_with_entity_marker": "Immediately after synthesis, [E1]E-cadherin[/E1], beta-catenin, and [E2]plakoglobin[/E2] cosedimented as complexes.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[29, 39]], "entity_1_idx_in_text_with_entity_marker": [33, 43], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[59, 70]], "entity_2_idx_in_text_with_entity_marker": [72, 83], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d285.s1_BioInfer.d285.s1.p0", "text": "alpha-Catenin was not associated with these complexes after synthesis, but a subpopulation of alpha-catenin joined the complex at a time coincident with the arrival of E-cadherin at the plasma membrane.", "text_with_entity_marker": "alpha-Catenin was not associated with these complexes after synthesis, but a subpopulation of [E1]alpha-catenin[/E1] joined the complex at a time coincident with the arrival of [E2]E-cadherin[/E2] at the plasma membrane.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[94, 107]], "entity_1_idx_in_text_with_entity_marker": [98, 111], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E-cadherin", "entity_2_idx": [[168, 178]], "entity_2_idx_in_text_with_entity_marker": [181, 191], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d261.s0_BioInfer.d261.s0.p0", "text": "Herpes simplex virus type 1 (HSV-1) encodes a heterotrimeric helicase-primase composed of the products of the three DNA replication-specific genes UL5, UL8, and UL52 (Crute, J. J., and Lehman, I. R. (1991) J. Biol. Chem. 266, 4484-4488).", "text_with_entity_marker": "Herpes simplex virus type 1 (HSV-1) encodes a heterotrimeric [E1]helicase-primase[/E1] composed of the products of the three DNA replication-specific genes UL5, [E2]UL8[/E2], and UL52 (Crute, J. J., and Lehman, I. R. (1991) J. Biol. Chem. 266, 4484-4488).", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "helicase-primase", "entity_1_idx": [[61, 77]], "entity_1_idx_in_text_with_entity_marker": [65, 81], "entity_1_type": "Protein_complex", "entity_1_type_id": 5, "entity_2": "UL8", "entity_2_idx": [[152, 155]], "entity_2_idx_in_text_with_entity_marker": [165, 168], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d261.s0_BioInfer.d261.s0.p3", "text": "Herpes simplex virus type 1 (HSV-1) encodes a heterotrimeric helicase-primase composed of the products of the three DNA replication-specific genes UL5, UL8, and UL52 (Crute, J. J., and Lehman, I. R. (1991) J. Biol. Chem. 266, 4484-4488).", "text_with_entity_marker": "Herpes simplex virus type 1 (HSV-1) encodes a heterotrimeric [E1]helicase-primase[/E1] composed of the products of the three DNA replication-specific genes [E2]UL5[/E2], UL8, and UL52 (Crute, J. J., and Lehman, I. R. (1991) J. Biol. Chem. 266, 4484-4488).", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "helicase-primase", "entity_1_idx": [[61, 77]], "entity_1_idx_in_text_with_entity_marker": [65, 81], "entity_1_type": "Protein_complex", "entity_1_type_id": 5, "entity_2": "UL5", "entity_2_idx": [[147, 150]], "entity_2_idx_in_text_with_entity_marker": [160, 163], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d261.s0_BioInfer.d261.s0.p4", "text": "Herpes simplex virus type 1 (HSV-1) encodes a heterotrimeric helicase-primase composed of the products of the three DNA replication-specific genes UL5, UL8, and UL52 (Crute, J. J., and Lehman, I. R. (1991) J. Biol. Chem. 266, 4484-4488).", "text_with_entity_marker": "Herpes simplex virus type 1 (HSV-1) encodes a heterotrimeric [E1]helicase-primase[/E1] composed of the products of the three DNA replication-specific genes UL5, UL8, and [E2]UL52[/E2] (Crute, J. J., and Lehman, I. R. (1991) J. Biol. Chem. 266, 4484-4488).", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "helicase-primase", "entity_1_idx": [[61, 77]], "entity_1_idx_in_text_with_entity_marker": [65, 81], "entity_1_type": "Protein_complex", "entity_1_type_id": 5, "entity_2": "UL52", "entity_2_idx": [[161, 165]], "entity_2_idx_in_text_with_entity_marker": [174, 178], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d333.s0_BioInfer.d333.s0.p1", "text": "In enriched cell lines and in a pure myocyte cell strain, EGF inhibited increases in immunoreactive sarcomeric actin and sarcomeric myosin heavy chain (SMHC) normally seen after serum withdrawal.", "text_with_entity_marker": "In enriched cell lines and in a pure myocyte cell strain, [E1]EGF[/E1] inhibited increases in immunoreactive [E2]sarcomeric actin[/E2] and sarcomeric myosin heavy chain (SMHC) normally seen after serum withdrawal.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "EGF", "entity_1_idx": [[58, 61]], "entity_1_idx_in_text_with_entity_marker": [62, 65], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "sarcomeric actin", "entity_2_idx": [[100, 116]], "entity_2_idx_in_text_with_entity_marker": [113, 129], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d333.s0_BioInfer.d333.s0.p3", "text": "In enriched cell lines and in a pure myocyte cell strain, EGF inhibited increases in immunoreactive sarcomeric actin and sarcomeric myosin heavy chain (SMHC) normally seen after serum withdrawal.", "text_with_entity_marker": "In enriched cell lines and in a pure myocyte cell strain, [E1]EGF[/E1] inhibited increases in immunoreactive sarcomeric actin and sarcomeric myosin heavy chain ([E2]SMHC[/E2]) normally seen after serum withdrawal.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "EGF", "entity_1_idx": [[58, 61]], "entity_1_idx_in_text_with_entity_marker": [62, 65], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "SMHC", "entity_2_idx": [[152, 156]], "entity_2_idx_in_text_with_entity_marker": [165, 169], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d333.s0_BioInfer.d333.s0.p5", "text": "In enriched cell lines and in a pure myocyte cell strain, EGF inhibited increases in immunoreactive sarcomeric actin and sarcomeric myosin heavy chain (SMHC) normally seen after serum withdrawal.", "text_with_entity_marker": "In enriched cell lines and in a pure myocyte cell strain, [E1]EGF[/E1] inhibited increases in immunoreactive sarcomeric actin and [E2]sarcomeric myosin heavy chain[/E2] (SMHC) normally seen after serum withdrawal.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "EGF", "entity_1_idx": [[58, 61]], "entity_1_idx_in_text_with_entity_marker": [62, 65], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "sarcomeric myosin heavy chain", "entity_2_idx": [[121, 150]], "entity_2_idx_in_text_with_entity_marker": [134, 163], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d803.s0_BioInfer.d803.s0.p1", "text": "We find that profilin and cofilin regulate actin-filament formation throughout the cell cortex.", "text_with_entity_marker": "We find that profilin and [E1]cofilin[/E1] regulate [E2]actin[/E2]-filament formation throughout the cell cortex.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[26, 33]], "entity_1_idx_in_text_with_entity_marker": [30, 37], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[43, 48]], "entity_2_idx_in_text_with_entity_marker": [56, 61], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d803.s0_BioInfer.d803.s0.p2", "text": "We find that profilin and cofilin regulate actin-filament formation throughout the cell cortex.", "text_with_entity_marker": "We find that [E1]profilin[/E1] and cofilin regulate [E2]actin[/E2]-filament formation throughout the cell cortex.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[13, 21]], "entity_1_idx_in_text_with_entity_marker": [17, 25], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[43, 48]], "entity_2_idx_in_text_with_entity_marker": [56, 61], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d319.s0_BioInfer.d319.s0.p0", "text": "In a model system, the interacting proteins recruiting TFIIIC to DNA were PRP21 and PRP9 or PRP21 and PRP11.", "text_with_entity_marker": "In a model system, the interacting proteins recruiting [E1]TFIIIC[/E1] to DNA were PRP21 and [E2]PRP9[/E2] or PRP21 and PRP11.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "TFIIIC", "entity_1_idx": [[55, 61]], "entity_1_idx_in_text_with_entity_marker": [59, 65], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "PRP9", "entity_2_idx": [[84, 88]], "entity_2_idx_in_text_with_entity_marker": [97, 101], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d319.s0_BioInfer.d319.s0.p3", "text": "In a model system, the interacting proteins recruiting TFIIIC to DNA were PRP21 and PRP9 or PRP21 and PRP11.", "text_with_entity_marker": "In a model system, the interacting proteins recruiting TFIIIC to DNA were [E1]PRP21[/E1] and [E2]PRP9[/E2] or PRP21 and PRP11.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "PRP21", "entity_1_idx": [[74, 79]], "entity_1_idx_in_text_with_entity_marker": [78, 83], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "PRP9", "entity_2_idx": [[84, 88]], "entity_2_idx_in_text_with_entity_marker": [97, 101], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d319.s0_BioInfer.d319.s0.p4", "text": "In a model system, the interacting proteins recruiting TFIIIC to DNA were PRP21 and PRP9 or PRP21 and PRP11.", "text_with_entity_marker": "In a model system, the interacting proteins recruiting [E1]TFIIIC[/E1] to DNA were PRP21 and PRP9 or [E2]PRP21[/E2] and PRP11.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "TFIIIC", "entity_1_idx": [[55, 61]], "entity_1_idx_in_text_with_entity_marker": [59, 65], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "PRP21", "entity_2_idx": [[92, 97]], "entity_2_idx_in_text_with_entity_marker": [105, 110], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d319.s0_BioInfer.d319.s0.p5", "text": "In a model system, the interacting proteins recruiting TFIIIC to DNA were PRP21 and PRP9 or PRP21 and PRP11.", "text_with_entity_marker": "In a model system, the interacting proteins recruiting [E1]TFIIIC[/E1] to DNA were PRP21 and PRP9 or PRP21 and [E2]PRP11[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "TFIIIC", "entity_1_idx": [[55, 61]], "entity_1_idx_in_text_with_entity_marker": [59, 65], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "PRP11", "entity_2_idx": [[102, 107]], "entity_2_idx_in_text_with_entity_marker": [115, 120], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d319.s0_BioInfer.d319.s0.p6", "text": "In a model system, the interacting proteins recruiting TFIIIC to DNA were PRP21 and PRP9 or PRP21 and PRP11.", "text_with_entity_marker": "In a model system, the interacting proteins recruiting [E1]TFIIIC[/E1] to DNA were [E2]PRP21[/E2] and PRP9 or PRP21 and PRP11.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "TFIIIC", "entity_1_idx": [[55, 61]], "entity_1_idx_in_text_with_entity_marker": [59, 65], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "PRP21", "entity_2_idx": [[74, 79]], "entity_2_idx_in_text_with_entity_marker": [87, 92], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d319.s0_BioInfer.d319.s0.p7", "text": "In a model system, the interacting proteins recruiting TFIIIC to DNA were PRP21 and PRP9 or PRP21 and PRP11.", "text_with_entity_marker": "In a model system, the interacting proteins recruiting TFIIIC to DNA were PRP21 and PRP9 or [E1]PRP21[/E1] and [E2]PRP11[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "PRP21", "entity_1_idx": [[92, 97]], "entity_1_idx_in_text_with_entity_marker": [96, 101], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "PRP11", "entity_2_idx": [[102, 107]], "entity_2_idx_in_text_with_entity_marker": [115, 120], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d726.s0_BioInfer.d726.s0.p1", "text": "The Tetrahymena fimbrin has two actin-binding domains, but lacks the EF-hand Ca(2+)-binding motif, suggesting that Tetrahymena fimbrin probably cross-links actin filaments in a Ca(2+)- insensitive manner during cytokinesis.", "text_with_entity_marker": "The Tetrahymena fimbrin has two actin-binding domains, but lacks the EF-hand Ca(2+)-binding motif, suggesting that Tetrahymena [E1]fimbrin[/E1] probably cross-links [E2]actin[/E2] filaments in a Ca(2+)- insensitive manner during cytokinesis.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "fimbrin", "entity_1_idx": [[127, 134]], "entity_1_idx_in_text_with_entity_marker": [131, 138], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[156, 161]], "entity_2_idx_in_text_with_entity_marker": [169, 174], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d726.s0_BioInfer.d726.s0.p4", "text": "The Tetrahymena fimbrin has two actin-binding domains, but lacks the EF-hand Ca(2+)-binding motif, suggesting that Tetrahymena fimbrin probably cross-links actin filaments in a Ca(2+)- insensitive manner during cytokinesis.", "text_with_entity_marker": "The Tetrahymena [E1]fimbrin[/E1] has two [E2]actin[/E2]-binding domains, but lacks the EF-hand Ca(2+)-binding motif, suggesting that Tetrahymena fimbrin probably cross-links actin filaments in a Ca(2+)- insensitive manner during cytokinesis.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "fimbrin", "entity_1_idx": [[16, 23]], "entity_1_idx_in_text_with_entity_marker": [20, 27], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[32, 37]], "entity_2_idx_in_text_with_entity_marker": [45, 50], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d218.s0_BioInfer.d218.s0.p7", "text": "From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that RAD51 and RAD52 have different functions, or that RAD52 has functions in addition to those of the Rad51/Rad52 protein complex.", "text_with_entity_marker": "From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that [E1]RAD51[/E1] and [E2]RAD52[/E2] have different functions, or that RAD52 has functions in addition to those of the Rad51/Rad52 protein complex.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "RAD51", "entity_1_idx": [[215, 220]], "entity_1_idx_in_text_with_entity_marker": [219, 224], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "RAD52", "entity_2_idx": [[225, 230]], "entity_2_idx_in_text_with_entity_marker": [238, 243], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d218.s0_BioInfer.d218.s0.p19", "text": "From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that RAD51 and RAD52 have different functions, or that RAD52 has functions in addition to those of the Rad51/Rad52 protein complex.", "text_with_entity_marker": "From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that RAD51 and RAD52 have different functions, or that RAD52 has functions in addition to those of the [E1]Rad51[/E1]/[E2]Rad52[/E2] protein complex.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Rad51", "entity_1_idx": [[313, 318]], "entity_1_idx_in_text_with_entity_marker": [317, 322], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Rad52", "entity_2_idx": [[319, 324]], "entity_2_idx_in_text_with_entity_marker": [332, 337], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d249.s0_BioInfer.d249.s0.p2", "text": "Here we report the functional importance of profilin in various actin-mediated morphological changes using H119E mutant profilin I, which is deficient only in actin binding.", "text_with_entity_marker": "Here we report the functional importance of profilin in various actin-mediated morphological changes using [E1]H119E[/E1] mutant profilin I, which is deficient only in [E2]actin[/E2] binding.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "H119E", "entity_1_idx": [[107, 112], [120, 130]], "entity_1_idx_in_text_with_entity_marker": [111, 116], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[159, 164]], "entity_2_idx_in_text_with_entity_marker": [172, 177], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d178.s0_BioInfer.d178.s0.p0", "text": "DNA sequence analysis of the cdc3+ gene reveals that it encodes profilin, an actin-monomer-binding protein.", "text_with_entity_marker": "DNA sequence analysis of the [E1]cdc3+[/E1] gene reveals that it encodes [E2]profilin[/E2], an actin-monomer-binding protein.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "cdc3+", "entity_1_idx": [[29, 34]], "entity_1_idx_in_text_with_entity_marker": [33, 38], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "profilin", "entity_2_idx": [[64, 72]], "entity_2_idx_in_text_with_entity_marker": [77, 85], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d178.s0_BioInfer.d178.s0.p1", "text": "DNA sequence analysis of the cdc3+ gene reveals that it encodes profilin, an actin-monomer-binding protein.", "text_with_entity_marker": "DNA sequence analysis of the cdc3+ gene reveals that it encodes [E1]profilin[/E1], an [E2]actin[/E2]-monomer-binding protein.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[64, 72]], "entity_1_idx_in_text_with_entity_marker": [68, 76], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[77, 82]], "entity_2_idx_in_text_with_entity_marker": [90, 95], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d178.s1_BioInfer.d178.s1.p0", "text": "We attribute these effects to potential sequestration of actin monomers by profilin, when present in excess.", "text_with_entity_marker": "We attribute these effects to potential sequestration of [E1]actin[/E1] monomers by [E2]profilin[/E2], when present in excess.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[57, 62]], "entity_1_idx_in_text_with_entity_marker": [61, 66], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[75, 83]], "entity_2_idx_in_text_with_entity_marker": [88, 96], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d329.s0_BioInfer.d329.s0.p2", "text": "In contrast to the model of actin binding proposed for fimbrin, the utrophin actin-binding domain appears to associate with actin in an extended conformation.", "text_with_entity_marker": "In contrast to the model of actin binding proposed for fimbrin, the [E1]utrophin[/E1] actin-binding domain appears to associate with [E2]actin[/E2] in an extended conformation.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "utrophin", "entity_1_idx": [[68, 76]], "entity_1_idx_in_text_with_entity_marker": [72, 80], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[124, 129]], "entity_2_idx_in_text_with_entity_marker": [137, 142], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d329.s0_BioInfer.d329.s0.p6", "text": "In contrast to the model of actin binding proposed for fimbrin, the utrophin actin-binding domain appears to associate with actin in an extended conformation.", "text_with_entity_marker": "In contrast to the model of [E1]actin[/E1] binding proposed for [E2]fimbrin[/E2], the utrophin actin-binding domain appears to associate with actin in an extended conformation.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[28, 33]], "entity_1_idx_in_text_with_entity_marker": [32, 37], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fimbrin", "entity_2_idx": [[55, 62]], "entity_2_idx_in_text_with_entity_marker": [68, 75], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d329.s0_BioInfer.d329.s0.p7", "text": "In contrast to the model of actin binding proposed for fimbrin, the utrophin actin-binding domain appears to associate with actin in an extended conformation.", "text_with_entity_marker": "In contrast to the model of actin binding proposed for fimbrin, the [E1]utrophin[/E1] [E2]actin[/E2]-binding domain appears to associate with actin in an extended conformation.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "utrophin", "entity_1_idx": [[68, 76]], "entity_1_idx_in_text_with_entity_marker": [72, 80], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[77, 82]], "entity_2_idx_in_text_with_entity_marker": [90, 95], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d587.s0_BioInfer.d587.s0.p1", "text": "The verprolin-like central (vc) region of Wiskott-Aldrich syndrome protein induces Arp2/3 complex-dependent actin nucleation.", "text_with_entity_marker": "The verprolin-like central (vc) region of Wiskott-Aldrich syndrome protein induces [E1]Arp[/E1]2/3 complex-dependent [E2]actin[/E2] nucleation.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Arp", "entity_1_idx": [[83, 86], [88, 89]], "entity_1_idx_in_text_with_entity_marker": [87, 90], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[108, 113]], "entity_2_idx_in_text_with_entity_marker": [121, 126], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d587.s0_BioInfer.d587.s0.p2", "text": "The verprolin-like central (vc) region of Wiskott-Aldrich syndrome protein induces Arp2/3 complex-dependent actin nucleation.", "text_with_entity_marker": "The verprolin-like central (vc) region of Wiskott-Aldrich syndrome protein induces [E1]Arp2[/E1]/3 complex-dependent [E2]actin[/E2] nucleation.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Arp2", "entity_1_idx": [[83, 87]], "entity_1_idx_in_text_with_entity_marker": [87, 91], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[108, 113]], "entity_2_idx_in_text_with_entity_marker": [121, 126], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d587.s0_BioInfer.d587.s0.p3", "text": "The verprolin-like central (vc) region of Wiskott-Aldrich syndrome protein induces Arp2/3 complex-dependent actin nucleation.", "text_with_entity_marker": "The verprolin-like central (vc) region of [E1]Wiskott-Aldrich syndrome protein[/E1] induces Arp2/3 complex-dependent [E2]actin[/E2] nucleation.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Wiskott-Aldrich syndrome protein", "entity_1_idx": [[42, 74]], "entity_1_idx_in_text_with_entity_marker": [46, 78], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[108, 113]], "entity_2_idx_in_text_with_entity_marker": [121, 126], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d587.s0_BioInfer.d587.s0.p6", "text": "The verprolin-like central (vc) region of Wiskott-Aldrich syndrome protein induces Arp2/3 complex-dependent actin nucleation.", "text_with_entity_marker": "The [E1]verprolin[/E1]-like central (vc) region of [E2]Wiskott-Aldrich syndrome protein[/E2] induces Arp2/3 complex-dependent actin nucleation.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "verprolin", "entity_1_idx": [[4, 13]], "entity_1_idx_in_text_with_entity_marker": [8, 17], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Wiskott-Aldrich syndrome protein", "entity_2_idx": [[42, 74]], "entity_2_idx_in_text_with_entity_marker": [55, 87], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d253.s0_BioInfer.d253.s0.p0", "text": "Here we show that the ubiquitin-dependent proteolysis system is involved in the regulation of beta-catenin turnover.", "text_with_entity_marker": "Here we show that the [E1]ubiquitin[/E1]-dependent proteolysis system is involved in the regulation of [E2]beta-catenin[/E2] turnover.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "ubiquitin", "entity_1_idx": [[22, 31]], "entity_1_idx_in_text_with_entity_marker": [26, 35], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[94, 106]], "entity_2_idx_in_text_with_entity_marker": [107, 119], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d15.s0_BioInfer.d15.s0.p0", "text": "Actin-binding proteins such as profilins participate in the restructuration of the actin cytoskeleton in plant cells.", "text_with_entity_marker": "[E1]Actin-binding proteins[/E1] such as profilins participate in the restructuration of the [E2]actin[/E2] cytoskeleton in plant cells.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Actin-binding proteins", "entity_1_idx": [[0, 22]], "entity_1_idx_in_text_with_entity_marker": [4, 26], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "actin", "entity_2_idx": [[83, 88]], "entity_2_idx_in_text_with_entity_marker": [96, 101], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d15.s0_BioInfer.d15.s0.p1", "text": "Actin-binding proteins such as profilins participate in the restructuration of the actin cytoskeleton in plant cells.", "text_with_entity_marker": "[E1]Actin-binding proteins[/E1] such as [E2]profilins[/E2] participate in the restructuration of the actin cytoskeleton in plant cells.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Actin-binding proteins", "entity_1_idx": [[0, 22]], "entity_1_idx_in_text_with_entity_marker": [4, 26], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "profilins", "entity_2_idx": [[31, 40]], "entity_2_idx_in_text_with_entity_marker": [44, 53], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d486.s1_BioInfer.d486.s1.p0", "text": "Phosphorylation of profilin by PKC was not affected by the presence of various concentrations of actin.", "text_with_entity_marker": "Phosphorylation of [E1]profilin[/E1] by PKC was not affected by the presence of various concentrations of [E2]actin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[19, 27]], "entity_1_idx_in_text_with_entity_marker": [23, 31], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[97, 102]], "entity_2_idx_in_text_with_entity_marker": [110, 115], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d486.s1_BioInfer.d486.s1.p1", "text": "Phosphorylation of profilin by PKC was not affected by the presence of various concentrations of actin.", "text_with_entity_marker": "Phosphorylation of profilin by [E1]PKC[/E1] was not affected by the presence of various concentrations of [E2]actin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "PKC", "entity_1_idx": [[31, 34]], "entity_1_idx_in_text_with_entity_marker": [35, 38], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[97, 102]], "entity_2_idx_in_text_with_entity_marker": [110, 115], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d486.s1_BioInfer.d486.s1.p2", "text": "Phosphorylation of profilin by PKC was not affected by the presence of various concentrations of actin.", "text_with_entity_marker": "Phosphorylation of [E1]profilin[/E1] by [E2]PKC[/E2] was not affected by the presence of various concentrations of actin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[19, 27]], "entity_1_idx_in_text_with_entity_marker": [23, 31], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "PKC", "entity_2_idx": [[31, 34]], "entity_2_idx_in_text_with_entity_marker": [44, 47], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d583.s0_BioInfer.d583.s0.p0", "text": "The binding surfaces for segment 1 and profilin are different, although they peripherally overlap on actin.", "text_with_entity_marker": "The binding surfaces for segment 1 and [E1]profilin[/E1] are different, although they peripherally overlap on [E2]actin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[39, 47]], "entity_1_idx_in_text_with_entity_marker": [43, 51], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[101, 106]], "entity_2_idx_in_text_with_entity_marker": [114, 119], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d583.s1_BioInfer.d583.s1.p0", "text": "This review describes three structures of actin complexed with different monomer-binding proteins, namely with DNase I, gelsolin segment 1, and profilin.", "text_with_entity_marker": "This review describes three structures of [E1]actin[/E1] complexed with different monomer-binding proteins, namely with [E2]DNase I[/E2], gelsolin segment 1, and profilin.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[42, 47]], "entity_1_idx_in_text_with_entity_marker": [46, 51], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "DNase I", "entity_2_idx": [[111, 118]], "entity_2_idx_in_text_with_entity_marker": [124, 131], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d583.s1_BioInfer.d583.s1.p1", "text": "This review describes three structures of actin complexed with different monomer-binding proteins, namely with DNase I, gelsolin segment 1, and profilin.", "text_with_entity_marker": "This review describes three structures of [E1]actin[/E1] complexed with different monomer-binding proteins, namely with DNase I, gelsolin segment 1, and [E2]profilin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[42, 47]], "entity_1_idx_in_text_with_entity_marker": [46, 51], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[144, 152]], "entity_2_idx_in_text_with_entity_marker": [157, 165], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d583.s1_BioInfer.d583.s1.p2", "text": "This review describes three structures of actin complexed with different monomer-binding proteins, namely with DNase I, gelsolin segment 1, and profilin.", "text_with_entity_marker": "This review describes three structures of [E1]actin[/E1] complexed with different monomer-binding proteins, namely with DNase I, [E2]gelsolin[/E2] segment 1, and profilin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[42, 47]], "entity_1_idx_in_text_with_entity_marker": [46, 51], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "gelsolin", "entity_2_idx": [[120, 128]], "entity_2_idx_in_text_with_entity_marker": [133, 141], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d303.s0_BioInfer.d303.s0.p0", "text": "Immunostaining showed that APBs also contain replication factor A, RAD51, and RAD52, proteins involved in DNA synthesis and recombination.", "text_with_entity_marker": "Immunostaining showed that APBs also contain replication factor A, [E1]RAD51[/E1], and [E2]RAD52[/E2], proteins involved in DNA synthesis and recombination.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "RAD51", "entity_1_idx": [[67, 72]], "entity_1_idx_in_text_with_entity_marker": [71, 76], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RAD52", "entity_2_idx": [[78, 83]], "entity_2_idx_in_text_with_entity_marker": [91, 96], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d303.s0_BioInfer.d303.s0.p1", "text": "Immunostaining showed that APBs also contain replication factor A, RAD51, and RAD52, proteins involved in DNA synthesis and recombination.", "text_with_entity_marker": "Immunostaining showed that APBs also contain [E1]replication factor A[/E1], [E2]RAD51[/E2], and RAD52, proteins involved in DNA synthesis and recombination.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "replication factor A", "entity_1_idx": [[45, 65]], "entity_1_idx_in_text_with_entity_marker": [49, 69], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RAD51", "entity_2_idx": [[67, 72]], "entity_2_idx_in_text_with_entity_marker": [80, 85], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d303.s0_BioInfer.d303.s0.p2", "text": "Immunostaining showed that APBs also contain replication factor A, RAD51, and RAD52, proteins involved in DNA synthesis and recombination.", "text_with_entity_marker": "Immunostaining showed that APBs also contain [E1]replication factor A[/E1], RAD51, and [E2]RAD52[/E2], proteins involved in DNA synthesis and recombination.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "replication factor A", "entity_1_idx": [[45, 65]], "entity_1_idx_in_text_with_entity_marker": [49, 69], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RAD52", "entity_2_idx": [[78, 83]], "entity_2_idx_in_text_with_entity_marker": [91, 96], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d222.s0_BioInfer.d222.s0.p0", "text": "Furthermore, a simultaneous expression of profilin, actin and extracellular matrix proteins was observed during the regeneration of rat liver, that is, all mRNAs of these proteins showed biphasic peaks around 6 h and 48 h after partial hepatectomy.", "text_with_entity_marker": "Furthermore, a simultaneous expression of profilin, [E1]actin[/E1] and [E2]extracellular matrix proteins[/E2] was observed during the regeneration of rat liver, that is, all mRNAs of these proteins showed biphasic peaks around 6 h and 48 h after partial hepatectomy.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[52, 57]], "entity_1_idx_in_text_with_entity_marker": [56, 61], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "extracellular matrix proteins", "entity_2_idx": [[62, 91]], "entity_2_idx_in_text_with_entity_marker": [75, 104], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d222.s0_BioInfer.d222.s0.p1", "text": "Furthermore, a simultaneous expression of profilin, actin and extracellular matrix proteins was observed during the regeneration of rat liver, that is, all mRNAs of these proteins showed biphasic peaks around 6 h and 48 h after partial hepatectomy.", "text_with_entity_marker": "Furthermore, a simultaneous expression of [E1]profilin[/E1], actin and [E2]extracellular matrix proteins[/E2] was observed during the regeneration of rat liver, that is, all mRNAs of these proteins showed biphasic peaks around 6 h and 48 h after partial hepatectomy.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[42, 50]], "entity_1_idx_in_text_with_entity_marker": [46, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "extracellular matrix proteins", "entity_2_idx": [[62, 91]], "entity_2_idx_in_text_with_entity_marker": [75, 104], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d222.s0_BioInfer.d222.s0.p2", "text": "Furthermore, a simultaneous expression of profilin, actin and extracellular matrix proteins was observed during the regeneration of rat liver, that is, all mRNAs of these proteins showed biphasic peaks around 6 h and 48 h after partial hepatectomy.", "text_with_entity_marker": "Furthermore, a simultaneous expression of [E1]profilin[/E1], [E2]actin[/E2] and extracellular matrix proteins was observed during the regeneration of rat liver, that is, all mRNAs of these proteins showed biphasic peaks around 6 h and 48 h after partial hepatectomy.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[42, 50]], "entity_1_idx_in_text_with_entity_marker": [46, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[52, 57]], "entity_2_idx_in_text_with_entity_marker": [65, 70], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d581.s0_BioInfer.d581.s0.p3", "text": "The adenosine deaminase-binding region is distinct from major anti-CD26 mAb epitopes on the human dipeptidyl peptidase IV(CD26) molecule.", "text_with_entity_marker": "The adenosine deaminase-binding region is distinct from major anti-[E1]CD26[/E1] mAb epitopes on the human dipeptidyl peptidase IV([E2]CD26[/E2]) molecule.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "CD26", "entity_1_idx": [[67, 71]], "entity_1_idx_in_text_with_entity_marker": [71, 75], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CD26", "entity_2_idx": [[122, 126]], "entity_2_idx_in_text_with_entity_marker": [135, 139], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d581.s0_BioInfer.d581.s0.p5", "text": "The adenosine deaminase-binding region is distinct from major anti-CD26 mAb epitopes on the human dipeptidyl peptidase IV(CD26) molecule.", "text_with_entity_marker": "The adenosine deaminase-binding region is distinct from major anti-[E1]CD26[/E1] mAb epitopes on the human [E2]dipeptidyl peptidase IV[/E2](CD26) molecule.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "CD26", "entity_1_idx": [[67, 71]], "entity_1_idx_in_text_with_entity_marker": [71, 75], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "dipeptidyl peptidase IV", "entity_2_idx": [[98, 121]], "entity_2_idx_in_text_with_entity_marker": [111, 134], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d240.s0_BioInfer.d240.s0.p0", "text": "Here we demonstrate that type XIII collagen is concentrated in cultured skin fibroblasts and several other human mesenchymal cell lines in the focal adhesions at the ends of actin stress fibers, co-localizing with the known focal adhesion components talin and vinculin.", "text_with_entity_marker": "Here we demonstrate that [E1]type XIII collagen[/E1] is concentrated in cultured skin fibroblasts and several other human mesenchymal cell lines in the focal adhesions at the ends of actin stress fibers, co-localizing with the known focal adhesion components [E2]talin[/E2] and vinculin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "type XIII collagen", "entity_1_idx": [[25, 43]], "entity_1_idx_in_text_with_entity_marker": [29, 47], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[250, 255]], "entity_2_idx_in_text_with_entity_marker": [263, 268], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d240.s0_BioInfer.d240.s0.p1", "text": "Here we demonstrate that type XIII collagen is concentrated in cultured skin fibroblasts and several other human mesenchymal cell lines in the focal adhesions at the ends of actin stress fibers, co-localizing with the known focal adhesion components talin and vinculin.", "text_with_entity_marker": "Here we demonstrate that [E1]type XIII collagen[/E1] is concentrated in cultured skin fibroblasts and several other human mesenchymal cell lines in the focal adhesions at the ends of actin stress fibers, co-localizing with the known focal adhesion components talin and [E2]vinculin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "type XIII collagen", "entity_1_idx": [[25, 43]], "entity_1_idx_in_text_with_entity_marker": [29, 47], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vinculin", "entity_2_idx": [[260, 268]], "entity_2_idx_in_text_with_entity_marker": [273, 281], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d240.s0_BioInfer.d240.s0.p2", "text": "Here we demonstrate that type XIII collagen is concentrated in cultured skin fibroblasts and several other human mesenchymal cell lines in the focal adhesions at the ends of actin stress fibers, co-localizing with the known focal adhesion components talin and vinculin.", "text_with_entity_marker": "Here we demonstrate that [E1]type XIII collagen[/E1] is concentrated in cultured skin fibroblasts and several other human mesenchymal cell lines in the focal adhesions at the ends of [E2]actin[/E2] stress fibers, co-localizing with the known focal adhesion components talin and vinculin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "type XIII collagen", "entity_1_idx": [[25, 43]], "entity_1_idx_in_text_with_entity_marker": [29, 47], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[174, 179]], "entity_2_idx_in_text_with_entity_marker": [187, 192], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d634.s0_BioInfer.d634.s0.p22", "text": "The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "text_with_entity_marker": "The involvement of the death adaptor proteins FADD/MORT1, [E1]TRADD[/E1], and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing [E2]TRAIL receptors 1[/E2] and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "TRADD", "entity_1_idx": [[58, 63]], "entity_1_idx_in_text_with_entity_marker": [62, 67], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRAIL receptors 1", "entity_2_idx": [[166, 183]], "entity_2_idx_in_text_with_entity_marker": [179, 196], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d634.s0_BioInfer.d634.s0.p23", "text": "The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "text_with_entity_marker": "The involvement of the death adaptor proteins FADD/MORT1, [E1]TRADD[/E1], and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and [E2]TRAIL-R2[/E2]) are controversial.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "TRADD", "entity_1_idx": [[58, 63]], "entity_1_idx_in_text_with_entity_marker": [62, 67], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRAIL-R2", "entity_2_idx": [[204, 212]], "entity_2_idx_in_text_with_entity_marker": [217, 225], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d634.s0_BioInfer.d634.s0.p24", "text": "The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "text_with_entity_marker": "The involvement of the death adaptor proteins FADD/[E1]MORT1[/E1], TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 ([E2]TRAIL-R1[/E2] and TRAIL-R2) are controversial.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "MORT1", "entity_1_idx": [[51, 56]], "entity_1_idx_in_text_with_entity_marker": [55, 60], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRAIL-R1", "entity_2_idx": [[191, 199]], "entity_2_idx_in_text_with_entity_marker": [204, 212], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d634.s0_BioInfer.d634.s0.p27", "text": "The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "text_with_entity_marker": "The involvement of the death adaptor proteins FADD/[E1]MORT1[/E1], TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing [E2]TRAIL receptors[/E2] 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "MORT1", "entity_1_idx": [[51, 56]], "entity_1_idx_in_text_with_entity_marker": [55, 60], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRAIL receptors", "entity_2_idx": [[166, 181], [188, 189]], "entity_2_idx_in_text_with_entity_marker": [179, 194], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d634.s0_BioInfer.d634.s0.p28", "text": "The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "text_with_entity_marker": "The involvement of the death adaptor proteins FADD/[E1]MORT1[/E1], TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing [E2]TRAIL receptors 1[/E2] and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "MORT1", "entity_1_idx": [[51, 56]], "entity_1_idx_in_text_with_entity_marker": [55, 60], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRAIL receptors 1", "entity_2_idx": [[166, 183]], "entity_2_idx_in_text_with_entity_marker": [179, 196], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d634.s0_BioInfer.d634.s0.p29", "text": "The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "text_with_entity_marker": "The involvement of the death adaptor proteins FADD/[E1]MORT1[/E1], TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and [E2]TRAIL-R2[/E2]) are controversial.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "MORT1", "entity_1_idx": [[51, 56]], "entity_1_idx_in_text_with_entity_marker": [55, 60], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRAIL-R2", "entity_2_idx": [[204, 212]], "entity_2_idx_in_text_with_entity_marker": [217, 225], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d634.s0_BioInfer.d634.s0.p30", "text": "The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "text_with_entity_marker": "The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating [E1]caspases[/E1]-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 ([E2]TRAIL-R1[/E2] and TRAIL-R2) are controversial.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "caspases", "entity_1_idx": [[102, 110], [117, 120]], "entity_1_idx_in_text_with_entity_marker": [106, 114], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRAIL-R1", "entity_2_idx": [[191, 199]], "entity_2_idx_in_text_with_entity_marker": [204, 212], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d634.s0_BioInfer.d634.s0.p31", "text": "The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "text_with_entity_marker": "The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating [E1]caspases-8[/E1] and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 ([E2]TRAIL-R1[/E2] and TRAIL-R2) are controversial.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "caspases-8", "entity_1_idx": [[102, 112]], "entity_1_idx_in_text_with_entity_marker": [106, 116], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRAIL-R1", "entity_2_idx": [[191, 199]], "entity_2_idx_in_text_with_entity_marker": [204, 212], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d634.s0_BioInfer.d634.s0.p36", "text": "The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "text_with_entity_marker": "The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating [E1]caspases[/E1]-8 and -10 in death signaling by the two death-inducing [E2]TRAIL receptors[/E2] 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "caspases", "entity_1_idx": [[102, 110], [117, 120]], "entity_1_idx_in_text_with_entity_marker": [106, 114], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRAIL receptors", "entity_2_idx": [[166, 181], [188, 189]], "entity_2_idx_in_text_with_entity_marker": [179, 194], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d634.s0_BioInfer.d634.s0.p37", "text": "The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "text_with_entity_marker": "The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating [E1]caspases[/E1]-8 and -10 in death signaling by the two death-inducing [E2]TRAIL receptors 1[/E2] and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "caspases", "entity_1_idx": [[102, 110], [117, 120]], "entity_1_idx_in_text_with_entity_marker": [106, 114], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRAIL receptors 1", "entity_2_idx": [[166, 183]], "entity_2_idx_in_text_with_entity_marker": [179, 196], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d739.s0_BioInfer.d739.s0.p0", "text": "This filament growth is driven by a large storage pool of actin bound to the sequestering protein, profilin.", "text_with_entity_marker": "This filament growth is driven by a large storage pool of [E1]actin[/E1] bound to the sequestering protein, [E2]profilin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[58, 63]], "entity_1_idx_in_text_with_entity_marker": [62, 67], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[99, 107]], "entity_2_idx_in_text_with_entity_marker": [112, 120], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d4.s0_BioInfer.d4.s0.p0", "text": "Abundance of actin, talin, alpha 5 and beta 1 integrins, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.", "text_with_entity_marker": "Abundance of actin, talin, alpha 5 and beta 1 integrins, pp125 focal adhesion kinase, and [E1]alpha-catenin[/E1] is not affected by the differential [E2]calreticulin[/E2] expression.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "alpha-catenin", "entity_1_idx": [[90, 103]], "entity_1_idx_in_text_with_entity_marker": [94, 107], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "calreticulin", "entity_2_idx": [[140, 152]], "entity_2_idx_in_text_with_entity_marker": [153, 165], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d4.s0_BioInfer.d4.s0.p7", "text": "Abundance of actin, talin, alpha 5 and beta 1 integrins, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.", "text_with_entity_marker": "Abundance of [E1]actin[/E1], talin, alpha 5 and beta 1 integrins, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential [E2]calreticulin[/E2] expression.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[13, 18]], "entity_1_idx_in_text_with_entity_marker": [17, 22], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "calreticulin", "entity_2_idx": [[140, 152]], "entity_2_idx_in_text_with_entity_marker": [153, 165], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d4.s0_BioInfer.d4.s0.p8", "text": "Abundance of actin, talin, alpha 5 and beta 1 integrins, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.", "text_with_entity_marker": "Abundance of actin, talin, [E1]alpha 5[/E1] and beta 1 integrins, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential [E2]calreticulin[/E2] expression.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "alpha 5", "entity_1_idx": [[27, 34], [46, 55]], "entity_1_idx_in_text_with_entity_marker": [31, 38], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "calreticulin", "entity_2_idx": [[140, 152]], "entity_2_idx_in_text_with_entity_marker": [153, 165], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d4.s0_BioInfer.d4.s0.p9", "text": "Abundance of actin, talin, alpha 5 and beta 1 integrins, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.", "text_with_entity_marker": "Abundance of actin, talin, alpha 5 and beta 1 integrins, [E1]pp125[/E1] focal adhesion kinase, and alpha-catenin is not affected by the differential [E2]calreticulin[/E2] expression.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "pp125", "entity_1_idx": [[57, 62]], "entity_1_idx_in_text_with_entity_marker": [61, 66], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "calreticulin", "entity_2_idx": [[140, 152]], "entity_2_idx_in_text_with_entity_marker": [153, 165], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d4.s0_BioInfer.d4.s0.p10", "text": "Abundance of actin, talin, alpha 5 and beta 1 integrins, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.", "text_with_entity_marker": "Abundance of actin, talin, alpha 5 and [E1]beta 1 integrins[/E1], pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential [E2]calreticulin[/E2] expression.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "beta 1 integrins", "entity_1_idx": [[39, 55]], "entity_1_idx_in_text_with_entity_marker": [43, 59], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "calreticulin", "entity_2_idx": [[140, 152]], "entity_2_idx_in_text_with_entity_marker": [153, 165], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d4.s0_BioInfer.d4.s0.p11", "text": "Abundance of actin, talin, alpha 5 and beta 1 integrins, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.", "text_with_entity_marker": "Abundance of actin, [E1]talin[/E1], alpha 5 and beta 1 integrins, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential [E2]calreticulin[/E2] expression.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "talin", "entity_1_idx": [[20, 25]], "entity_1_idx_in_text_with_entity_marker": [24, 29], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "calreticulin", "entity_2_idx": [[140, 152]], "entity_2_idx_in_text_with_entity_marker": [153, 165], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d4.s0_BioInfer.d4.s0.p24", "text": "Abundance of actin, talin, alpha 5 and beta 1 integrins, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.", "text_with_entity_marker": "Abundance of actin, talin, alpha 5 and beta 1 integrins, [E1]pp125[/E1] [E2]focal adhesion kinase[/E2], and alpha-catenin is not affected by the differential calreticulin expression.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "pp125", "entity_1_idx": [[57, 62]], "entity_1_idx_in_text_with_entity_marker": [61, 66], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "focal adhesion kinase", "entity_2_idx": [[63, 84]], "entity_2_idx_in_text_with_entity_marker": [76, 97], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d18.s0_BioInfer.d18.s0.p2", "text": "Actin isoforms from different species were also compared, and the effect of profilin on the thermal stability of actin was studied.", "text_with_entity_marker": "Actin isoforms from different species were also compared, and the effect of [E1]profilin[/E1] on the thermal stability of [E2]actin[/E2] was studied.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[76, 84]], "entity_1_idx_in_text_with_entity_marker": [80, 88], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[113, 118]], "entity_2_idx_in_text_with_entity_marker": [126, 131], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d740.s0_BioInfer.d740.s0.p0", "text": "This is consistent with cofilin activation being required for actin reorganization during exocytosis.", "text_with_entity_marker": "This is consistent with [E1]cofilin[/E1] activation being required for [E2]actin[/E2] reorganization during exocytosis.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[24, 31]], "entity_1_idx_in_text_with_entity_marker": [28, 35], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[62, 67]], "entity_2_idx_in_text_with_entity_marker": [75, 80], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d60.s0_BioInfer.d60.s0.p0", "text": "Analysis of V3, a hamster equivalent of SCID, indicates that the protein level increases of RAD51 and RAD52 from G0 to G1/S/G2 do not require DNA-PK.", "text_with_entity_marker": "Analysis of V3, a hamster equivalent of SCID, indicates that the protein level increases of [E1]RAD51[/E1] and RAD52 from G0 to G1/S/G2 do not require [E2]DNA-PK[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "RAD51", "entity_1_idx": [[92, 97]], "entity_1_idx_in_text_with_entity_marker": [96, 101], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "DNA-PK", "entity_2_idx": [[142, 148]], "entity_2_idx_in_text_with_entity_marker": [155, 161], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d60.s0_BioInfer.d60.s0.p1", "text": "Analysis of V3, a hamster equivalent of SCID, indicates that the protein level increases of RAD51 and RAD52 from G0 to G1/S/G2 do not require DNA-PK.", "text_with_entity_marker": "Analysis of V3, a hamster equivalent of SCID, indicates that the protein level increases of RAD51 and [E1]RAD52[/E1] from G0 to G1/S/G2 do not require [E2]DNA-PK[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "RAD52", "entity_1_idx": [[102, 107]], "entity_1_idx_in_text_with_entity_marker": [106, 111], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "DNA-PK", "entity_2_idx": [[142, 148]], "entity_2_idx_in_text_with_entity_marker": [155, 161], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d708.s0_BioInfer.d708.s0.p0", "text": "These results indicate that (i) cotranslational assembly of myosin heavy chains is developmentally regulated, (ii) structures containing actin and not microtubules may mediate initial association of the heavy chains with the cytoskeleton, and (iii) the site of translation dictates where a significant fraction of the heavy chains will be inserted into the cytoskeleton.", "text_with_entity_marker": "These results indicate that (i) cotranslational assembly of [E1]myosin heavy chains[/E1] is developmentally regulated, (ii) structures containing [E2]actin[/E2] and not microtubules may mediate initial association of the heavy chains with the cytoskeleton, and (iii) the site of translation dictates where a significant fraction of the heavy chains will be inserted into the cytoskeleton.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "myosin heavy chains", "entity_1_idx": [[60, 79]], "entity_1_idx_in_text_with_entity_marker": [64, 83], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[137, 142]], "entity_2_idx_in_text_with_entity_marker": [150, 155], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d627.s0_BioInfer.d627.s0.p0", "text": "The influence of these collagens on cell morphology and the distribution pattern of actin, vimentin, talin, and vinculin was analyzed by light microscopy, conventional electron microscopy, immunofluorescence, and immunogold labeling after lysis-squirting.", "text_with_entity_marker": "The influence of these [E1]collagens[/E1] on cell morphology and the distribution pattern of actin, [E2]vimentin[/E2], talin, and vinculin was analyzed by light microscopy, conventional electron microscopy, immunofluorescence, and immunogold labeling after lysis-squirting.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "collagens", "entity_1_idx": [[23, 32]], "entity_1_idx_in_text_with_entity_marker": [27, 36], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "vimentin", "entity_2_idx": [[91, 99]], "entity_2_idx_in_text_with_entity_marker": [104, 112], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d627.s0_BioInfer.d627.s0.p1", "text": "The influence of these collagens on cell morphology and the distribution pattern of actin, vimentin, talin, and vinculin was analyzed by light microscopy, conventional electron microscopy, immunofluorescence, and immunogold labeling after lysis-squirting.", "text_with_entity_marker": "The influence of these [E1]collagens[/E1] on cell morphology and the distribution pattern of [E2]actin[/E2], vimentin, talin, and vinculin was analyzed by light microscopy, conventional electron microscopy, immunofluorescence, and immunogold labeling after lysis-squirting.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "collagens", "entity_1_idx": [[23, 32]], "entity_1_idx_in_text_with_entity_marker": [27, 36], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "actin", "entity_2_idx": [[84, 89]], "entity_2_idx_in_text_with_entity_marker": [97, 102], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d627.s0_BioInfer.d627.s0.p2", "text": "The influence of these collagens on cell morphology and the distribution pattern of actin, vimentin, talin, and vinculin was analyzed by light microscopy, conventional electron microscopy, immunofluorescence, and immunogold labeling after lysis-squirting.", "text_with_entity_marker": "The influence of these [E1]collagens[/E1] on cell morphology and the distribution pattern of actin, vimentin, talin, and [E2]vinculin[/E2] was analyzed by light microscopy, conventional electron microscopy, immunofluorescence, and immunogold labeling after lysis-squirting.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "collagens", "entity_1_idx": [[23, 32]], "entity_1_idx_in_text_with_entity_marker": [27, 36], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "vinculin", "entity_2_idx": [[112, 120]], "entity_2_idx_in_text_with_entity_marker": [125, 133], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d627.s0_BioInfer.d627.s0.p3", "text": "The influence of these collagens on cell morphology and the distribution pattern of actin, vimentin, talin, and vinculin was analyzed by light microscopy, conventional electron microscopy, immunofluorescence, and immunogold labeling after lysis-squirting.", "text_with_entity_marker": "The influence of these [E1]collagens[/E1] on cell morphology and the distribution pattern of actin, vimentin, [E2]talin[/E2], and vinculin was analyzed by light microscopy, conventional electron microscopy, immunofluorescence, and immunogold labeling after lysis-squirting.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "collagens", "entity_1_idx": [[23, 32]], "entity_1_idx_in_text_with_entity_marker": [27, 36], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "talin", "entity_2_idx": [[101, 106]], "entity_2_idx_in_text_with_entity_marker": [114, 119], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d451.s0_BioInfer.d451.s0.p1", "text": "Newly disclosed interactions between gephyrin, exchange factors for G proteins of the Rho and Rac families, the translational regulator RAFT1, and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.", "text_with_entity_marker": "Newly disclosed interactions between gephyrin, exchange factors for [E1]G proteins[/E1] of the [E2]Rho[/E2] and Rac families, the translational regulator RAFT1, and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "G proteins", "entity_1_idx": [[68, 78]], "entity_1_idx_in_text_with_entity_marker": [72, 82], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Rho", "entity_2_idx": [[86, 89]], "entity_2_idx_in_text_with_entity_marker": [99, 102], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d451.s0_BioInfer.d451.s0.p13", "text": "Newly disclosed interactions between gephyrin, exchange factors for G proteins of the Rho and Rac families, the translational regulator RAFT1, and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.", "text_with_entity_marker": "Newly disclosed interactions between gephyrin, exchange factors for [E1]G proteins[/E1] of the Rho and Rac families, the translational regulator [E2]RAFT1[/E2], and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "G proteins", "entity_1_idx": [[68, 78]], "entity_1_idx_in_text_with_entity_marker": [72, 82], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RAFT1", "entity_2_idx": [[136, 141]], "entity_2_idx_in_text_with_entity_marker": [149, 154], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d451.s0_BioInfer.d451.s0.p15", "text": "Newly disclosed interactions between gephyrin, exchange factors for G proteins of the Rho and Rac families, the translational regulator RAFT1, and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.", "text_with_entity_marker": "Newly disclosed interactions between gephyrin, exchange factors for [E1]G proteins[/E1] of the Rho and Rac families, the translational regulator RAFT1, and [E2]actin-binding proteins[/E2] like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "G proteins", "entity_1_idx": [[68, 78]], "entity_1_idx_in_text_with_entity_marker": [72, 82], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin-binding proteins", "entity_2_idx": [[147, 169]], "entity_2_idx_in_text_with_entity_marker": [160, 182], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d451.s0_BioInfer.d451.s0.p16", "text": "Newly disclosed interactions between gephyrin, exchange factors for G proteins of the Rho and Rac families, the translational regulator RAFT1, and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.", "text_with_entity_marker": "Newly disclosed interactions between [E1]gephyrin[/E1], exchange factors for [E2]G proteins[/E2] of the Rho and Rac families, the translational regulator RAFT1, and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "gephyrin", "entity_1_idx": [[37, 45]], "entity_1_idx_in_text_with_entity_marker": [41, 49], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "G proteins", "entity_2_idx": [[68, 78]], "entity_2_idx_in_text_with_entity_marker": [81, 91], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d451.s0_BioInfer.d451.s0.p17", "text": "Newly disclosed interactions between gephyrin, exchange factors for G proteins of the Rho and Rac families, the translational regulator RAFT1, and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.", "text_with_entity_marker": "Newly disclosed interactions between gephyrin, exchange factors for [E1]G proteins[/E1] of the Rho and [E2]Rac[/E2] families, the translational regulator RAFT1, and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "G proteins", "entity_1_idx": [[68, 78]], "entity_1_idx_in_text_with_entity_marker": [72, 82], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Rac", "entity_2_idx": [[94, 97]], "entity_2_idx_in_text_with_entity_marker": [107, 110], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d451.s0_BioInfer.d451.s0.p19", "text": "Newly disclosed interactions between gephyrin, exchange factors for G proteins of the Rho and Rac families, the translational regulator RAFT1, and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.", "text_with_entity_marker": "Newly disclosed interactions between gephyrin, exchange factors for G proteins of the Rho and Rac families, the translational regulator [E1]RAFT1[/E1], and [E2]actin-binding proteins[/E2] like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "RAFT1", "entity_1_idx": [[136, 141]], "entity_1_idx_in_text_with_entity_marker": [140, 145], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin-binding proteins", "entity_2_idx": [[147, 169]], "entity_2_idx_in_text_with_entity_marker": [160, 182], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d451.s0_BioInfer.d451.s0.p20", "text": "Newly disclosed interactions between gephyrin, exchange factors for G proteins of the Rho and Rac families, the translational regulator RAFT1, and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.", "text_with_entity_marker": "Newly disclosed interactions between [E1]gephyrin[/E1], exchange factors for G proteins of the Rho and Rac families, the translational regulator [E2]RAFT1[/E2], and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "gephyrin", "entity_1_idx": [[37, 45]], "entity_1_idx_in_text_with_entity_marker": [41, 49], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RAFT1", "entity_2_idx": [[136, 141]], "entity_2_idx_in_text_with_entity_marker": [149, 154], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d451.s0_BioInfer.d451.s0.p22", "text": "Newly disclosed interactions between gephyrin, exchange factors for G proteins of the Rho and Rac families, the translational regulator RAFT1, and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.", "text_with_entity_marker": "Newly disclosed interactions between gephyrin, exchange factors for G proteins of the Rho and Rac families, the translational regulator RAFT1, and [E1]actin-binding proteins[/E1] like [E2]profilin[/E2] might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin-binding proteins", "entity_1_idx": [[147, 169]], "entity_1_idx_in_text_with_entity_marker": [151, 173], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "profilin", "entity_2_idx": [[175, 183]], "entity_2_idx_in_text_with_entity_marker": [188, 196], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d451.s0_BioInfer.d451.s0.p25", "text": "Newly disclosed interactions between gephyrin, exchange factors for G proteins of the Rho and Rac families, the translational regulator RAFT1, and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.", "text_with_entity_marker": "Newly disclosed interactions between [E1]gephyrin[/E1], exchange factors for G proteins of the Rho and Rac families, the translational regulator RAFT1, and [E2]actin-binding proteins[/E2] like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "gephyrin", "entity_1_idx": [[37, 45]], "entity_1_idx_in_text_with_entity_marker": [41, 49], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin-binding proteins", "entity_2_idx": [[147, 169]], "entity_2_idx_in_text_with_entity_marker": [160, 182], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d86.s0_BioInfer.d86.s0.p0", "text": "At least one element of the actin-binding region of human profilin is an alpha-helix.", "text_with_entity_marker": "At least one element of the [E1]actin[/E1]-binding region of human [E2]profilin[/E2] is an alpha-helix.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[28, 33]], "entity_1_idx_in_text_with_entity_marker": [32, 37], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[58, 66]], "entity_2_idx_in_text_with_entity_marker": [71, 79], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d117.s0_BioInfer.d117.s0.p1", "text": "By 1 h the cells were well spread with straight actin bundles many of which ended at more central sites terminating on patches containing vinculin and talin; thus the cells assemble typical stress fibers but do not appear to polarize.", "text_with_entity_marker": "By 1 h the cells were well spread with straight actin bundles many of which ended at more central sites terminating on patches containing [E1]vinculin[/E1] and [E2]talin[/E2]; thus the cells assemble typical stress fibers but do not appear to polarize.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "vinculin", "entity_1_idx": [[138, 146]], "entity_1_idx_in_text_with_entity_marker": [142, 150], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[151, 156]], "entity_2_idx_in_text_with_entity_marker": [164, 169], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d473.s0_BioInfer.d473.s0.p5", "text": "Our data, which suggest that pollen profilin can regulate actin-based cytoskeletal protein assembly and protein kinase or phosphatase activity, indicate a possible role for the involvement of profilin in signaling pathways that may regulate pollen tube growth.", "text_with_entity_marker": "Our data, which suggest that pollen [E1]profilin[/E1] can regulate actin-based cytoskeletal protein assembly and [E2]protein kinase[/E2] or phosphatase activity, indicate a possible role for the involvement of profilin in signaling pathways that may regulate pollen tube growth.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[36, 44]], "entity_1_idx_in_text_with_entity_marker": [40, 48], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "protein kinase", "entity_2_idx": [[104, 118]], "entity_2_idx_in_text_with_entity_marker": [117, 131], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d473.s0_BioInfer.d473.s0.p6", "text": "Our data, which suggest that pollen profilin can regulate actin-based cytoskeletal protein assembly and protein kinase or phosphatase activity, indicate a possible role for the involvement of profilin in signaling pathways that may regulate pollen tube growth.", "text_with_entity_marker": "Our data, which suggest that pollen [E1]profilin[/E1] can regulate actin-based cytoskeletal protein assembly and [E2]protein[/E2] kinase or phosphatase activity, indicate a possible role for the involvement of profilin in signaling pathways that may regulate pollen tube growth.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[36, 44]], "entity_1_idx_in_text_with_entity_marker": [40, 48], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "protein", "entity_2_idx": [[104, 111], [122, 133]], "entity_2_idx_in_text_with_entity_marker": [117, 124], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d573.s0_BioInfer.d573.s0.p0", "text": "The amount of unassembled actin (12 microM) is accounted for by the sequestering functions of T beta 4Xen (20 microM) and profilin (5 microM), the barbed ends being capped.", "text_with_entity_marker": "The amount of unassembled [E1]actin[/E1] (12 microM) is accounted for by the sequestering functions of T beta 4Xen (20 microM) and [E2]profilin[/E2] (5 microM), the barbed ends being capped.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[26, 31]], "entity_1_idx_in_text_with_entity_marker": [30, 35], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[122, 130]], "entity_2_idx_in_text_with_entity_marker": [135, 143], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d573.s0_BioInfer.d573.s0.p2", "text": "The amount of unassembled actin (12 microM) is accounted for by the sequestering functions of T beta 4Xen (20 microM) and profilin (5 microM), the barbed ends being capped.", "text_with_entity_marker": "The amount of unassembled [E1]actin[/E1] (12 microM) is accounted for by the sequestering functions of [E2]T beta 4Xen[/E2] (20 microM) and profilin (5 microM), the barbed ends being capped.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[26, 31]], "entity_1_idx_in_text_with_entity_marker": [30, 35], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "T beta 4Xen", "entity_2_idx": [[94, 105]], "entity_2_idx_in_text_with_entity_marker": [107, 118], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d189.s0_BioInfer.d189.s0.p0", "text": "Elevation of cAMP induced morphologic alterations indicative of changes in the adhesive status of the macrophage, including cell rounding and disassembly of structures that represent points of contact with substrate containing actin and talin.", "text_with_entity_marker": "Elevation of cAMP induced morphologic alterations indicative of changes in the adhesive status of the macrophage, including cell rounding and disassembly of structures that represent points of contact with substrate containing [E1]actin[/E1] and [E2]talin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[227, 232]], "entity_1_idx_in_text_with_entity_marker": [231, 236], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[237, 242]], "entity_2_idx_in_text_with_entity_marker": [250, 255], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d262.s0_BioInfer.d262.s0.p4", "text": "HGF/SF treatment of LoVo reduced the amount of alpha-catenin complexed with E-cadherin more markedly than in L-10, but in both cell lines this reduction was not accompanied by increased tyrosine phosphorylation of beta-catenin, suggesting the presence of a mechanism other than phosphorylation for release from cell-cell adhesion during cell motility.", "text_with_entity_marker": "HGF/SF treatment of LoVo reduced the amount of [E1]alpha-catenin[/E1] complexed with [E2]E-cadherin[/E2] more markedly than in L-10, but in both cell lines this reduction was not accompanied by increased tyrosine phosphorylation of beta-catenin, suggesting the presence of a mechanism other than phosphorylation for release from cell-cell adhesion during cell motility.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[47, 60]], "entity_1_idx_in_text_with_entity_marker": [51, 64], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E-cadherin", "entity_2_idx": [[76, 86]], "entity_2_idx_in_text_with_entity_marker": [89, 99], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d215.s0_BioInfer.d215.s0.p1", "text": "For example, it is associated with alpha-catenin and beta-catenin (Armadillo), and protected from trypsin digestion only in the presence of Ca2+, as is the case for many of classic cadherins.", "text_with_entity_marker": "For example, it is associated with alpha-catenin and [E1]beta-catenin[/E1] (Armadillo), and protected from trypsin digestion only in the presence of Ca2+, as is the case for many of classic [E2]cadherins[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[53, 65]], "entity_1_idx_in_text_with_entity_marker": [57, 69], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cadherins", "entity_2_idx": [[181, 190]], "entity_2_idx_in_text_with_entity_marker": [194, 203], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d215.s0_BioInfer.d215.s0.p4", "text": "For example, it is associated with alpha-catenin and beta-catenin (Armadillo), and protected from trypsin digestion only in the presence of Ca2+, as is the case for many of classic cadherins.", "text_with_entity_marker": "For example, it is associated with alpha-catenin and beta-catenin ([E1]Armadillo[/E1]), and protected from trypsin digestion only in the presence of Ca2+, as is the case for many of classic [E2]cadherins[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Armadillo", "entity_1_idx": [[67, 76]], "entity_1_idx_in_text_with_entity_marker": [71, 80], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cadherins", "entity_2_idx": [[181, 190]], "entity_2_idx_in_text_with_entity_marker": [194, 203], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d215.s0_BioInfer.d215.s0.p7", "text": "For example, it is associated with alpha-catenin and beta-catenin (Armadillo), and protected from trypsin digestion only in the presence of Ca2+, as is the case for many of classic cadherins.", "text_with_entity_marker": "For example, it is associated with [E1]alpha-catenin[/E1] and beta-catenin (Armadillo), and protected from trypsin digestion only in the presence of Ca2+, as is the case for many of classic [E2]cadherins[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[35, 48]], "entity_1_idx_in_text_with_entity_marker": [39, 52], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cadherins", "entity_2_idx": [[181, 190]], "entity_2_idx_in_text_with_entity_marker": [194, 203], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d215.s0_BioInfer.d215.s0.p8", "text": "For example, it is associated with alpha-catenin and beta-catenin (Armadillo), and protected from trypsin digestion only in the presence of Ca2+, as is the case for many of classic cadherins.", "text_with_entity_marker": "For example, it is associated with alpha-catenin and beta-catenin (Armadillo), and protected from [E1]trypsin[/E1] digestion only in the presence of Ca2+, as is the case for many of classic [E2]cadherins[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "trypsin", "entity_1_idx": [[98, 105]], "entity_1_idx_in_text_with_entity_marker": [102, 109], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cadherins", "entity_2_idx": [[181, 190]], "entity_2_idx_in_text_with_entity_marker": [194, 203], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d391.s0_BioInfer.d391.s0.p0", "text": "Isolation of profilin from embryonic chicken skeletal muscle and evaluation of its interaction with different actin isoforms.", "text_with_entity_marker": "Isolation of [E1]profilin[/E1] from embryonic chicken skeletal muscle and evaluation of its interaction with different [E2]actin[/E2] isoforms.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[13, 21]], "entity_1_idx_in_text_with_entity_marker": [17, 25], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[110, 115]], "entity_2_idx_in_text_with_entity_marker": [123, 128], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d391.s1_BioInfer.d391.s1.p0", "text": "These results indicate that the assembly of cytoskeletal and sarcomeric actins is regulated differently by profilin in the developing skeletal muscle, and that the former may not be involved in myofibril assembly.", "text_with_entity_marker": "These results indicate that the assembly of cytoskeletal and [E1]sarcomeric actins[/E1] is regulated differently by [E2]profilin[/E2] in the developing skeletal muscle, and that the former may not be involved in myofibril assembly.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "sarcomeric actins", "entity_1_idx": [[61, 78]], "entity_1_idx_in_text_with_entity_marker": [65, 82], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[107, 115]], "entity_2_idx_in_text_with_entity_marker": [120, 128], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d391.s1_BioInfer.d391.s1.p1", "text": "These results indicate that the assembly of cytoskeletal and sarcomeric actins is regulated differently by profilin in the developing skeletal muscle, and that the former may not be involved in myofibril assembly.", "text_with_entity_marker": "These results indicate that the assembly of [E1]cytoskeletal[/E1] and sarcomeric actins is regulated differently by [E2]profilin[/E2] in the developing skeletal muscle, and that the former may not be involved in myofibril assembly.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "cytoskeletal", "entity_1_idx": [[44, 56], [72, 78]], "entity_1_idx_in_text_with_entity_marker": [48, 60], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[107, 115]], "entity_2_idx_in_text_with_entity_marker": [120, 128], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d231.s0_BioInfer.d231.s0.p1", "text": "Genetic analysis suggested that this phenotype was due to msh6-F337A sequestering MSH2 and preventing it from interacting with MSH3 and MSH6.", "text_with_entity_marker": "Genetic analysis suggested that this phenotype was due to [E1]msh6-F337A[/E1] sequestering MSH2 and preventing it from interacting with [E2]MSH3[/E2] and MSH6.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "msh6-F337A", "entity_1_idx": [[58, 68]], "entity_1_idx_in_text_with_entity_marker": [62, 72], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "MSH3", "entity_2_idx": [[127, 131]], "entity_2_idx_in_text_with_entity_marker": [140, 144], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d231.s0_BioInfer.d231.s0.p2", "text": "Genetic analysis suggested that this phenotype was due to msh6-F337A sequestering MSH2 and preventing it from interacting with MSH3 and MSH6.", "text_with_entity_marker": "Genetic analysis suggested that this phenotype was due to [E1]msh6-F337A[/E1] sequestering [E2]MSH2[/E2] and preventing it from interacting with MSH3 and MSH6.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "msh6-F337A", "entity_1_idx": [[58, 68]], "entity_1_idx_in_text_with_entity_marker": [62, 72], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "MSH2", "entity_2_idx": [[82, 86]], "entity_2_idx_in_text_with_entity_marker": [95, 99], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d231.s0_BioInfer.d231.s0.p4", "text": "Genetic analysis suggested that this phenotype was due to msh6-F337A sequestering MSH2 and preventing it from interacting with MSH3 and MSH6.", "text_with_entity_marker": "Genetic analysis suggested that this phenotype was due to msh6-F337A sequestering [E1]MSH2[/E1] and preventing it from interacting with MSH3 and [E2]MSH6[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "MSH2", "entity_1_idx": [[82, 86]], "entity_1_idx_in_text_with_entity_marker": [86, 90], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "MSH6", "entity_2_idx": [[136, 140]], "entity_2_idx_in_text_with_entity_marker": [149, 153], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d231.s0_BioInfer.d231.s0.p5", "text": "Genetic analysis suggested that this phenotype was due to msh6-F337A sequestering MSH2 and preventing it from interacting with MSH3 and MSH6.", "text_with_entity_marker": "Genetic analysis suggested that this phenotype was due to msh6-F337A sequestering [E1]MSH2[/E1] and preventing it from interacting with [E2]MSH3[/E2] and MSH6.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "MSH2", "entity_1_idx": [[82, 86]], "entity_1_idx_in_text_with_entity_marker": [86, 90], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "MSH3", "entity_2_idx": [[127, 131]], "entity_2_idx_in_text_with_entity_marker": [140, 144], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d85.s0_BioInfer.d85.s0.p5", "text": "Associations of UBE2I with RAD52, UBL1, p53, and RAD51 proteins in a yeast two-hybrid system.", "text_with_entity_marker": "Associations of [E1]UBE2I[/E1] with RAD52, UBL1, p53, and [E2]RAD51[/E2] proteins in a yeast two-hybrid system.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "UBE2I", "entity_1_idx": [[16, 21]], "entity_1_idx_in_text_with_entity_marker": [20, 25], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RAD51", "entity_2_idx": [[49, 54]], "entity_2_idx_in_text_with_entity_marker": [62, 67], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d85.s0_BioInfer.d85.s0.p7", "text": "Associations of UBE2I with RAD52, UBL1, p53, and RAD51 proteins in a yeast two-hybrid system.", "text_with_entity_marker": "Associations of [E1]UBE2I[/E1] with [E2]RAD52[/E2], UBL1, p53, and RAD51 proteins in a yeast two-hybrid system.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "UBE2I", "entity_1_idx": [[16, 21]], "entity_1_idx_in_text_with_entity_marker": [20, 25], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RAD52", "entity_2_idx": [[27, 32]], "entity_2_idx_in_text_with_entity_marker": [40, 45], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d63.s0_BioInfer.d63.s0.p2", "text": "An association was seen between E-cadherin and alpha-catenin expression, in both effusions and solid tumours, and for beta-catenin in solid tumours (range p<0. 001 to p=0.014).", "text_with_entity_marker": "An association was seen between [E1]E-cadherin[/E1] and [E2]alpha-catenin[/E2] expression, in both effusions and solid tumours, and for beta-catenin in solid tumours (range p<0. 001 to p=0.014).", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[32, 42]], "entity_1_idx_in_text_with_entity_marker": [36, 46], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[47, 60]], "entity_2_idx_in_text_with_entity_marker": [60, 73], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d418.s0_BioInfer.d418.s0.p0", "text": "Membranous staining and concomitant cytoplasmic localization of E-cadherin, alpha-catenin and gamma-catenin were seen in one case with abnormal beta-catenin immunoreactivity.", "text_with_entity_marker": "Membranous staining and concomitant cytoplasmic localization of E-cadherin, [E1]alpha-catenin[/E1] and [E2]gamma-catenin[/E2] were seen in one case with abnormal beta-catenin immunoreactivity.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[76, 89]], "entity_1_idx_in_text_with_entity_marker": [80, 93], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "gamma-catenin", "entity_2_idx": [[94, 107]], "entity_2_idx_in_text_with_entity_marker": [107, 120], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d418.s0_BioInfer.d418.s0.p1", "text": "Membranous staining and concomitant cytoplasmic localization of E-cadherin, alpha-catenin and gamma-catenin were seen in one case with abnormal beta-catenin immunoreactivity.", "text_with_entity_marker": "Membranous staining and concomitant cytoplasmic localization of [E1]E-cadherin[/E1], alpha-catenin and [E2]gamma-catenin[/E2] were seen in one case with abnormal beta-catenin immunoreactivity.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[64, 74]], "entity_1_idx_in_text_with_entity_marker": [68, 78], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "gamma-catenin", "entity_2_idx": [[94, 107]], "entity_2_idx_in_text_with_entity_marker": [107, 120], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d418.s0_BioInfer.d418.s0.p3", "text": "Membranous staining and concomitant cytoplasmic localization of E-cadherin, alpha-catenin and gamma-catenin were seen in one case with abnormal beta-catenin immunoreactivity.", "text_with_entity_marker": "Membranous staining and concomitant cytoplasmic localization of [E1]E-cadherin[/E1], [E2]alpha-catenin[/E2] and gamma-catenin were seen in one case with abnormal beta-catenin immunoreactivity.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[64, 74]], "entity_1_idx_in_text_with_entity_marker": [68, 78], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[76, 89]], "entity_2_idx_in_text_with_entity_marker": [89, 102], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d833.s0_BioInfer.d833.s0.p20", "text": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "text_with_entity_marker": "Within 1 hour of raising the concentration of calcium ions, [E1]integrins[/E1], cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, [E2]paxillin[/E2] and talin, did not.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "integrins", "entity_1_idx": [[60, 69]], "entity_1_idx_in_text_with_entity_marker": [64, 73], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "paxillin", "entity_2_idx": [[232, 240]], "entity_2_idx_in_text_with_entity_marker": [245, 253], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d833.s0_BioInfer.d833.s0.p21", "text": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "text_with_entity_marker": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, [E1]plakoglobin[/E1], vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and [E2]talin[/E2], did not.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "plakoglobin", "entity_1_idx": [[111, 122]], "entity_1_idx_in_text_with_entity_marker": [115, 126], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[245, 250]], "entity_2_idx_in_text_with_entity_marker": [258, 263], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d833.s0_BioInfer.d833.s0.p22", "text": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "text_with_entity_marker": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and [E1]alpha-actinin[/E1] appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and [E2]talin[/E2], did not.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "alpha-actinin", "entity_1_idx": [[137, 150]], "entity_1_idx_in_text_with_entity_marker": [141, 154], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[245, 250]], "entity_2_idx_in_text_with_entity_marker": [258, 263], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d833.s0_BioInfer.d833.s0.p23", "text": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "text_with_entity_marker": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, [E1]vinculin[/E1] and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and [E2]talin[/E2], did not.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "vinculin", "entity_1_idx": [[124, 132]], "entity_1_idx_in_text_with_entity_marker": [128, 136], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[245, 250]], "entity_2_idx_in_text_with_entity_marker": [258, 263], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d833.s0_BioInfer.d833.s0.p24", "text": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "text_with_entity_marker": "Within 1 hour of raising the concentration of calcium ions, integrins, [E1]cadherins[/E1], alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and [E2]talin[/E2], did not.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "cadherins", "entity_1_idx": [[71, 80]], "entity_1_idx_in_text_with_entity_marker": [75, 84], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[245, 250]], "entity_2_idx_in_text_with_entity_marker": [258, 263], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d833.s0_BioInfer.d833.s0.p25", "text": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "text_with_entity_marker": "Within 1 hour of raising the concentration of calcium ions, [E1]integrins[/E1], cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and [E2]talin[/E2], did not.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "integrins", "entity_1_idx": [[60, 69]], "entity_1_idx_in_text_with_entity_marker": [64, 73], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[245, 250]], "entity_2_idx_in_text_with_entity_marker": [258, 263], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d833.s0_BioInfer.d833.s0.p26", "text": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "text_with_entity_marker": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, [E1]plakoglobin[/E1], vinculin and [E2]alpha-actinin[/E2] appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "plakoglobin", "entity_1_idx": [[111, 122]], "entity_1_idx_in_text_with_entity_marker": [115, 126], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-actinin", "entity_2_idx": [[137, 150]], "entity_2_idx_in_text_with_entity_marker": [150, 163], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d833.s0_BioInfer.d833.s0.p27", "text": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "text_with_entity_marker": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, [E1]plakoglobin[/E1], [E2]vinculin[/E2] and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "plakoglobin", "entity_1_idx": [[111, 122]], "entity_1_idx_in_text_with_entity_marker": [115, 126], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vinculin", "entity_2_idx": [[124, 132]], "entity_2_idx_in_text_with_entity_marker": [137, 145], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d833.s0_BioInfer.d833.s0.p28", "text": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "text_with_entity_marker": "Within 1 hour of raising the concentration of calcium ions, integrins, [E1]cadherins[/E1], alpha-catenin, beta-catenin, [E2]plakoglobin[/E2], vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "cadherins", "entity_1_idx": [[71, 80]], "entity_1_idx_in_text_with_entity_marker": [75, 84], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[111, 122]], "entity_2_idx_in_text_with_entity_marker": [124, 135], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d833.s0_BioInfer.d833.s0.p29", "text": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "text_with_entity_marker": "Within 1 hour of raising the concentration of calcium ions, [E1]integrins[/E1], cadherins, alpha-catenin, beta-catenin, [E2]plakoglobin[/E2], vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "integrins", "entity_1_idx": [[60, 69]], "entity_1_idx_in_text_with_entity_marker": [64, 73], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[111, 122]], "entity_2_idx_in_text_with_entity_marker": [124, 135], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d113.s0_BioInfer.d113.s0.p7", "text": "Both tyrosine phosphorylation and association of beta-catenin with EGFR were inhibited by tyrphostin, a specific inhibitor of the EGFR tyrosine kinase, whereas dissociation of alpha-catenin from E-cadherin was not.", "text_with_entity_marker": "Both tyrosine phosphorylation and association of beta-catenin with EGFR were inhibited by tyrphostin, a specific inhibitor of the EGFR tyrosine kinase, whereas dissociation of [E1]alpha-catenin[/E1] from [E2]E-cadherin[/E2] was not.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[176, 189]], "entity_1_idx_in_text_with_entity_marker": [180, 193], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E-cadherin", "entity_2_idx": [[195, 205]], "entity_2_idx_in_text_with_entity_marker": [208, 218], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d113.s0_BioInfer.d113.s0.p9", "text": "Both tyrosine phosphorylation and association of beta-catenin with EGFR were inhibited by tyrphostin, a specific inhibitor of the EGFR tyrosine kinase, whereas dissociation of alpha-catenin from E-cadherin was not.", "text_with_entity_marker": "Both tyrosine phosphorylation and association of beta-catenin with EGFR were inhibited by tyrphostin, a specific inhibitor of the [E1]EGFR[/E1] [E2]tyrosine kinase[/E2], whereas dissociation of alpha-catenin from E-cadherin was not.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "EGFR", "entity_1_idx": [[130, 134]], "entity_1_idx_in_text_with_entity_marker": [134, 138], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "tyrosine kinase", "entity_2_idx": [[135, 150]], "entity_2_idx_in_text_with_entity_marker": [148, 163], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d113.s1_BioInfer.d113.s1.p0", "text": "The results suggest that tyrosine phosphorylation of beta-catenin is achieved by EGFR upon tryptic digestion of cells and concurrent with but independent of dissociation of alpha-catenin from E-cadherin.", "text_with_entity_marker": "The results suggest that tyrosine phosphorylation of [E1]beta-catenin[/E1] is achieved by EGFR upon tryptic digestion of cells and concurrent with but independent of dissociation of [E2]alpha-catenin[/E2] from E-cadherin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[53, 65]], "entity_1_idx_in_text_with_entity_marker": [57, 69], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[173, 186]], "entity_2_idx_in_text_with_entity_marker": [186, 199], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d113.s1_BioInfer.d113.s1.p2", "text": "The results suggest that tyrosine phosphorylation of beta-catenin is achieved by EGFR upon tryptic digestion of cells and concurrent with but independent of dissociation of alpha-catenin from E-cadherin.", "text_with_entity_marker": "The results suggest that tyrosine phosphorylation of beta-catenin is achieved by EGFR upon tryptic digestion of cells and concurrent with but independent of dissociation of [E1]alpha-catenin[/E1] from [E2]E-cadherin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[173, 186]], "entity_1_idx_in_text_with_entity_marker": [177, 190], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E-cadherin", "entity_2_idx": [[192, 202]], "entity_2_idx_in_text_with_entity_marker": [205, 215], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d113.s1_BioInfer.d113.s1.p4", "text": "The results suggest that tyrosine phosphorylation of beta-catenin is achieved by EGFR upon tryptic digestion of cells and concurrent with but independent of dissociation of alpha-catenin from E-cadherin.", "text_with_entity_marker": "The results suggest that tyrosine phosphorylation of [E1]beta-catenin[/E1] is achieved by EGFR upon tryptic digestion of cells and concurrent with but independent of dissociation of alpha-catenin from [E2]E-cadherin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[53, 65]], "entity_1_idx_in_text_with_entity_marker": [57, 69], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E-cadherin", "entity_2_idx": [[192, 202]], "entity_2_idx_in_text_with_entity_marker": [205, 215], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d113.s2_BioInfer.d113.s2.p4", "text": "Tyrosine phosphorylation of beta-catenin was concomitantly induced with association of beta-catenin with EGF receptor (EGFR) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of alpha-catenin from E-cadherin.", "text_with_entity_marker": "Tyrosine phosphorylation of beta-catenin was concomitantly induced with association of beta-catenin with EGF receptor (EGFR) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of [E1]alpha-catenin[/E1] from [E2]E-cadherin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[254, 267]], "entity_1_idx_in_text_with_entity_marker": [258, 271], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E-cadherin", "entity_2_idx": [[273, 283]], "entity_2_idx_in_text_with_entity_marker": [286, 296], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d582.s0_BioInfer.d582.s0.p3", "text": "The binding constants of Acanthamoeba profilin to fluorescein-labeled actin from Acanthamoeba and from rabbit skeletal muscle have been determined by measuring the reduction in the actin tracer diffusion coefficients, determined by fluorescence photobleaching recovery, as a function of added profilin concentration.", "text_with_entity_marker": "The binding constants of Acanthamoeba [E1]profilin[/E1] to fluorescein-labeled [E2]actin[/E2] from Acanthamoeba and from rabbit skeletal muscle have been determined by measuring the reduction in the actin tracer diffusion coefficients, determined by fluorescence photobleaching recovery, as a function of added profilin concentration.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[38, 46]], "entity_1_idx_in_text_with_entity_marker": [42, 50], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[70, 75]], "entity_2_idx_in_text_with_entity_marker": [83, 88], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d582.s1_BioInfer.d582.s1.p0", "text": "These dissociation constants are the first to be determined from direct physical measurement; they are in agreement with values inferred from earlier studies on the effect of profilin on the assembly of actin that had been fluorescently labeled or otherwise modified at Cys 374.", "text_with_entity_marker": "These dissociation constants are the first to be determined from direct physical measurement; they are in agreement with values inferred from earlier studies on the effect of [E1]profilin[/E1] on the assembly of [E2]actin[/E2] that had been fluorescently labeled or otherwise modified at Cys 374.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[175, 183]], "entity_1_idx_in_text_with_entity_marker": [179, 187], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[203, 208]], "entity_2_idx_in_text_with_entity_marker": [216, 221], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d537.s0_BioInfer.d537.s0.p0", "text": "Signaling pathways involved in dephosphorylation and localization of the actin-binding protein cofilin in stimulated human neutrophils.", "text_with_entity_marker": "Signaling pathways involved in dephosphorylation and localization of the [E1]actin-binding protein[/E1] [E2]cofilin[/E2] in stimulated human neutrophils.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin-binding protein", "entity_1_idx": [[73, 94]], "entity_1_idx_in_text_with_entity_marker": [77, 98], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "cofilin", "entity_2_idx": [[95, 102]], "entity_2_idx_in_text_with_entity_marker": [108, 115], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d537.s1_BioInfer.d537.s1.p0", "text": "These findings suggest a role of cofilin in stimulus-dependent actin remodeling in motile neutrophils.", "text_with_entity_marker": "These findings suggest a role of [E1]cofilin[/E1] in stimulus-dependent [E2]actin[/E2] remodeling in motile neutrophils.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[33, 40]], "entity_1_idx_in_text_with_entity_marker": [37, 44], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[63, 68]], "entity_2_idx_in_text_with_entity_marker": [76, 81], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d41.s0_BioInfer.d41.s0.p1", "text": "Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.", "text_with_entity_marker": "Although [E1]profilin[/E1] released actin at the appropriate time to stimulate [E2]actin[/E2] assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[9, 17]], "entity_1_idx_in_text_with_entity_marker": [13, 21], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[70, 75]], "entity_2_idx_in_text_with_entity_marker": [83, 88], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d41.s0_BioInfer.d41.s0.p2", "text": "Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.", "text_with_entity_marker": "Although [E1]profilin[/E1] released [E2]actin[/E2] at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[9, 17]], "entity_1_idx_in_text_with_entity_marker": [13, 21], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[27, 32]], "entity_2_idx_in_text_with_entity_marker": [40, 45], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d41.s0_BioInfer.d41.s0.p11", "text": "Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.", "text_with_entity_marker": "Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of [E1]actin[/E1] released from profilin too small to account for the large shifts from unpolymerized to polymerized [E2]actin[/E2] associated with maximal chemoattractant stimulation.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[264, 269]], "entity_1_idx_in_text_with_entity_marker": [268, 273], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[369, 374]], "entity_2_idx_in_text_with_entity_marker": [382, 387], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d41.s0_BioInfer.d41.s0.p12", "text": "Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.", "text_with_entity_marker": "Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of [E1]actin[/E1] released from [E2]profilin[/E2] too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[264, 269]], "entity_1_idx_in_text_with_entity_marker": [268, 273], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[284, 292]], "entity_2_idx_in_text_with_entity_marker": [297, 305], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d41.s0_BioInfer.d41.s0.p13", "text": "Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.", "text_with_entity_marker": "Although profilin released [E1]actin[/E1] at the appropriate time to stimulate [E2]actin[/E2] assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[27, 32]], "entity_1_idx_in_text_with_entity_marker": [31, 36], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[70, 75]], "entity_2_idx_in_text_with_entity_marker": [83, 88], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d41.s0_BioInfer.d41.s0.p22", "text": "Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.", "text_with_entity_marker": "Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of [E1]profilin[/E1] in PMN was insufficient to explain the high unpolymerized [E2]actin[/E2] content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[143, 151]], "entity_1_idx_in_text_with_entity_marker": [147, 155], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[210, 215]], "entity_2_idx_in_text_with_entity_marker": [223, 228], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d41.s2_BioInfer.d41.s2.p0", "text": "We examined the role of the actin monomer sequestering protein, profilin, in the regulation of PMN actin filament assembly during chemoattractant stimulation using a Triton extraction method.", "text_with_entity_marker": "We examined the role of the [E1]actin[/E1] monomer sequestering protein, [E2]profilin[/E2], in the regulation of PMN actin filament assembly during chemoattractant stimulation using a Triton extraction method.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[28, 33]], "entity_1_idx_in_text_with_entity_marker": [32, 37], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[64, 72]], "entity_2_idx_in_text_with_entity_marker": [77, 85], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d41.s2_BioInfer.d41.s2.p1", "text": "We examined the role of the actin monomer sequestering protein, profilin, in the regulation of PMN actin filament assembly during chemoattractant stimulation using a Triton extraction method.", "text_with_entity_marker": "We examined the role of the actin monomer sequestering protein, [E1]profilin[/E1], in the regulation of [E2]PMN actin[/E2] filament assembly during chemoattractant stimulation using a Triton extraction method.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[64, 72]], "entity_1_idx_in_text_with_entity_marker": [68, 76], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "PMN actin", "entity_2_idx": [[95, 104]], "entity_2_idx_in_text_with_entity_marker": [108, 117], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d65.s1_BioInfer.d65.s1.p0", "text": "The cellular tumor antigen p53 is bound to the simian virus 40 (SV40) large T-antigen in SV40-infected and -transformed cells.", "text_with_entity_marker": "The cellular tumor antigen [E1]p53[/E1] is bound to the simian virus 40 (SV40) [E2]large T-antigen[/E2] in SV40-infected and -transformed cells.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "p53", "entity_1_idx": [[27, 30]], "entity_1_idx_in_text_with_entity_marker": [31, 34], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "large T-antigen", "entity_2_idx": [[70, 85]], "entity_2_idx_in_text_with_entity_marker": [83, 98], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d462.s0_BioInfer.d462.s0.p1", "text": "One mutation, sac6-69, is in the gene encoding fimbrin, another actin-binding protein, which was expected because null mutations in SAC6 and CAP2 are known to be synthetic-lethal.", "text_with_entity_marker": "One mutation, sac6-69, is in the gene encoding [E1]fimbrin[/E1], another [E2]actin-binding protein[/E2], which was expected because null mutations in SAC6 and CAP2 are known to be synthetic-lethal.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "fimbrin", "entity_1_idx": [[47, 54]], "entity_1_idx_in_text_with_entity_marker": [51, 58], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin-binding protein", "entity_2_idx": [[64, 85]], "entity_2_idx_in_text_with_entity_marker": [77, 98], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d377.s0_BioInfer.d377.s0.p0", "text": "In this study, by immunoprecipitation and affinity chromatography it is shown that adenosine deaminase and A1 adenosine receptors interact in pig brain cortical membranes.", "text_with_entity_marker": "In this study, by immunoprecipitation and affinity chromatography it is shown that [E1]adenosine deaminase[/E1] and [E2]A1 adenosine receptors[/E2] interact in pig brain cortical membranes.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "adenosine deaminase", "entity_1_idx": [[83, 102]], "entity_1_idx_in_text_with_entity_marker": [87, 106], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "A1 adenosine receptors", "entity_2_idx": [[107, 129]], "entity_2_idx_in_text_with_entity_marker": [120, 142], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d501.s0_BioInfer.d501.s0.p0", "text": "PS1 fragments form complexes with E-cadherin, beta-catenin, and alpha-catenin, all components of adherens junctions.", "text_with_entity_marker": "[E1]PS1[/E1] fragments form complexes with E-cadherin, [E2]beta-catenin[/E2], and alpha-catenin, all components of adherens junctions.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "PS1", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[46, 58]], "entity_2_idx_in_text_with_entity_marker": [59, 71], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d501.s0_BioInfer.d501.s0.p1", "text": "PS1 fragments form complexes with E-cadherin, beta-catenin, and alpha-catenin, all components of adherens junctions.", "text_with_entity_marker": "[E1]PS1[/E1] fragments form complexes with [E2]E-cadherin[/E2], beta-catenin, and alpha-catenin, all components of adherens junctions.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "PS1", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E-cadherin", "entity_2_idx": [[34, 44]], "entity_2_idx_in_text_with_entity_marker": [47, 57], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d501.s0_BioInfer.d501.s0.p2", "text": "PS1 fragments form complexes with E-cadherin, beta-catenin, and alpha-catenin, all components of adherens junctions.", "text_with_entity_marker": "[E1]PS1[/E1] fragments form complexes with E-cadherin, beta-catenin, and [E2]alpha-catenin[/E2], all components of adherens junctions.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "PS1", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[64, 77]], "entity_2_idx_in_text_with_entity_marker": [77, 90], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d501.s0_BioInfer.d501.s0.p3", "text": "PS1 fragments form complexes with E-cadherin, beta-catenin, and alpha-catenin, all components of adherens junctions.", "text_with_entity_marker": "PS1 fragments form complexes with [E1]E-cadherin[/E1], [E2]beta-catenin[/E2], and alpha-catenin, all components of adherens junctions.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[34, 44]], "entity_1_idx_in_text_with_entity_marker": [38, 48], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[46, 58]], "entity_2_idx_in_text_with_entity_marker": [59, 71], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d501.s0_BioInfer.d501.s0.p4", "text": "PS1 fragments form complexes with E-cadherin, beta-catenin, and alpha-catenin, all components of adherens junctions.", "text_with_entity_marker": "PS1 fragments form complexes with E-cadherin, [E1]beta-catenin[/E1], and [E2]alpha-catenin[/E2], all components of adherens junctions.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[46, 58]], "entity_1_idx_in_text_with_entity_marker": [50, 62], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[64, 77]], "entity_2_idx_in_text_with_entity_marker": [77, 90], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d501.s0_BioInfer.d501.s0.p5", "text": "PS1 fragments form complexes with E-cadherin, beta-catenin, and alpha-catenin, all components of adherens junctions.", "text_with_entity_marker": "PS1 fragments form complexes with [E1]E-cadherin[/E1], beta-catenin, and [E2]alpha-catenin[/E2], all components of adherens junctions.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[34, 44]], "entity_1_idx_in_text_with_entity_marker": [38, 48], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[64, 77]], "entity_2_idx_in_text_with_entity_marker": [77, 90], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d388.s0_BioInfer.d388.s0.p0", "text": "In vivo importance of actin nucleotide exchange catalyzed by profilin.", "text_with_entity_marker": "In vivo importance of [E1]actin[/E1] nucleotide exchange catalyzed by [E2]profilin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[22, 27]], "entity_1_idx_in_text_with_entity_marker": [26, 31], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[61, 69]], "entity_2_idx_in_text_with_entity_marker": [74, 82], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d388.s1_BioInfer.d388.s1.p2", "text": "act1-157, an actin mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in actin organization, cell growth, and fluid-phase endocytosis of pfy1-4, a profilin mutant defective in actin binding.", "text_with_entity_marker": "act1-157, an [E1]actin[/E1] mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in actin organization, cell growth, and fluid-phase endocytosis of [E2]pfy1-4[/E2], a profilin mutant defective in actin binding.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[13, 18]], "entity_1_idx_in_text_with_entity_marker": [17, 22], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "pfy1-4", "entity_2_idx": [[169, 175]], "entity_2_idx_in_text_with_entity_marker": [182, 188], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d388.s1_BioInfer.d388.s1.p4", "text": "act1-157, an actin mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in actin organization, cell growth, and fluid-phase endocytosis of pfy1-4, a profilin mutant defective in actin binding.", "text_with_entity_marker": "act1-157, an actin mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in actin organization, cell growth, and fluid-phase endocytosis of [E1]pfy1-4[/E1], a profilin mutant defective in [E2]actin[/E2] binding.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "pfy1-4", "entity_1_idx": [[169, 175]], "entity_1_idx_in_text_with_entity_marker": [173, 179], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[208, 213]], "entity_2_idx_in_text_with_entity_marker": [221, 226], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d388.s1_BioInfer.d388.s1.p5", "text": "act1-157, an actin mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in actin organization, cell growth, and fluid-phase endocytosis of pfy1-4, a profilin mutant defective in actin binding.", "text_with_entity_marker": "[E1]act1-157[/E1], an actin mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in actin organization, cell growth, and fluid-phase endocytosis of pfy1-4, a [E2]profilin[/E2] mutant defective in actin binding.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "act1-157", "entity_1_idx": [[0, 8]], "entity_1_idx_in_text_with_entity_marker": [4, 12], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[179, 187]], "entity_2_idx_in_text_with_entity_marker": [192, 200], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d388.s1_BioInfer.d388.s1.p7", "text": "act1-157, an actin mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in actin organization, cell growth, and fluid-phase endocytosis of pfy1-4, a profilin mutant defective in actin binding.", "text_with_entity_marker": "[E1]act1-157[/E1], an actin mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in [E2]actin[/E2] organization, cell growth, and fluid-phase endocytosis of pfy1-4, a profilin mutant defective in actin binding.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "act1-157", "entity_1_idx": [[0, 8]], "entity_1_idx_in_text_with_entity_marker": [4, 12], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[105, 110]], "entity_2_idx_in_text_with_entity_marker": [118, 123], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d388.s1_BioInfer.d388.s1.p9", "text": "act1-157, an actin mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in actin organization, cell growth, and fluid-phase endocytosis of pfy1-4, a profilin mutant defective in actin binding.", "text_with_entity_marker": "act1-157, an [E1]actin[/E1] mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in actin organization, cell growth, and fluid-phase endocytosis of pfy1-4, a [E2]profilin[/E2] mutant defective in actin binding.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[13, 18]], "entity_1_idx_in_text_with_entity_marker": [17, 22], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[179, 187]], "entity_2_idx_in_text_with_entity_marker": [192, 200], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d388.s1_BioInfer.d388.s1.p11", "text": "act1-157, an actin mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in actin organization, cell growth, and fluid-phase endocytosis of pfy1-4, a profilin mutant defective in actin binding.", "text_with_entity_marker": "act1-157, an actin mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in actin organization, cell growth, and fluid-phase endocytosis of pfy1-4, a [E1]profilin[/E1] mutant defective in [E2]actin[/E2] binding.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[179, 187]], "entity_1_idx_in_text_with_entity_marker": [183, 191], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[208, 213]], "entity_2_idx_in_text_with_entity_marker": [221, 226], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d388.s1_BioInfer.d388.s1.p12", "text": "act1-157, an actin mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in actin organization, cell growth, and fluid-phase endocytosis of pfy1-4, a profilin mutant defective in actin binding.", "text_with_entity_marker": "act1-157, an [E1]actin[/E1] mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in [E2]actin[/E2] organization, cell growth, and fluid-phase endocytosis of pfy1-4, a profilin mutant defective in actin binding.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[13, 18]], "entity_1_idx_in_text_with_entity_marker": [17, 22], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[105, 110]], "entity_2_idx_in_text_with_entity_marker": [118, 123], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d388.s2_BioInfer.d388.s2.p2", "text": "The actin monomer-binding protein, profilin, influences the dynamics of actin filaments in vitro by suppressing nucleation, enhancing nucleotide exchange on actin, and promoting barbed-end assembly.", "text_with_entity_marker": "The [E1]actin[/E1] monomer-binding protein, [E2]profilin[/E2], influences the dynamics of actin filaments in vitro by suppressing nucleation, enhancing nucleotide exchange on actin, and promoting barbed-end assembly.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[4, 9]], "entity_1_idx_in_text_with_entity_marker": [8, 13], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[35, 43]], "entity_2_idx_in_text_with_entity_marker": [48, 56], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d388.s2_BioInfer.d388.s2.p3", "text": "The actin monomer-binding protein, profilin, influences the dynamics of actin filaments in vitro by suppressing nucleation, enhancing nucleotide exchange on actin, and promoting barbed-end assembly.", "text_with_entity_marker": "The actin monomer-binding protein, profilin, influences the dynamics of [E1]actin[/E1] filaments in vitro by suppressing nucleation, enhancing nucleotide exchange on [E2]actin[/E2], and promoting barbed-end assembly.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[72, 77]], "entity_1_idx_in_text_with_entity_marker": [76, 81], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[157, 162]], "entity_2_idx_in_text_with_entity_marker": [170, 175], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d696.s0_BioInfer.d696.s0.p0", "text": "These differences in contractile protein profiles between single and cultured cells were collaborated with the observation of cells using immunofluorescence microscope with responsible antibodies to isoforms of myosin heavy chain, actin and tropomyosin.", "text_with_entity_marker": "These differences in contractile protein profiles between single and cultured cells were collaborated with the observation of cells using immunofluorescence microscope with responsible antibodies to isoforms of [E1]myosin heavy chain[/E1], actin and [E2]tropomyosin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin heavy chain", "entity_1_idx": [[211, 229]], "entity_1_idx_in_text_with_entity_marker": [215, 233], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "tropomyosin", "entity_2_idx": [[241, 252]], "entity_2_idx_in_text_with_entity_marker": [254, 265], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d696.s0_BioInfer.d696.s0.p1", "text": "These differences in contractile protein profiles between single and cultured cells were collaborated with the observation of cells using immunofluorescence microscope with responsible antibodies to isoforms of myosin heavy chain, actin and tropomyosin.", "text_with_entity_marker": "These differences in contractile protein profiles between single and cultured cells were collaborated with the observation of cells using immunofluorescence microscope with responsible antibodies to isoforms of myosin heavy chain, [E1]actin[/E1] and [E2]tropomyosin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[231, 236]], "entity_1_idx_in_text_with_entity_marker": [235, 240], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "tropomyosin", "entity_2_idx": [[241, 252]], "entity_2_idx_in_text_with_entity_marker": [254, 265], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d696.s0_BioInfer.d696.s0.p2", "text": "These differences in contractile protein profiles between single and cultured cells were collaborated with the observation of cells using immunofluorescence microscope with responsible antibodies to isoforms of myosin heavy chain, actin and tropomyosin.", "text_with_entity_marker": "These differences in contractile protein profiles between single and cultured cells were collaborated with the observation of cells using immunofluorescence microscope with responsible antibodies to isoforms of [E1]myosin heavy chain[/E1], [E2]actin[/E2] and tropomyosin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin heavy chain", "entity_1_idx": [[211, 229]], "entity_1_idx_in_text_with_entity_marker": [215, 233], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[231, 236]], "entity_2_idx_in_text_with_entity_marker": [244, 249], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p40", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included [E1]actin[/E1], tropomyosin, troponin I, myosin regulatory light chain, [E2]myosin light chain kinase[/E2], myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[34, 39]], "entity_1_idx_in_text_with_entity_marker": [38, 43], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin light chain kinase", "entity_2_idx": [[97, 122]], "entity_2_idx_in_text_with_entity_marker": [110, 135], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p41", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, [E1]myosin light chain kinase[/E1], myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, [E2]muscle LIM[/E2] protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin light chain kinase", "entity_1_idx": [[97, 122]], "entity_1_idx_in_text_with_entity_marker": [101, 126], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "muscle LIM", "entity_2_idx": [[207, 217]], "entity_2_idx_in_text_with_entity_marker": [220, 230], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p42", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, [E1]myosin light chain kinase[/E1], myosin heavy chain, calmodulin, [E2]calponin[/E2], calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin light chain kinase", "entity_1_idx": [[97, 122]], "entity_1_idx_in_text_with_entity_marker": [101, 126], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "calponin", "entity_2_idx": [[156, 164]], "entity_2_idx_in_text_with_entity_marker": [169, 177], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p43", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, [E1]myosin light chain kinase[/E1], myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and [E2]SH3-binding glutamate-rich protein[/E2], suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin light chain kinase", "entity_1_idx": [[97, 122]], "entity_1_idx_in_text_with_entity_marker": [101, 126], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SH3-binding glutamate-rich protein", "entity_2_idx": [[231, 265]], "entity_2_idx_in_text_with_entity_marker": [244, 278], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p44", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, [E1]myosin light chain kinase[/E1], myosin heavy chain, calmodulin, calponin, calcium vector protein, [E2]creatine kinase[/E2], muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin light chain kinase", "entity_1_idx": [[97, 122]], "entity_1_idx_in_text_with_entity_marker": [101, 126], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "creatine kinase", "entity_2_idx": [[190, 205]], "entity_2_idx_in_text_with_entity_marker": [203, 218], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p45", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included actin, [E1]tropomyosin[/E1], [E2]troponin I[/E2], myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "tropomyosin", "entity_1_idx": [[41, 52]], "entity_1_idx_in_text_with_entity_marker": [45, 56], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "troponin I", "entity_2_idx": [[54, 64]], "entity_2_idx_in_text_with_entity_marker": [67, 77], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p46", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included [E1]actin[/E1], [E2]tropomyosin[/E2], troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[34, 39]], "entity_1_idx_in_text_with_entity_marker": [38, 43], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "tropomyosin", "entity_2_idx": [[41, 52]], "entity_2_idx_in_text_with_entity_marker": [54, 65], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p47", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included actin, [E1]tropomyosin[/E1], troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, [E2]muscle LIM[/E2] protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "tropomyosin", "entity_1_idx": [[41, 52]], "entity_1_idx_in_text_with_entity_marker": [45, 56], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "muscle LIM", "entity_2_idx": [[207, 217]], "entity_2_idx_in_text_with_entity_marker": [220, 230], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p48", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included actin, [E1]tropomyosin[/E1], troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, [E2]calponin[/E2], calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "tropomyosin", "entity_1_idx": [[41, 52]], "entity_1_idx_in_text_with_entity_marker": [45, 56], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "calponin", "entity_2_idx": [[156, 164]], "entity_2_idx_in_text_with_entity_marker": [169, 177], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p49", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included actin, [E1]tropomyosin[/E1], troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and [E2]SH3-binding glutamate-rich protein[/E2], suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "tropomyosin", "entity_1_idx": [[41, 52]], "entity_1_idx_in_text_with_entity_marker": [45, 56], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SH3-binding glutamate-rich protein", "entity_2_idx": [[231, 265]], "entity_2_idx_in_text_with_entity_marker": [244, 278], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p10", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, [E1]DDC2[/E1] [E2]MEC3[/E2], RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "DDC2", "entity_1_idx": [[57, 61]], "entity_1_idx_in_text_with_entity_marker": [61, 65], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MEC3", "entity_2_idx": [[62, 66]], "entity_2_idx_in_text_with_entity_marker": [75, 79], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p11", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, [E1]DDC2[/E1] MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, [E2]BUB3[/E2], and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "DDC2", "entity_1_idx": [[57, 61]], "entity_1_idx_in_text_with_entity_marker": [61, 65], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "BUB3", "entity_2_idx": [[196, 200]], "entity_2_idx_in_text_with_entity_marker": [209, 213], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p12", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, [E1]DDC2[/E1] MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and [E2]MAD3[/E2] had little effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "DDC2", "entity_1_idx": [[57, 61]], "entity_1_idx_in_text_with_entity_marker": [61, 65], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MAD3", "entity_2_idx": [[206, 210]], "entity_2_idx_in_text_with_entity_marker": [219, 223], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p13", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and [E1]DUN1[/E1] increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, [E2]RAD24[/E2], BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "DUN1", "entity_1_idx": [[91, 95]], "entity_1_idx_in_text_with_entity_marker": [95, 99], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD24", "entity_2_idx": [[189, 194]], "entity_2_idx_in_text_with_entity_marker": [202, 207], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p14", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in [E1]RAD9[/E1], RAD17, [E2]RAD24[/E2], BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD9", "entity_1_idx": [[176, 180]], "entity_1_idx_in_text_with_entity_marker": [180, 184], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD24", "entity_2_idx": [[189, 194]], "entity_2_idx_in_text_with_entity_marker": [202, 207], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p15", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, [E1]CHK1[/E1], PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, [E2]RAD24[/E2], BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "CHK1", "entity_1_idx": [[75, 79]], "entity_1_idx_in_text_with_entity_marker": [79, 83], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD24", "entity_2_idx": [[189, 194]], "entity_2_idx_in_text_with_entity_marker": [202, 207], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p16", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, [E1]PDS1[/E1], and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, [E2]RAD24[/E2], BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "PDS1", "entity_1_idx": [[81, 85]], "entity_1_idx_in_text_with_entity_marker": [85, 89], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD24", "entity_2_idx": [[189, 194]], "entity_2_idx_in_text_with_entity_marker": [202, 207], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p17", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, [E1]RAD17[/E1], [E2]RAD24[/E2], BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD17", "entity_1_idx": [[182, 187]], "entity_1_idx_in_text_with_entity_marker": [186, 191], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD24", "entity_2_idx": [[189, 194]], "entity_2_idx_in_text_with_entity_marker": [202, 207], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p18", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, [E1]RAD53[/E1], CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, [E2]RAD24[/E2], BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD53", "entity_1_idx": [[68, 73]], "entity_1_idx_in_text_with_entity_marker": [72, 77], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD24", "entity_2_idx": [[189, 194]], "entity_2_idx_in_text_with_entity_marker": [202, 207], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p19", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, [E1]DPB11[/E1], MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, [E2]RAD24[/E2], BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "DPB11", "entity_1_idx": [[44, 49]], "entity_1_idx_in_text_with_entity_marker": [48, 53], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD24", "entity_2_idx": [[189, 194]], "entity_2_idx_in_text_with_entity_marker": [202, 207], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p50", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, [E1]MEC1[/E1], DDC2 MEC3, RAD53, [E2]CHK1[/E2], PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MEC1", "entity_1_idx": [[51, 55]], "entity_1_idx_in_text_with_entity_marker": [55, 59], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "CHK1", "entity_2_idx": [[75, 79]], "entity_2_idx_in_text_with_entity_marker": [88, 92], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p51", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae [E1]RFC5[/E1], DPB11, MEC1, DDC2 MEC3, RAD53, [E2]CHK1[/E2], PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RFC5", "entity_1_idx": [[38, 42]], "entity_1_idx_in_text_with_entity_marker": [42, 46], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "CHK1", "entity_2_idx": [[75, 79]], "entity_2_idx_in_text_with_entity_marker": [88, 92], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p52", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 [E1]MEC3[/E1], RAD53, [E2]CHK1[/E2], PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MEC3", "entity_1_idx": [[62, 66]], "entity_1_idx_in_text_with_entity_marker": [66, 70], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "CHK1", "entity_2_idx": [[75, 79]], "entity_2_idx_in_text_with_entity_marker": [88, 92], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p53", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, [E1]CHK1[/E1], PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, [E2]BUB3[/E2], and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "CHK1", "entity_1_idx": [[75, 79]], "entity_1_idx_in_text_with_entity_marker": [79, 83], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "BUB3", "entity_2_idx": [[196, 200]], "entity_2_idx_in_text_with_entity_marker": [209, 213], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p54", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, [E1]CHK1[/E1], PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and [E2]MAD3[/E2] had little effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "CHK1", "entity_1_idx": [[75, 79]], "entity_1_idx_in_text_with_entity_marker": [79, 83], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MAD3", "entity_2_idx": [[206, 210]], "entity_2_idx_in_text_with_entity_marker": [219, 223], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p55", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, [E1]PDS1[/E1], and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, [E2]RAD17[/E2], RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "PDS1", "entity_1_idx": [[81, 85]], "entity_1_idx_in_text_with_entity_marker": [85, 89], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD17", "entity_2_idx": [[182, 187]], "entity_2_idx_in_text_with_entity_marker": [195, 200], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p56", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, [E1]RAD53[/E1], CHK1, [E2]PDS1[/E2], and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD53", "entity_1_idx": [[68, 73]], "entity_1_idx_in_text_with_entity_marker": [72, 77], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "PDS1", "entity_2_idx": [[81, 85]], "entity_2_idx_in_text_with_entity_marker": [94, 98], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p57", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, [E1]DPB11[/E1], MEC1, DDC2 MEC3, RAD53, CHK1, [E2]PDS1[/E2], and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "DPB11", "entity_1_idx": [[44, 49]], "entity_1_idx_in_text_with_entity_marker": [48, 53], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "PDS1", "entity_2_idx": [[81, 85]], "entity_2_idx_in_text_with_entity_marker": [94, 98], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p58", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, [E1]MEC1[/E1], DDC2 MEC3, RAD53, CHK1, [E2]PDS1[/E2], and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MEC1", "entity_1_idx": [[51, 55]], "entity_1_idx_in_text_with_entity_marker": [55, 59], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "PDS1", "entity_2_idx": [[81, 85]], "entity_2_idx_in_text_with_entity_marker": [94, 98], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p59", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae [E1]RFC5[/E1], DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, [E2]PDS1[/E2], and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RFC5", "entity_1_idx": [[38, 42]], "entity_1_idx_in_text_with_entity_marker": [42, 46], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "PDS1", "entity_2_idx": [[81, 85]], "entity_2_idx_in_text_with_entity_marker": [94, 98], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d214.s0_BioInfer.d214.s0.p0", "text": "Fluorographic analysis showed that the specific activity of soluble actin was two to three times that of its particulate form and that soluble actin, cofilin, actin depolymerizing factor, and profilin were transported at similar rates in slow component b of axonal flow.", "text_with_entity_marker": "Fluorographic analysis showed that the specific activity of soluble actin was two to three times that of its particulate form and that soluble actin, cofilin, [E1]actin depolymerizing factor[/E1], and [E2]profilin[/E2] were transported at similar rates in slow component b of axonal flow.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin depolymerizing factor", "entity_1_idx": [[159, 186]], "entity_1_idx_in_text_with_entity_marker": [163, 190], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilin", "entity_2_idx": [[192, 200]], "entity_2_idx_in_text_with_entity_marker": [205, 213], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d214.s0_BioInfer.d214.s0.p1", "text": "Fluorographic analysis showed that the specific activity of soluble actin was two to three times that of its particulate form and that soluble actin, cofilin, actin depolymerizing factor, and profilin were transported at similar rates in slow component b of axonal flow.", "text_with_entity_marker": "Fluorographic analysis showed that the specific activity of soluble actin was two to three times that of its particulate form and that soluble [E1]actin[/E1], cofilin, [E2]actin depolymerizing factor[/E2], and profilin were transported at similar rates in slow component b of axonal flow.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[143, 148]], "entity_1_idx_in_text_with_entity_marker": [147, 152], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin depolymerizing factor", "entity_2_idx": [[159, 186]], "entity_2_idx_in_text_with_entity_marker": [172, 199], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d214.s0_BioInfer.d214.s0.p2", "text": "Fluorographic analysis showed that the specific activity of soluble actin was two to three times that of its particulate form and that soluble actin, cofilin, actin depolymerizing factor, and profilin were transported at similar rates in slow component b of axonal flow.", "text_with_entity_marker": "Fluorographic analysis showed that the specific activity of soluble actin was two to three times that of its particulate form and that soluble actin, [E1]cofilin[/E1], [E2]actin depolymerizing factor[/E2], and profilin were transported at similar rates in slow component b of axonal flow.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "cofilin", "entity_1_idx": [[150, 157]], "entity_1_idx_in_text_with_entity_marker": [154, 161], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin depolymerizing factor", "entity_2_idx": [[159, 186]], "entity_2_idx_in_text_with_entity_marker": [172, 199], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d214.s0_BioInfer.d214.s0.p3", "text": "Fluorographic analysis showed that the specific activity of soluble actin was two to three times that of its particulate form and that soluble actin, cofilin, actin depolymerizing factor, and profilin were transported at similar rates in slow component b of axonal flow.", "text_with_entity_marker": "Fluorographic analysis showed that the specific activity of soluble [E1]actin[/E1] was two to three times that of its particulate form and that soluble actin, cofilin, [E2]actin depolymerizing factor[/E2], and profilin were transported at similar rates in slow component b of axonal flow.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[68, 73]], "entity_1_idx_in_text_with_entity_marker": [72, 77], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin depolymerizing factor", "entity_2_idx": [[159, 186]], "entity_2_idx_in_text_with_entity_marker": [172, 199], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d214.s0_BioInfer.d214.s0.p4", "text": "Fluorographic analysis showed that the specific activity of soluble actin was two to three times that of its particulate form and that soluble actin, cofilin, actin depolymerizing factor, and profilin were transported at similar rates in slow component b of axonal flow.", "text_with_entity_marker": "Fluorographic analysis showed that the specific activity of soluble actin was two to three times that of its particulate form and that soluble [E1]actin[/E1], cofilin, actin depolymerizing factor, and [E2]profilin[/E2] were transported at similar rates in slow component b of axonal flow.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[143, 148]], "entity_1_idx_in_text_with_entity_marker": [147, 152], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilin", "entity_2_idx": [[192, 200]], "entity_2_idx_in_text_with_entity_marker": [205, 213], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d214.s0_BioInfer.d214.s0.p5", "text": "Fluorographic analysis showed that the specific activity of soluble actin was two to three times that of its particulate form and that soluble actin, cofilin, actin depolymerizing factor, and profilin were transported at similar rates in slow component b of axonal flow.", "text_with_entity_marker": "Fluorographic analysis showed that the specific activity of soluble actin was two to three times that of its particulate form and that soluble actin, [E1]cofilin[/E1], actin depolymerizing factor, and [E2]profilin[/E2] were transported at similar rates in slow component b of axonal flow.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "cofilin", "entity_1_idx": [[150, 157]], "entity_1_idx_in_text_with_entity_marker": [154, 161], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilin", "entity_2_idx": [[192, 200]], "entity_2_idx_in_text_with_entity_marker": [205, 213], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d214.s0_BioInfer.d214.s0.p6", "text": "Fluorographic analysis showed that the specific activity of soluble actin was two to three times that of its particulate form and that soluble actin, cofilin, actin depolymerizing factor, and profilin were transported at similar rates in slow component b of axonal flow.", "text_with_entity_marker": "Fluorographic analysis showed that the specific activity of soluble [E1]actin[/E1] was two to three times that of its particulate form and that soluble actin, cofilin, actin depolymerizing factor, and [E2]profilin[/E2] were transported at similar rates in slow component b of axonal flow.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[68, 73]], "entity_1_idx_in_text_with_entity_marker": [72, 77], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilin", "entity_2_idx": [[192, 200]], "entity_2_idx_in_text_with_entity_marker": [205, 213], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d214.s0_BioInfer.d214.s0.p7", "text": "Fluorographic analysis showed that the specific activity of soluble actin was two to three times that of its particulate form and that soluble actin, cofilin, actin depolymerizing factor, and profilin were transported at similar rates in slow component b of axonal flow.", "text_with_entity_marker": "Fluorographic analysis showed that the specific activity of soluble actin was two to three times that of its particulate form and that soluble [E1]actin[/E1], [E2]cofilin[/E2], actin depolymerizing factor, and profilin were transported at similar rates in slow component b of axonal flow.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[143, 148]], "entity_1_idx_in_text_with_entity_marker": [147, 152], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "cofilin", "entity_2_idx": [[150, 157]], "entity_2_idx_in_text_with_entity_marker": [163, 170], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d214.s0_BioInfer.d214.s0.p8", "text": "Fluorographic analysis showed that the specific activity of soluble actin was two to three times that of its particulate form and that soluble actin, cofilin, actin depolymerizing factor, and profilin were transported at similar rates in slow component b of axonal flow.", "text_with_entity_marker": "Fluorographic analysis showed that the specific activity of soluble [E1]actin[/E1] was two to three times that of its particulate form and that soluble [E2]actin[/E2], cofilin, actin depolymerizing factor, and profilin were transported at similar rates in slow component b of axonal flow.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[68, 73]], "entity_1_idx_in_text_with_entity_marker": [72, 77], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[143, 148]], "entity_2_idx_in_text_with_entity_marker": [156, 161], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d214.s0_BioInfer.d214.s0.p9", "text": "Fluorographic analysis showed that the specific activity of soluble actin was two to three times that of its particulate form and that soluble actin, cofilin, actin depolymerizing factor, and profilin were transported at similar rates in slow component b of axonal flow.", "text_with_entity_marker": "Fluorographic analysis showed that the specific activity of soluble [E1]actin[/E1] was two to three times that of its particulate form and that soluble actin, [E2]cofilin[/E2], actin depolymerizing factor, and profilin were transported at similar rates in slow component b of axonal flow.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[68, 73]], "entity_1_idx_in_text_with_entity_marker": [72, 77], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "cofilin", "entity_2_idx": [[150, 157]], "entity_2_idx_in_text_with_entity_marker": [163, 170], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d73.s0_BioInfer.d73.s0.p0", "text": "RAD51, RAD54, RAD55 and RAD57 are all required to facilitate strand invasion into otherwise inaccessible donor sequences.", "text_with_entity_marker": "[E1]RAD51[/E1], RAD54, [E2]RAD55[/E2] and RAD57 are all required to facilitate strand invasion into otherwise inaccessible donor sequences.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD51", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD55", "entity_2_idx": [[14, 19]], "entity_2_idx_in_text_with_entity_marker": [27, 32], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d73.s0_BioInfer.d73.s0.p1", "text": "RAD51, RAD54, RAD55 and RAD57 are all required to facilitate strand invasion into otherwise inaccessible donor sequences.", "text_with_entity_marker": "[E1]RAD51[/E1], [E2]RAD54[/E2], RAD55 and RAD57 are all required to facilitate strand invasion into otherwise inaccessible donor sequences.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD51", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD54", "entity_2_idx": [[7, 12]], "entity_2_idx_in_text_with_entity_marker": [20, 25], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d73.s0_BioInfer.d73.s0.p2", "text": "RAD51, RAD54, RAD55 and RAD57 are all required to facilitate strand invasion into otherwise inaccessible donor sequences.", "text_with_entity_marker": "[E1]RAD51[/E1], RAD54, RAD55 and [E2]RAD57[/E2] are all required to facilitate strand invasion into otherwise inaccessible donor sequences.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD51", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD57", "entity_2_idx": [[24, 29]], "entity_2_idx_in_text_with_entity_marker": [37, 42], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d73.s0_BioInfer.d73.s0.p3", "text": "RAD51, RAD54, RAD55 and RAD57 are all required to facilitate strand invasion into otherwise inaccessible donor sequences.", "text_with_entity_marker": "RAD51, [E1]RAD54[/E1], [E2]RAD55[/E2] and RAD57 are all required to facilitate strand invasion into otherwise inaccessible donor sequences.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD54", "entity_1_idx": [[7, 12]], "entity_1_idx_in_text_with_entity_marker": [11, 16], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD55", "entity_2_idx": [[14, 19]], "entity_2_idx_in_text_with_entity_marker": [27, 32], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d73.s0_BioInfer.d73.s0.p4", "text": "RAD51, RAD54, RAD55 and RAD57 are all required to facilitate strand invasion into otherwise inaccessible donor sequences.", "text_with_entity_marker": "RAD51, RAD54, [E1]RAD55[/E1] and [E2]RAD57[/E2] are all required to facilitate strand invasion into otherwise inaccessible donor sequences.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD55", "entity_1_idx": [[14, 19]], "entity_1_idx_in_text_with_entity_marker": [18, 23], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD57", "entity_2_idx": [[24, 29]], "entity_2_idx_in_text_with_entity_marker": [37, 42], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d73.s0_BioInfer.d73.s0.p5", "text": "RAD51, RAD54, RAD55 and RAD57 are all required to facilitate strand invasion into otherwise inaccessible donor sequences.", "text_with_entity_marker": "RAD51, [E1]RAD54[/E1], RAD55 and [E2]RAD57[/E2] are all required to facilitate strand invasion into otherwise inaccessible donor sequences.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD54", "entity_1_idx": [[7, 12]], "entity_1_idx_in_text_with_entity_marker": [11, 16], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD57", "entity_2_idx": [[24, 29]], "entity_2_idx_in_text_with_entity_marker": [37, 42], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d73.s1_BioInfer.d73.s1.p0", "text": "RAD51, RAD54, RAD55 and RAD57 are still required when the same transcribed donor is on the chromosome.", "text_with_entity_marker": "[E1]RAD51[/E1], RAD54, [E2]RAD55[/E2] and RAD57 are still required when the same transcribed donor is on the chromosome.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD51", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD55", "entity_2_idx": [[14, 19]], "entity_2_idx_in_text_with_entity_marker": [27, 32], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d73.s1_BioInfer.d73.s1.p1", "text": "RAD51, RAD54, RAD55 and RAD57 are still required when the same transcribed donor is on the chromosome.", "text_with_entity_marker": "RAD51, RAD54, [E1]RAD55[/E1] and [E2]RAD57[/E2] are still required when the same transcribed donor is on the chromosome.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD55", "entity_1_idx": [[14, 19]], "entity_1_idx_in_text_with_entity_marker": [18, 23], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD57", "entity_2_idx": [[24, 29]], "entity_2_idx_in_text_with_entity_marker": [37, 42], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d73.s1_BioInfer.d73.s1.p2", "text": "RAD51, RAD54, RAD55 and RAD57 are still required when the same transcribed donor is on the chromosome.", "text_with_entity_marker": "RAD51, [E1]RAD54[/E1], [E2]RAD55[/E2] and RAD57 are still required when the same transcribed donor is on the chromosome.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD54", "entity_1_idx": [[7, 12]], "entity_1_idx_in_text_with_entity_marker": [11, 16], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD55", "entity_2_idx": [[14, 19]], "entity_2_idx_in_text_with_entity_marker": [27, 32], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d73.s1_BioInfer.d73.s1.p3", "text": "RAD51, RAD54, RAD55 and RAD57 are still required when the same transcribed donor is on the chromosome.", "text_with_entity_marker": "[E1]RAD51[/E1], RAD54, RAD55 and [E2]RAD57[/E2] are still required when the same transcribed donor is on the chromosome.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD51", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD57", "entity_2_idx": [[24, 29]], "entity_2_idx_in_text_with_entity_marker": [37, 42], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d654.s0_BioInfer.d654.s0.p0", "text": "The observed in vivo expression patterns of alpha-catenin, beta-catenin, and plakoglobin suggest that these proteins are directly linked with the developmental regulation of cell junctions, as cardiac cells become stably committed and phenotypically differentiated to eventually form a mature myocardium.", "text_with_entity_marker": "The observed in vivo expression patterns of [E1]alpha-catenin[/E1], [E2]beta-catenin[/E2], and plakoglobin suggest that these proteins are directly linked with the developmental regulation of cell junctions, as cardiac cells become stably committed and phenotypically differentiated to eventually form a mature myocardium.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-catenin", "entity_1_idx": [[44, 57]], "entity_1_idx_in_text_with_entity_marker": [48, 61], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[59, 71]], "entity_2_idx_in_text_with_entity_marker": [72, 84], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d654.s0_BioInfer.d654.s0.p1", "text": "The observed in vivo expression patterns of alpha-catenin, beta-catenin, and plakoglobin suggest that these proteins are directly linked with the developmental regulation of cell junctions, as cardiac cells become stably committed and phenotypically differentiated to eventually form a mature myocardium.", "text_with_entity_marker": "The observed in vivo expression patterns of alpha-catenin, [E1]beta-catenin[/E1], and [E2]plakoglobin[/E2] suggest that these proteins are directly linked with the developmental regulation of cell junctions, as cardiac cells become stably committed and phenotypically differentiated to eventually form a mature myocardium.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "beta-catenin", "entity_1_idx": [[59, 71]], "entity_1_idx_in_text_with_entity_marker": [63, 75], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "plakoglobin", "entity_2_idx": [[77, 88]], "entity_2_idx_in_text_with_entity_marker": [90, 101], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d654.s0_BioInfer.d654.s0.p2", "text": "The observed in vivo expression patterns of alpha-catenin, beta-catenin, and plakoglobin suggest that these proteins are directly linked with the developmental regulation of cell junctions, as cardiac cells become stably committed and phenotypically differentiated to eventually form a mature myocardium.", "text_with_entity_marker": "The observed in vivo expression patterns of [E1]alpha-catenin[/E1], beta-catenin, and [E2]plakoglobin[/E2] suggest that these proteins are directly linked with the developmental regulation of cell junctions, as cardiac cells become stably committed and phenotypically differentiated to eventually form a mature myocardium.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-catenin", "entity_1_idx": [[44, 57]], "entity_1_idx_in_text_with_entity_marker": [48, 61], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "plakoglobin", "entity_2_idx": [[77, 88]], "entity_2_idx_in_text_with_entity_marker": [90, 101], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d654.s1_BioInfer.d654.s1.p0", "text": "This study details the expression patterns of alpha-catenin, beta-catenin, and gamma-catenin, during definition of the cardiac cell population as distinct compartments in the anterior regions of the chick embryo between stages 5 and 9.", "text_with_entity_marker": "This study details the expression patterns of [E1]alpha-catenin[/E1], beta-catenin, and [E2]gamma-catenin[/E2], during definition of the cardiac cell population as distinct compartments in the anterior regions of the chick embryo between stages 5 and 9.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-catenin", "entity_1_idx": [[46, 59]], "entity_1_idx_in_text_with_entity_marker": [50, 63], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "gamma-catenin", "entity_2_idx": [[79, 92]], "entity_2_idx_in_text_with_entity_marker": [92, 105], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d654.s1_BioInfer.d654.s1.p1", "text": "This study details the expression patterns of alpha-catenin, beta-catenin, and gamma-catenin, during definition of the cardiac cell population as distinct compartments in the anterior regions of the chick embryo between stages 5 and 9.", "text_with_entity_marker": "This study details the expression patterns of [E1]alpha-catenin[/E1], [E2]beta-catenin[/E2], and gamma-catenin, during definition of the cardiac cell population as distinct compartments in the anterior regions of the chick embryo between stages 5 and 9.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-catenin", "entity_1_idx": [[46, 59]], "entity_1_idx_in_text_with_entity_marker": [50, 63], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[61, 73]], "entity_2_idx_in_text_with_entity_marker": [74, 86], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d654.s1_BioInfer.d654.s1.p2", "text": "This study details the expression patterns of alpha-catenin, beta-catenin, and gamma-catenin, during definition of the cardiac cell population as distinct compartments in the anterior regions of the chick embryo between stages 5 and 9.", "text_with_entity_marker": "This study details the expression patterns of alpha-catenin, [E1]beta-catenin[/E1], and [E2]gamma-catenin[/E2], during definition of the cardiac cell population as distinct compartments in the anterior regions of the chick embryo between stages 5 and 9.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "beta-catenin", "entity_1_idx": [[61, 73]], "entity_1_idx_in_text_with_entity_marker": [65, 77], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "gamma-catenin", "entity_2_idx": [[79, 92]], "entity_2_idx_in_text_with_entity_marker": [92, 105], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d355.s1_BioInfer.d355.s1.p0", "text": "To determine the effect of insulin-like growth factor I (IGF-I) on cardiac contractile protein synthesis in vivo, we measured L-[ring-2, 6-3H]phenylalanine incorporation into myosin heavy chain and actin during intravenous infusions (4 h) of either saline or IGF-I (1 microgram. kg-1. min-1) in awake rats.", "text_with_entity_marker": "To determine the effect of insulin-like growth factor I (IGF-I) on cardiac contractile protein synthesis in vivo, we measured L-[ring-2, 6-3H]phenylalanine incorporation into [E1]myosin heavy chain[/E1] and [E2]actin[/E2] during intravenous infusions (4 h) of either saline or IGF-I (1 microgram. kg-1. min-1) in awake rats.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin heavy chain", "entity_1_idx": [[175, 193]], "entity_1_idx_in_text_with_entity_marker": [179, 197], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[198, 203]], "entity_2_idx_in_text_with_entity_marker": [211, 216], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d355.s1_BioInfer.d355.s1.p1", "text": "To determine the effect of insulin-like growth factor I (IGF-I) on cardiac contractile protein synthesis in vivo, we measured L-[ring-2, 6-3H]phenylalanine incorporation into myosin heavy chain and actin during intravenous infusions (4 h) of either saline or IGF-I (1 microgram. kg-1. min-1) in awake rats.", "text_with_entity_marker": "To determine the effect of [E1]insulin-like growth factor I[/E1] (IGF-I) on cardiac contractile protein synthesis in vivo, we measured L-[ring-2, 6-3H]phenylalanine incorporation into myosin heavy chain and [E2]actin[/E2] during intravenous infusions (4 h) of either saline or IGF-I (1 microgram. kg-1. min-1) in awake rats.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "insulin-like growth factor I", "entity_1_idx": [[27, 55]], "entity_1_idx_in_text_with_entity_marker": [31, 59], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[198, 203]], "entity_2_idx_in_text_with_entity_marker": [211, 216], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d355.s1_BioInfer.d355.s1.p2", "text": "To determine the effect of insulin-like growth factor I (IGF-I) on cardiac contractile protein synthesis in vivo, we measured L-[ring-2, 6-3H]phenylalanine incorporation into myosin heavy chain and actin during intravenous infusions (4 h) of either saline or IGF-I (1 microgram. kg-1. min-1) in awake rats.", "text_with_entity_marker": "To determine the effect of insulin-like growth factor I (IGF-I) on cardiac contractile protein synthesis in vivo, we measured L-[ring-2, 6-3H]phenylalanine incorporation into myosin heavy chain and [E1]actin[/E1] during intravenous infusions (4 h) of either saline or [E2]IGF-I[/E2] (1 microgram. kg-1. min-1) in awake rats.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[198, 203]], "entity_1_idx_in_text_with_entity_marker": [202, 207], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "IGF-I", "entity_2_idx": [[259, 264]], "entity_2_idx_in_text_with_entity_marker": [272, 277], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d355.s1_BioInfer.d355.s1.p3", "text": "To determine the effect of insulin-like growth factor I (IGF-I) on cardiac contractile protein synthesis in vivo, we measured L-[ring-2, 6-3H]phenylalanine incorporation into myosin heavy chain and actin during intravenous infusions (4 h) of either saline or IGF-I (1 microgram. kg-1. min-1) in awake rats.", "text_with_entity_marker": "To determine the effect of insulin-like growth factor I ([E1]IGF-I[/E1]) on cardiac contractile protein synthesis in vivo, we measured L-[ring-2, 6-3H]phenylalanine incorporation into myosin heavy chain and [E2]actin[/E2] during intravenous infusions (4 h) of either saline or IGF-I (1 microgram. kg-1. min-1) in awake rats.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IGF-I", "entity_1_idx": [[57, 62]], "entity_1_idx_in_text_with_entity_marker": [61, 66], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[198, 203]], "entity_2_idx_in_text_with_entity_marker": [211, 216], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d355.s1_BioInfer.d355.s1.p4", "text": "To determine the effect of insulin-like growth factor I (IGF-I) on cardiac contractile protein synthesis in vivo, we measured L-[ring-2, 6-3H]phenylalanine incorporation into myosin heavy chain and actin during intravenous infusions (4 h) of either saline or IGF-I (1 microgram. kg-1. min-1) in awake rats.", "text_with_entity_marker": "To determine the effect of [E1]insulin-like growth factor I[/E1] (IGF-I) on cardiac contractile protein synthesis in vivo, we measured L-[ring-2, 6-3H]phenylalanine incorporation into [E2]myosin heavy chain[/E2] and actin during intravenous infusions (4 h) of either saline or IGF-I (1 microgram. kg-1. min-1) in awake rats.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "insulin-like growth factor I", "entity_1_idx": [[27, 55]], "entity_1_idx_in_text_with_entity_marker": [31, 59], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "myosin heavy chain", "entity_2_idx": [[175, 193]], "entity_2_idx_in_text_with_entity_marker": [188, 206], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d355.s1_BioInfer.d355.s1.p5", "text": "To determine the effect of insulin-like growth factor I (IGF-I) on cardiac contractile protein synthesis in vivo, we measured L-[ring-2, 6-3H]phenylalanine incorporation into myosin heavy chain and actin during intravenous infusions (4 h) of either saline or IGF-I (1 microgram. kg-1. min-1) in awake rats.", "text_with_entity_marker": "To determine the effect of insulin-like growth factor I (IGF-I) on cardiac contractile protein synthesis in vivo, we measured L-[ring-2, 6-3H]phenylalanine incorporation into [E1]myosin heavy chain[/E1] and actin during intravenous infusions (4 h) of either saline or [E2]IGF-I[/E2] (1 microgram. kg-1. min-1) in awake rats.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin heavy chain", "entity_1_idx": [[175, 193]], "entity_1_idx_in_text_with_entity_marker": [179, 197], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "IGF-I", "entity_2_idx": [[259, 264]], "entity_2_idx_in_text_with_entity_marker": [272, 277], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d355.s1_BioInfer.d355.s1.p6", "text": "To determine the effect of insulin-like growth factor I (IGF-I) on cardiac contractile protein synthesis in vivo, we measured L-[ring-2, 6-3H]phenylalanine incorporation into myosin heavy chain and actin during intravenous infusions (4 h) of either saline or IGF-I (1 microgram. kg-1. min-1) in awake rats.", "text_with_entity_marker": "To determine the effect of insulin-like growth factor I ([E1]IGF-I[/E1]) on cardiac contractile protein synthesis in vivo, we measured L-[ring-2, 6-3H]phenylalanine incorporation into [E2]myosin heavy chain[/E2] and actin during intravenous infusions (4 h) of either saline or IGF-I (1 microgram. kg-1. min-1) in awake rats.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IGF-I", "entity_1_idx": [[57, 62]], "entity_1_idx_in_text_with_entity_marker": [61, 66], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "myosin heavy chain", "entity_2_idx": [[175, 193]], "entity_2_idx_in_text_with_entity_marker": [188, 206], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d355.s1_BioInfer.d355.s1.p7", "text": "To determine the effect of insulin-like growth factor I (IGF-I) on cardiac contractile protein synthesis in vivo, we measured L-[ring-2, 6-3H]phenylalanine incorporation into myosin heavy chain and actin during intravenous infusions (4 h) of either saline or IGF-I (1 microgram. kg-1. min-1) in awake rats.", "text_with_entity_marker": "To determine the effect of [E1]insulin-like growth factor I[/E1] (IGF-I) on cardiac contractile protein synthesis in vivo, we measured L-[ring-2, 6-3H]phenylalanine incorporation into myosin heavy chain and actin during intravenous infusions (4 h) of either saline or [E2]IGF-I[/E2] (1 microgram. kg-1. min-1) in awake rats.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "insulin-like growth factor I", "entity_1_idx": [[27, 55]], "entity_1_idx_in_text_with_entity_marker": [31, 59], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "IGF-I", "entity_2_idx": [[259, 264]], "entity_2_idx_in_text_with_entity_marker": [272, 277], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d355.s1_BioInfer.d355.s1.p8", "text": "To determine the effect of insulin-like growth factor I (IGF-I) on cardiac contractile protein synthesis in vivo, we measured L-[ring-2, 6-3H]phenylalanine incorporation into myosin heavy chain and actin during intravenous infusions (4 h) of either saline or IGF-I (1 microgram. kg-1. min-1) in awake rats.", "text_with_entity_marker": "To determine the effect of [E1]insulin-like growth factor I[/E1] ([E2]IGF-I[/E2]) on cardiac contractile protein synthesis in vivo, we measured L-[ring-2, 6-3H]phenylalanine incorporation into myosin heavy chain and actin during intravenous infusions (4 h) of either saline or IGF-I (1 microgram. kg-1. min-1) in awake rats.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "insulin-like growth factor I", "entity_1_idx": [[27, 55]], "entity_1_idx_in_text_with_entity_marker": [31, 59], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "IGF-I", "entity_2_idx": [[57, 62]], "entity_2_idx_in_text_with_entity_marker": [70, 75], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d355.s1_BioInfer.d355.s1.p9", "text": "To determine the effect of insulin-like growth factor I (IGF-I) on cardiac contractile protein synthesis in vivo, we measured L-[ring-2, 6-3H]phenylalanine incorporation into myosin heavy chain and actin during intravenous infusions (4 h) of either saline or IGF-I (1 microgram. kg-1. min-1) in awake rats.", "text_with_entity_marker": "To determine the effect of insulin-like growth factor I ([E1]IGF-I[/E1]) on cardiac contractile protein synthesis in vivo, we measured L-[ring-2, 6-3H]phenylalanine incorporation into myosin heavy chain and actin during intravenous infusions (4 h) of either saline or [E2]IGF-I[/E2] (1 microgram. kg-1. min-1) in awake rats.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IGF-I", "entity_1_idx": [[57, 62]], "entity_1_idx_in_text_with_entity_marker": [61, 66], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "IGF-I", "entity_2_idx": [[259, 264]], "entity_2_idx_in_text_with_entity_marker": [272, 277], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d269.s0_BioInfer.d269.s0.p0", "text": "However, immunofluorescence staining revealed a similar organisation of actin microfilaments, talin and phosphotyrosyl-containing proteins on both substrates.", "text_with_entity_marker": "However, immunofluorescence staining revealed a similar organisation of [E1]actin[/E1] microfilaments, [E2]talin[/E2] and phosphotyrosyl-containing proteins on both substrates.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[72, 77]], "entity_1_idx_in_text_with_entity_marker": [76, 81], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "talin", "entity_2_idx": [[94, 99]], "entity_2_idx_in_text_with_entity_marker": [107, 112], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d291.s0_BioInfer.d291.s0.p0", "text": "Immunohistochemical identification and localization of actin and fimbrin in vestibular hair cells in the normal guinea pig and in a strain of the waltzing guinea pig.", "text_with_entity_marker": "Immunohistochemical identification and localization of [E1]actin[/E1] and [E2]fimbrin[/E2] in vestibular hair cells in the normal guinea pig and in a strain of the waltzing guinea pig.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[55, 60]], "entity_1_idx_in_text_with_entity_marker": [59, 64], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "fimbrin", "entity_2_idx": [[65, 72]], "entity_2_idx_in_text_with_entity_marker": [78, 85], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d390.s0_BioInfer.d390.s0.p40", "text": "Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "text_with_entity_marker": "Isolation and characterization of death domain ([E1]TNF-RI[/E1], [E2]Fas[/E2], TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TNF-RI", "entity_1_idx": [[48, 54]], "entity_1_idx_in_text_with_entity_marker": [52, 58], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Fas", "entity_2_idx": [[56, 59]], "entity_2_idx_in_text_with_entity_marker": [69, 72], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d390.s0_BioInfer.d390.s0.p41", "text": "Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "text_with_entity_marker": "Isolation and characterization of death domain ([E1]TNF-RI[/E1], Fas, TRADD, FADD/MORT-1, [E2]RIP[/E2]) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TNF-RI", "entity_1_idx": [[48, 54]], "entity_1_idx_in_text_with_entity_marker": [52, 58], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RIP", "entity_2_idx": [[81, 84]], "entity_2_idx_in_text_with_entity_marker": [94, 97], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d390.s0_BioInfer.d390.s0.p42", "text": "Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "text_with_entity_marker": "Isolation and characterization of death domain (TNF-RI, [E1]Fas[/E1], [E2]TRADD[/E2], FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Fas", "entity_1_idx": [[56, 59]], "entity_1_idx_in_text_with_entity_marker": [60, 63], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "TRADD", "entity_2_idx": [[61, 66]], "entity_2_idx_in_text_with_entity_marker": [74, 79], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d390.s0_BioInfer.d390.s0.p43", "text": "Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "text_with_entity_marker": "Isolation and characterization of death domain (TNF-RI, Fas, [E1]TRADD[/E1], FADD/MORT-1, [E2]RIP[/E2]) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TRADD", "entity_1_idx": [[61, 66]], "entity_1_idx_in_text_with_entity_marker": [65, 70], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RIP", "entity_2_idx": [[81, 84]], "entity_2_idx_in_text_with_entity_marker": [94, 97], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d390.s0_BioInfer.d390.s0.p44", "text": "Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "text_with_entity_marker": "Isolation and characterization of death domain (TNF-RI, [E1]Fas[/E1], TRADD, FADD/MORT-1, [E2]RIP[/E2]) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Fas", "entity_1_idx": [[56, 59]], "entity_1_idx_in_text_with_entity_marker": [60, 63], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RIP", "entity_2_idx": [[81, 84]], "entity_2_idx_in_text_with_entity_marker": [94, 97], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d557.s0_BioInfer.d557.s0.p20", "text": "Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous MyoD1, MRF4, Myf5, the skeletal muscle actin, or the myosin heavy chain genes.", "text_with_entity_marker": "Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous [E1]myogenin[/E1] and [E2]myosin light chain 2[/E2] gene but not the endogenous MyoD1, MRF4, Myf5, the skeletal muscle actin, or the myosin heavy chain genes.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myogenin", "entity_1_idx": [[138, 146]], "entity_1_idx_in_text_with_entity_marker": [142, 150], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin light chain 2", "entity_2_idx": [[151, 171]], "entity_2_idx_in_text_with_entity_marker": [164, 184], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d84.s0_BioInfer.d84.s0.p0", "text": "As shown by in situ hybridization with cloned probes and analysis of in vitro translation products, M. occulta embryos do not accumulate high levels of alpha actin or myosin heavy chain mRNA.", "text_with_entity_marker": "As shown by in situ hybridization with cloned probes and analysis of in vitro translation products, M. occulta embryos do not accumulate high levels of [E1]alpha actin[/E1] or [E2]myosin heavy chain[/E2] mRNA.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha actin", "entity_1_idx": [[152, 163]], "entity_1_idx_in_text_with_entity_marker": [156, 167], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin heavy chain", "entity_2_idx": [[167, 185]], "entity_2_idx_in_text_with_entity_marker": [180, 198], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d84.s1_BioInfer.d84.s1.p0", "text": "In contrast, alpha actin and myosin heavy chain mRNA accumulation was not enhanced in hybrid embryos.", "text_with_entity_marker": "In contrast, [E1]alpha actin[/E1] and [E2]myosin heavy chain[/E2] mRNA accumulation was not enhanced in hybrid embryos.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha actin", "entity_1_idx": [[13, 24]], "entity_1_idx_in_text_with_entity_marker": [17, 28], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin heavy chain", "entity_2_idx": [[29, 47]], "entity_2_idx_in_text_with_entity_marker": [42, 60], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d301.s0_BioInfer.d301.s0.p0", "text": "Immunoreactive E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients' survival.", "text_with_entity_marker": "Immunoreactive [E1]E-cadherin[/E1], alpha-catenin, [E2]beta-catenin[/E2], and gamma-catenin proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients' survival.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E-cadherin", "entity_1_idx": [[15, 25]], "entity_1_idx_in_text_with_entity_marker": [19, 29], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[42, 54]], "entity_2_idx_in_text_with_entity_marker": [55, 67], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d301.s0_BioInfer.d301.s0.p1", "text": "Immunoreactive E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients' survival.", "text_with_entity_marker": "Immunoreactive [E1]E-cadherin[/E1], [E2]alpha-catenin[/E2], beta-catenin, and gamma-catenin proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients' survival.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E-cadherin", "entity_1_idx": [[15, 25]], "entity_1_idx_in_text_with_entity_marker": [19, 29], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[27, 40]], "entity_2_idx_in_text_with_entity_marker": [40, 53], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d301.s0_BioInfer.d301.s0.p2", "text": "Immunoreactive E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients' survival.", "text_with_entity_marker": "Immunoreactive [E1]E-cadherin[/E1], alpha-catenin, beta-catenin, and [E2]gamma-catenin[/E2] proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients' survival.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E-cadherin", "entity_1_idx": [[15, 25]], "entity_1_idx_in_text_with_entity_marker": [19, 29], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "gamma-catenin", "entity_2_idx": [[60, 73]], "entity_2_idx_in_text_with_entity_marker": [73, 86], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d301.s0_BioInfer.d301.s0.p3", "text": "Immunoreactive E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients' survival.", "text_with_entity_marker": "Immunoreactive E-cadherin, [E1]alpha-catenin[/E1], [E2]beta-catenin[/E2], and gamma-catenin proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients' survival.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-catenin", "entity_1_idx": [[27, 40]], "entity_1_idx_in_text_with_entity_marker": [31, 44], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[42, 54]], "entity_2_idx_in_text_with_entity_marker": [55, 67], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d301.s0_BioInfer.d301.s0.p4", "text": "Immunoreactive E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients' survival.", "text_with_entity_marker": "Immunoreactive E-cadherin, alpha-catenin, [E1]beta-catenin[/E1], and [E2]gamma-catenin[/E2] proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients' survival.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "beta-catenin", "entity_1_idx": [[42, 54]], "entity_1_idx_in_text_with_entity_marker": [46, 58], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "gamma-catenin", "entity_2_idx": [[60, 73]], "entity_2_idx_in_text_with_entity_marker": [73, 86], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d301.s0_BioInfer.d301.s0.p5", "text": "Immunoreactive E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients' survival.", "text_with_entity_marker": "Immunoreactive E-cadherin, [E1]alpha-catenin[/E1], beta-catenin, and [E2]gamma-catenin[/E2] proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients' survival.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-catenin", "entity_1_idx": [[27, 40]], "entity_1_idx_in_text_with_entity_marker": [31, 44], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "gamma-catenin", "entity_2_idx": [[60, 73]], "entity_2_idx_in_text_with_entity_marker": [73, 86], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d347.s0_BioInfer.d347.s0.p0", "text": "In localization studies with mammalian cells, all fusion proteins showed the localization expected for profilin in areas of high actin dynamics, such as leading lamellae and ruffles induced by epidermal growth factor.", "text_with_entity_marker": "In localization studies with mammalian cells, all fusion proteins showed the localization expected for [E1]profilin[/E1] in areas of high actin dynamics, such as leading lamellae and ruffles induced by [E2]epidermal growth factor[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "profilin", "entity_1_idx": [[103, 111]], "entity_1_idx_in_text_with_entity_marker": [107, 115], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "epidermal growth factor", "entity_2_idx": [[193, 216]], "entity_2_idx_in_text_with_entity_marker": [206, 229], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d347.s0_BioInfer.d347.s0.p1", "text": "In localization studies with mammalian cells, all fusion proteins showed the localization expected for profilin in areas of high actin dynamics, such as leading lamellae and ruffles induced by epidermal growth factor.", "text_with_entity_marker": "In localization studies with mammalian cells, all fusion proteins showed the localization expected for [E1]profilin[/E1] in areas of high [E2]actin[/E2] dynamics, such as leading lamellae and ruffles induced by epidermal growth factor.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "profilin", "entity_1_idx": [[103, 111]], "entity_1_idx_in_text_with_entity_marker": [107, 115], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[129, 134]], "entity_2_idx_in_text_with_entity_marker": [142, 147], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d347.s0_BioInfer.d347.s0.p2", "text": "In localization studies with mammalian cells, all fusion proteins showed the localization expected for profilin in areas of high actin dynamics, such as leading lamellae and ruffles induced by epidermal growth factor.", "text_with_entity_marker": "In localization studies with mammalian cells, all fusion proteins showed the localization expected for profilin in areas of high [E1]actin[/E1] dynamics, such as leading lamellae and ruffles induced by [E2]epidermal growth factor[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[129, 134]], "entity_1_idx_in_text_with_entity_marker": [133, 138], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "epidermal growth factor", "entity_2_idx": [[193, 216]], "entity_2_idx_in_text_with_entity_marker": [206, 229], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d514.s0_BioInfer.d514.s0.p0", "text": "Reduced expression of E-cadherin and alpha-catenin, as well as mutations in the E-cadherin gene, have been found in various carcinomas, whereas mutations in the alpha- and beta-catenin genes have been described only in carcinoma cell lines.", "text_with_entity_marker": "Reduced expression of E-cadherin and [E1]alpha-catenin[/E1], as well as mutations in the E-cadherin gene, have been found in various carcinomas, whereas mutations in the [E2]alpha-[/E2] and beta-catenin genes have been described only in carcinoma cell lines.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-catenin", "entity_1_idx": [[37, 50]], "entity_1_idx_in_text_with_entity_marker": [41, 54], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-", "entity_2_idx": [[161, 167], [177, 184]], "entity_2_idx_in_text_with_entity_marker": [174, 180], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d514.s0_BioInfer.d514.s0.p1", "text": "Reduced expression of E-cadherin and alpha-catenin, as well as mutations in the E-cadherin gene, have been found in various carcinomas, whereas mutations in the alpha- and beta-catenin genes have been described only in carcinoma cell lines.", "text_with_entity_marker": "Reduced expression of E-cadherin and alpha-catenin, as well as mutations in the E-cadherin gene, have been found in various carcinomas, whereas mutations in the [E1]alpha-[/E1] and [E2]beta-catenin[/E2] genes have been described only in carcinoma cell lines.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-", "entity_1_idx": [[161, 167], [177, 184]], "entity_1_idx_in_text_with_entity_marker": [165, 171], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[172, 184]], "entity_2_idx_in_text_with_entity_marker": [185, 197], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d514.s0_BioInfer.d514.s0.p2", "text": "Reduced expression of E-cadherin and alpha-catenin, as well as mutations in the E-cadherin gene, have been found in various carcinomas, whereas mutations in the alpha- and beta-catenin genes have been described only in carcinoma cell lines.", "text_with_entity_marker": "Reduced expression of [E1]E-cadherin[/E1] and alpha-catenin, as well as mutations in the E-cadherin gene, have been found in various carcinomas, whereas mutations in the [E2]alpha-[/E2] and beta-catenin genes have been described only in carcinoma cell lines.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E-cadherin", "entity_1_idx": [[22, 32]], "entity_1_idx_in_text_with_entity_marker": [26, 36], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-", "entity_2_idx": [[161, 167], [177, 184]], "entity_2_idx_in_text_with_entity_marker": [174, 180], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d514.s0_BioInfer.d514.s0.p3", "text": "Reduced expression of E-cadherin and alpha-catenin, as well as mutations in the E-cadherin gene, have been found in various carcinomas, whereas mutations in the alpha- and beta-catenin genes have been described only in carcinoma cell lines.", "text_with_entity_marker": "Reduced expression of E-cadherin and alpha-catenin, as well as mutations in the [E1]E-cadherin[/E1] gene, have been found in various carcinomas, whereas mutations in the [E2]alpha-[/E2] and beta-catenin genes have been described only in carcinoma cell lines.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E-cadherin", "entity_1_idx": [[80, 90]], "entity_1_idx_in_text_with_entity_marker": [84, 94], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-", "entity_2_idx": [[161, 167], [177, 184]], "entity_2_idx_in_text_with_entity_marker": [174, 180], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d514.s0_BioInfer.d514.s0.p4", "text": "Reduced expression of E-cadherin and alpha-catenin, as well as mutations in the E-cadherin gene, have been found in various carcinomas, whereas mutations in the alpha- and beta-catenin genes have been described only in carcinoma cell lines.", "text_with_entity_marker": "Reduced expression of E-cadherin and [E1]alpha-catenin[/E1], as well as mutations in the E-cadherin gene, have been found in various carcinomas, whereas mutations in the alpha- and [E2]beta-catenin[/E2] genes have been described only in carcinoma cell lines.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-catenin", "entity_1_idx": [[37, 50]], "entity_1_idx_in_text_with_entity_marker": [41, 54], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[172, 184]], "entity_2_idx_in_text_with_entity_marker": [185, 197], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d514.s0_BioInfer.d514.s0.p5", "text": "Reduced expression of E-cadherin and alpha-catenin, as well as mutations in the E-cadherin gene, have been found in various carcinomas, whereas mutations in the alpha- and beta-catenin genes have been described only in carcinoma cell lines.", "text_with_entity_marker": "Reduced expression of [E1]E-cadherin[/E1] and [E2]alpha-catenin[/E2], as well as mutations in the E-cadherin gene, have been found in various carcinomas, whereas mutations in the alpha- and beta-catenin genes have been described only in carcinoma cell lines.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E-cadherin", "entity_1_idx": [[22, 32]], "entity_1_idx_in_text_with_entity_marker": [26, 36], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[37, 50]], "entity_2_idx_in_text_with_entity_marker": [50, 63], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d514.s0_BioInfer.d514.s0.p6", "text": "Reduced expression of E-cadherin and alpha-catenin, as well as mutations in the E-cadherin gene, have been found in various carcinomas, whereas mutations in the alpha- and beta-catenin genes have been described only in carcinoma cell lines.", "text_with_entity_marker": "Reduced expression of E-cadherin and [E1]alpha-catenin[/E1], as well as mutations in the [E2]E-cadherin[/E2] gene, have been found in various carcinomas, whereas mutations in the alpha- and beta-catenin genes have been described only in carcinoma cell lines.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-catenin", "entity_1_idx": [[37, 50]], "entity_1_idx_in_text_with_entity_marker": [41, 54], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "E-cadherin", "entity_2_idx": [[80, 90]], "entity_2_idx_in_text_with_entity_marker": [93, 103], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d514.s0_BioInfer.d514.s0.p7", "text": "Reduced expression of E-cadherin and alpha-catenin, as well as mutations in the E-cadherin gene, have been found in various carcinomas, whereas mutations in the alpha- and beta-catenin genes have been described only in carcinoma cell lines.", "text_with_entity_marker": "Reduced expression of [E1]E-cadherin[/E1] and alpha-catenin, as well as mutations in the E-cadherin gene, have been found in various carcinomas, whereas mutations in the alpha- and [E2]beta-catenin[/E2] genes have been described only in carcinoma cell lines.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E-cadherin", "entity_1_idx": [[22, 32]], "entity_1_idx_in_text_with_entity_marker": [26, 36], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[172, 184]], "entity_2_idx_in_text_with_entity_marker": [185, 197], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d514.s0_BioInfer.d514.s0.p8", "text": "Reduced expression of E-cadherin and alpha-catenin, as well as mutations in the E-cadherin gene, have been found in various carcinomas, whereas mutations in the alpha- and beta-catenin genes have been described only in carcinoma cell lines.", "text_with_entity_marker": "Reduced expression of E-cadherin and alpha-catenin, as well as mutations in the [E1]E-cadherin[/E1] gene, have been found in various carcinomas, whereas mutations in the alpha- and [E2]beta-catenin[/E2] genes have been described only in carcinoma cell lines.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E-cadherin", "entity_1_idx": [[80, 90]], "entity_1_idx_in_text_with_entity_marker": [84, 94], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[172, 184]], "entity_2_idx_in_text_with_entity_marker": [185, 197], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d514.s0_BioInfer.d514.s0.p9", "text": "Reduced expression of E-cadherin and alpha-catenin, as well as mutations in the E-cadherin gene, have been found in various carcinomas, whereas mutations in the alpha- and beta-catenin genes have been described only in carcinoma cell lines.", "text_with_entity_marker": "Reduced expression of [E1]E-cadherin[/E1] and alpha-catenin, as well as mutations in the [E2]E-cadherin[/E2] gene, have been found in various carcinomas, whereas mutations in the alpha- and beta-catenin genes have been described only in carcinoma cell lines.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E-cadherin", "entity_1_idx": [[22, 32]], "entity_1_idx_in_text_with_entity_marker": [26, 36], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "E-cadherin", "entity_2_idx": [[80, 90]], "entity_2_idx_in_text_with_entity_marker": [93, 103], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p70", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), [E1]haemagglutinin neuraminidase[/E1] (HN; 74 kDa), [E2]nucleocapsid[/E2] (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "haemagglutinin neuraminidase", "entity_1_idx": [[183, 211], [351, 359]], "entity_1_idx_in_text_with_entity_marker": [187, 215], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "nucleocapsid", "entity_2_idx": [[226, 238], [351, 359]], "entity_2_idx_in_text_with_entity_marker": [239, 251], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p71", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), [E1]nucleocapsid[/E1] (N; 66 kDa), fusion (F0; 63 kDa), [E2]phosphoprotein[/E2] (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "nucleocapsid", "entity_1_idx": [[226, 238], [351, 359]], "entity_1_idx_in_text_with_entity_marker": [230, 242], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "phosphoprotein", "entity_2_idx": [[273, 287], [351, 359]], "entity_2_idx_in_text_with_entity_marker": [286, 300], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p72", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), [E1]nucleocapsid[/E1] (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein ([E2]P[/E2]; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "nucleocapsid", "entity_1_idx": [[226, 238], [351, 359]], "entity_1_idx_in_text_with_entity_marker": [230, 242], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[289, 290]], "entity_2_idx_in_text_with_entity_marker": [302, 303], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p73", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), [E1]nucleocapsid[/E1] (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural ([E2]V[/E2]; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "nucleocapsid", "entity_1_idx": [[226, 238], [351, 359]], "entity_1_idx_in_text_with_entity_marker": [230, 242], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "V", "entity_2_idx": [[340, 341]], "entity_2_idx_in_text_with_entity_marker": [353, 354], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p74", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), [E1]nucleocapsid[/E1] ([E2]N[/E2]; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "nucleocapsid", "entity_1_idx": [[226, 238], [351, 359]], "entity_1_idx_in_text_with_entity_marker": [230, 242], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "N", "entity_2_idx": [[240, 241]], "entity_2_idx_in_text_with_entity_marker": [253, 254], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p75", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), [E1]nucleocapsid[/E1] (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix ([E2]M[/E2]; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "nucleocapsid", "entity_1_idx": [[226, 238], [351, 359]], "entity_1_idx_in_text_with_entity_marker": [230, 242], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "M", "entity_2_idx": [[309, 310]], "entity_2_idx_in_text_with_entity_marker": [322, 323], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p76", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), [E1]haemagglutinin neuraminidase[/E1] (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), [E2]phosphoprotein[/E2] (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "haemagglutinin neuraminidase", "entity_1_idx": [[183, 211], [351, 359]], "entity_1_idx_in_text_with_entity_marker": [187, 215], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "phosphoprotein", "entity_2_idx": [[273, 287], [351, 359]], "entity_2_idx_in_text_with_entity_marker": [286, 300], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p77", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), [E1]haemagglutinin neuraminidase[/E1] (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein ([E2]P[/E2]; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "haemagglutinin neuraminidase", "entity_1_idx": [[183, 211], [351, 359]], "entity_1_idx_in_text_with_entity_marker": [187, 215], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[289, 290]], "entity_2_idx_in_text_with_entity_marker": [302, 303], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p78", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), [E1]haemagglutinin neuraminidase[/E1] (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural ([E2]V[/E2]; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "haemagglutinin neuraminidase", "entity_1_idx": [[183, 211], [351, 359]], "entity_1_idx_in_text_with_entity_marker": [187, 215], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "V", "entity_2_idx": [[340, 341]], "entity_2_idx_in_text_with_entity_marker": [353, 354], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p79", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), [E1]haemagglutinin neuraminidase[/E1] (HN; 74 kDa), nucleocapsid ([E2]N[/E2]; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "haemagglutinin neuraminidase", "entity_1_idx": [[183, 211], [351, 359]], "entity_1_idx_in_text_with_entity_marker": [187, 215], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "N", "entity_2_idx": [[240, 241]], "entity_2_idx_in_text_with_entity_marker": [253, 254], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d423.s0_BioInfer.d423.s0.p20", "text": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "text_with_entity_marker": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain ([E1]MHC[/E1]), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 ([E2]Cx43[/E2]), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MHC", "entity_1_idx": [[96, 99]], "entity_1_idx_in_text_with_entity_marker": [100, 103], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Cx43", "entity_2_idx": [[168, 172]], "entity_2_idx_in_text_with_entity_marker": [181, 185], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d423.s0_BioInfer.d423.s0.p21", "text": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "text_with_entity_marker": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 ([E1]Cx43[/E1]), desmin and [E2]alpha-smooth muscle actin[/E2] (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Cx43", "entity_1_idx": [[168, 172]], "entity_1_idx_in_text_with_entity_marker": [172, 176], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-smooth muscle actin", "entity_2_idx": [[186, 211]], "entity_2_idx_in_text_with_entity_marker": [199, 224], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d423.s0_BioInfer.d423.s0.p22", "text": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "text_with_entity_marker": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I ([E1]TnI[/E1]) isoforms, connexin 43 ([E2]Cx43[/E2]), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TnI", "entity_1_idx": [[140, 143]], "entity_1_idx_in_text_with_entity_marker": [144, 147], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Cx43", "entity_2_idx": [[168, 172]], "entity_2_idx_in_text_with_entity_marker": [181, 185], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d423.s0_BioInfer.d423.s0.p23", "text": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "text_with_entity_marker": "METHODS: We have performed a detailed study of the pattern of expression of [E1]myosin heavy chain[/E1] (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 ([E2]Cx43[/E2]), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin heavy chain", "entity_1_idx": [[76, 94]], "entity_1_idx_in_text_with_entity_marker": [80, 98], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Cx43", "entity_2_idx": [[168, 172]], "entity_2_idx_in_text_with_entity_marker": [181, 185], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d423.s0_BioInfer.d423.s0.p24", "text": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "text_with_entity_marker": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), [E1]troponin I[/E1] (TnI) isoforms, connexin 43 ([E2]Cx43[/E2]), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "troponin I", "entity_1_idx": [[128, 138]], "entity_1_idx_in_text_with_entity_marker": [132, 142], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Cx43", "entity_2_idx": [[168, 172]], "entity_2_idx_in_text_with_entity_marker": [181, 185], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d423.s0_BioInfer.d423.s0.p25", "text": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "text_with_entity_marker": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), [E1]myosin light chain[/E1] (MLC), troponin I (TnI) isoforms, connexin 43 ([E2]Cx43[/E2]), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin light chain", "entity_1_idx": [[102, 120]], "entity_1_idx_in_text_with_entity_marker": [106, 124], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Cx43", "entity_2_idx": [[168, 172]], "entity_2_idx_in_text_with_entity_marker": [181, 185], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d423.s0_BioInfer.d423.s0.p26", "text": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "text_with_entity_marker": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 ([E1]Cx43[/E1]), [E2]desmin[/E2] and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Cx43", "entity_1_idx": [[168, 172]], "entity_1_idx_in_text_with_entity_marker": [172, 176], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "desmin", "entity_2_idx": [[175, 181]], "entity_2_idx_in_text_with_entity_marker": [188, 194], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d423.s0_BioInfer.d423.s0.p27", "text": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "text_with_entity_marker": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain ([E1]MHC[/E1]), myosin light chain (MLC), troponin I (TnI) isoforms, [E2]connexin 43[/E2] (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MHC", "entity_1_idx": [[96, 99]], "entity_1_idx_in_text_with_entity_marker": [100, 103], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "connexin 43", "entity_2_idx": [[155, 166]], "entity_2_idx_in_text_with_entity_marker": [168, 179], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d423.s0_BioInfer.d423.s0.p28", "text": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "text_with_entity_marker": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, [E1]connexin 43[/E1] (Cx43), desmin and [E2]alpha-smooth muscle actin[/E2] (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "connexin 43", "entity_1_idx": [[155, 166]], "entity_1_idx_in_text_with_entity_marker": [159, 170], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-smooth muscle actin", "entity_2_idx": [[186, 211]], "entity_2_idx_in_text_with_entity_marker": [199, 224], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d423.s0_BioInfer.d423.s0.p29", "text": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "text_with_entity_marker": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I ([E1]TnI[/E1]) isoforms, [E2]connexin 43[/E2] (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TnI", "entity_1_idx": [[140, 143]], "entity_1_idx_in_text_with_entity_marker": [144, 147], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "connexin 43", "entity_2_idx": [[155, 166]], "entity_2_idx_in_text_with_entity_marker": [168, 179], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d615.s0_BioInfer.d615.s0.p0", "text": "The gene for the human CREB binding protein, the transcriptional coactivator CBP, is included in the RT1 cosmid, and mutations in CBP have recently been identified in nondeleted RTS patients.", "text_with_entity_marker": "The gene for the human CREB binding protein, the transcriptional coactivator [E1]CBP[/E1], is included in the RT1 cosmid, and mutations in [E2]CBP[/E2] have recently been identified in nondeleted RTS patients.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "CBP", "entity_1_idx": [[77, 80]], "entity_1_idx_in_text_with_entity_marker": [81, 84], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CBP", "entity_2_idx": [[130, 133]], "entity_2_idx_in_text_with_entity_marker": [143, 146], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d615.s0_BioInfer.d615.s0.p1", "text": "The gene for the human CREB binding protein, the transcriptional coactivator CBP, is included in the RT1 cosmid, and mutations in CBP have recently been identified in nondeleted RTS patients.", "text_with_entity_marker": "The gene for the human [E1]CREB binding protein[/E1], the transcriptional coactivator [E2]CBP[/E2], is included in the RT1 cosmid, and mutations in CBP have recently been identified in nondeleted RTS patients.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "CREB binding protein", "entity_1_idx": [[23, 43]], "entity_1_idx_in_text_with_entity_marker": [27, 47], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CBP", "entity_2_idx": [[77, 80]], "entity_2_idx_in_text_with_entity_marker": [90, 93], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d615.s0_BioInfer.d615.s0.p2", "text": "The gene for the human CREB binding protein, the transcriptional coactivator CBP, is included in the RT1 cosmid, and mutations in CBP have recently been identified in nondeleted RTS patients.", "text_with_entity_marker": "The gene for the human [E1]CREB binding protein[/E1], the transcriptional coactivator CBP, is included in the RT1 cosmid, and mutations in [E2]CBP[/E2] have recently been identified in nondeleted RTS patients.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "CREB binding protein", "entity_1_idx": [[23, 43]], "entity_1_idx_in_text_with_entity_marker": [27, 47], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CBP", "entity_2_idx": [[130, 133]], "entity_2_idx_in_text_with_entity_marker": [143, 146], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d805.s0_BioInfer.d805.s0.p0", "text": "We found normal levels of alpha-catenin and beta-catenin in BT549 and HS578t cells; however, low levels of plakoglobin were expressed in these cells compared to those found in weakly invasive MCF-7 cells.", "text_with_entity_marker": "We found normal levels of [E1]alpha-catenin[/E1] and [E2]beta-catenin[/E2] in BT549 and HS578t cells; however, low levels of plakoglobin were expressed in these cells compared to those found in weakly invasive MCF-7 cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-catenin", "entity_1_idx": [[26, 39]], "entity_1_idx_in_text_with_entity_marker": [30, 43], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[44, 56]], "entity_2_idx_in_text_with_entity_marker": [57, 69], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d805.s0_BioInfer.d805.s0.p1", "text": "We found normal levels of alpha-catenin and beta-catenin in BT549 and HS578t cells; however, low levels of plakoglobin were expressed in these cells compared to those found in weakly invasive MCF-7 cells.", "text_with_entity_marker": "We found normal levels of alpha-catenin and [E1]beta-catenin[/E1] in BT549 and HS578t cells; however, low levels of [E2]plakoglobin[/E2] were expressed in these cells compared to those found in weakly invasive MCF-7 cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "beta-catenin", "entity_1_idx": [[44, 56]], "entity_1_idx_in_text_with_entity_marker": [48, 60], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "plakoglobin", "entity_2_idx": [[107, 118]], "entity_2_idx_in_text_with_entity_marker": [120, 131], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d805.s0_BioInfer.d805.s0.p2", "text": "We found normal levels of alpha-catenin and beta-catenin in BT549 and HS578t cells; however, low levels of plakoglobin were expressed in these cells compared to those found in weakly invasive MCF-7 cells.", "text_with_entity_marker": "We found normal levels of [E1]alpha-catenin[/E1] and beta-catenin in BT549 and HS578t cells; however, low levels of [E2]plakoglobin[/E2] were expressed in these cells compared to those found in weakly invasive MCF-7 cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-catenin", "entity_1_idx": [[26, 39]], "entity_1_idx_in_text_with_entity_marker": [30, 43], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "plakoglobin", "entity_2_idx": [[107, 118]], "entity_2_idx_in_text_with_entity_marker": [120, 131], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p60", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), [E1]nucleocapsid protein[/E1] (NP), phosphoprotein ([E2]P[/E2]) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "nucleocapsid protein", "entity_1_idx": [[69, 89], [130, 138]], "entity_1_idx_in_text_with_entity_marker": [73, 93], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[112, 113]], "entity_2_idx_in_text_with_entity_marker": [125, 126], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p61", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), [E1]nucleocapsid protein[/E1] ([E2]NP[/E2]), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "nucleocapsid protein", "entity_1_idx": [[69, 89], [130, 138]], "entity_1_idx_in_text_with_entity_marker": [73, 93], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "NP", "entity_2_idx": [[91, 93]], "entity_2_idx_in_text_with_entity_marker": [104, 106], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p62", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), [E1]nucleocapsid protein[/E1] (NP), phosphoprotein (P) and matrix ([E2]M[/E2]) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "nucleocapsid protein", "entity_1_idx": [[69, 89], [130, 138]], "entity_1_idx_in_text_with_entity_marker": [73, 93], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "M", "entity_2_idx": [[127, 128]], "entity_2_idx_in_text_with_entity_marker": [140, 141], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p63", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the [E1]H[/E1], F, NP and [E2]P proteins[/E2] of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "H", "entity_1_idx": [[153, 154], [168, 176]], "entity_1_idx_in_text_with_entity_marker": [157, 158], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "P proteins", "entity_2_idx": [[166, 176]], "entity_2_idx_in_text_with_entity_marker": [179, 189], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p64", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), [E1]phosphoprotein[/E1] (P) and matrix (M) proteins of MV and the [E2]H[/E2], F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "phosphoprotein", "entity_1_idx": [[96, 110], [130, 138]], "entity_1_idx_in_text_with_entity_marker": [100, 114], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H", "entity_2_idx": [[153, 154], [168, 176]], "entity_2_idx_in_text_with_entity_marker": [166, 167], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p65", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the [E1]H[/E1], [E2]F[/E2], NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "H", "entity_1_idx": [[153, 154], [168, 176]], "entity_1_idx_in_text_with_entity_marker": [157, 158], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "F", "entity_2_idx": [[156, 157], [168, 176]], "entity_2_idx_in_text_with_entity_marker": [169, 170], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p66", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin ([E1]H[/E1]), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the [E2]H[/E2], F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "H", "entity_1_idx": [[53, 54]], "entity_1_idx_in_text_with_entity_marker": [57, 58], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H", "entity_2_idx": [[153, 154], [168, 176]], "entity_2_idx_in_text_with_entity_marker": [166, 167], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p67", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein ([E1]P[/E1]) and matrix (M) proteins of MV and the [E2]H[/E2], F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "P", "entity_1_idx": [[112, 113]], "entity_1_idx_in_text_with_entity_marker": [116, 117], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H", "entity_2_idx": [[153, 154], [168, 176]], "entity_2_idx_in_text_with_entity_marker": [166, 167], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p68", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein ([E1]NP[/E1]), phosphoprotein (P) and matrix (M) proteins of MV and the [E2]H[/E2], F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "NP", "entity_1_idx": [[91, 93]], "entity_1_idx_in_text_with_entity_marker": [95, 97], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H", "entity_2_idx": [[153, 154], [168, 176]], "entity_2_idx_in_text_with_entity_marker": [166, 167], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p69", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix ([E1]M[/E1]) proteins of MV and the [E2]H[/E2], F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "M", "entity_1_idx": [[127, 128]], "entity_1_idx_in_text_with_entity_marker": [131, 132], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H", "entity_2_idx": [[153, 154], [168, 176]], "entity_2_idx_in_text_with_entity_marker": [166, 167], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s0_BioInfer.d148.s0.p30", "text": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "text_with_entity_marker": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for [E1]Fas[/E1], Fas ligand, [E2]TNF-R1[/E2], TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Fas", "entity_1_idx": [[194, 197]], "entity_1_idx_in_text_with_entity_marker": [198, 201], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "TNF-R1", "entity_2_idx": [[211, 217]], "entity_2_idx_in_text_with_entity_marker": [224, 230], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s0_BioInfer.d148.s0.p31", "text": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "text_with_entity_marker": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, [E1]TNF-R1[/E1], TRAIL, [E2]TRADD[/E2], RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TNF-R1", "entity_1_idx": [[211, 217]], "entity_1_idx_in_text_with_entity_marker": [215, 221], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "TRADD", "entity_2_idx": [[226, 231]], "entity_2_idx_in_text_with_entity_marker": [239, 244], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s0_BioInfer.d148.s0.p32", "text": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "text_with_entity_marker": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, [E1]Fas ligand[/E1], [E2]TNF-R1[/E2], TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Fas ligand", "entity_1_idx": [[199, 209]], "entity_1_idx_in_text_with_entity_marker": [203, 213], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "TNF-R1", "entity_2_idx": [[211, 217]], "entity_2_idx_in_text_with_entity_marker": [224, 230], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s0_BioInfer.d148.s0.p33", "text": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "text_with_entity_marker": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, [E1]TNF-R1[/E1], TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for [E2]FAF[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TNF-R1", "entity_1_idx": [[211, 217]], "entity_1_idx_in_text_with_entity_marker": [215, 221], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "FAF", "entity_2_idx": [[333, 336]], "entity_2_idx_in_text_with_entity_marker": [346, 349], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s0_BioInfer.d148.s0.p34", "text": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "text_with_entity_marker": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, [E1]TNF-R1[/E1], TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for [E2]FADD[/E2] and FAP, but there was little change for FAF.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TNF-R1", "entity_1_idx": [[211, 217]], "entity_1_idx_in_text_with_entity_marker": [215, 221], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "FADD", "entity_2_idx": [[287, 291]], "entity_2_idx_in_text_with_entity_marker": [300, 304], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s0_BioInfer.d148.s0.p35", "text": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "text_with_entity_marker": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for [E1]Fas[/E1], Fas ligand, TNF-R1, TRAIL, [E2]TRADD[/E2], RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Fas", "entity_1_idx": [[194, 197]], "entity_1_idx_in_text_with_entity_marker": [198, 201], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "TRADD", "entity_2_idx": [[226, 231]], "entity_2_idx_in_text_with_entity_marker": [239, 244], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s0_BioInfer.d148.s0.p36", "text": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "text_with_entity_marker": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for [E1]Fas[/E1], [E2]Fas ligand[/E2], TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Fas", "entity_1_idx": [[194, 197]], "entity_1_idx_in_text_with_entity_marker": [198, 201], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Fas ligand", "entity_2_idx": [[199, 209]], "entity_2_idx_in_text_with_entity_marker": [212, 222], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s0_BioInfer.d148.s0.p37", "text": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "text_with_entity_marker": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for [E1]Fas[/E1], Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for [E2]FAF[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Fas", "entity_1_idx": [[194, 197]], "entity_1_idx_in_text_with_entity_marker": [198, 201], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "FAF", "entity_2_idx": [[333, 336]], "entity_2_idx_in_text_with_entity_marker": [346, 349], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s0_BioInfer.d148.s0.p38", "text": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "text_with_entity_marker": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for [E1]Fas[/E1], Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for [E2]FADD[/E2] and FAP, but there was little change for FAF.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Fas", "entity_1_idx": [[194, 197]], "entity_1_idx_in_text_with_entity_marker": [198, 201], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "FADD", "entity_2_idx": [[287, 291]], "entity_2_idx_in_text_with_entity_marker": [300, 304], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s0_BioInfer.d148.s0.p39", "text": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "text_with_entity_marker": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, [E1]Fas ligand[/E1], TNF-R1, TRAIL, [E2]TRADD[/E2], RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Fas ligand", "entity_1_idx": [[199, 209]], "entity_1_idx_in_text_with_entity_marker": [203, 213], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "TRADD", "entity_2_idx": [[226, 231]], "entity_2_idx_in_text_with_entity_marker": [239, 244], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d730.s0_BioInfer.d730.s0.p10", "text": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "text_with_entity_marker": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to [E1]laminin[/E1], but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or [E2]actin[/E2] stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "laminin", "entity_1_idx": [[185, 192]], "entity_1_idx_in_text_with_entity_marker": [189, 196], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[504, 509]], "entity_2_idx_in_text_with_entity_marker": [517, 522], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d730.s0_BioInfer.d730.s0.p11", "text": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "text_with_entity_marker": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a [E1]vinculin[/E1] (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or [E2]actin[/E2] stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "vinculin", "entity_1_idx": [[395, 403]], "entity_1_idx_in_text_with_entity_marker": [399, 407], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[504, 509]], "entity_2_idx_in_text_with_entity_marker": [517, 522], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d730.s0_BioInfer.d730.s0.p12", "text": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "text_with_entity_marker": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas [E1]vinculin[/E1] (-/-) ES cells were able to assemble [E2]talin[/E2]-containing focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "vinculin", "entity_1_idx": [[548, 556]], "entity_1_idx_in_text_with_entity_marker": [552, 560], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "talin", "entity_2_idx": [[594, 599]], "entity_2_idx_in_text_with_entity_marker": [607, 612], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d730.s0_BioInfer.d730.s0.p13", "text": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "text_with_entity_marker": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble [E1]vinculin[/E1] or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble [E2]talin[/E2]-containing focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "vinculin", "entity_1_idx": [[453, 461]], "entity_1_idx_in_text_with_entity_marker": [457, 465], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "talin", "entity_2_idx": [[594, 599]], "entity_2_idx_in_text_with_entity_marker": [607, 612], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d730.s0_BioInfer.d730.s0.p14", "text": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "text_with_entity_marker": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on [E1]fibronectin[/E1], whereas vinculin (-/-) ES cells were able to assemble [E2]talin[/E2]-containing focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "fibronectin", "entity_1_idx": [[527, 538]], "entity_1_idx_in_text_with_entity_marker": [531, 542], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "talin", "entity_2_idx": [[594, 599]], "entity_2_idx_in_text_with_entity_marker": [607, 612], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d730.s0_BioInfer.d730.s0.p15", "text": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "text_with_entity_marker": "The undifferentiated cells (a) were unable to spread on gelatin or [E1]laminin[/E1] and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble [E2]talin[/E2]-containing focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "laminin", "entity_1_idx": [[67, 74]], "entity_1_idx_in_text_with_entity_marker": [71, 78], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "talin", "entity_2_idx": [[594, 599]], "entity_2_idx_in_text_with_entity_marker": [607, 612], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d730.s0_BioInfer.d730.s0.p16", "text": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "text_with_entity_marker": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not [E1]fibronectin[/E1] (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble [E2]talin[/E2]-containing focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "fibronectin", "entity_1_idx": [[202, 213]], "entity_1_idx_in_text_with_entity_marker": [206, 217], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "talin", "entity_2_idx": [[594, 599]], "entity_2_idx_in_text_with_entity_marker": [607, 612], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d730.s0_BioInfer.d730.s0.p17", "text": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "text_with_entity_marker": "The undifferentiated cells (a) were unable to spread on [E1]gelatin[/E1] or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble [E2]talin[/E2]-containing focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "gelatin", "entity_1_idx": [[56, 63]], "entity_1_idx_in_text_with_entity_marker": [60, 67], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "talin", "entity_2_idx": [[594, 599]], "entity_2_idx_in_text_with_entity_marker": [607, 612], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d730.s0_BioInfer.d730.s0.p18", "text": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "text_with_entity_marker": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on [E1]fibronectin[/E1] (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble [E2]talin[/E2]-containing focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "fibronectin", "entity_1_idx": [[142, 153]], "entity_1_idx_in_text_with_entity_marker": [146, 157], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "talin", "entity_2_idx": [[594, 599]], "entity_2_idx_in_text_with_entity_marker": [607, 612], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d730.s0_BioInfer.d730.s0.p19", "text": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "text_with_entity_marker": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of [E1]beta1 integrin[/E1], although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble [E2]talin[/E2]-containing focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "beta1 integrin", "entity_1_idx": [[251, 265]], "entity_1_idx_in_text_with_entity_marker": [255, 269], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "talin", "entity_2_idx": [[594, 599]], "entity_2_idx_in_text_with_entity_marker": [607, 612], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d411.s0_BioInfer.d411.s0.p0", "text": "Mammalian homologues of two important yeast genes involved in DNA double-strand break repair and recombination, RAD51 and RAD54, have been isolated.", "text_with_entity_marker": "Mammalian homologues of two important yeast genes involved in DNA double-strand break repair and recombination, [E1]RAD51[/E1] and [E2]RAD54[/E2], have been isolated.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD51", "entity_1_idx": [[112, 117]], "entity_1_idx_in_text_with_entity_marker": [116, 121], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD54", "entity_2_idx": [[122, 127]], "entity_2_idx_in_text_with_entity_marker": [135, 140], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d25.s0_BioInfer.d25.s0.p20", "text": "Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, beta-catenin, plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.", "text_with_entity_marker": "Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, [E1]beta-catenin[/E1], plakoglobin, and [E2]actin[/E2]) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "beta-catenin", "entity_1_idx": [[67, 79]], "entity_1_idx_in_text_with_entity_marker": [71, 83], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[98, 103]], "entity_2_idx_in_text_with_entity_marker": [111, 116], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d691.s0_BioInfer.d691.s0.p0", "text": "The same steady state concentrations of polymerized and nonpolymerized actin are reached whether profilin is added before initiation of polymerization or after polymerization is complete.", "text_with_entity_marker": "The same steady state concentrations of polymerized and nonpolymerized [E1]actin[/E1] are reached whether [E2]profilin[/E2] is added before initiation of polymerization or after polymerization is complete.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[71, 76]], "entity_1_idx_in_text_with_entity_marker": [75, 80], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilin", "entity_2_idx": [[97, 105]], "entity_2_idx_in_text_with_entity_marker": [110, 118], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d483.s0_BioInfer.d483.s0.p20", "text": "PDGF treatment had no effect on talin, vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor (EGF), 30 ng/ml somatomedin C, or 10 microM insulin also had no effect on vinculin or actin distribution.", "text_with_entity_marker": "PDGF treatment had no effect on [E1]talin[/E1], vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml [E2]epidermal growth factor[/E2] (EGF), 30 ng/ml somatomedin C, or 10 microM insulin also had no effect on vinculin or actin distribution.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "talin", "entity_1_idx": [[32, 37]], "entity_1_idx_in_text_with_entity_marker": [36, 41], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "epidermal growth factor", "entity_2_idx": [[182, 205]], "entity_2_idx_in_text_with_entity_marker": [195, 218], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d483.s0_BioInfer.d483.s0.p21", "text": "PDGF treatment had no effect on talin, vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor (EGF), 30 ng/ml somatomedin C, or 10 microM insulin also had no effect on vinculin or actin distribution.", "text_with_entity_marker": "PDGF treatment had no effect on talin, vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor (EGF), 30 ng/ml somatomedin C, or 10 microM [E1]insulin[/E1] also had no effect on vinculin or [E2]actin[/E2] distribution.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "insulin", "entity_1_idx": [[250, 257]], "entity_1_idx_in_text_with_entity_marker": [254, 261], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[292, 297]], "entity_2_idx_in_text_with_entity_marker": [305, 310], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d483.s0_BioInfer.d483.s0.p22", "text": "PDGF treatment had no effect on talin, vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor (EGF), 30 ng/ml somatomedin C, or 10 microM insulin also had no effect on vinculin or actin distribution.", "text_with_entity_marker": "PDGF treatment had no effect on talin, vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor (EGF), 30 ng/ml [E1]somatomedin C[/E1], or 10 microM insulin also had no effect on vinculin or [E2]actin[/E2] distribution.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "somatomedin C", "entity_1_idx": [[222, 235]], "entity_1_idx_in_text_with_entity_marker": [226, 239], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[292, 297]], "entity_2_idx_in_text_with_entity_marker": [305, 310], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d483.s0_BioInfer.d483.s0.p23", "text": "PDGF treatment had no effect on talin, vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor (EGF), 30 ng/ml somatomedin C, or 10 microM insulin also had no effect on vinculin or actin distribution.", "text_with_entity_marker": "PDGF treatment had no effect on talin, vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor ([E1]EGF[/E1]), 30 ng/ml somatomedin C, or 10 microM insulin also had no effect on vinculin or [E2]actin[/E2] distribution.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "EGF", "entity_1_idx": [[207, 210]], "entity_1_idx_in_text_with_entity_marker": [211, 214], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[292, 297]], "entity_2_idx_in_text_with_entity_marker": [305, 310], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d483.s0_BioInfer.d483.s0.p24", "text": "PDGF treatment had no effect on talin, vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor (EGF), 30 ng/ml somatomedin C, or 10 microM insulin also had no effect on vinculin or actin distribution.", "text_with_entity_marker": "[E1]PDGF[/E1] treatment had no effect on talin, vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor (EGF), 30 ng/ml somatomedin C, or 10 microM insulin also had no effect on vinculin or [E2]actin[/E2] distribution.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "PDGF", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[292, 297]], "entity_2_idx_in_text_with_entity_marker": [305, 310], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d483.s0_BioInfer.d483.s0.p25", "text": "PDGF treatment had no effect on talin, vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor (EGF), 30 ng/ml somatomedin C, or 10 microM insulin also had no effect on vinculin or actin distribution.", "text_with_entity_marker": "PDGF treatment had no effect on talin, vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml [E1]epidermal growth factor[/E1] (EGF), 30 ng/ml somatomedin C, or 10 microM insulin also had no effect on vinculin or [E2]actin[/E2] distribution.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "epidermal growth factor", "entity_1_idx": [[182, 205]], "entity_1_idx_in_text_with_entity_marker": [186, 209], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[292, 297]], "entity_2_idx_in_text_with_entity_marker": [305, 310], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d483.s0_BioInfer.d483.s0.p26", "text": "PDGF treatment had no effect on talin, vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor (EGF), 30 ng/ml somatomedin C, or 10 microM insulin also had no effect on vinculin or actin distribution.", "text_with_entity_marker": "PDGF treatment had no effect on talin, vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor (EGF), 30 ng/ml [E1]somatomedin C[/E1], or 10 microM [E2]insulin[/E2] also had no effect on vinculin or actin distribution.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "somatomedin C", "entity_1_idx": [[222, 235]], "entity_1_idx_in_text_with_entity_marker": [226, 239], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[250, 257]], "entity_2_idx_in_text_with_entity_marker": [263, 270], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d483.s0_BioInfer.d483.s0.p27", "text": "PDGF treatment had no effect on talin, vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor (EGF), 30 ng/ml somatomedin C, or 10 microM insulin also had no effect on vinculin or actin distribution.", "text_with_entity_marker": "PDGF treatment had no effect on talin, vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor ([E1]EGF[/E1]), 30 ng/ml somatomedin C, or 10 microM [E2]insulin[/E2] also had no effect on vinculin or actin distribution.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "EGF", "entity_1_idx": [[207, 210]], "entity_1_idx_in_text_with_entity_marker": [211, 214], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[250, 257]], "entity_2_idx_in_text_with_entity_marker": [263, 270], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d483.s0_BioInfer.d483.s0.p28", "text": "PDGF treatment had no effect on talin, vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor (EGF), 30 ng/ml somatomedin C, or 10 microM insulin also had no effect on vinculin or actin distribution.", "text_with_entity_marker": "[E1]PDGF[/E1] treatment had no effect on talin, vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor (EGF), 30 ng/ml somatomedin C, or 10 microM [E2]insulin[/E2] also had no effect on vinculin or actin distribution.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "PDGF", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[250, 257]], "entity_2_idx_in_text_with_entity_marker": [263, 270], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d483.s0_BioInfer.d483.s0.p29", "text": "PDGF treatment had no effect on talin, vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor (EGF), 30 ng/ml somatomedin C, or 10 microM insulin also had no effect on vinculin or actin distribution.", "text_with_entity_marker": "PDGF treatment had no effect on talin, vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml [E1]epidermal growth factor[/E1] (EGF), 30 ng/ml somatomedin C, or 10 microM [E2]insulin[/E2] also had no effect on vinculin or actin distribution.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "epidermal growth factor", "entity_1_idx": [[182, 205]], "entity_1_idx_in_text_with_entity_marker": [186, 209], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[250, 257]], "entity_2_idx_in_text_with_entity_marker": [263, 270], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d371.s0_BioInfer.d371.s0.p0", "text": "In the present work we have used profilin and DNAse I injections, as well as latrunculin B and cytochalasin D treatments, under quantitatively controlled conditions, to perturb actin microfilament structure and assembly in an attempt to answer this question.", "text_with_entity_marker": "In the present work we have used [E1]profilin[/E1] and DNAse I injections, as well as latrunculin B and cytochalasin D treatments, under quantitatively controlled conditions, to perturb [E2]actin[/E2] microfilament structure and assembly in an attempt to answer this question.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "profilin", "entity_1_idx": [[33, 41]], "entity_1_idx_in_text_with_entity_marker": [37, 45], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[177, 182]], "entity_2_idx_in_text_with_entity_marker": [190, 195], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d371.s0_BioInfer.d371.s0.p1", "text": "In the present work we have used profilin and DNAse I injections, as well as latrunculin B and cytochalasin D treatments, under quantitatively controlled conditions, to perturb actin microfilament structure and assembly in an attempt to answer this question.", "text_with_entity_marker": "In the present work we have used [E1]profilin[/E1] and [E2]DNAse I[/E2] injections, as well as latrunculin B and cytochalasin D treatments, under quantitatively controlled conditions, to perturb actin microfilament structure and assembly in an attempt to answer this question.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "profilin", "entity_1_idx": [[33, 41]], "entity_1_idx_in_text_with_entity_marker": [37, 45], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "DNAse I", "entity_2_idx": [[46, 53]], "entity_2_idx_in_text_with_entity_marker": [59, 66], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d371.s0_BioInfer.d371.s0.p2", "text": "In the present work we have used profilin and DNAse I injections, as well as latrunculin B and cytochalasin D treatments, under quantitatively controlled conditions, to perturb actin microfilament structure and assembly in an attempt to answer this question.", "text_with_entity_marker": "In the present work we have used profilin and [E1]DNAse I[/E1] injections, as well as latrunculin B and cytochalasin D treatments, under quantitatively controlled conditions, to perturb [E2]actin[/E2] microfilament structure and assembly in an attempt to answer this question.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "DNAse I", "entity_1_idx": [[46, 53]], "entity_1_idx_in_text_with_entity_marker": [50, 57], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[177, 182]], "entity_2_idx_in_text_with_entity_marker": [190, 195], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d287.s0_BioInfer.d287.s0.p0", "text": "Immunocytochemical localisation of actin and profilin in the generative cell of angiosperm pollen: TEM studies on high-pressure frozen and freeze-substituted Ledebouria socialis Roth (Hyacinthaceae).", "text_with_entity_marker": "Immunocytochemical localisation of [E1]actin[/E1] and [E2]profilin[/E2] in the generative cell of angiosperm pollen: TEM studies on high-pressure frozen and freeze-substituted Ledebouria socialis Roth (Hyacinthaceae).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[35, 40]], "entity_1_idx_in_text_with_entity_marker": [39, 44], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilin", "entity_2_idx": [[45, 53]], "entity_2_idx_in_text_with_entity_marker": [58, 66], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d287.s1_BioInfer.d287.s1.p0", "text": "We attribute the detection of actin and profilin to the applied cryomethods which yield a much better preservation of ultrastructure and antigenicity of delicate cytoskeletal constituents than conventional fixation techniques.", "text_with_entity_marker": "We attribute the detection of [E1]actin[/E1] and [E2]profilin[/E2] to the applied cryomethods which yield a much better preservation of ultrastructure and antigenicity of delicate cytoskeletal constituents than conventional fixation techniques.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[30, 35]], "entity_1_idx_in_text_with_entity_marker": [34, 39], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilin", "entity_2_idx": [[40, 48]], "entity_2_idx_in_text_with_entity_marker": [53, 61], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d454.s0_BioInfer.d454.s0.p0", "text": "No significant changes in glomerular vinculin, talin, beta 1-integrin, or total actin expression occurred at any time point during disease development.", "text_with_entity_marker": "No significant changes in glomerular [E1]vinculin[/E1], talin, [E2]beta 1-integrin[/E2], or total actin expression occurred at any time point during disease development.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "vinculin", "entity_1_idx": [[37, 45]], "entity_1_idx_in_text_with_entity_marker": [41, 49], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta 1-integrin", "entity_2_idx": [[54, 69]], "entity_2_idx_in_text_with_entity_marker": [67, 82], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d454.s0_BioInfer.d454.s0.p1", "text": "No significant changes in glomerular vinculin, talin, beta 1-integrin, or total actin expression occurred at any time point during disease development.", "text_with_entity_marker": "No significant changes in glomerular vinculin, talin, [E1]beta 1-integrin[/E1], or total [E2]actin[/E2] expression occurred at any time point during disease development.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "beta 1-integrin", "entity_1_idx": [[54, 69]], "entity_1_idx_in_text_with_entity_marker": [58, 73], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[80, 85]], "entity_2_idx_in_text_with_entity_marker": [93, 98], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d454.s0_BioInfer.d454.s0.p2", "text": "No significant changes in glomerular vinculin, talin, beta 1-integrin, or total actin expression occurred at any time point during disease development.", "text_with_entity_marker": "No significant changes in glomerular vinculin, [E1]talin[/E1], [E2]beta 1-integrin[/E2], or total actin expression occurred at any time point during disease development.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "talin", "entity_1_idx": [[47, 52]], "entity_1_idx_in_text_with_entity_marker": [51, 56], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta 1-integrin", "entity_2_idx": [[54, 69]], "entity_2_idx_in_text_with_entity_marker": [67, 82], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d454.s0_BioInfer.d454.s0.p3", "text": "No significant changes in glomerular vinculin, talin, beta 1-integrin, or total actin expression occurred at any time point during disease development.", "text_with_entity_marker": "No significant changes in glomerular [E1]vinculin[/E1], talin, beta 1-integrin, or total [E2]actin[/E2] expression occurred at any time point during disease development.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "vinculin", "entity_1_idx": [[37, 45]], "entity_1_idx_in_text_with_entity_marker": [41, 49], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[80, 85]], "entity_2_idx_in_text_with_entity_marker": [93, 98], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d454.s0_BioInfer.d454.s0.p4", "text": "No significant changes in glomerular vinculin, talin, beta 1-integrin, or total actin expression occurred at any time point during disease development.", "text_with_entity_marker": "No significant changes in glomerular [E1]vinculin[/E1], [E2]talin[/E2], beta 1-integrin, or total actin expression occurred at any time point during disease development.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "vinculin", "entity_1_idx": [[37, 45]], "entity_1_idx_in_text_with_entity_marker": [41, 49], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "talin", "entity_2_idx": [[47, 52]], "entity_2_idx_in_text_with_entity_marker": [60, 65], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d454.s0_BioInfer.d454.s0.p5", "text": "No significant changes in glomerular vinculin, talin, beta 1-integrin, or total actin expression occurred at any time point during disease development.", "text_with_entity_marker": "No significant changes in glomerular vinculin, [E1]talin[/E1], beta 1-integrin, or total [E2]actin[/E2] expression occurred at any time point during disease development.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "talin", "entity_1_idx": [[47, 52]], "entity_1_idx_in_text_with_entity_marker": [51, 56], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[80, 85]], "entity_2_idx_in_text_with_entity_marker": [93, 98], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s0_BioInfer.d296.s0.p0", "text": "Immunolocalization of E-cadherin (E-cad), alpha-catenin, beta-catenin, and CD44 has rarely been investigated in human cholangiocarcinoma (CC).", "text_with_entity_marker": "Immunolocalization of [E1]E-cadherin[/E1] (E-cad), alpha-catenin, [E2]beta-catenin[/E2], and CD44 has rarely been investigated in human cholangiocarcinoma (CC).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E-cadherin", "entity_1_idx": [[22, 32]], "entity_1_idx_in_text_with_entity_marker": [26, 36], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[57, 69]], "entity_2_idx_in_text_with_entity_marker": [70, 82], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s0_BioInfer.d296.s0.p1", "text": "Immunolocalization of E-cadherin (E-cad), alpha-catenin, beta-catenin, and CD44 has rarely been investigated in human cholangiocarcinoma (CC).", "text_with_entity_marker": "Immunolocalization of E-cadherin ([E1]E-cad[/E1]), alpha-catenin, [E2]beta-catenin[/E2], and CD44 has rarely been investigated in human cholangiocarcinoma (CC).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E-cad", "entity_1_idx": [[34, 39]], "entity_1_idx_in_text_with_entity_marker": [38, 43], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[57, 69]], "entity_2_idx_in_text_with_entity_marker": [70, 82], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s0_BioInfer.d296.s0.p2", "text": "Immunolocalization of E-cadherin (E-cad), alpha-catenin, beta-catenin, and CD44 has rarely been investigated in human cholangiocarcinoma (CC).", "text_with_entity_marker": "Immunolocalization of E-cadherin (E-cad), [E1]alpha-catenin[/E1], [E2]beta-catenin[/E2], and CD44 has rarely been investigated in human cholangiocarcinoma (CC).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-catenin", "entity_1_idx": [[42, 55]], "entity_1_idx_in_text_with_entity_marker": [46, 59], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[57, 69]], "entity_2_idx_in_text_with_entity_marker": [70, 82], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s0_BioInfer.d296.s0.p3", "text": "Immunolocalization of E-cadherin (E-cad), alpha-catenin, beta-catenin, and CD44 has rarely been investigated in human cholangiocarcinoma (CC).", "text_with_entity_marker": "Immunolocalization of E-cadherin (E-cad), alpha-catenin, [E1]beta-catenin[/E1], and [E2]CD44[/E2] has rarely been investigated in human cholangiocarcinoma (CC).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "beta-catenin", "entity_1_idx": [[57, 69]], "entity_1_idx_in_text_with_entity_marker": [61, 73], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "CD44", "entity_2_idx": [[75, 79]], "entity_2_idx_in_text_with_entity_marker": [88, 92], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s0_BioInfer.d296.s0.p4", "text": "Immunolocalization of E-cadherin (E-cad), alpha-catenin, beta-catenin, and CD44 has rarely been investigated in human cholangiocarcinoma (CC).", "text_with_entity_marker": "Immunolocalization of [E1]E-cadherin[/E1] ([E2]E-cad[/E2]), alpha-catenin, beta-catenin, and CD44 has rarely been investigated in human cholangiocarcinoma (CC).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E-cadherin", "entity_1_idx": [[22, 32]], "entity_1_idx_in_text_with_entity_marker": [26, 36], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E-cad", "entity_2_idx": [[34, 39]], "entity_2_idx_in_text_with_entity_marker": [47, 52], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s0_BioInfer.d296.s0.p5", "text": "Immunolocalization of E-cadherin (E-cad), alpha-catenin, beta-catenin, and CD44 has rarely been investigated in human cholangiocarcinoma (CC).", "text_with_entity_marker": "Immunolocalization of [E1]E-cadherin[/E1] (E-cad), [E2]alpha-catenin[/E2], beta-catenin, and CD44 has rarely been investigated in human cholangiocarcinoma (CC).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E-cadherin", "entity_1_idx": [[22, 32]], "entity_1_idx_in_text_with_entity_marker": [26, 36], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[42, 55]], "entity_2_idx_in_text_with_entity_marker": [55, 68], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s0_BioInfer.d296.s0.p6", "text": "Immunolocalization of E-cadherin (E-cad), alpha-catenin, beta-catenin, and CD44 has rarely been investigated in human cholangiocarcinoma (CC).", "text_with_entity_marker": "Immunolocalization of [E1]E-cadherin[/E1] (E-cad), alpha-catenin, beta-catenin, and [E2]CD44[/E2] has rarely been investigated in human cholangiocarcinoma (CC).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E-cadherin", "entity_1_idx": [[22, 32]], "entity_1_idx_in_text_with_entity_marker": [26, 36], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CD44", "entity_2_idx": [[75, 79]], "entity_2_idx_in_text_with_entity_marker": [88, 92], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s0_BioInfer.d296.s0.p7", "text": "Immunolocalization of E-cadherin (E-cad), alpha-catenin, beta-catenin, and CD44 has rarely been investigated in human cholangiocarcinoma (CC).", "text_with_entity_marker": "Immunolocalization of E-cadherin ([E1]E-cad[/E1]), [E2]alpha-catenin[/E2], beta-catenin, and CD44 has rarely been investigated in human cholangiocarcinoma (CC).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E-cad", "entity_1_idx": [[34, 39]], "entity_1_idx_in_text_with_entity_marker": [38, 43], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[42, 55]], "entity_2_idx_in_text_with_entity_marker": [55, 68], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s0_BioInfer.d296.s0.p8", "text": "Immunolocalization of E-cadherin (E-cad), alpha-catenin, beta-catenin, and CD44 has rarely been investigated in human cholangiocarcinoma (CC).", "text_with_entity_marker": "Immunolocalization of E-cadherin ([E1]E-cad[/E1]), alpha-catenin, beta-catenin, and [E2]CD44[/E2] has rarely been investigated in human cholangiocarcinoma (CC).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E-cad", "entity_1_idx": [[34, 39]], "entity_1_idx_in_text_with_entity_marker": [38, 43], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CD44", "entity_2_idx": [[75, 79]], "entity_2_idx_in_text_with_entity_marker": [88, 92], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s0_BioInfer.d296.s0.p9", "text": "Immunolocalization of E-cadherin (E-cad), alpha-catenin, beta-catenin, and CD44 has rarely been investigated in human cholangiocarcinoma (CC).", "text_with_entity_marker": "Immunolocalization of E-cadherin (E-cad), [E1]alpha-catenin[/E1], beta-catenin, and [E2]CD44[/E2] has rarely been investigated in human cholangiocarcinoma (CC).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-catenin", "entity_1_idx": [[42, 55]], "entity_1_idx_in_text_with_entity_marker": [46, 59], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "CD44", "entity_2_idx": [[75, 79]], "entity_2_idx_in_text_with_entity_marker": [88, 92], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s1_BioInfer.d296.s1.p0", "text": "In CC, membranous expression of E-cad, alpha-catenin, and beta-catenin was the same or reduced when compared with non-cancerous bile ducts in the majority of CC.", "text_with_entity_marker": "In CC, membranous expression of [E1]E-cad[/E1], alpha-catenin, and [E2]beta-catenin[/E2] was the same or reduced when compared with non-cancerous bile ducts in the majority of CC.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E-cad", "entity_1_idx": [[32, 37]], "entity_1_idx_in_text_with_entity_marker": [36, 41], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[58, 70]], "entity_2_idx_in_text_with_entity_marker": [71, 83], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s1_BioInfer.d296.s1.p1", "text": "In CC, membranous expression of E-cad, alpha-catenin, and beta-catenin was the same or reduced when compared with non-cancerous bile ducts in the majority of CC.", "text_with_entity_marker": "In CC, membranous expression of [E1]E-cad[/E1], [E2]alpha-catenin[/E2], and beta-catenin was the same or reduced when compared with non-cancerous bile ducts in the majority of CC.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E-cad", "entity_1_idx": [[32, 37]], "entity_1_idx_in_text_with_entity_marker": [36, 41], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[39, 52]], "entity_2_idx_in_text_with_entity_marker": [52, 65], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s1_BioInfer.d296.s1.p2", "text": "In CC, membranous expression of E-cad, alpha-catenin, and beta-catenin was the same or reduced when compared with non-cancerous bile ducts in the majority of CC.", "text_with_entity_marker": "In CC, membranous expression of E-cad, [E1]alpha-catenin[/E1], and [E2]beta-catenin[/E2] was the same or reduced when compared with non-cancerous bile ducts in the majority of CC.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-catenin", "entity_1_idx": [[39, 52]], "entity_1_idx_in_text_with_entity_marker": [43, 56], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[58, 70]], "entity_2_idx_in_text_with_entity_marker": [71, 83], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d662.s0_BioInfer.d662.s0.p0", "text": "The posttranslational metabolism of myosin heavy chain (MHC) and actin was regulated in parallel with the total contractile protein pool.", "text_with_entity_marker": "The posttranslational metabolism of [E1]myosin heavy chain[/E1] ([E2]MHC[/E2]) and actin was regulated in parallel with the total contractile protein pool.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin heavy chain", "entity_1_idx": [[36, 54]], "entity_1_idx_in_text_with_entity_marker": [40, 58], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "MHC", "entity_2_idx": [[56, 59]], "entity_2_idx_in_text_with_entity_marker": [69, 72], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d662.s0_BioInfer.d662.s0.p1", "text": "The posttranslational metabolism of myosin heavy chain (MHC) and actin was regulated in parallel with the total contractile protein pool.", "text_with_entity_marker": "The posttranslational metabolism of [E1]myosin heavy chain[/E1] (MHC) and [E2]actin[/E2] was regulated in parallel with the total contractile protein pool.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin heavy chain", "entity_1_idx": [[36, 54]], "entity_1_idx_in_text_with_entity_marker": [40, 58], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[65, 70]], "entity_2_idx_in_text_with_entity_marker": [78, 83], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d662.s0_BioInfer.d662.s0.p2", "text": "The posttranslational metabolism of myosin heavy chain (MHC) and actin was regulated in parallel with the total contractile protein pool.", "text_with_entity_marker": "The posttranslational metabolism of myosin heavy chain ([E1]MHC[/E1]) and [E2]actin[/E2] was regulated in parallel with the total contractile protein pool.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MHC", "entity_1_idx": [[56, 59]], "entity_1_idx_in_text_with_entity_marker": [60, 63], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[65, 70]], "entity_2_idx_in_text_with_entity_marker": [78, 83], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d295.s0_BioInfer.d295.s0.p0", "text": "Immunohistochemistry revealed that arteries had three distinct populations of cells in respect to alpha-smooth muscle actin, smooth muscle myosin heavy chain and vimentin (staining intensities '-', '+' or '++' for each protein), but only two populations in respect to desmin ('-' and '+').", "text_with_entity_marker": "Immunohistochemistry revealed that arteries had three distinct populations of cells in respect to [E1]alpha-smooth muscle actin[/E1], smooth muscle myosin heavy chain and [E2]vimentin[/E2] (staining intensities '-', '+' or '++' for each protein), but only two populations in respect to desmin ('-' and '+').", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-smooth muscle actin", "entity_1_idx": [[98, 123]], "entity_1_idx_in_text_with_entity_marker": [102, 127], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "vimentin", "entity_2_idx": [[162, 170]], "entity_2_idx_in_text_with_entity_marker": [175, 183], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d295.s0_BioInfer.d295.s0.p1", "text": "Immunohistochemistry revealed that arteries had three distinct populations of cells in respect to alpha-smooth muscle actin, smooth muscle myosin heavy chain and vimentin (staining intensities '-', '+' or '++' for each protein), but only two populations in respect to desmin ('-' and '+').", "text_with_entity_marker": "Immunohistochemistry revealed that arteries had three distinct populations of cells in respect to [E1]alpha-smooth muscle actin[/E1], [E2]smooth muscle myosin heavy chain[/E2] and vimentin (staining intensities '-', '+' or '++' for each protein), but only two populations in respect to desmin ('-' and '+').", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-smooth muscle actin", "entity_1_idx": [[98, 123]], "entity_1_idx_in_text_with_entity_marker": [102, 127], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "smooth muscle myosin heavy chain", "entity_2_idx": [[125, 157]], "entity_2_idx_in_text_with_entity_marker": [138, 170], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d295.s0_BioInfer.d295.s0.p2", "text": "Immunohistochemistry revealed that arteries had three distinct populations of cells in respect to alpha-smooth muscle actin, smooth muscle myosin heavy chain and vimentin (staining intensities '-', '+' or '++' for each protein), but only two populations in respect to desmin ('-' and '+').", "text_with_entity_marker": "Immunohistochemistry revealed that arteries had three distinct populations of cells in respect to [E1]alpha-smooth muscle actin[/E1], smooth muscle myosin heavy chain and vimentin (staining intensities '-', '+' or '++' for each protein), but only two populations in respect to [E2]desmin[/E2] ('-' and '+').", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-smooth muscle actin", "entity_1_idx": [[98, 123]], "entity_1_idx_in_text_with_entity_marker": [102, 127], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "desmin", "entity_2_idx": [[268, 274]], "entity_2_idx_in_text_with_entity_marker": [281, 287], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d295.s0_BioInfer.d295.s0.p3", "text": "Immunohistochemistry revealed that arteries had three distinct populations of cells in respect to alpha-smooth muscle actin, smooth muscle myosin heavy chain and vimentin (staining intensities '-', '+' or '++' for each protein), but only two populations in respect to desmin ('-' and '+').", "text_with_entity_marker": "Immunohistochemistry revealed that arteries had three distinct populations of cells in respect to alpha-smooth muscle actin, [E1]smooth muscle myosin heavy chain[/E1] and [E2]vimentin[/E2] (staining intensities '-', '+' or '++' for each protein), but only two populations in respect to desmin ('-' and '+').", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "smooth muscle myosin heavy chain", "entity_1_idx": [[125, 157]], "entity_1_idx_in_text_with_entity_marker": [129, 161], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "vimentin", "entity_2_idx": [[162, 170]], "entity_2_idx_in_text_with_entity_marker": [175, 183], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d295.s0_BioInfer.d295.s0.p4", "text": "Immunohistochemistry revealed that arteries had three distinct populations of cells in respect to alpha-smooth muscle actin, smooth muscle myosin heavy chain and vimentin (staining intensities '-', '+' or '++' for each protein), but only two populations in respect to desmin ('-' and '+').", "text_with_entity_marker": "Immunohistochemistry revealed that arteries had three distinct populations of cells in respect to alpha-smooth muscle actin, smooth muscle myosin heavy chain and [E1]vimentin[/E1] (staining intensities '-', '+' or '++' for each protein), but only two populations in respect to [E2]desmin[/E2] ('-' and '+').", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "vimentin", "entity_1_idx": [[162, 170]], "entity_1_idx_in_text_with_entity_marker": [166, 174], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "desmin", "entity_2_idx": [[268, 274]], "entity_2_idx_in_text_with_entity_marker": [281, 287], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d295.s0_BioInfer.d295.s0.p5", "text": "Immunohistochemistry revealed that arteries had three distinct populations of cells in respect to alpha-smooth muscle actin, smooth muscle myosin heavy chain and vimentin (staining intensities '-', '+' or '++' for each protein), but only two populations in respect to desmin ('-' and '+').", "text_with_entity_marker": "Immunohistochemistry revealed that arteries had three distinct populations of cells in respect to alpha-smooth muscle actin, [E1]smooth muscle myosin heavy chain[/E1] and vimentin (staining intensities '-', '+' or '++' for each protein), but only two populations in respect to [E2]desmin[/E2] ('-' and '+').", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "smooth muscle myosin heavy chain", "entity_1_idx": [[125, 157]], "entity_1_idx_in_text_with_entity_marker": [129, 161], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "desmin", "entity_2_idx": [[268, 274]], "entity_2_idx_in_text_with_entity_marker": [281, 287], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d87.s1_BioInfer.d87.s1.p0", "text": "However, the recombinant fusion protein containing wild-type beta-catenin precipitated alpha-catenin from these cells.", "text_with_entity_marker": "However, the recombinant fusion protein containing wild-type [E1]beta-catenin[/E1] precipitated [E2]alpha-catenin[/E2] from these cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "beta-catenin", "entity_1_idx": [[61, 73]], "entity_1_idx_in_text_with_entity_marker": [65, 77], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[87, 100]], "entity_2_idx_in_text_with_entity_marker": [100, 113], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d794.s0_BioInfer.d794.s0.p0", "text": "Vimentin and actin were also up-regulated, whereas an isoform of myosin heavy chain was down-regulated.", "text_with_entity_marker": "[E1]Vimentin[/E1] and actin were also up-regulated, whereas an isoform of [E2]myosin heavy chain[/E2] was down-regulated.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Vimentin", "entity_1_idx": [[0, 8]], "entity_1_idx_in_text_with_entity_marker": [4, 12], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin heavy chain", "entity_2_idx": [[65, 83]], "entity_2_idx_in_text_with_entity_marker": [78, 96], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d794.s0_BioInfer.d794.s0.p1", "text": "Vimentin and actin were also up-regulated, whereas an isoform of myosin heavy chain was down-regulated.", "text_with_entity_marker": "Vimentin and [E1]actin[/E1] were also up-regulated, whereas an isoform of [E2]myosin heavy chain[/E2] was down-regulated.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[13, 18]], "entity_1_idx_in_text_with_entity_marker": [17, 22], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin heavy chain", "entity_2_idx": [[65, 83]], "entity_2_idx_in_text_with_entity_marker": [78, 96], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d794.s0_BioInfer.d794.s0.p2", "text": "Vimentin and actin were also up-regulated, whereas an isoform of myosin heavy chain was down-regulated.", "text_with_entity_marker": "[E1]Vimentin[/E1] and [E2]actin[/E2] were also up-regulated, whereas an isoform of myosin heavy chain was down-regulated.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Vimentin", "entity_1_idx": [[0, 8]], "entity_1_idx_in_text_with_entity_marker": [4, 12], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[13, 18]], "entity_2_idx_in_text_with_entity_marker": [26, 31], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d410.s0_BioInfer.d410.s0.p0", "text": "Loss of memberanous expression of E-cadherin, alpha-catenin and beta-catenin was demonstrated in 52%, 85% and 40% of tumours respectively.", "text_with_entity_marker": "Loss of memberanous expression of [E1]E-cadherin[/E1], alpha-catenin and [E2]beta-catenin[/E2] was demonstrated in 52%, 85% and 40% of tumours respectively.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E-cadherin", "entity_1_idx": [[34, 44]], "entity_1_idx_in_text_with_entity_marker": [38, 48], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[64, 76]], "entity_2_idx_in_text_with_entity_marker": [77, 89], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d410.s0_BioInfer.d410.s0.p1", "text": "Loss of memberanous expression of E-cadherin, alpha-catenin and beta-catenin was demonstrated in 52%, 85% and 40% of tumours respectively.", "text_with_entity_marker": "Loss of memberanous expression of [E1]E-cadherin[/E1], [E2]alpha-catenin[/E2] and beta-catenin was demonstrated in 52%, 85% and 40% of tumours respectively.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E-cadherin", "entity_1_idx": [[34, 44]], "entity_1_idx_in_text_with_entity_marker": [38, 48], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[46, 59]], "entity_2_idx_in_text_with_entity_marker": [59, 72], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d410.s0_BioInfer.d410.s0.p2", "text": "Loss of memberanous expression of E-cadherin, alpha-catenin and beta-catenin was demonstrated in 52%, 85% and 40% of tumours respectively.", "text_with_entity_marker": "Loss of memberanous expression of E-cadherin, [E1]alpha-catenin[/E1] and [E2]beta-catenin[/E2] was demonstrated in 52%, 85% and 40% of tumours respectively.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-catenin", "entity_1_idx": [[46, 59]], "entity_1_idx_in_text_with_entity_marker": [50, 63], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[64, 76]], "entity_2_idx_in_text_with_entity_marker": [77, 89], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d410.s1_BioInfer.d410.s1.p0", "text": "There was a trend towards an association between advanced tumour stage and loss of membranous expression of alpha-catenin or beta-catenin, although these associations were not statistically significant.", "text_with_entity_marker": "There was a trend towards an association between advanced tumour stage and loss of membranous expression of [E1]alpha-catenin[/E1] or [E2]beta-catenin[/E2], although these associations were not statistically significant.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-catenin", "entity_1_idx": [[108, 121]], "entity_1_idx_in_text_with_entity_marker": [112, 125], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[125, 137]], "entity_2_idx_in_text_with_entity_marker": [138, 150], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d484.s0_BioInfer.d484.s0.p0", "text": "Pervanadate caused a dramatic augmentation of the phosphorylation of E-cadherin, beta-catenin, and gamma-catenin (plakoglobin), but alpha-catenin was not detectably phosphorylated.", "text_with_entity_marker": "Pervanadate caused a dramatic augmentation of the phosphorylation of [E1]E-cadherin[/E1], beta-catenin, and [E2]gamma-catenin[/E2] (plakoglobin), but alpha-catenin was not detectably phosphorylated.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E-cadherin", "entity_1_idx": [[69, 79]], "entity_1_idx_in_text_with_entity_marker": [73, 83], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "gamma-catenin", "entity_2_idx": [[99, 112]], "entity_2_idx_in_text_with_entity_marker": [112, 125], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d484.s0_BioInfer.d484.s0.p1", "text": "Pervanadate caused a dramatic augmentation of the phosphorylation of E-cadherin, beta-catenin, and gamma-catenin (plakoglobin), but alpha-catenin was not detectably phosphorylated.", "text_with_entity_marker": "Pervanadate caused a dramatic augmentation of the phosphorylation of E-cadherin, beta-catenin, and [E1]gamma-catenin[/E1] ([E2]plakoglobin[/E2]), but alpha-catenin was not detectably phosphorylated.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "gamma-catenin", "entity_1_idx": [[99, 112]], "entity_1_idx_in_text_with_entity_marker": [103, 116], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[114, 125]], "entity_2_idx_in_text_with_entity_marker": [127, 138], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d484.s0_BioInfer.d484.s0.p2", "text": "Pervanadate caused a dramatic augmentation of the phosphorylation of E-cadherin, beta-catenin, and gamma-catenin (plakoglobin), but alpha-catenin was not detectably phosphorylated.", "text_with_entity_marker": "Pervanadate caused a dramatic augmentation of the phosphorylation of E-cadherin, [E1]beta-catenin[/E1], and [E2]gamma-catenin[/E2] (plakoglobin), but alpha-catenin was not detectably phosphorylated.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "beta-catenin", "entity_1_idx": [[81, 93]], "entity_1_idx_in_text_with_entity_marker": [85, 97], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "gamma-catenin", "entity_2_idx": [[99, 112]], "entity_2_idx_in_text_with_entity_marker": [112, 125], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d484.s0_BioInfer.d484.s0.p3", "text": "Pervanadate caused a dramatic augmentation of the phosphorylation of E-cadherin, beta-catenin, and gamma-catenin (plakoglobin), but alpha-catenin was not detectably phosphorylated.", "text_with_entity_marker": "Pervanadate caused a dramatic augmentation of the phosphorylation of E-cadherin, beta-catenin, and [E1]gamma-catenin[/E1] (plakoglobin), but [E2]alpha-catenin[/E2] was not detectably phosphorylated.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "gamma-catenin", "entity_1_idx": [[99, 112]], "entity_1_idx_in_text_with_entity_marker": [103, 116], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[132, 145]], "entity_2_idx_in_text_with_entity_marker": [145, 158], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d484.s0_BioInfer.d484.s0.p4", "text": "Pervanadate caused a dramatic augmentation of the phosphorylation of E-cadherin, beta-catenin, and gamma-catenin (plakoglobin), but alpha-catenin was not detectably phosphorylated.", "text_with_entity_marker": "Pervanadate caused a dramatic augmentation of the phosphorylation of [E1]E-cadherin[/E1], beta-catenin, and gamma-catenin ([E2]plakoglobin[/E2]), but alpha-catenin was not detectably phosphorylated.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E-cadherin", "entity_1_idx": [[69, 79]], "entity_1_idx_in_text_with_entity_marker": [73, 83], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "plakoglobin", "entity_2_idx": [[114, 125]], "entity_2_idx_in_text_with_entity_marker": [127, 138], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d484.s0_BioInfer.d484.s0.p5", "text": "Pervanadate caused a dramatic augmentation of the phosphorylation of E-cadherin, beta-catenin, and gamma-catenin (plakoglobin), but alpha-catenin was not detectably phosphorylated.", "text_with_entity_marker": "Pervanadate caused a dramatic augmentation of the phosphorylation of [E1]E-cadherin[/E1], [E2]beta-catenin[/E2], and gamma-catenin (plakoglobin), but alpha-catenin was not detectably phosphorylated.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E-cadherin", "entity_1_idx": [[69, 79]], "entity_1_idx_in_text_with_entity_marker": [73, 83], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[81, 93]], "entity_2_idx_in_text_with_entity_marker": [94, 106], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d484.s0_BioInfer.d484.s0.p6", "text": "Pervanadate caused a dramatic augmentation of the phosphorylation of E-cadherin, beta-catenin, and gamma-catenin (plakoglobin), but alpha-catenin was not detectably phosphorylated.", "text_with_entity_marker": "Pervanadate caused a dramatic augmentation of the phosphorylation of [E1]E-cadherin[/E1], beta-catenin, and gamma-catenin (plakoglobin), but [E2]alpha-catenin[/E2] was not detectably phosphorylated.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E-cadherin", "entity_1_idx": [[69, 79]], "entity_1_idx_in_text_with_entity_marker": [73, 83], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[132, 145]], "entity_2_idx_in_text_with_entity_marker": [145, 158], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d484.s0_BioInfer.d484.s0.p7", "text": "Pervanadate caused a dramatic augmentation of the phosphorylation of E-cadherin, beta-catenin, and gamma-catenin (plakoglobin), but alpha-catenin was not detectably phosphorylated.", "text_with_entity_marker": "Pervanadate caused a dramatic augmentation of the phosphorylation of E-cadherin, [E1]beta-catenin[/E1], and gamma-catenin ([E2]plakoglobin[/E2]), but alpha-catenin was not detectably phosphorylated.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "beta-catenin", "entity_1_idx": [[81, 93]], "entity_1_idx_in_text_with_entity_marker": [85, 97], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "plakoglobin", "entity_2_idx": [[114, 125]], "entity_2_idx_in_text_with_entity_marker": [127, 138], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d484.s0_BioInfer.d484.s0.p8", "text": "Pervanadate caused a dramatic augmentation of the phosphorylation of E-cadherin, beta-catenin, and gamma-catenin (plakoglobin), but alpha-catenin was not detectably phosphorylated.", "text_with_entity_marker": "Pervanadate caused a dramatic augmentation of the phosphorylation of E-cadherin, beta-catenin, and gamma-catenin ([E1]plakoglobin[/E1]), but [E2]alpha-catenin[/E2] was not detectably phosphorylated.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "plakoglobin", "entity_1_idx": [[114, 125]], "entity_1_idx_in_text_with_entity_marker": [118, 129], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[132, 145]], "entity_2_idx_in_text_with_entity_marker": [145, 158], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d484.s0_BioInfer.d484.s0.p9", "text": "Pervanadate caused a dramatic augmentation of the phosphorylation of E-cadherin, beta-catenin, and gamma-catenin (plakoglobin), but alpha-catenin was not detectably phosphorylated.", "text_with_entity_marker": "Pervanadate caused a dramatic augmentation of the phosphorylation of E-cadherin, [E1]beta-catenin[/E1], and gamma-catenin (plakoglobin), but [E2]alpha-catenin[/E2] was not detectably phosphorylated.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "beta-catenin", "entity_1_idx": [[81, 93]], "entity_1_idx_in_text_with_entity_marker": [85, 97], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[132, 145]], "entity_2_idx_in_text_with_entity_marker": [145, 158], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d228.s0_BioInfer.d228.s0.p0", "text": "Fusion of the endocardial ridges of the truncus on late ED13 is accompanied by the organization of alpha-smooth muscle actin-and nonmuscle myosin heavy chain-positive myofibroblasts into a central whorl and the appearance of the semilunar valve anlagen at their definitive topographical position within the proximal portion of the truncus.", "text_with_entity_marker": "Fusion of the endocardial ridges of the truncus on late ED13 is accompanied by the organization of [E1]alpha-smooth muscle actin[/E1]-and [E2]nonmuscle myosin heavy chain[/E2]-positive myofibroblasts into a central whorl and the appearance of the semilunar valve anlagen at their definitive topographical position within the proximal portion of the truncus.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-smooth muscle actin", "entity_1_idx": [[99, 124]], "entity_1_idx_in_text_with_entity_marker": [103, 128], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "nonmuscle myosin heavy chain", "entity_2_idx": [[129, 157]], "entity_2_idx_in_text_with_entity_marker": [142, 170], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "HPRD50.d26.s0_HPRD50.d26.s0.p0", "text": "The protein pVHL functions in a multi-subunit E3 ubiquitin ligase that targets the hypoxia-inducible transcription factor Hif1 alpha for proteasomal degradation during normoxia", "text_with_entity_marker": "The protein [E1]pVHL[/E1] functions in a multi-subunit E3 ubiquitin ligase that targets the hypoxia-inducible transcription factor [E2]Hif1 alpha[/E2] for proteasomal degradation during normoxia", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "pVHL", "entity_1_idx": [[12, 16]], "entity_1_idx_in_text_with_entity_marker": [16, 20], "entity_1_type": "pm0104236", "entity_1_type_id": 92, "entity_2": "Hif1 alpha", "entity_2_idx": [[122, 132]], "entity_2_idx_in_text_with_entity_marker": [135, 145], "entity_2_type": "pm0100197", "entity_2_type_id": 93}], "directed": false, "reverse": false}
{"id": "HPRD50.d26.s1_HPRD50.d26.s1.p0", "text": "We establish that pVHL binds to Tat-binding protein-1 (TBP-1), a component of the 19S regulatory complex of the proteasome", "text_with_entity_marker": "We establish that [E1]pVHL[/E1] binds to [E2]Tat-binding protein-1[/E2] (TBP-1), a component of the 19S regulatory complex of the proteasome", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "pVHL", "entity_1_idx": [[18, 22]], "entity_1_idx_in_text_with_entity_marker": [22, 26], "entity_1_type": "pm0104236", "entity_1_type_id": 92, "entity_2": "Tat-binding protein-1", "entity_2_idx": [[32, 53]], "entity_2_idx_in_text_with_entity_marker": [45, 66], "entity_2_type": "pm0113245", "entity_2_type_id": 94}], "directed": false, "reverse": false}
{"id": "HPRD50.d26.s1_HPRD50.d26.s1.p1", "text": "We establish that pVHL binds to Tat-binding protein-1 (TBP-1), a component of the 19S regulatory complex of the proteasome", "text_with_entity_marker": "We establish that [E1]pVHL[/E1] binds to Tat-binding protein-1 ([E2]TBP-1[/E2]), a component of the 19S regulatory complex of the proteasome", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "pVHL", "entity_1_idx": [[18, 22]], "entity_1_idx_in_text_with_entity_marker": [22, 26], "entity_1_type": "pm0104236", "entity_1_type_id": 92, "entity_2": "TBP-1", "entity_2_idx": [[55, 60]], "entity_2_idx_in_text_with_entity_marker": [68, 73], "entity_2_type": "pm0113245||pm0120764", "entity_2_type_id": 95}], "directed": false, "reverse": false}
{"id": "HPRD50.d26.s2_HPRD50.d26.s2.p0", "text": "TBP-1 associates with the beta-domain of pVHL and complexes with pVHL and Hif1 alpha in vivo", "text_with_entity_marker": "[E1]TBP-1[/E1] associates with the beta-domain of [E2]pVHL[/E2] and complexes with pVHL and Hif1 alpha in vivo", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "TBP-1", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "pm0113245||pm0120764", "entity_1_type_id": 95, "entity_2": "pVHL", "entity_2_idx": [[41, 45]], "entity_2_idx_in_text_with_entity_marker": [54, 58], "entity_2_type": "pm0104236", "entity_2_type_id": 92}], "directed": false, "reverse": false}
{"id": "HPRD50.d26.s2_HPRD50.d26.s2.p1", "text": "TBP-1 associates with the beta-domain of pVHL and complexes with pVHL and Hif1 alpha in vivo", "text_with_entity_marker": "[E1]TBP-1[/E1] associates with the beta-domain of pVHL and complexes with [E2]pVHL[/E2] and Hif1 alpha in vivo", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "TBP-1", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "pm0113245||pm0120764", "entity_1_type_id": 95, "entity_2": "pVHL", "entity_2_idx": [[65, 69]], "entity_2_idx_in_text_with_entity_marker": [78, 82], "entity_2_type": "pm0104236", "entity_2_type_id": 92}], "directed": false, "reverse": false}
{"id": "HPRD50.d26.s2_HPRD50.d26.s2.p2", "text": "TBP-1 associates with the beta-domain of pVHL and complexes with pVHL and Hif1 alpha in vivo", "text_with_entity_marker": "[E1]TBP-1[/E1] associates with the beta-domain of pVHL and complexes with pVHL and [E2]Hif1 alpha[/E2] in vivo", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "TBP-1", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "pm0113245||pm0120764", "entity_1_type_id": 95, "entity_2": "Hif1 alpha", "entity_2_idx": [[74, 84]], "entity_2_idx_in_text_with_entity_marker": [87, 97], "entity_2_type": "pm0100197", "entity_2_type_id": 93}], "directed": false, "reverse": false}
{"id": "HPRD50.d26.s3_HPRD50.d26.s3.p0", "text": "Overexpression of TBP-1 promotes degradation of Hif1 alpha in a pVHL-dependent manner that requires the ATPase domain of TBP-1", "text_with_entity_marker": "Overexpression of [E1]TBP-1[/E1] promotes degradation of [E2]Hif1 alpha[/E2] in a pVHL-dependent manner that requires the ATPase domain of TBP-1", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "TBP-1", "entity_1_idx": [[18, 23]], "entity_1_idx_in_text_with_entity_marker": [22, 27], "entity_1_type": "pm0113245||pm0120764", "entity_1_type_id": 95, "entity_2": "Hif1 alpha", "entity_2_idx": [[48, 58]], "entity_2_idx_in_text_with_entity_marker": [61, 71], "entity_2_type": "pm0100197", "entity_2_type_id": 93}], "directed": false, "reverse": false}
{"id": "HPRD50.d26.s3_HPRD50.d26.s3.p2", "text": "Overexpression of TBP-1 promotes degradation of Hif1 alpha in a pVHL-dependent manner that requires the ATPase domain of TBP-1", "text_with_entity_marker": "Overexpression of TBP-1 promotes degradation of [E1]Hif1 alpha[/E1] in a pVHL-dependent manner that requires the ATPase domain of [E2]TBP-1[/E2]", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Hif1 alpha", "entity_1_idx": [[48, 58]], "entity_1_idx_in_text_with_entity_marker": [52, 62], "entity_1_type": "pm0100197", "entity_1_type_id": 93, "entity_2": "TBP-1", "entity_2_idx": [[121, 126]], "entity_2_idx_in_text_with_entity_marker": [134, 139], "entity_2_type": "pm0113245||pm0120764", "entity_2_type_id": 95}], "directed": false, "reverse": false}
{"id": "HPRD50.d26.s4_HPRD50.d26.s4.p0", "text": "Blockade of TBP-1 expression by small interfering RNA (siRNA) causes prolonged degradation kinetics of Hif1 alpha", "text_with_entity_marker": "Blockade of [E1]TBP-1[/E1] expression by small interfering RNA (siRNA) causes prolonged degradation kinetics of [E2]Hif1 alpha[/E2]", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "TBP-1", "entity_1_idx": [[12, 17]], "entity_1_idx_in_text_with_entity_marker": [16, 21], "entity_1_type": "pm0113245||pm0120764", "entity_1_type_id": 95, "entity_2": "Hif1 alpha", "entity_2_idx": [[103, 113]], "entity_2_idx_in_text_with_entity_marker": [116, 126], "entity_2_type": "pm0100197", "entity_2_type_id": 93}], "directed": false, "reverse": false}
{"id": "HPRD50.d26.s5_HPRD50.d26.s5.p1", "text": "Several distinct mutations in exon 2 of VHL disrupt binding of pVHL to TBP-1", "text_with_entity_marker": "Several distinct mutations in exon 2 of [E1]VHL[/E1] disrupt binding of pVHL to [E2]TBP-1[/E2]", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "VHL", "entity_1_idx": [[40, 43]], "entity_1_idx_in_text_with_entity_marker": [44, 47], "entity_1_type": "pm0104236", "entity_1_type_id": 92, "entity_2": "TBP-1", "entity_2_idx": [[71, 76]], "entity_2_idx_in_text_with_entity_marker": [84, 89], "entity_2_type": "pm0113245||pm0120764", "entity_2_type_id": 95}], "directed": false, "reverse": false}
{"id": "HPRD50.d26.s5_HPRD50.d26.s5.p2", "text": "Several distinct mutations in exon 2 of VHL disrupt binding of pVHL to TBP-1", "text_with_entity_marker": "Several distinct mutations in exon 2 of VHL disrupt binding of [E1]pVHL[/E1] to [E2]TBP-1[/E2]", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "pVHL", "entity_1_idx": [[63, 67]], "entity_1_idx_in_text_with_entity_marker": [67, 71], "entity_1_type": "pm0104236", "entity_1_type_id": 92, "entity_2": "TBP-1", "entity_2_idx": [[71, 76]], "entity_2_idx_in_text_with_entity_marker": [84, 89], "entity_2_type": "pm0113245||pm0120764", "entity_2_type_id": 95}], "directed": false, "reverse": false}
{"id": "HPRD50.d26.s7_HPRD50.d26.s7.p0", "text": "Thus, the ability of pVHL to degrade Hif1 alpha depends in part on its interaction with TBP-1 and suggests a new mechanism for Hif1 alpha stabilization in some pVHL-deficient tumors", "text_with_entity_marker": "Thus, the ability of [E1]pVHL[/E1] to degrade [E2]Hif1 alpha[/E2] depends in part on its interaction with TBP-1 and suggests a new mechanism for Hif1 alpha stabilization in some pVHL-deficient tumors", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "pVHL", "entity_1_idx": [[21, 25]], "entity_1_idx_in_text_with_entity_marker": [25, 29], "entity_1_type": "pm0104236", "entity_1_type_id": 92, "entity_2": "Hif1 alpha", "entity_2_idx": [[37, 47]], "entity_2_idx_in_text_with_entity_marker": [50, 60], "entity_2_type": "pm0100197", "entity_2_type_id": 93}], "directed": false, "reverse": false}
{"id": "HPRD50.d26.s7_HPRD50.d26.s7.p1", "text": "Thus, the ability of pVHL to degrade Hif1 alpha depends in part on its interaction with TBP-1 and suggests a new mechanism for Hif1 alpha stabilization in some pVHL-deficient tumors", "text_with_entity_marker": "Thus, the ability of [E1]pVHL[/E1] to degrade Hif1 alpha depends in part on its interaction with [E2]TBP-1[/E2] and suggests a new mechanism for Hif1 alpha stabilization in some pVHL-deficient tumors", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "pVHL", "entity_1_idx": [[21, 25]], "entity_1_idx_in_text_with_entity_marker": [25, 29], "entity_1_type": "pm0104236", "entity_1_type_id": 92, "entity_2": "TBP-1", "entity_2_idx": [[88, 93]], "entity_2_idx_in_text_with_entity_marker": [101, 106], "entity_2_type": "pm0113245||pm0120764", "entity_2_type_id": 95}], "directed": false, "reverse": false}
{"id": "HPRD50.d26.s7_HPRD50.d26.s7.p9", "text": "Thus, the ability of pVHL to degrade Hif1 alpha depends in part on its interaction with TBP-1 and suggests a new mechanism for Hif1 alpha stabilization in some pVHL-deficient tumors", "text_with_entity_marker": "Thus, the ability of pVHL to degrade Hif1 alpha depends in part on its interaction with TBP-1 and suggests a new mechanism for [E1]Hif1 alpha[/E1] stabilization in some [E2]pVHL[/E2]-deficient tumors", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Hif1 alpha", "entity_1_idx": [[127, 137]], "entity_1_idx_in_text_with_entity_marker": [131, 141], "entity_1_type": "pm0100197", "entity_1_type_id": 93, "entity_2": "pVHL", "entity_2_idx": [[160, 164]], "entity_2_idx_in_text_with_entity_marker": [173, 177], "entity_2_type": "pm0104236", "entity_2_type_id": 92}], "directed": false, "reverse": false}
{"id": "HPRD50.d11.s0_HPRD50.d11.s0.p0", "text": "Direct interaction between the cytoplasmic tail of ADAM 12 and the Src homology 3 domain of p85alpha activates phosphatidylinositol 3-kinase in C2C12 cells", "text_with_entity_marker": "Direct interaction between the cytoplasmic tail of [E1]ADAM 12[/E1] and the Src homology 3 domain of [E2]p85alpha[/E2] activates phosphatidylinositol 3-kinase in C2C12 cells", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "ADAM 12", "entity_1_idx": [[51, 58]], "entity_1_idx_in_text_with_entity_marker": [55, 62], "entity_1_type": "pm0118647", "entity_1_type_id": 39, "entity_2": "p85alpha", "entity_2_idx": [[92, 100]], "entity_2_idx_in_text_with_entity_marker": [105, 113], "entity_2_type": "pm0124741", "entity_2_type_id": 40}], "directed": false, "reverse": false}
{"id": "HPRD50.d11.s0_HPRD50.d11.s0.p1", "text": "Direct interaction between the cytoplasmic tail of ADAM 12 and the Src homology 3 domain of p85alpha activates phosphatidylinositol 3-kinase in C2C12 cells", "text_with_entity_marker": "Direct interaction between the cytoplasmic tail of [E1]ADAM 12[/E1] and the Src homology 3 domain of p85alpha activates [E2]phosphatidylinositol 3-kinase[/E2] in C2C12 cells", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "ADAM 12", "entity_1_idx": [[51, 58]], "entity_1_idx_in_text_with_entity_marker": [55, 62], "entity_1_type": "pm0118647", "entity_1_type_id": 39, "entity_2": "phosphatidylinositol 3-kinase", "entity_2_idx": [[111, 140]], "entity_2_idx_in_text_with_entity_marker": [124, 153], "entity_2_type": "pm0104655||pm0110290||pm0120114||pm0122783||pm0124741", "entity_2_type_id": 12}], "directed": false, "reverse": false}
{"id": "HPRD50.d11.s0_HPRD50.d11.s0.p2", "text": "Direct interaction between the cytoplasmic tail of ADAM 12 and the Src homology 3 domain of p85alpha activates phosphatidylinositol 3-kinase in C2C12 cells", "text_with_entity_marker": "Direct interaction between the cytoplasmic tail of ADAM 12 and the Src homology 3 domain of [E1]p85alpha[/E1] activates [E2]phosphatidylinositol 3-kinase[/E2] in C2C12 cells", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "p85alpha", "entity_1_idx": [[92, 100]], "entity_1_idx_in_text_with_entity_marker": [96, 104], "entity_1_type": "pm0124741", "entity_1_type_id": 40, "entity_2": "phosphatidylinositol 3-kinase", "entity_2_idx": [[111, 140]], "entity_2_idx_in_text_with_entity_marker": [124, 153], "entity_2_type": "pm0104655||pm0110290||pm0120114||pm0122783||pm0124741", "entity_2_type_id": 12}], "directed": false, "reverse": false}
{"id": "HPRD50.d11.s1_HPRD50.d11.s1.p0", "text": "This suggests that transmembrane ADAM 12, by providing docking sites for the Src homology 3 domain of p85alpha, activates PI 3-kinase by mediating its recruitment to the membrane", "text_with_entity_marker": "This suggests that transmembrane [E1]ADAM 12[/E1], by providing docking sites for the Src homology 3 domain of [E2]p85alpha[/E2], activates PI 3-kinase by mediating its recruitment to the membrane", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "ADAM 12", "entity_1_idx": [[33, 40]], "entity_1_idx_in_text_with_entity_marker": [37, 44], "entity_1_type": "pm0118647", "entity_1_type_id": 39, "entity_2": "p85alpha", "entity_2_idx": [[102, 110]], "entity_2_idx_in_text_with_entity_marker": [115, 123], "entity_2_type": "pm0124741", "entity_2_type_id": 40}], "directed": false, "reverse": false}
{"id": "HPRD50.d41.s0_HPRD50.d41.s0.p0", "text": "We report here that PLZF, and a structurally similar transcriptional repressor, BCL-6, can interact with a variety of corepressor proteins in addition to SMRT, including the mSin3A protein and (for PLZF) histone deacetylase-1", "text_with_entity_marker": "We report here that PLZF, and a structurally similar transcriptional repressor, [E1]BCL-6[/E1], can interact with a variety of corepressor proteins in addition to SMRT, including the mSin3A protein and (for PLZF) [E2]histone deacetylase-1[/E2]", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "BCL-6", "entity_1_idx": [[80, 85]], "entity_1_idx_in_text_with_entity_marker": [84, 89], "entity_1_type": "pm0100563", "entity_1_type_id": 150, "entity_2": "histone deacetylase-1", "entity_2_idx": [[204, 225]], "entity_2_idx_in_text_with_entity_marker": [217, 238], "entity_2_type": "pm0119729", "entity_2_type_id": 108}], "directed": false, "reverse": false}
{"id": "HPRD50.d10.s1_HPRD50.d10.s1.p0", "text": "The 130- and 240-kDa sialoadhesin-binding glycoproteins were identified as the sialomucins CD43 and P-selectin glycoprotein ligand 1 (CD162), respectively", "text_with_entity_marker": "The 130- and 240-kDa sialoadhesin-binding glycoproteins were identified as the sialomucins [E1]CD43[/E1] and [E2]P-selectin glycoprotein ligand 1[/E2] (CD162), respectively", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "CD43", "entity_1_idx": [[91, 95]], "entity_1_idx_in_text_with_entity_marker": [95, 99], "entity_1_type": "pm0122945", "entity_1_type_id": 36, "entity_2": "P-selectin glycoprotein ligand 1", "entity_2_idx": [[100, 132]], "entity_2_idx_in_text_with_entity_marker": [113, 145], "entity_2_type": "pm0119091", "entity_2_type_id": 38}], "directed": false, "reverse": false}
{"id": "HPRD50.d10.s1_HPRD50.d10.s1.p1", "text": "The 130- and 240-kDa sialoadhesin-binding glycoproteins were identified as the sialomucins CD43 and P-selectin glycoprotein ligand 1 (CD162), respectively", "text_with_entity_marker": "The 130- and 240-kDa sialoadhesin-binding glycoproteins were identified as the sialomucins [E1]CD43[/E1] and P-selectin glycoprotein ligand 1 ([E2]CD162[/E2]), respectively", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "CD43", "entity_1_idx": [[91, 95]], "entity_1_idx_in_text_with_entity_marker": [95, 99], "entity_1_type": "pm0122945", "entity_1_type_id": 36, "entity_2": "CD162", "entity_2_idx": [[134, 139]], "entity_2_idx_in_text_with_entity_marker": [147, 152], "entity_2_type": "pm0119091", "entity_2_type_id": 38}], "directed": false, "reverse": false}
{"id": "HPRD50.d10.s1_HPRD50.d10.s1.p2", "text": "The 130- and 240-kDa sialoadhesin-binding glycoproteins were identified as the sialomucins CD43 and P-selectin glycoprotein ligand 1 (CD162), respectively", "text_with_entity_marker": "The 130- and 240-kDa sialoadhesin-binding glycoproteins were identified as the sialomucins CD43 and [E1]P-selectin glycoprotein ligand 1[/E1] ([E2]CD162[/E2]), respectively", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "P-selectin glycoprotein ligand 1", "entity_1_idx": [[100, 132]], "entity_1_idx_in_text_with_entity_marker": [104, 136], "entity_1_type": "pm0119091", "entity_1_type_id": 38, "entity_2": "CD162", "entity_2_idx": [[134, 139]], "entity_2_idx_in_text_with_entity_marker": [147, 152], "entity_2_type": "pm0119091", "entity_2_type_id": 38}], "directed": false, "reverse": false}
{"id": "HPRD50.d42.s1_HPRD50.d42.s1.p0", "text": "In contrast to IkappaBbeta, Bcl3 did not interact with the AF2 domain of RXR", "text_with_entity_marker": "In contrast to [E1]IkappaBbeta[/E1], [E2]Bcl3[/E2] did not interact with the AF2 domain of RXR", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IkappaBbeta", "entity_1_idx": [[15, 26]], "entity_1_idx_in_text_with_entity_marker": [19, 30], "entity_1_type": "pm0122183", "entity_1_type_id": 152, "entity_2": "Bcl3", "entity_2_idx": [[28, 32]], "entity_2_idx_in_text_with_entity_marker": [41, 45], "entity_2_type": "pm0126712", "entity_2_type_id": 151}], "directed": false, "reverse": false}
{"id": "HPRD50.d42.s3_HPRD50.d42.s3.p0", "text": "TBP and TFIIA, however, were not able to interact with IkappaBbeta", "text_with_entity_marker": "TBP and [E1]TFIIA[/E1], however, were not able to interact with [E2]IkappaBbeta[/E2]", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TFIIA", "entity_1_idx": [[8, 13]], "entity_1_idx_in_text_with_entity_marker": [12, 17], "entity_1_type": "pm0112153||pm0118250", "entity_1_type_id": 154, "entity_2": "IkappaBbeta", "entity_2_idx": [[55, 66]], "entity_2_idx_in_text_with_entity_marker": [68, 79], "entity_2_type": "pm0122183", "entity_2_type_id": 152}], "directed": false, "reverse": false}
{"id": "IEPA.d114.s274_IEPA.d114.s274.p0", "text": "In normal pancreatic islets, UCP-2 is upregulated by leptin and is low in leptin-resistant islets of ZDF rats", "text_with_entity_marker": "In normal pancreatic islets, [E1]UCP-2[/E1] is upregulated by [E2]leptin[/E2] and is low in leptin-resistant islets of ZDF rats", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "UCP-2", "entity_1_idx": [[29, 34]], "entity_1_idx_in_text_with_entity_marker": [33, 38], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[53, 59]], "entity_2_idx_in_text_with_entity_marker": [66, 72], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d146.s351_IEPA.d146.s351.p0", "text": "Ca2+ signalling in rat vascular smooth muscle cells: a role for protein kinase C at physiological vasoconstrictor concentrations of vasopressin", "text_with_entity_marker": "Ca2+ signalling in rat vascular smooth muscle cells: a role for [E1]protein kinase C[/E1] at physiological vasoconstrictor concentrations of [E2]vasopressin[/E2]", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "protein kinase C", "entity_1_idx": [[64, 80]], "entity_1_idx_in_text_with_entity_marker": [68, 84], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "vasopressin", "entity_2_idx": [[132, 143]], "entity_2_idx_in_text_with_entity_marker": [145, 156], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d146.s353_IEPA.d146.s353.p0", "text": "The PKC inhibitors Ro-31-8220 (1 microM) and calphostin C (250 nM) completely blocked the stimulation of Ca2+ spiking by either PMA or AVP", "text_with_entity_marker": "The [E1]PKC inhibitors[/E1] Ro-31-8220 (1 microM) and calphostin C (250 nM) completely blocked the stimulation of Ca2+ spiking by either PMA or [E2]AVP[/E2]", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "PKC inhibitors", "entity_1_idx": [[4, 18]], "entity_1_idx_in_text_with_entity_marker": [8, 22], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "AVP", "entity_2_idx": [[135, 138]], "entity_2_idx_in_text_with_entity_marker": [148, 151], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d146.s354_IEPA.d146.s354.p0", "text": "Time-dependent redistribution of PKC-alpha, -delta and -epsilon isoforms between the membrane and cytosolic fractions occurred in response to 100 pM AVP", "text_with_entity_marker": "Time-dependent redistribution of [E1]PKC-alpha[/E1], -delta and -epsilon isoforms between the membrane and cytosolic fractions occurred in response to 100 pM [E2]AVP[/E2]", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "PKC-alpha", "entity_1_idx": [[33, 42]], "entity_1_idx_in_text_with_entity_marker": [37, 46], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "AVP", "entity_2_idx": [[149, 152]], "entity_2_idx_in_text_with_entity_marker": [162, 165], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d146.s356_IEPA.d146.s356.p0", "text": "We conclude that PKC activation is a necessary step in the signal transduction pathway linking low concentrations of AVP to Ca2+ spiking in A7r5 cells", "text_with_entity_marker": "We conclude that [E1]PKC[/E1] activation is a necessary step in the signal transduction pathway linking low concentrations of [E2]AVP[/E2] to Ca2+ spiking in A7r5 cells", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "PKC", "entity_1_idx": [[17, 20]], "entity_1_idx_in_text_with_entity_marker": [21, 24], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "AVP", "entity_2_idx": [[117, 120]], "entity_2_idx_in_text_with_entity_marker": [130, 133], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d27.s57_IEPA.d27.s57.p0", "text": "8-OH-DPAT also increased insulin and decreased CCK and somatostatin levels, effects that were blocked by pretreatment with the oxytocin antagonist", "text_with_entity_marker": "8-OH-DPAT also increased [E1]insulin[/E1] and decreased CCK and somatostatin levels, effects that were blocked by pretreatment with the [E2]oxytocin[/E2] antagonist", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "insulin", "entity_1_idx": [[25, 32]], "entity_1_idx_in_text_with_entity_marker": [29, 36], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "oxytocin", "entity_2_idx": [[127, 135]], "entity_2_idx_in_text_with_entity_marker": [140, 148], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d27.s58_IEPA.d27.s58.p0", "text": "Taken together, these data suggest that the effect of 8-OH-DPAT on plasma levels of insulin, somatostatin and CCK may be mediated by oxytocin", "text_with_entity_marker": "Taken together, these data suggest that the effect of 8-OH-DPAT on plasma levels of [E1]insulin[/E1], somatostatin and CCK may be mediated by [E2]oxytocin[/E2]", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "insulin", "entity_1_idx": [[84, 91]], "entity_1_idx_in_text_with_entity_marker": [88, 95], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "oxytocin", "entity_2_idx": [[133, 141]], "entity_2_idx_in_text_with_entity_marker": [146, 154], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d27.s59_IEPA.d27.s59.p0", "text": "In previous experiments, we have shown that following i.c.v. application of oxytocin, plasma levels of insulin are increased through a cholinergic mechanism", "text_with_entity_marker": "In previous experiments, we have shown that following i.c.v. application of [E1]oxytocin[/E1], plasma levels of [E2]insulin[/E2] are increased through a cholinergic mechanism", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "oxytocin", "entity_1_idx": [[76, 84]], "entity_1_idx_in_text_with_entity_marker": [80, 88], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[103, 110]], "entity_2_idx_in_text_with_entity_marker": [116, 123], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d116.s284_IEPA.d116.s284.p0", "text": "In the present study we found that at increasing GA concentrations, increasing numbers of barley (Hordeum vulgare) cells showed the enhanced amylase secretion and vacuolation characteristic of the GA response", "text_with_entity_marker": "In the present study we found that at increasing [E1]GA[/E1] concentrations, increasing numbers of barley (Hordeum vulgare) cells showed the enhanced [E2]amylase[/E2] secretion and vacuolation characteristic of the GA response", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "GA", "entity_1_idx": [[49, 51]], "entity_1_idx_in_text_with_entity_marker": [53, 55], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "amylase", "entity_2_idx": [[141, 148]], "entity_2_idx_in_text_with_entity_marker": [154, 161], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d25.s55_IEPA.d25.s55.p0", "text": "Stimulation of 5HT-1D receptors with sumatriptan was unable to change neither AVP nor OT response to insulin-induced hypoglycemia", "text_with_entity_marker": "Stimulation of 5HT-1D receptors with sumatriptan was unable to change neither AVP nor [E1]OT[/E1] response to [E2]insulin[/E2]-induced hypoglycemia", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "OT", "entity_1_idx": [[86, 88]], "entity_1_idx_in_text_with_entity_marker": [90, 92], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[101, 108]], "entity_2_idx_in_text_with_entity_marker": [114, 121], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d147.s358_IEPA.d147.s358.p0", "text": "With regard to CK2, phosphorylation occurs at Ser 154 with a stoichiometry of about 0.1 mol phosphate/mol rbPrP, which is doubled by mild heat treatment of rbPrP", "text_with_entity_marker": "With regard to [E1]CK2[/E1], phosphorylation occurs at Ser 154 with a stoichiometry of about 0.1 mol phosphate/mol [E2]rbPrP[/E2], which is doubled by mild heat treatment of rbPrP", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "CK2", "entity_1_idx": [[15, 18]], "entity_1_idx_in_text_with_entity_marker": [19, 22], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "rbPrP", "entity_2_idx": [[106, 111]], "entity_2_idx_in_text_with_entity_marker": [119, 124], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d99.s237_IEPA.d99.s237.p0", "text": "Enhanced phosphoinositide hydrolysis via overexpression of phospholipase C beta1 or delta1 inhibits stimulus-induced insulin release in insulinoma MIN6 cells.", "text_with_entity_marker": "Enhanced phosphoinositide hydrolysis via overexpression of [E1]phospholipase C[/E1] beta1 or delta1 inhibits stimulus-induced [E2]insulin[/E2] release in insulinoma MIN6 cells.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "phospholipase C", "entity_1_idx": [[59, 74]], "entity_1_idx_in_text_with_entity_marker": [63, 78], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[117, 124]], "entity_2_idx_in_text_with_entity_marker": [130, 137], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d170.s412_IEPA.d170.s412.p0", "text": "Both leptin and insulin can reduce hypothalamic NPY production and secretion", "text_with_entity_marker": "Both [E1]leptin[/E1] and insulin can reduce hypothalamic [E2]NPY[/E2] production and secretion", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "leptin", "entity_1_idx": [[5, 11]], "entity_1_idx_in_text_with_entity_marker": [9, 15], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "NPY", "entity_2_idx": [[48, 51]], "entity_2_idx_in_text_with_entity_marker": [61, 64], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d47.s120_IEPA.d47.s120.p0", "text": "Effects of oxytocin, arginine-vasopressin and lysine-vasopressin on insulin and glucagon secretion in sheep", "text_with_entity_marker": "Effects of [E1]oxytocin[/E1], arginine-vasopressin and lysine-vasopressin on [E2]insulin[/E2] and glucagon secretion in sheep", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "oxytocin", "entity_1_idx": [[11, 19]], "entity_1_idx_in_text_with_entity_marker": [15, 23], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[68, 75]], "entity_2_idx_in_text_with_entity_marker": [81, 88], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d47.s121_IEPA.d47.s121.p0", "text": "The effects of the posterior-pituitary peptides oxytocin (OT), arginine-vasopressin (AVP) and lysine-vasopressin (LVP) on insulin and glucagon secretion were examined in adult sheep", "text_with_entity_marker": "The effects of the posterior-pituitary peptides [E1]oxytocin[/E1] (OT), arginine-vasopressin (AVP) and lysine-vasopressin (LVP) on [E2]insulin[/E2] and glucagon secretion were examined in adult sheep", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "oxytocin", "entity_1_idx": [[48, 56]], "entity_1_idx_in_text_with_entity_marker": [52, 60], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[122, 129]], "entity_2_idx_in_text_with_entity_marker": [135, 142], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d47.s122_IEPA.d47.s122.p0", "text": "The maximal insulin responses induced by OT and AVP were very similar, but the threshold and maximal doses of AVP for increasing plasma insulin were higher than those of OT", "text_with_entity_marker": "The maximal [E1]insulin[/E1] responses induced by [E2]OT[/E2] and AVP were very similar, but the threshold and maximal doses of AVP for increasing plasma insulin were higher than those of OT", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "insulin", "entity_1_idx": [[12, 19]], "entity_1_idx_in_text_with_entity_marker": [16, 23], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "OT", "entity_2_idx": [[41, 43]], "entity_2_idx_in_text_with_entity_marker": [54, 56], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d47.s122_IEPA.d47.s122.p5", "text": "The maximal insulin responses induced by OT and AVP were very similar, but the threshold and maximal doses of AVP for increasing plasma insulin were higher than those of OT", "text_with_entity_marker": "The maximal insulin responses induced by OT and AVP were very similar, but the threshold and maximal doses of AVP for increasing plasma [E1]insulin[/E1] were higher than those of [E2]OT[/E2]", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "insulin", "entity_1_idx": [[136, 143]], "entity_1_idx_in_text_with_entity_marker": [140, 147], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "OT", "entity_2_idx": [[170, 172]], "entity_2_idx_in_text_with_entity_marker": [183, 185], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d77.s186_IEPA.d77.s186.p0", "text": "Three weeks after administration of STZ, the diabetic rats were subcutaneously treated with insulin for 1 week, which resulted in significant suppression of the induction of nNOS, AVP and oxytocin gene expression in the PVN and SON", "text_with_entity_marker": "Three weeks after administration of STZ, the diabetic rats were subcutaneously treated with [E1]insulin[/E1] for 1 week, which resulted in significant suppression of the induction of nNOS, AVP and [E2]oxytocin[/E2] gene expression in the PVN and SON", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "insulin", "entity_1_idx": [[92, 99]], "entity_1_idx_in_text_with_entity_marker": [96, 103], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "oxytocin", "entity_2_idx": [[188, 196]], "entity_2_idx_in_text_with_entity_marker": [201, 209], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d23.s47_IEPA.d23.s47.p5", "text": "The resulting abnormally phosphorylated PrPsc aggregates to freshly synthesized PrPc, transforming it into same; due to a system of positive feedback invoked by the organophosphate-induced blockage of a prion protein-specific protein kinase.", "text_with_entity_marker": "The resulting abnormally phosphorylated PrPsc aggregates to freshly synthesized PrPc, transforming it into same; due to a system of positive feedback invoked by the organophosphate-induced blockage of a [E1]prion protein[/E1]-specific [E2]protein kinase[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "prion protein", "entity_1_idx": [[203, 216]], "entity_1_idx_in_text_with_entity_marker": [207, 220], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "protein kinase", "entity_2_idx": [[226, 240]], "entity_2_idx_in_text_with_entity_marker": [239, 253], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d102.s241_IEPA.d102.s241.p0", "text": "Constitutive expression of PKABA1 drastically suppressed expression of low- and high-pI alpha-amylase and protease genes induced by GA", "text_with_entity_marker": "Constitutive expression of PKABA1 drastically suppressed expression of low- and high-pI [E1]alpha-amylase[/E1] and protease genes induced by [E2]GA[/E2]", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "alpha-amylase", "entity_1_idx": [[88, 101]], "entity_1_idx_in_text_with_entity_marker": [92, 105], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "GA", "entity_2_idx": [[132, 134]], "entity_2_idx_in_text_with_entity_marker": [145, 147], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d5.s10_IEPA.d5.s10.p0", "text": "For each Exp, 100 mg endometrium was incubated, in duplicate, for 2 h with 10 microCi [3H] inositol and treated with 0 or 100 nM oxytocin (OT) for 20 min, then [3H]inositol mono-, bis-, and trisphosphates (IP1, IP2, and IP3, respectively) were quantified", "text_with_entity_marker": "For each Exp, 100 mg endometrium was incubated, in duplicate, for 2 h with 10 microCi [3H] inositol and treated with 0 or 100 nM [E1]oxytocin[/E1] (OT) for 20 min, then [3H]inositol mono-, bis-, and trisphosphates (IP1, IP2, and [E2]IP3[/E2], respectively) were quantified", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "oxytocin", "entity_1_idx": [[129, 137]], "entity_1_idx_in_text_with_entity_marker": [133, 141], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "IP3", "entity_2_idx": [[220, 223]], "entity_2_idx_in_text_with_entity_marker": [233, 236], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d4.s5_IEPA.d4.s5.p0", "text": "The effects of prostaglandin F2 alpha (PGF2 alpha) on intracellular Ca2+ concentration ([Ca2+]i) and inositol phosphate (IP) generation in human myometrial cells were evaluated and compared to the effects of oxytocin", "text_with_entity_marker": "The effects of prostaglandin F2 alpha (PGF2 alpha) on intracellular Ca2+ concentration ([Ca2+]i) and [E1]inositol phosphate[/E1] (IP) generation in human myometrial cells were evaluated and compared to the effects of [E2]oxytocin[/E2]", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "inositol phosphate", "entity_1_idx": [[101, 119]], "entity_1_idx_in_text_with_entity_marker": [105, 123], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "oxytocin", "entity_2_idx": [[208, 216]], "entity_2_idx_in_text_with_entity_marker": [221, 229], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d94.s227_IEPA.d94.s227.p0", "text": "Oxytocin (OT) is more expressed in the TEC/TNC than vasopressin (VP); insulin-like growth factor 2 (IGF-2) thymic expression predominates over IGF-1, and much more over (pro)insulin", "text_with_entity_marker": "[E1]Oxytocin[/E1] (OT) is more expressed in the TEC/TNC than vasopressin (VP); insulin-like growth factor 2 (IGF-2) thymic expression predominates over IGF-1, and much more over [E2](pro)insulin[/E2]", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Oxytocin", "entity_1_idx": [[0, 8]], "entity_1_idx_in_text_with_entity_marker": [4, 12], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "(pro)insulin", "entity_2_idx": [[169, 181]], "entity_2_idx_in_text_with_entity_marker": [182, 194], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d56.s144_IEPA.d56.s144.p0", "text": "Surprisingly, however, when islets were depolarized directly using either of two agonists, glyburide (which does not act via generation of purine nucleotides) or 40 mM K+ (which acts distal to KATP channel), PLC and insulin secretion were again obliterated by IL-1 beta", "text_with_entity_marker": "Surprisingly, however, when islets were depolarized directly using either of two agonists, glyburide (which does not act via generation of purine nucleotides) or 40 mM K+ (which acts distal to KATP channel), [E1]PLC[/E1] and [E2]insulin[/E2] secretion were again obliterated by IL-1 beta", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "PLC", "entity_1_idx": [[208, 211]], "entity_1_idx_in_text_with_entity_marker": [212, 215], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[216, 223]], "entity_2_idx_in_text_with_entity_marker": [229, 236], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d190.s456_IEPA.d190.s456.p0", "text": "We aimed at studying the effects of leptin, CART and NPY on the hypothalamic control of the pituitary-gonadal system.", "text_with_entity_marker": "We aimed at studying the effects of [E1]leptin[/E1], CART and [E2]NPY[/E2] on the hypothalamic control of the pituitary-gonadal system.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "leptin", "entity_1_idx": [[36, 42]], "entity_1_idx_in_text_with_entity_marker": [40, 46], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "NPY", "entity_2_idx": [[53, 56]], "entity_2_idx_in_text_with_entity_marker": [66, 69], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d44.s113_IEPA.d44.s113.p0", "text": "The data obtained suggest (i) that selective oxytocin receptors are present on the membranes of guinea-pig antral smooth muscle cells, (ii) that the oxytocin-related relaxation may result from the activation of Ca(2+)-sensitive K+ conductivity via activation of IP3-induced release of Ca2+ from the submembrane located cisternae of the sarcoplasmic reticulum Ca2+ stores and (iii) in turn, this evokes a non-inactivating component of IK, hyperpolarizing the cell membrane", "text_with_entity_marker": "The data obtained suggest (i) that selective [E1]oxytocin[/E1] receptors are present on the membranes of guinea-pig antral smooth muscle cells, (ii) that the oxytocin-related relaxation may result from the activation of Ca(2+)-sensitive K+ conductivity via activation of [E2]IP3[/E2]-induced release of Ca2+ from the submembrane located cisternae of the sarcoplasmic reticulum Ca2+ stores and (iii) in turn, this evokes a non-inactivating component of IK, hyperpolarizing the cell membrane", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "oxytocin", "entity_1_idx": [[45, 53]], "entity_1_idx_in_text_with_entity_marker": [49, 57], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "IP3", "entity_2_idx": [[262, 265]], "entity_2_idx_in_text_with_entity_marker": [275, 278], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d13.s30_IEPA.d13.s30.p0", "text": "Current interest in reducing heart disease risks by diet involves attention to total fat; saturated, monounsaturated, polyunsaturated and trans fatty acids, as well as dietary cholesterol, soluble fiber, salt, alcohol, antioxidants, dietary alterations causing homocysteinemia and other dietary constituents, such as flavonoid compounds in some soy products", "text_with_entity_marker": "Current interest in reducing heart disease risks by diet involves attention to total fat; saturated, monounsaturated, polyunsaturated and trans fatty acids, as well as dietary [E1]cholesterol[/E1], soluble fiber, salt, alcohol, antioxidants, dietary alterations causing homocysteinemia and other dietary constituents, such as [E2]flavonoid[/E2] compounds in some soy products", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "cholesterol", "entity_1_idx": [[176, 187]], "entity_1_idx_in_text_with_entity_marker": [180, 191], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "flavonoid", "entity_2_idx": [[317, 326]], "entity_2_idx_in_text_with_entity_marker": [330, 339], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d183.s437_IEPA.d183.s437.p0", "text": "Plasma insulin, cholecystokinin, galanin, neuropeptide Y and leptin levels in obese women with and without type 2 diabetes mellitus", "text_with_entity_marker": "Plasma insulin, cholecystokinin, galanin, [E1]neuropeptide Y[/E1] and [E2]leptin[/E2] levels in obese women with and without type 2 diabetes mellitus", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "neuropeptide Y", "entity_1_idx": [[42, 56]], "entity_1_idx_in_text_with_entity_marker": [46, 60], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[61, 67]], "entity_2_idx_in_text_with_entity_marker": [74, 80], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d183.s438_IEPA.d183.s438.p0", "text": "Experimental studies provided evidences that leptin, cholecystokinin (CCK), galanin (GAL), neuropeptide Y (NPY) and insulin are involved in feeding behaviour", "text_with_entity_marker": "Experimental studies provided evidences that [E1]leptin[/E1], cholecystokinin (CCK), galanin (GAL), [E2]neuropeptide Y[/E2] (NPY) and insulin are involved in feeding behaviour", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "leptin", "entity_1_idx": [[45, 51]], "entity_1_idx_in_text_with_entity_marker": [49, 55], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "neuropeptide Y", "entity_2_idx": [[91, 105]], "entity_2_idx_in_text_with_entity_marker": [104, 118], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d183.s439_IEPA.d183.s439.p0", "text": "Plasma concentrations of FSH, leptin, CCK, GAL, NPY and insulin were determined using commercial RIA kits", "text_with_entity_marker": "Plasma concentrations of FSH, [E1]leptin[/E1], CCK, GAL, [E2]NPY[/E2] and insulin were determined using commercial RIA kits", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "leptin", "entity_1_idx": [[30, 36]], "entity_1_idx_in_text_with_entity_marker": [34, 40], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "NPY", "entity_2_idx": [[48, 51]], "entity_2_idx_in_text_with_entity_marker": [61, 64], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d183.s440_IEPA.d183.s440.p0", "text": "Our results, ie higher mean plasma NPY levels in postmenopausal diabetic women and positive correlation of CCK with leptin and insulin, may suggest the role of these neuropeptides in metabolic disorders leading to type 2 diabetes mellitus", "text_with_entity_marker": "Our results, ie higher mean plasma [E1]NPY[/E1] levels in postmenopausal diabetic women and positive correlation of CCK with [E2]leptin[/E2] and insulin, may suggest the role of these neuropeptides in metabolic disorders leading to type 2 diabetes mellitus", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "NPY", "entity_1_idx": [[35, 38]], "entity_1_idx_in_text_with_entity_marker": [39, 42], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[116, 122]], "entity_2_idx_in_text_with_entity_marker": [129, 135], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "LLL.d25.s0_LLL.d25.s0.p0", "text": "The expression of the bkd operon was induced by the presence of isoleucine or valine in the growth medium and depended upon the presence of the sigma factor SigL, a member of the sigma 54 family.", "text_with_entity_marker": "The expression of the [E1]bkd[/E1] operon was induced by the presence of isoleucine or valine in the growth medium and depended upon the presence of the sigma factor [E2]SigL[/E2], a member of the sigma 54 family.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "bkd", "entity_1_idx": [[22, 25]], "entity_1_idx_in_text_with_entity_marker": [26, 29], "entity_1_type": "target", "entity_1_type_id": 1, "entity_2": "SigL", "entity_2_idx": [[157, 161]], "entity_2_idx_in_text_with_entity_marker": [170, 174], "entity_2_type": "agent", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "LLL.d24.s0_LLL.d24.s0.p1", "text": "Furthermore, YtxH and YvyD seemed to be induced after phosphate starvation in the wild type in a sigma(B)-dependent manner and in the sigB mutant probably via sigma(H).", "text_with_entity_marker": "Furthermore, [E1]YtxH[/E1] and YvyD seemed to be induced after phosphate starvation in the wild type in a [E2]sigma(B)[/E2]-dependent manner and in the sigB mutant probably via sigma(H).", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "YtxH", "entity_1_idx": [[13, 17]], "entity_1_idx_in_text_with_entity_marker": [17, 21], "entity_1_type": "target", "entity_1_type_id": 1, "entity_2": "sigma(B)", "entity_2_idx": [[97, 105]], "entity_2_idx_in_text_with_entity_marker": [110, 118], "entity_2_type": "agent", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "LLL.d24.s0_LLL.d24.s0.p2", "text": "Furthermore, YtxH and YvyD seemed to be induced after phosphate starvation in the wild type in a sigma(B)-dependent manner and in the sigB mutant probably via sigma(H).", "text_with_entity_marker": "Furthermore, YtxH and [E1]YvyD[/E1] seemed to be induced after phosphate starvation in the wild type in a [E2]sigma(B)[/E2]-dependent manner and in the sigB mutant probably via sigma(H).", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "YvyD", "entity_1_idx": [[22, 26]], "entity_1_idx_in_text_with_entity_marker": [26, 30], "entity_1_type": "target", "entity_1_type_id": 1, "entity_2": "sigma(B)", "entity_2_idx": [[97, 105]], "entity_2_idx_in_text_with_entity_marker": [110, 118], "entity_2_type": "agent", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "LLL.d24.s0_LLL.d24.s0.p3", "text": "Furthermore, YtxH and YvyD seemed to be induced after phosphate starvation in the wild type in a sigma(B)-dependent manner and in the sigB mutant probably via sigma(H).", "text_with_entity_marker": "Furthermore, [E1]YtxH[/E1] and YvyD seemed to be induced after phosphate starvation in the wild type in a sigma(B)-dependent manner and in the sigB mutant probably via [E2]sigma(H)[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "YtxH", "entity_1_idx": [[13, 17]], "entity_1_idx_in_text_with_entity_marker": [17, 21], "entity_1_type": "target", "entity_1_type_id": 1, "entity_2": "sigma(H)", "entity_2_idx": [[159, 167]], "entity_2_idx_in_text_with_entity_marker": [172, 180], "entity_2_type": "agent", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "LLL.d24.s0_LLL.d24.s0.p4", "text": "Furthermore, YtxH and YvyD seemed to be induced after phosphate starvation in the wild type in a sigma(B)-dependent manner and in the sigB mutant probably via sigma(H).", "text_with_entity_marker": "Furthermore, YtxH and [E1]YvyD[/E1] seemed to be induced after phosphate starvation in the wild type in a sigma(B)-dependent manner and in the sigB mutant probably via [E2]sigma(H)[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "YvyD", "entity_1_idx": [[22, 26]], "entity_1_idx_in_text_with_entity_marker": [26, 30], "entity_1_type": "target", "entity_1_type_id": 1, "entity_2": "sigma(H)", "entity_2_idx": [[159, 167]], "entity_2_idx_in_text_with_entity_marker": [172, 180], "entity_2_type": "agent", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "LLL.d34.s0_LLL.d34.s0.p0", "text": "However, the mutant was unable to stimulate transcription by final sigma(A)-RNA polymerase from the Spo0A-dependent spoIIG operon promoter.", "text_with_entity_marker": "However, the mutant was unable to stimulate transcription by final [E1]sigma(A)[/E1]-RNA polymerase from the [E2]Spo0A[/E2]-dependent spoIIG operon promoter.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "sigma(A)", "entity_1_idx": [[67, 75]], "entity_1_idx_in_text_with_entity_marker": [71, 79], "entity_1_type": "agent/target", "entity_1_type_id": 2, "entity_2": "Spo0A", "entity_2_idx": [[100, 105]], "entity_2_idx_in_text_with_entity_marker": [113, 118], "entity_2_type": "agent", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "LLL.d34.s0_LLL.d34.s0.p1", "text": "However, the mutant was unable to stimulate transcription by final sigma(A)-RNA polymerase from the Spo0A-dependent spoIIG operon promoter.", "text_with_entity_marker": "However, the mutant was unable to stimulate transcription by final sigma(A)-RNA polymerase from the [E1]Spo0A[/E1]-dependent [E2]spoIIG[/E2] operon promoter.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Spo0A", "entity_1_idx": [[100, 105]], "entity_1_idx_in_text_with_entity_marker": [104, 109], "entity_1_type": "agent", "entity_1_type_id": 0, "entity_2": "spoIIG", "entity_2_idx": [[116, 122]], "entity_2_idx_in_text_with_entity_marker": [129, 135], "entity_2_type": "target", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "LLL.d34.s0_LLL.d34.s0.p2", "text": "However, the mutant was unable to stimulate transcription by final sigma(A)-RNA polymerase from the Spo0A-dependent spoIIG operon promoter.", "text_with_entity_marker": "However, the mutant was unable to stimulate transcription by final [E1]sigma(A)[/E1]-RNA polymerase from the Spo0A-dependent [E2]spoIIG[/E2] operon promoter.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "sigma(A)", "entity_1_idx": [[67, 75]], "entity_1_idx_in_text_with_entity_marker": [71, 79], "entity_1_type": "agent/target", "entity_1_type_id": 2, "entity_2": "spoIIG", "entity_2_idx": [[116, 122]], "entity_2_idx_in_text_with_entity_marker": [129, 135], "entity_2_type": "target", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "LLL.d40.s0_LLL.d40.s0.p0", "text": "Although spo0H is transcriptionally regulated by the key regulatory device that controls sporulation initiation, the Spo0 phosphorelay, there is considerable evidence implicating a mechanism of post-translational control that governs the activity and concentration of sigmaH.", "text_with_entity_marker": "Although [E1]spo0H[/E1] is transcriptionally regulated by the key regulatory device that controls sporulation initiation, the [E2]Spo0[/E2] phosphorelay, there is considerable evidence implicating a mechanism of post-translational control that governs the activity and concentration of sigmaH.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "spo0H", "entity_1_idx": [[9, 14]], "entity_1_idx_in_text_with_entity_marker": [13, 18], "entity_1_type": "target", "entity_1_type_id": 1, "entity_2": "Spo0", "entity_2_idx": [[117, 121]], "entity_2_idx_in_text_with_entity_marker": [130, 134], "entity_2_type": "agent", "entity_2_type_id": 0}], "directed": false, "reverse": false}
